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What in the midst lay but the Tower itself?
The round, squat turret, blind as the fool's heart, 
Built of brown stone, without a counterpart 
In the whole world. The tempest's mocking elf 
Points to the shipman this the unseen shelf 
He strikes on, only when the timbers start.
Not see? because of night perhaps? - why, day 
Came back again for that', before it left,
The dying sunset kindled through a cleft:
The hills, like giants at a hunting, lay.
Chin upon hand, to see the game at bay,-
"Now stab and end the creature - to the heft: "
Not hear? when noise was everywhere! it tolled 
Increasing like a bell. Names in my ears 
Of all the lost adventurers my peers, - 
How such a one was strong, and such was bold,
And such was fortunate, yet each of old
Lost, lost', one moment knelled the woe of years.
There they stood, ranged along the hillsides, met 
To view the last of me, a living frame 
For one more picture! in a sheet of flame 
I saw them and I knew them all. And yet 
Dauntless the slug-horn to my lips I set,
And blew.
'Childe Roland to the Dark Tower came'.
Ts'ui gathering together
Sui following Chien development
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SUMMARY
The interactions of derivatives of lipoic acid and unsaturated 
fatty acids with the mitochondrial energy coupling system was 
investigated. Derivatives of dihydrolipoic acid, oleoyl-S-lipoate and 
oleoyl phosphate were observed to stimulate ATP synthesis in a number of 
ATPase preparations derived from bovine heart and other mitochondria.
This synthesis was sensitive to various inhibitors of oxidative 
phosphorylation such as oligomycin, efrapeptin, triorganotin halides 
and uncoupling agents.
A derivative of dihydrolipoic acid also stimulated an energy-linked 
transhydrogenase reaction in bovine heart SMP. This reaction has 
features in common with both ATP and respiration-driven transhydrogenase.
All these reactions were observed at a low frequency. The reasons 
for this were investigated as were the precise natures of the compounds 
stimulating ATP synthesis. No clear answers were obtained to either 
question, although suggestions were made.
The role of ubiquinone in energy coupling was also investigated, 
using solvent extraction studies and a low molecular weight homologue 
of ubiquinone, ubiquinone 3. These studies suggest that ubiquinone 
may have a role in energy coupling reactions other than that expected 
from its well-know role as a respiratory chain redox carrier, possibly 
in the control of various ATPase-linked reactions, e.g. ATP synthesis, 
ATP—Pi exchange, ATP-driven transhydrogenase.
X V
The results presented here describing 'dihydrolipoate' 
driven ATP synthesis (tables 3.1-3.19 & fig.3.2) and oleoyl 
phosphate driven ATP synthesis and ATP-Pi exchange ( tables 
5.3-5.10 & figs.5.1-5.7 ) were most of those obtained showing 
these reactions over a two year period and represent 'v 1% of the 
total number of attempts to demonstrate them (see pp 88-89,212-213).
The remaining results presented in this thesis are 
usually representative of 2-6 experiments performed in duplicate.
1CHAPTER 1
COMPONENTS OF THE RESPIRATORY CHAIN
The major source of energy used for metabolic processes in cells 
comes from the oxidation of low molecular weight carbon compounds by the 
enzymes of the tricarboxylic acid cycle (TCA) cycle). The final steps 
of this oxidative process are the transport of reducing equivalents 
(electrons & hydrocr^n / via a series of carriers leading to the 
reduction of molecular oxygen to water. This releases large amounts 
of free energy which can be used to condense phosphate (Pi) into 
adenosine triphosphate (ATP) This energy is released upon hydrolysis 
of ATP to adenosine diphosphate (ADP) . ATP thus becomes the energy 
currency of the cell. This oxidative process has been termed 
'oxidative phosphorylation'. A full historical survey of the origins of 
the study of oxidative phosphorylation is not within the scope of this 
introduction; however, some outline of the early work involved in the 
recognition and elucidation of this phenomenon is required to understand 
recent work in the area. For further reviews see (21-26).
The study of respiration and oxidative phosphorylation perhaps 
began in 1913 when Warburg found that respiration was associated with 
insoluble granular elements of cellular structure that could be 
recovered by filtration of tissue dispersions (1) . These insoluble 
elements were later termed mitochondria. The major part of the ground­
work prerequisite to the study of oxidative phosphorylation was carried 
out in the 1930's. The recognition that oxidation and phosphorylation 
might be linked in some way was made by Engelhardt in 1930, who showed 
that the esterification of Pi by lysed erythrocytes occurred during 
respiration (2,3). Lohmann had, in 1931, discovered ATP in muscle, but 
thought it peculiar to this tissue (4). Its real significance was not 
realised until 1937-8 when Warburg and Meyerhof showed that ATP formation
2was linked to the oxidation of glyceraldehyde-3-phosphate and phospho- 
pyruvate. Hans Krebs, working on previous suggestions and observations 
of Szent-Gyorgyi and Martius and Knoop proposed that pyruvate could be 
oxidised to 3 molecules of CC> 2 by a cycle of reactions, later known as the
pyruvate + oxalo- 
acetate
citrate cis- — > iso- > a-ketoglutarate
aconitate citrate 2
malate •<---  fumarate <--  succinate
tricarboxylic acid, citric acid or Krebs cycle.
Lehninger later showed that the TCA cycle was the main pathway for 
the oxidation C 2  units derived from the breakdown of fatty acids by the 
6-oxidation pathway. Bretscher later demonstrated that C., units derived 
from the catabolism of ketone bodies are also oxidised via the cycle.
The TCA cycle then occupies a cardinal position in cellular oxidative 
processes.
In 1937,Kalckar showed an oxygen dependent phosphorylation of 
glucose, glycerol and adenosine monophosphate (AMP) during the oxidation 
of citrate and other substrates in kidney homogenates (5). The oxygen 
dependency of this phosphorylation precluded it occurring by glycolysis. 
He later demonstrated that respiration dependent ATP synthesis could 
take place in cell free tissue preparations (6). Quantitative 
evaluations of the amount of Pi esterified in ATP per oxygen consumed 
(P:0 ratios) were first made by Belitzer and Tsibakowa, working on 
muscle (7) and Ochoa working with cell free brain and heart preparations 
(8-10), who reported P:0 ratios of 2-3:1. They proposed that phosphoryl­
ation occurred not only during the dehydrogenation of substrate 
(substrate level phosphorylation) but also during the transport of 
hydrogen (or electrons) to water. Ochoa recognised that the presence of 
ATPases would interfere with the determination of P:0 ratios: to minimise
3this he used an assay in which the concentration of ATP was kept 
constant by an enzymic regenerating system. With this system, average 
P:0 ratios of 3:1 were obtained for the complete oxidation of pyruvate 
to C02 + H.,0. Further investigation of these reactions required the 
isolation of functional, intact mitochondria.
Early attempts to isolate mitochondria by differential centrifugation 
of tissue homogenates had failed because the mitochondria obtained were 
extensively osmolysed (11) . Intact functional mitochondria were 
eventually obtained by Hogeboom, Schneider and Palade in 1948 (12). This 
led to the demonstration by Friedkin and Lehninger that mitochondrial 
phosphorylation was coupled to the oxidation of reduced nicotinamide 
adenine dinucleotide (NADH) by the respiratory chain (13) . The P:0 
ratios obtained though were low, due to the relative impermeability of 
mitochondria to NADH. Lehninger (14) and Jacob and Sanadi (15) later 
demonstrated that, after treatment of mitochondria with hypotonic salt 
solutions, NADH enters easily and P:0 ratios up to 2.6:1 could be 
obtained. Isolation of mitochondria led to the demonstration that most 
cell fatty acid oxidase activity and TCA cycle activity of rat liver 
tissue was localised in the mitochondria, whereas none of its glycolytic 
activity was (32).
Friedkin and Lehninger also demonstrated that the oxidation of
ascorbate via cytochrome c in rat liver mitochondria led to the 
32esterification of Pi into ATP (13). This was later confirmed by Judah, 
using non-radiolabelled Pi, who obtained P:0 ratios close to 1 (6) .
Maley and Lardy found that adrenalin or 3,4-dihydroxyphenylalanine 
could replace ascorbate (17) . Lehninger (14) and Slater (18) demonstrated 
that chemically reduced external cytochrome c was oxidised by mitochondria 
and that this oxidation was coupled to ATP synthesis in a reaction 
inhibited by a known inhibitor (uncoupler, see Chapter 2 and Appendix A) 
of oxidative phosphorylation 2,4-dinitrophenol (DNP) . PtO ratios of
40.5 - 0.8 were obtained. These studies confirmed that there was a 
phsophorylation 'site' between cytochrome c and oxygen. This site was 
termed site 3. Sites 1 and 2 were also identified. Copenhaver and 
Lardy, using a mitochondria preparation with electron transport blocked 
by the inhibitor antimycin A (see Appendix A), showed that phosphorylation 
driven by NADH could still occur if ferricyanide was used as an electron 
acceptor (19) . P:Fe(CN) 3 ratios of 1 were obtained. The region of 
the respiratory chain between NADH and Fe(CN) 3 was said to containD
'site 1'. Slater obtained P:0 ratios of 1 and 2 with succinate and 
6-hydroxy butyrate (respectively) if cytochrome c was used as an electron 
acceptor. The region succinate -*■ cyt c contains 'site 2'. We can turn 
now from an historical survey to a description of the known structure 
and functions of mitochondria.
Mitochondria (mitochondrion singular) are intracellular organelles 
with a characteristic double membrane structure. The outer membrane is 
separated from the inner by a well defined 'intermembrane space'. The
inner membrane is folded into cristae, dramatically increasing its*
surface area. The number and size of these cristae is dependent on the 
respiratory activity of the tissue containing the mitochondria. In 
tissues of high respiratory activity, e,g■ myocardium, insect flight 
muscle, avian salt gland, the cristae are large and densely packed, 
whereas in liver they are smaller and less densely packed. The inner 
matrix space, that bounded by the inner membrane, varies in volume with 
its ionic content, and as a result the inner membrane occurs in various 
configurations. These have been described as 'orthodox', 'condensed', 
'energised' and 'energy twisted', but these terms are only generalisations 
of types. Cristae can and do adopt a bewildering array of shapes, 
ranging from simple fingerlike projections to complex paracrystalline 
arrays that appear to occupy the whole matrix space. Attempts have been 
made to relate changes in cristal structure to mitochondrial respiratory
5states. This has led to certain proposals about the nature of energy 
coupling in mitochondria (27-29) (see Chapter 2).
The number and morphology of mitochondria in each cell is highly 
variable. Yeast cells appear to contain about lO mitochondria, mammalian 
cells, several hundred, while the giantamoeba. Chaos chaos, contains 
500,000. These mitochondria appear in electron micrographs to vary 
somewhat in shape and size but they are roughly cylindrical with axes 
of 1.5 vim and 0.5 vim and volumes of ^ 0.8 vim^ . Isolated preparations 
of mitochondria certainly have these dimensions but these appear different 
to mitochondria observed in situ. Using phase contrast light microscopy, 
Shelton has observed mitochondria in cultured fibroblasts and noticed 
that over a few hours they adopt an array of shapes. Mitochondria would 
appear to rutpure and reform into circles, V and Y shapes and many other 
filamentous forms (30). Many similar observations on other tissues have 
been made (24) . This suggests that in vitro mitochondria do not possess 
this fixed cylindrical morphology.
Recent work by Skulachev and co-workers (33) and Davison and Garland 
(34) has gone some way to reconcile the electron and light microscopical 
views of mitochondrial shape. They have denonstrated by serial 
sectioning of tissues that apparently isolated mitochondria form weaving 
interlinked reticula through the cells. The more metabolically active 
the cells, the more complex the reticulum. These heart cells contain 
not several hundred mitochondria but a few (possibly one) giant reticulate 
mitochondria. It is salutory to reflect,then,that most work on mito­
chondria has been done on severely disrupted systems. Certain authors 
have suggested that this complex structure might impose restrictions on 
the mechanisms of energy conservation in such systems (98) .
The inner and outer mitochondrial membranes are quite distinct 
structurally and functionally, the former being the most complex and 
metabolically active. The outer membrane is usually isolated from the
6inner by its rupture, followed by differential centrifugation. Parsons 
et al. (36,24) used a method which involved large amplitude mito­
chondrial swelling in a phosphate, bovine serum albumin buffer system.
This gave an outermembrane preparation selectively enriched in cyto­
chrome b,.. This was later shown to be not due to contamination by 
smooth endoplasmic reticulum (er) »which also contains b^,as the b,. species 
are electrophoretically distinct (38). Sotocasa et al. isolated outer 
membrane from mitochondria subjected to shrinking swelling cycles 
followed by sonication. This membrane fraction contained 90% of the 
mitochondrial rotenone insensitive NADH-cyt c oxidase activity (39). 
Schnaitman et. al. concluded that monoamine oxidase and kynurenine 
hydroxylase were also concentrated in the outer membrane (40). Mono­
amine oxidase activity is frequently used as a marker for the outer 
membrane.
The outer membrane is freely permeable to water, low molecular 
weight solutes (e ,g. sucrose) ions and also some compounds of 
considerably higher M.W. such as ferritin and various dextrans.
Electron microscopy has revealed that the outer membrane is
studded with spherical substructures (41) ; projections from the membrane
have not been generally observed (42) , cf. inner membrane, but see (43) .
Its general structure appears to be rather similar to that of smooth er
and there have been suggestions that the two are contiguous in^  vivo.
Parsons has reported that the outer membrane contains hollow cylinders 
o o60 A tall and 60 A wide in a regular array with centre to centre 
o
spacing of 80 A (44) , but this may be due to artefacts produced by the 
specific staining techniqe used,as other workers have not observed this 
structure.
The inner membrane is very different to the outer, not only in the 
range and type of enzymic functions contained within it but in its 
protein lipid ratio (3—4 1 1 in bovine heart compnrod to 1 1 3 for outer
7membrane and smooth er from the same tissue). Mitochondria from other 
tissues, e,g. liver, have lower ratios but still higher than those of 
the outer membrane and smooth er.
Much presumptive evidence had accumulated in the 1940's, supporting 
the idea that the enzymes of the respiratory chain were contained only 
in the inner membrane (45-47). It was not till 1963, however, that 
definitive work by Klingenberg (24) and Vogel (24) established this.
The inner membrane is now known to contain many of the enzymes of 
the TCA cycle; the enzymes of the respiratory chain, the ATP synthase 
and related activities; specific transport systems for ions and 
metabolites, e.g.Na+, K+, dicarboxylic acids, phosphate, adenine nucleo­
tides, and protons. The inner membrane is highly impermeable
to most of these compounds, and these specific transport systems allow 
the vectorial transport of them to take place.
The enzymes on or in the inner membrane have been classified into 
three types (24) These are (a) those dissociable only by surfactants. 
These are firmly bound and include cytochrome bc^ complex, succinate 
dehydrogenase, NADH dehydrogenase and parts of the ATPase. (b) Those 
dissociable by sonication. These are considered 'tightly enclosed' and 
include NADPH dehydrogenase, malate,isocitrate,glutamate and lipoate 
dehydrogenase, various transaminases and phosphate transferases and 
parts of the ATPase. (c) Those dissociable ionically in a hypotonic 
solution. These are loosely bound and include 'secondary phosphate 
transferases', adenylate kinase, creatine kinase, an ATP-ADP 
exchangease and cytochrome c: many of the enzymes in this group may 
be of matrix space origin.
Proteins are distributed asymmetrically across the inner membrane 
this distribution is considered important to various theories of 
energy conservation. This is dealt with in Chapter 2.
The inner membrane is usually isolated as submitochondrial particles
8(SMP) or electron transport particles (ETP) from sonicated mitochondria 
or as mitoplasts made by stripping away the outer membrane with 
digitonin.
Fig. 1. 1 Mitochondria, submitochondrial particles and mitoplasts
Sonication shears off the 
outer membrane and disrupts 
the inner which reseals into 
smaller vesicles,mainly with 
an inside-out morphology.
Digitonin disrupts the outer 
membrane which can be removed 
from the largely intact inner 
by differential centrifugation 
leaving vesicles of right side 
out morphology.____________
These various particulate preparations vary somewhat in protein 
constitution, mainly because of the different preparation methods used 
(see (51) for review) .
Electron microscopy has not given a clear picture of inner membrane
structure. FernSndez-Moran observed arrays of spherical or polyhedral
particles protruding from the inner membrane (52). These were
occasionally attached to the membrane by a thin stalk. The size of the
osubstructures was variable but was usually v 150 A in diameter. This
owould give cristae a minimum thickness of 300 A. The particles were 
observed in cristal fragments, negatively stained with phosphotungstate.
They were not observable in mitochondria stained in_ situ which appear
to contain spherical substructures embedded in the inner membrane.
Later electron microscopical studies led Fernandez-Moran ctal. to
conclude that cristae were composed of thousands of these substructures,
termed electron transport particles (53-4) . These were composed of
o
three parts (a) spherical or polyhedral headpiece, 80-100 A diameter;
o o
(b) a cylindrical stalk 50 A long, 30-40 A diameter; (c) a base piece, 
o
dimensions 40-110 A. The isolated particle appeared in electron micro-
o
graphs to be a studded prolate ellipsoid of short axis 120 A and long,
o
180 A. Although similar particles have been observed in mitochondria 
from many tissues (24, 44),many workers suggest that they are artefacts 
produced by the staining techniques used for visualisation under 
electron microscopy. Indeed, Fleischer e^ t a)U (55) made microdensito­
meter tracings of cristae from intact mitochondria which gave them a 
o o o
thickness of 48.8 A ± 6.5 A (300 A would be the minimum expected for 
two opposing arrays of electron transport particles). Attempts have 
been made,however, to identify the function of the spherical headpieces. 
Racker e_t A .  found that urea treated bovine heart SMP lost ATPase 
activity and the phosphotungstate visualisable headpiece particles, 
suggesting that they were the seat of ATPase activity (56). Subsequently, 
Kagawa and Racker demonstrated that addition of ATPase to salt 
inactivated SMP led to the restoration of the particles in electron 
micrographs (57) . This view has been challenged by Green, who claimed 
that if urea was removed from urea treated SMP by dialysis, both ATPase 
activity and the particles reappeared without the need for any addition 
of free ATPase.
The structure along cristal membranes is little studied now as 
most structural investigations have been devoted to transmembrane 
protein distributions. The 2D structure is considered to be of prime 
importance to the mechanism of energy transduction by Green in his
10
■paired moving charge' theory (59).
The mitochondrial matrix space possesses a distinct enzyme 
population including some TCA cycle enzymes and accessory systems, 
L-glutamate dehydrogenase, certain transaminases linking carbohydrate 
and protein metabolism to the TCA cycle and the enzymes of the 
8-oxidation sequence for fatty acid breakdown. Hackenbrock has 
calculated that the proteins in the matirx space are in a 56% solution 
(60), that is, they cannot be considered to be in true aqueous solution. 
On the basis of this and electron microscopical studies, Hackenbrock 
has suggested that the matrix protein is organised into an ultra- 
structural reticulate network, continuous with the inner membrane.
Matrix protein may be as much as 67% of the total mitochondrial 
protein (61) .
The intermembrane or intracristal space contains about 7% of mito­
chondrial protein, and possibly most of the mitochondrial adenylate 
kinase activity (61) .
The respiratory chain
This is a series of inner membrane associated redox carriers 
directiy responsible for catalysing the oxidation of various metabolites 
by molecular oxygen. This, however, is not its only function as it is, 
with certain other enzymic groupings (e.g. ATP synthetase, energy 
linked transhydrogenase) responsiHe for thç transduction of free energy 
released by these redox reactions into other forms, notably ATP, ion 
gradients, conformational changes of inner membrane proteins and a high 
energy state of the membrane '■v* (see Chapter 2) .
The respiratory chain is a complex array of proteins, lipids and 
active metallic groupings (see Fig. 1.2 ).
The bovine heart mitochondrial respiratory chain was fractionated 
into four fractional complexes by the pioneering work of Hatefi et al.
(83, 84), viz
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Complex I 
Complex II
NADH ubiquinone reductase: NADH + UQ + H NAD + UQH_
succinate ubiquinone reductase: succinate + UQ -► fumarate +
UQH,
Complex III UQH 2 -cytochrome c reductase: UQ^t 2ferricytochrome c UQ +
2fer rocytochrome c
Complex IV cytochrome (c) oxidase: 2ferrocytochrcme c + 2H+ + ^ 2  -*•
2 f err icytochrome c +H 2 O
The individual complexes will be dealt with in greater detail later in 
this chapter, but it will first be worth considering some of their 
chemical components separately.
The cytochromes
These were first discovered by a Scottish physician, C.A. MacMunn, 
in 1886 who had noticed the widespread distribution of two coloured 
pigments, histohaematin and myohaematin in tissues by hand spectroscopy 
(63-4). As the names suggest, he thought they contained haem. He 
assigned them a respiratory function connected with oxygen transfer.
His work was, though, ignored for 20 years, mainly because of criticism 
by the chemist Hoppe-Seyler. The 'rediscovery' of cytochromes was 
largely due to the work of Keilin. Keilin had noticed the apparently 
universal occurrence of a pigment, which he termed cytochrome, in 
insect tissues (65). This pigment exhibited reversible redox changes 
as part of its function. He later demonstrated that 'cytochrome' 
consisted of three spectroscopically distinct components, a, b, c (67).
He also obtained evidence that cytochrome b was closest to the substrate 
side of the reactions mediated through it, and that there existed an 
entity sensitive to CO, CN~ and that linked cytochromes to oxygen.
He termed this 'cytochrome oxidase' and suggested that it contained 
copper. By 1940, Keilin had shown that cytochrome oxidase was identical 
to or contained cyt a^, that the cytochromes probably acted as a 
linear chain of electron carriers and that the terminal portion of this 
chain consisted of cyt c and cytochrome oxidase (68). Warburg had
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earlier identified a CO sensitive 'Atmungsferment' , later shown to be 
identical with cytochrome oxidase (69).
Detailed analysis of the cytochromes owes much to the work of 
Britton Chance and associates, who developed the techniques of dual 
beam and dual wavelength spectroscopy (70-1). Careful analysis of 
mitochondrial absorption spectra has permitted the detection of inter­
actions between cytochromes, cytochrcmes and copper ions, cytochromes 
and energy transfer inhibitors (73) and 'high' and 'low* energy forms 
of cytochromes (74) .
Mitochondria contain other components having characteristic 
absorption spectra. These include flavoproteins, nonhaem iron proteins, 
ubiquinone and copper ions (75-6).
Other techniques have also proved useful in identifying the redox 
carriers of the respiratory chain. These include electron spin 
resonance spectroscopy, particularly useful in the study of Fe-S 
centres and also cytochromes, copper ions and flavoproteins (80) .
Low temperature esr studies have revealed several 'new' redox active 
Fe-S centres in the respiratory chain (81).
The kinetic characteristics of redox centres possibly involved in 
the chain has been investigated by careful titrations of these with 
oxygen, revealing at least seven redox centres on the oxygen side of 
the antimycin A block (82) .
The cytochrcmes consist of a haan-based prosthetic group linked 
to an apoprotein moiety. The haem centres are the redox active 
electron transferring groups. Most have their haem Fe as a low spin 
hexaco-ordinate complex, two co-ordinate bonds being donated by protein 
cysteine-SH groups adding across the vinyl groups of the haem.
The mammalian respiratory chain contains three main types 
of cytochrome, b, c and a.
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The b group of cytochromes are characterised by relatively low 
potentials, suitable for their roles as substrate,and dehydrogenase 
proximal components of the electron transfer chain. The haems are hexa- 
co-ordinated and will not react with o2,co or CN • Most authors agree 
that there are at least 3 b type cytochromes in the respiratory chain, 
one in complex II and two in complex III (77-9).
The c type cytochromes are generally central electron carriers 
lying between the b type cytochromes and the terminal oxidases in redox 
potential. Mammalian respiratory chains usually contain two,c^ and c. 
One, c, is usually freely diffusible in the membrane and is easily 
extractable. The other is more firmly embedded in the matrix of the 
membrane. Yeast mitochondria possess two cyt c species (as well as c^) , 
iso-1 (major) and iso-2 (minor) , whose proteins differ in 22 amino 
acids.
The a type cytochromes are involved in the terminal oxidase of 
the respiratory chain. Mammalian systems have two, a and a^. The 
differences between these are unclear. Cytochrome a^ has a penta-co- 
ordinated haem, as one ligand is required to react with oxygen.
Cyanide, , H.,S and CO can also react with this.
Iron sulphur centres (nonhaem iron centres)
Submitochondrial particles contain ^ 8 x more nonhaem iron than 
haem (cytochrome) iron (24). Most of this iron is associated with 
labile sulphur atoms. These nonhaem irons are now known as iron- 
sulphur centres (Fe-S centres) and can be defined as protein prosthetic 
groups having 2-4 Fe atoms ccmplexed with 2-4 atoms of inorganic 
sulphur and 2-4 sulphur atoms from cysteine. These iron sulphur 
proteins often contain more than one Fe-S centre. These can occupy a 
wide range of redox potentials. Each centre can take up 1 e and will 
then exhibit electron spin resonance. Esr spectroscopy has been the 
major research tool used to elucidate the function of these components 
in the respiratory chain.
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The respiratory chain contains at least 9 Fe-S centres most 
associated with the early steps of NADH and succinate oxidation (81).
Complex I contains 4 well defined Fe-S centres, 1, 2, 3 and 4 
(86-7) . All appear to be kinetically competent to participate in 
electron transport between NADH and ubiquinone. Centre 1 has been 
split into two components, a and b (81) .
Fe-S centre 1 2  3 4
Em value, component a -38O±20mV -20±20mV -24O±20mV -410±20mV
component b -240±20mV
The redox potentials for centres 2 and 3 reported by Onishi (81) (see 
above) have been disputed by Beinert and co-workers (87). The kinetic 
sequence of reduction by NADH appears to be 1, then 3 and 4, then 2.
Three Fe-S centres have been identified as being associated with 
succinate dehydrogenase, S-l, S-2, S-3, of redox potential 0, -400 mV,
+ 60 mV (± lO mV) respectively (88-9). S-l and S-3 have been 
kinetically implicated in electron transport between succinate and UQ; 
the function of S-2 (not reduced by succinate) is unknown.
Complex III appears to contain one Fe-S centre associated with a 
26,000 M.W. protein of redox potential + 220 mV. It is not clear 
whether it is an obligatory electron carrier but recent reports suggest 
that it is (90) .
Two new Fe-S flavoproteins have been identified by Ruzicka and 
Beinert (ISO) and by Hatefi and coworkers (84) . The former has been 
implicated in electron transport processes between the 8-oxidation of 
fatty acids and the respiratory chain, and may be identical to the 
centre-S described by Onishi (91). The latter, which copurifies with 
complex V ATPase has, as yet, no described function and may be identical 
with the former preparation; both appear to contain FAD as prosthetic 
groups.
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Flavoproteins
The respiratory chain contains other well defined flavoproteins, 
notably those associated with the NADH and succinate dehydrogenases 
(see sections on complexes I and II) .
Lipids
Although mitochondria generally have lower lipid:protein ratios 
than other cellular membrane assemblies, lipids still play an essential 
role in their structure and function. Indeed, one (ubiquinone) is an 
essential redox component of the respiratory chain. Mitochondria from 
different tissues have broadly similar lipid compositions. Liver 
mitochondria are 21-30% lipid dry weight, 90% of which is phospholipid. 
Heart mitochondria are similar, pig being 28% lipid, 91% of which is 
phospholipid (93); ox being 't 26% lipid, 88% of which is phospholipid 
(94) .
The lipid composition of inner and outer membranes differs widely, 
particularly in terms of ubiquinone (entirely localised in the inner 
membrane) and phospholipid content.
Table 1.1 Phospholipid composition of inner and outer mitochondrial 
membranes
phospholipid mitochondria inner
membrane
outer
membrane
microsomes
% phospholipid
(wt. of total dry wt.) 14.4 21.4 45.1 28.0
cardiolipin 22.5 21.5 3.2 0.5
phosphatidyl inositol 7.0 4.2 13.5 13.4
phosphatidyl serine ND ND ND 4.5
phosphatidyl ethanolamine 28.4 27.7 25.3 18.3
phosphatidyl choline 40.0 44.5 55.2 62.8
unidentified 2.3 2.2 2.5 1.1
Data modified after (92) .
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The similarity in composition between outer membrane and micro- 
somes has led to the suggestion that the former may have a microsomal 
origin (92) ; indeed, continuity between them has been observed in gold­
fish brain mitochondria (9 2 ) .
Phospholipids
Lecithin is the predominant mitochondrial phospholipid, comprising 
up to 40% of total phospholipid. Heart and liver lecithin contain 
large amounts of lecithin plasmalogen; its function is unknown.
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Phosphatidyl serine and ethanolamine comprise 30% of mitochondrial 
phospholipid; much of this may be in the plasmalogen form (95).
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Mitochondria contain an unique phospholipid, cardiolipin, 
which can comprise as much as 20% of mitochondrial phospholipid; it is 
almost entirely localised in the inner membrane.
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Cardiolipin. RR’R"R"' are fatty acyl groups, 
The other major mitochondrial phospholipid
usually unsaturated, 
is phosphatidyl
inositol. It is mainly found in the outer membrane, and can canpose 
as much as 15% of mitochondrial phospholipid (99) .
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Mitochondrial phospholipids are rich in unsaturated fatty acids, 
particularly oleic, linoleic, arachidonic and docosahexaenoic. At 
least 55-65% of all mitochondrial fatty acids contain one double bond, 
while as much as 40-50% contain 2 or more.
Research has clearly demonstrated that phospholipids are essential 
to many mitochondrial functions.
The particulate succinate dehydrogenase isolated by Zeigler and 
Doeg (101) contains 20% w/w phospholipid which is not required if UQ 2 
is used as electron acceptor, but is if UQ lO is used. This is 
probably due to the insolubility of UQ lO in aqueous systems. Acetone 
extraction will remove 85% of this phospholipid leading to an 
inactivation of the enzyme (102). Phospholipids will restore activity. 
Phosphatidyl inositol, phosphatidyl ethanolamine, cardiolipin and 
Tween 80 (a nonionic detergent) restore 'v 50% activity, while lecithin 
restores only 25% (103) . The residual activity of succinate 
dehydrogenase after acetone extraction is not inhibited by theonyltri- 
fluoroacetone (TTFA), an inhibitor of the native enzyme. Readdition 
of phospholipids restored sensitivity to TTFA.
A phospholipid requirement for NADH dehydrogenase activity was 
first demonstrated by Fleischer et al. (104) who found that phospho­
lipase A treatment inhibited NADH-UQ reductase activity. This activity 
could be restored by phospholipids. These results were extended by 
Machinist and Singer who showed that most bovine heart SMP NADH-UQ 
reductase activity could be removed by short incubations with low 
levels of phospholipase A (105) . This inactivation could be reversed
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by phospholipids (except cardiolipin cf.to succinate dehydrogenase). 
Prolonged phospholipase A treatment led to an irreversible inactivation 
of the dehydrogenase and its solubilisation from the membrane. This 
has led to the suggestion that phospholipid is important in the 
attachment of the dehydrogenase to the rest of the respiratory chain. 
Awasthi e_t al. have shown it to be necessary to hydrolyse cardiolipin 
to release the dehydrogenase.
Preparations of cytochrome oxidase consist of 10-33% phospholipid 
(w/w). Cardiolipin seems to be concentrated in cytochrome oxidase, 
especially in the 'tightly bound' lipid fraction, of which it may be 
■v 70% w/w. Greenlees and Wainio demonstrated that phospholipids 
would restore activity to deoxycholate delipidated cytochrome oxidase 
preparations; phosphatidyl serine was the most effective (107).
Acetone extraction also inactivates the enzyme; phospholipid restores 
the activity. Both lysolecithin (108) and phosphatidyl ethanolamine 
(102) have been reported to be the most effective in restoring 
activity. Phospholipase A treatment seems to have varying effects on 
cytochrome oxidase activity, depending on the source of the enzyme, 
inhibiting that of a rat brain homogenate (109) while having no effect 
on rat liver mitochondrial activity (110). Cytochrome oxidase has 
been prepared depleted in phospholipids, notably by the methods of 
Tzagoloff and MacLennan (111) and Crane and Sun (92). Both preparations 
have low activity in the absence of phospholipids which restore it on 
readdition with little specificity for phospholipid. These methods 
do not remove the 'tightly bound' cardiolipin, removal of which 
completely inactivates the enzyme. Maximal activity is only restored 
to the oxidase if it and phospholipid are mixed in high concentration, 
suggesting particle-particle interaction is required for maximal 
activity. Similar observations have been reported for complexes I, II 
and III (92) . Phospholipid appears to be required for the interaction
20
between oxidase and cyt c. Morrison et al. have suggested that the 
true substrate for the enzyme is not cyt c but a phospholipid-cyt c 
complex (113) .
Energy linked processes and phospholipids
It is not known if phospholipids play any direct role in energy 
conservation but there are indications that the ATPase requires phospho­
lipids for maximal activity (116). The P:0 ratio in ageing rat liver 
mitochondria decreases with the breakdown of membrane phospholipids, 
probably due to the uncoupling effect of the free fatty acids released 
by this breakdown (114-5) . Vignais at a l . have reported that 
phosphatidyl inositol was specifically associated with a KC1 soluble 
protein factor required for the ATP-driven contraction of aged rat 
liver mitochondria (117). The requirement for phospholipid was 
absolutely specific for cofactor-like levels of phosphatidyl inositol. 
Neutral lipids
The bulk of the remaining mitochondrial lipid is loosely classified 
as neutral lipid and consists mainly of neutral fats, triglycerides, 
ubiquinone, cholesterol and lbwer amounts of tocopherol and ubichromenal. 
These comprise about 10% of total mitochondrial lipids.
Cholesterol
Cholesterol is a well known membrane component; although its 
function is not clear it has been suggested that it acts to stabilise 
phospholipid bilayers (loo) . This requires equimolar amounts of phospho­
lipid and cholesterol, however, so it is unlikely to be its role in 
mitochondria. It does not appear to be required for electron transport. 
Digitonin fragmentation of mitochondria is considered to be due to its 
affinity for cholesterol (118). Cholesterol is found in higher 
concentration in the outer rather than the inner membrane (hence
digitonins action) .
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Ubiquinone
The ubiquinones are a series of ?( 3-dimethoxy-5-methyl-6-isoprenyl 
benzoquinones that can undergo redox reactions. They are essential 
members of the respiratory chain and lie either between the dehydrogenases 
and the b type cytochromes or between cyt b and cyt c^ (79, 120, 121) .
A more detailed description of the ubiquinones and their function can be 
found in the introduction to Chapter 7.
Ubichromenal
This is a cyclised derivative of UQ lO, consistently found in small 
amounts in mitochondria (12 5) . It does not appear to have any role in 
electron transport or energy coupling and is probably merely a breakdown 
product of ubiquinone.
OH
Vitamin K, menaquinone
There is conflicting evidence as to whether mitochondria contain 
vitamin K. Bioassays have given both a positive (126) (60 umoles K/mg
mitochondria protein) and a negative response (127) .
It may be involved in electron transport in mammalian NADH oxidase 
systems as it is in many bacterial ones (128) . In bacterial systems, 
u.v. light destroys vitamin K and therefore NADH oxidase activity. 
Similar effects are obtained in mammalian NADH oxidases. Solvent
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extraction does not generally lead to a requirement for vitamin K 
in these systems; such a requirement has been reported after a series 
of ether extractions, however (92). A role for K in phosphate 
transfer has been proposed, based on studies of K deficient chicks 
which display low phosphorylation efficiencies (130). This work has 
been challenged, however, and the roles, if any, of vitamin K in 
electron transport and energy transfer remain obscure (131). 
Nenniquinone
This is a benzoquinone found in mitochondria. Its structure is 
unclear. It is more polar than ubiquinone and present to 5-10% of 
the amount of ubiquinone (132) . It may be a modified ubiquinone.
The tocopherols
Four roles for these in mitochondria have been proposed: (a) as 
an antioxidant, a well known general, membrane role of tocopherols;
(b) as a component of NADH oxidase (133); (c) as a cofactor for 
oxidative phosphorylation (134); (d) as a specific stabilising agent 
for a-ketoglutarate dehydrogenase (135).
Tocopherol's role as an antioxidant in mitochondria is open to 
some doubt as ubiquinol is present in much higher concentration and is 
better at preventing lipid peroxidation. Nason and Lehman reported 
that tocopherol restored NADH-cyt c reductase activity to isooctane 
extracted mitochondria (133). This was probably due to a general 
'lipid activation' effect. They later reported a specific tocopherol 
requirement for NADH dehydrogenase activity in an NADH dehydrogenase 
preparation obtained from digitonin treated mitochondria (136). A 
redox function is.unlikely, though, as tocopherol undergoes no redox 
or concentration changes in heavily aerated mitochondria.
Slater et al^  suggested a tocopheryl quinol phosphate could act 
as a cofactor for oxidative phosphorylation. Phosphate transfer from 
this to ADP was observed in vitro but not in vivo, however (134).
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Schwarz attributed the loss of respiratory activity in tissue 
slices frcm tocopherol deficient chicks to a decline of a-ketoglutarate 
dehydrogenase activity (135). This is probably due to a lack of 
protection from oxidation of the enzyme.
Lipid R283
This is a mitochondrial neutral lipid of similar chromatographic 
but not chemical properties to the tocopherols. It may be a precursor 
of ubiquinone. It is present at low levels and is unlikely to be an 
electron carrier.
Carotenoids
These are present in mammalian mitochondria. They derive entirely 
from the diet. This presence may not be due to a mere portioning of 
lipids as mitochondrial lipid levels do not generally mirror dietary 
lipid levels (137) . Their function, if any, is unknown.
Triglycerides
Free triglycerides are present at very low levels in mitochondria. 
Little is known about their functions.
The respiratory chain complexes
The respiratory chain has been fractionated into four complexes. 
These have been extensively investigated following their preliminary 
isolation by Hatefi et^  al. (83-4) .
Complex I; NADH-ubiquinone reductase
Complex I is a large lipoprotein enzyme complex, first extracted 
from bovine heart mitochondria by Hatefi, Haavick and Griffiths (138-9). 
It has the following properties:-
(a) it catalyses, a rapid rotenone sensitive reduction of UQ 1 by NADH,
(b) it catalyses a rapid NADH-ferricyanide oxidoreductase activity 
but reacts slowly with other e” acceptors,
(c) NADH induces multiple esr signals in complex I of similar line 
shape and E' values to those in SMP's,
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(d) other types of NADI1 hydrogenase can be prepared from complex I,
(e) it reconstitutes NADH oxidase with complex III, IV and cytochrome c,
(f) energisation and ATP synthesis can be coupled to NADH-UQ 1 
oxidase activity when complex I is reconstituted with the ATP 
synthase in phospholipid vesicles.
There have been other preparations of complex I-like enzymes, 
notably the types I and II NADH dehydrogenases, but they do not share 
all its properties (143).
Type I (high M.W.) soluble NADH hydrogenases
These were first prepared by Ringler et al^ . (140) and by Huang and 
Pharo (141). They appear similar to complex I but lack phospholipid 
and ro tenone sensitive UQ 1 reductase activity. It has been thought 
that they only differ from complex I in their phospholipid content, 
though this may not be so. Hare and Crane have provided evidence that 
type I dehydrogenases differ frcm complex I in that they lack a 16,000 
M.W. Fe-S protein (142).
Type II (low M.W.) soluble NADH dehydrogenases
Degradation of the type I dehydrogenases by heat, acid and ethanol, 
proteolytic enzymes, urea and other chaotropes causes the loss of their 
original activities and the appearance of new ones, notably a rotenone 
insensitive NADH-UQ 1 oxidoreductase (143). Their properties have 
been extensively reviewed (145-7).
The reduction of UQ 1 by NADH in complex I exhibits a phospholipid 
dependence. SMP's lose this activity after brief exposure to phospho­
lipase A. Activity can be restored by addition of phospholipid. More 
prolonged exposure leads to an irreversible inactivation. Lipid 
extraction of complex I has to be carried out under anaerobic reducing 
conditions if reconstitution of rotenone sensitive electron transport 
activity by addition of phospholipids is required. Both lecithin and 
cardiolipin will restore activity Bingly but both are needed to restore 
it to in vivo rates (148) .
Rotenone is generally thought to inhibit electron transport through 
complex X at about a 1:1 molar level with the enzyme (based on FMN 
content) (139). There have been reports, though, that there may be 2 
rotenone bindinj sites per NADH dehydrogenase in bovine heart SMP (149) . 
Prosthetic groups of complex I
There is one, flavin mononucleotide (FMN) . FAD has also been 
reported present but this has been shown to be due to contamination by 
an Fe containing flavoprotein associated with 6-oxidation pathways in 
mitochondria (150). FMN does not appear to be covalently bound to the 
complex and can indeed by partially removed without any effect on NADH- 
ferricyanide oxidoreductase activity (151) . There is no firm evidence 
that it is involved in complex I's activities at all. There appear to 
be 1 - 1.2 FMN/mole complex I (143) .
Fe-S centres
Complex I and the type I dehydrogenases contain several Fe-S 
groups. Most workers agree on four containing 4 Fe each (87, 139, 151, 
140, 153, 141). Recent work by Onishi and coworkers suggests that 
there may be as many as 7 Fe-S centres per complex I (152) .
SH groups
Complex I contains several SH groups. These have been classified 
by Gutmann et aJL. into five distinct groups on the basis of the 
preparation used (complex I, type I and II dehydrogenase, SMP) and their 
sensitivity to p-chloromercuribenzoic acid (154) . It is not clear 
whether they play any direct role in electron transport. Complex I 
NADH-UQ 1 reductase activity is 90% inhibited by 6 pM p-chloromercui- 
benzoate. Its NADH-ferricyanide oxidoreductase is unaffected by 
concentrations as high as 200 pM (155) .
Ubiquinone
Complex I contains 4.2 - 4.5 nmoles UQ/mg protein. Recent work has 
suggested that complex I may contain a specific ubiquinone binding 
protein (124) (see introduction to Chapter 7) .
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Molecular weight and subunit composition
Estimations of molecular weight vary; most values are in the region 
of 670,000-800,000. This variation is probably due to differing amounts 
of bound lipid in different complex I preparations and possibly also 
due to minor differences in subunit structure.
Table 1.2 Subunit composition of complex I
Hare and Crane Ragan 
preparation (156) preparation (157)
Stoicheiometry'
74,000 75,000 0.95 ± 0.04
53,000 53,000 2.24 ± 0.04
42.000
37.000
42.000 j
39.000
2.12 ± 0.15
33,000 0.90 ± 0.05
29,000 0.91 ± 0.03
26,000 1.0
27,000 25,000
23,500
23,000 22,000
20,500
19,000 18,000
16,000 15,500
8,000
5,000
mol per 850,000 g (M.W. based on FMN content)
Gel profiles very similar, but Hare and Crane did not assign M.W. to 
all peak shoulders.
Complex I and energy conservation
Complex I contains an energy coupling site, site I. The mechanism 
of energy coupling in general is unclear (see Chapter 2) . Phospholipid 
vesicles that contain complex I as the sole protein component 
accumulate protons during NADH-UQ 1 reductase activity in a manner 
sensitive to rotenone and uncouplers. The H/2e ratio for this is 
1.4:1 (150) . These vesicles, which have 'v* 85% of their complex I in 
a SMP-like configuration, also catalyse the uptake of the lipophilic
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anion, tetraphenyl boron, further suppotting the idea that their insides 
become more + ve during electron transport. NADH-UQ 1 reductase 
activity in these phospholipid vesicles is greatly stimulated by 
uncouplers or valinomycin + nigericin + K+. These observations have 
given rise to the suggestions that complex I is or contains a proton 
motive redox loop or a proton pump.
Complex I has also been incorporated into vesicles containing the
32ATP synthase enzyme. These vesicles catalyse ATP- Pi exchange,
ATP linked proton uptake and NADH-UQ 1 oxidoreductase linked to ATP 
synthesis (159). This latter reaction was sensitive to rutamycin 
and various uncouplers. This experiment does not unequivocally 
demonstrate the existence of an osmotically linked coupling site in 
complex I as the ATP synthase preparation contained a 'hydrophobic 
protein' preparation that is known to be substantially contaminated 
by other respiratory chain components and activities.
Organisation of complex I in the membrane
Complex I is transmembraneous. This would theoretically allow it 
to act as a Mitchellian proton translocating redox loop (160) or as a 
redox linked proton pump. Present information on the transmembrane 
distribution of redox active centres in complex I makes the former 
possibility unlikely.
Mechanism of electron flow in complex I
Little is known about this. Electron transfer reactions are not 
easy to study because of their rapidity. Onisbi has suggested that esr 
evidence supports the following sequence for electron flow in complex I
( 1 5 2 ) .
FMN
NADH — —  ( (Fe-S)(Fe-S) (Fe-S) (Fe-S) (Fe-S) ) ---- ;-*UQ| la lb 3 4 2
site I rotenone
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Complex II: Succinate-ubiquinone oxidoreductase
Complex II is probably the least studied of the four complexes.
It is the only one that does not contain a coupling site. It catalyses 
the following reaction
succinate + UQ ----- > fumarate + UQH2
The natural electron acceptor is ubiquinone but ferricyanide, phenazine 
methosulphate and 2,6-dichloroindophenol are all used to assay the 
purified enzyme. Succinate dehydrogenase comprises 'v 50% by weight of 
complex II. Complex II contains 4-5 nmoles flavin, 36-38 nmoles nonhaem 
iron, 32-38 ranoles acid labile sulphur and 4.5 - 4.8 nmoles cyt b per mg 
protein and is 20% by weight lipid. It contains no ubiquinone (84).
The flavin, nonhaem Fe and inorganic sulphide are all found in the 
succinate dehydrogenase part of the molecule.
Succinate dehydrogenase
This is a water soluble enzyme of M.W. 97,000 ± 4%. It is 
composed of two subunits,M.W. 70,000 ± 7% and 27,000 ± 5% (84). The 
enzyme contains 1 mole FAD per mole; this is covalently linked to the 
N3 nitrogen of a protein histidine's imidazole ring via the 8 Me group 
of the isoalloxazine ring in FAD. The flavin appears to be entirely 
bound to the 70,000 M.W. subunit.
There cure three Fe-S centres in succinate dehydrogenase. Their 
distribution is unclear but available data suggests one subunit 
contains2 FejSj centres while the other contains one Fe4S4 centre (402, 
406) .
Both membrane bound and soluble succinate dehydrogenase undergo a
reversible (de)activation. Activators include succinate, malonate,
2-fumarate, Pi, S04 , ITP, IDP, formate, FMNHj, various chaotropic anions
such as C104 , I , Br and NO^ . The enzyme is inhibited by thiol 
reagents, oxaloacetate, malonate, fumarate, methylene succinate, maleate, 
HCO^ , glyoxylate, acetoacetate, glycolate and formate. Oxaloacetate
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appears to be involved i.n ¿n vivo regulation of succinate dehydrogenase 
(405) .
Protein components of complex II
Early examinations of the polypeptide components of complex II 
revealed 7 different polypeptides (403, 338). More recent studies, 
however, reveal lO (404).Four of these are major components while the 
other 6 appear to be due to contamination by complex III. The major 
subunits are of 70,000, 24,000, 13,500 and 7,000 M.W. The 70,000 and 
24,000 M.W. subunits contain flavin and Fe-S centres and appear identical 
to the 70,000 and 27,000 components of succinate dehydrogenase (84).
The 2 smaller subunits are very hydrophobic. The 13,500 one is the 
link betwen succinate dehydrogenase and the respiratory chain. The b 
cytochrome of complex II is contained in one of these subunits.
The b cytochrome of complex II
This was first described by Davis et a_l.and was designated j-
It appears to be confined exclusively to complex II. It is not reduced 
by succinate but if reduced by dithionite is rapidly oxidised by 
fumarate and ubiquinone. Its role in electron transfer is unclear (402). 
Complex III: b-c^ complex: ubiquinone-cytochrome c reductase
This complex has been isolated by a number of groups (23, 161-3). 
Much interest has surrounded its purification and properties as it 
contains a coupling site and is much smaller than complex I. It was 
hoped that this would make study of energy coupling in complex III 
easier than in complex I; this has not proved to be the case.
Protein components of complex III
There are four main groups of protein components, the b cytochromes, 
cyt c^,an Fe-S protein and the colourless 'core protein'; the last 
mentioned contains more than one protein (164-6). Cytochromesc (162) 
and b (170 have been isolated in relatively pure form. SDS polyacryl­
amide gel electrophoresis under dissociating conditions reveals 7 or 8
subunits (164) .
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Table 1.3 Polypeptide components of complex III
Band Baum et al. (161) Dasgupta and 
Rieske (162)
Gellerfors and 
Nelson (163)
I core protein core protein I 
(46,000)
core protein 
(50,000)
II
IIA
core protein core protein II 
(43,000)
core protein
(42.000) 
cyt b dimer?
(34.000)
III cyt cx cyt c I 
(29,000)
cyt c 
(29,000)
IV Fe-S protein Fe-S protein 
(25,000)
Fe-S protein 
(25,000)
V cyt cx cyt b 
(15,000)
cyt b 
(14,500)
VI cyt b cyt c 
(14,OOO)
cyt c 
(13,000)
VII no assignment antimycin A core 
protein (11,500)
antimycin A binding 
site (10,000)
VIII unidentified (7,000-8,000) from Rieske (164)
From this table it can be seen that cyt c^ appears to be in two 
bands, M.W. 29,000 and 13-14,000. Baum et al. tried to explain this 
on the basis of a monomer-dimer transition (161). Yu et al., however, 
showed that highly purified cyt c^ had a M.W. of 40,000 and that only 
band III contained haem (168). They suggested that the low M.W.
'cyt c^’ might be bound to the high M.W. molecule by disulphide bridges 
and that it might be a glycoprotein. A similar dimeric structure has 
been suggested for cyt f in chloroplasts (169) . Complex III appears to 
contain 'v 15% phospholipid (w/w) .
Molecular weight and shape of complex III
Minimum M.W. estimates of 250,000 have been made on the basis of 
sedimentation characteristics. Light scanning techniques give 262-288,000 
Complex III appears to be roughly spherical in shape on electron micro­
graphs after both negative staining and freeze fracture techniques have
obeen used. Its diameter is 'v 75-90 A and the molecule appears to
33
o o
contain a cleft 25 A deep and 15 A in diameter. This may be the 
antimycin A or the ubiquinone binding site (164) , but it could just be 
an artefact of electron microscopical visualisation.
The three dimensional structure of the complex has been investigated, 
using a combination of cross-linking studies (233) and surface poly­
peptide labelling with diazobenzene sulphonate (234) ,by Capaldi
et al.
Figure 1. 3 Three dimensional structure of complex III
This structure has certain implications for the mechanism of 
energy transduction in the complex. All the known redox active centres 
lie on the cytosolic side of the membrane (V, (Fe-S) IV and VI (c^)).
(The haem group of cyt b, III, also lies on this side of the membrane) . 
This makes transmembrane electron flow, and thus a strict chemiosmotic 
mechanism of energy transduction in complex III unlikely.
Function of components of complex III
Complex III acts in^  vivo as a single unit but this is best under­
stood or described in terms of complex arrangements of mutually inter­
acting components.
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The b cytochromes
These have been the most studied components of complex III because 
of their multiplicity of forms and their possible relation to energy 
coupling (78) .
Chance originally proposed that there were three distinct forms,
b b562' b566 • He later redesignated as bggg- That
classical b cytochrome, i.e. the one reducible by succinate is bc,_;---- 562
b_^_ and b rrr to one b cytochrome, b_; b_,_ was termed b„ (173-4).558 .566 T 562 K
Other groups have reported that the reducibility of all the b cyto­
chromes increases in the presence of ATP (175-7). It is unclear if 
b558/566 are tW° ^istinct cytochromes or one cytochrome with 2 
a-absorption bands. Present evidence supports the former view (178) . 
Wikstrom has proposed a cyt b stoicheiometry of 1:3:2 (558 : 562 > 566)
(78) whereas Flatmark and Pederson have reported 1:5:5 (177). Weiss 
and Ziganke have reported the isolation of two cytochrcme b species 
distinct in amino acid composition in Neurospora crassa mitochondria 
(164) . Phelps and Crane have reported the spectroscopic resolution of 
four cytochrome b associated peaks at 558, 561-562, 564 and 567 nm.
The apparent multiplicity of cyt b species has led to the suggestion 
that mitochondria contain dual or branched respiratory chains (180).
One containing brrc + bcco contains a functional coupling site in •565 5.5o
complex III; the other, containing b_,_, does not. The proposal has5b2
been criticized, however, and the reported observations supporting the 
hypothesis were probably obtained because the SMP preparation used 
contained a mixed population of coupled and uncoupled particles (78).
The antimycin A binding site in complex III: effects of antlmycln A 
on complex III
(a) °Qh2 “ ferricytochrome c reductase blocked by 1 mol antimycin A/ 
mol Cj^
(b) complex III dissociation into b + cx fragments by chaotropic 
agents inhibited by antimycin A stoicheiometrically
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(c) causes changes in spectral and redox properties of the b cytochromes
The nature of the antimycin A binding site remains obscure. Storey 
has suggested that a b,.g2 /ant:*-mycin A complex analogous to the a^/CO 
complex in CO inhibited cytochrome oxidase is formed (181) . Fluorescence 
quenching analysis of the complex II-antimycin A complex indicated that 
this is unlikely (182) .
Antimycin A can chelate Fe. It was thought that it might therefore 
act at the level of the Fe-S protein of complex III. The idea has now
been discarded as antimycin will inhibit the chaotrope induced
dissociation of complex II, depleted of the Fe-S protein (183). Dasgupta 
and Rieske synthesised a tritiated affinity label for antimycin A, 
deformamido azido antimycin A. This inhibited poorly but bound to an 
11,500 M.W. component in an antimycin A sensitive manner (162).
Fe-S centre of complex III
This was first isolated as a succinylated derivative by Rieske et^  
al. (166) . Esr studies indicate it to be on the oxygen side of the 
antimycin A block. Lee and Slater have suggested that complex III 
contains 2 esr detectable Fe-S centres (184). Analysis of complex III, 
however, reveals only one Fe/molecule. Lee and Slater's results may be 
due to a partially denatured complex III preparation containing native 
and denatured Fe-S centres.
The function of the Fe-S centre is unclear. Its necessity for
electron transport has been questioned (185). Suggestions for its
function have included (a) that it is the anitmycin A binding site
+(see above, however), (b) that it is involved in transmembrane H 
transport (186), (c) that it controls electron flow between cyt b and 
cyt c^ (187), (d) that is has a role in energy coupling (188). Redox
potentiometric measurements make (b) unlikely: (a) can be dismissed on 
evidence previously presented. Suggestion (d) is also unlikely as Fe 
chelators that inhibit energy coupling have no effect on complex III
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Fe-S centre's esr spectra. Recent evidence suggests that it may indeed 
play a role in electron transport or in the control of it between b and 
c (400) .
Mechanism of electron transport in complex III
This is still not understood. There are two main hypotheses, those 
of Rieske (190) and of Wikstrom and Berden (191) . Present evidence 
does not enable us to choose between them. Mitchell has used Wikstrom 
and Berden's scheme as the basis for his 'protonmotive Q cycle' 
hypothesis (34 2) .
Complex IV: cytochrome oxidase, cytochrcme c oxidase
Cytochrome oxidase catalyses the reduction of molecular oxygen to 
water. There have been numerous methods of preparing cytochrome 
oxidase; all depend on disrupting the inner mitochondrial membrane, 
usually with cholate and deoxycholate (75, 107, 192, 194-5, 197). Of 
these early preparations, that giving the highest activity, lowest M.W. 
and least bound lipid was that of Griffiths and Wharton (75). These 
preparations all have a M.W. ^ 200,000 and contain 2 haem residues and 
2 Cu atoms.
Copper in cytochrome oxidase
Keilin originally thought that cytochrcme oxidase was not a haemo- 
protein but a copper containing protein (68) . He later discarded this 
idea when it was shown that the oxidase was a haemoprotein. It was not 
until 25 years later that firm evidence showing that the enzyme 
contained copper was presented by Takemori (196) and Griffiths and 
Wharton (198-9) . There was much debate about whether this copper was 
intrinsic to the enzyme's activity. Yonetani, on the basis of studies 
with bathocuproine sulphonate, a Cu chelator, claimed that it was not 
(200) . Later studies showed that not all the copper was accessible to 
this chelator, however. Esr spectroscopy has proved of great value in 
the study of cytochrome oxidase copper (201-4) . Beinert and Palmer
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demonstrated that Cu in excess of 1:1 with haem Fe in complex IV has a 
different hyperfine esr structure to that of intrinsic (1:1) copper 
(203-4). This excess copper has no relationship to the enzyme's
activity. The role of intrinsic Cu, although now known to be essential 
to activity, is not understood. Only 25% of intrinsic Cu is esr 
detectable. This Cu is easily reduced by ferrocytochrome c and 
reoxidised by 02 in a CN , and CO sensitive manner (205). Sulphydryl
groups may be involved in the binding of intrinsic copper.
Protein components of complex IV
Estimates of the number of subunits in bovine heart cytochrome 
oxidase have varied between 2 ( 222) and 7 (210) . It is likely that 
functional cytochrome oxidase has 7 subunits.
Table 1■4 Polypeptide components of cytochrome oxidase: molecular
component
weight
bovine heart yeast
(206) (207) (208) (209) (210) (211)
I 40 40 37 47.5 40 40
II 25 21 20 21 33
III 19 19 14.5 14.8 23.5
IV 14 15 14 14.5 13.5 14.5
V 10 13 10 13 11.6 13
VI 8 12 11 9.5 12.5
VII 7.6 4.7
Figures refer to M.W. in thousands
Yu and Yu estimated the stoicheiometry of the subunits to be 1 per 
complex. This gives a minimum M.W. of 'v 120,000 for cytochrome oxidase 
(210). Early estimates of 200,000 for complex IV's M.W. are now thought 
to be due to aggregation of the enzyme. Yu and Yu also purified various 
polypeptides from cytochrome oxidase. Component II appears to contain 
'v 40 nmoles Cu/mg protein (stoicheiometry of v 0.8:1) . Cu may be found 
elsewhere in complex IV as not all Cu atoms in it have similar properties 
(212) . Copper may be associated with haem binding subunit (213) . Two
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subunits, X and V, may be involved in haem binding; V contains haem but 
not copper (214) . The subunits are probably linked by cysteine disulphide 
bonds (215-7) .
Electron microscopy of cytochrome oxidase/phospholipid vesicles
o
indicates that the molecule spans the bilayer (long axis 83 A) (222). 
Antibody studies suggest that it is aggregated in the membrane in 
hexamers or octamers of the 120,000 M.W. unit (223) . Hackenbrock has 
demonstrated that the complex is highly mobile in the lateral phase of 
the membrane and that it may be associated with the F^ portion of the 
ATPase as well as cyt c (224).
Nonpenetrant protein labelling reagents indicate that the molecule 
is 'plugged through' the inner membrane (225). Studies by Eytan et al., 
using p-diazonium benzene sulphonate,indicate that subunits II, V and VI 
lie on the cytosol side of the membrane, subunit III lies on the matrix 
side of the membrane and subunits IV and I are buried in the membrane 
(226). A similar position for II had already been suggested by Kornblatt 
et al., based on studies using N-ethyl maleimide (226).
The cytochrome c binding site
The site of interaction , cyt c with the complex, is unclear.
Various methods based on using affinity label derivatives of cyt c have 
given a wide range of answers, i,e. subunit II (228) ; III and others 
(229-30) j VI and VII (231) . Recent work by Seiter et al. suggests that 
cyt c binds to subunit IV (232) . This result seems at odds with the 
transmembrane position of IV suggested by Eytan et al_. (226) . The 
apparent contradiction has yet to be resolved.
Mechanism of action .of cytochrome oxidase
Cytochrome oxidase reduces molecular oxygen to water. The reactions 
are very rapid and thus difficult to study. At least four groupings 
are involved, cyt a, cyt a^ and 2 Cu atoms (copper's role remains
obscure) .
37
Low temperature, 'freeze clench techniques' introduced by Chance 
et al. indicate that the enzyme cycles between a fully oxidised form
2+ 3+„ . a a^ C>2 and the half reduced peroxy form (218) . More recent work
suggests that this peroxy form may be a mixture , 2+ 3+ 2- . of a , a 0_ and
a3+a32+02" (2-9) . The reaction would proceed as outlined below:-
2+ 2+ a a3 reduced
1. Jr°2 3+---  ---- c
2+ 2+ „ a a3 .02 2.
reduced-0_ 
2H+ I
2+ 3+ _ - a a3 .02 3. ▼ 2- h reduced-0o
2H--J I
----c2+
3+ 3+ a a3 4.
Ÿ y
oxidised + 2 
1 «2°
3+ 3+* a a3
1
oxidised*
ATP hydrolysis 
AÎTH
* energised form of the enzyme
This scheme has many features in common with that described by Nicholls 
and Pederson (220). The stabilisation of the enzyme at high 
phosphorylation potentials would limit respiration (221) . Such a 
kinetic component to respiratory control (in addition to equilibrium 
types of control at coupling sites 1 and 2) may be necessary at cytochrome 
oxidase to ensure irreversibility and hence rapid electron flow in the 
respiratory state.
Cytochrome oxidase also contains coupling site 3. This is currently 
the subject of intense controversy and is discussed in Chapter 2.
Adenosine triphosphate (ATP) synthase; ATPase; Complex V
The enzyme responsible for the synthesis of ATP during oxidative 
phosphorylation is the ATP synthase. It is located in the inner 
membrane and protrudes out of it into the matrix space. It is a complex 
multisubunit enzyme of M.W. 450-500,000. It has been termed complex V 
by Hatefi and coworkers (350). It catalyses a number of reactions in 
situ; these include:-
(i) ATP synthesis: ADP + Pi + nH+ ---> ATP + H20
(ii) ATP hydrolysis: ATP + H20 --- > ADP + Pi + nH+
n is pH dependent and is t 0.7 at pH 7.0.
(iii) exchange reactions: these are a series of reactions in which 
atoms from ^0, Pi, ATP and ADP can be exchanged between each other.
The most studied of these are ATP-Pi exchange, ATP-ADP exchange, ATP-H.,0 
and Pi-H20 exchange.
The enzyme appears to be divided into two functionally dissimilar 
parts; the hydrophilic ATPase which protrudes from the inner 
membrane into the matrix space and the Fq portion of the ATPase which is 
highly hydrophobic in nature and is buried in the inner membrane. Both 
the F^ ATPase and F^F^ ATPases have been purified from the inner mito­
chondrial membrane. As well as differing in their subunit structure 
they also have different kinetic and catalytic properties and different 
sensitivities to inhibitors of ATP synthesis and hydrolysis (see Appendix 
A) .
F^ ATPase. - The F^ ATPase can be removed from the inner membrane by a 
number of tecnhiques including sonication (409, 262) and chloroform 
treatment (236). The isolated enzyme displays only ATP hydrolase activity 
and is not sensitive to inhibitors of ATP synthase and ATPase activity 
such as oligomycin, venturicidin and trialkyltin compounds. The FQ sub­
units of the ATPase are necessary for the enzyme to display oligomycin 
sensitivity and ATP-Pi exchange reactions. The released F^ ATPase appears 
to be a spherical molecule in ultracentrifugation (410) and electron 
microscopy experiments (22, 53). The enzyme prepared from bovine heart 
mitochondria has a M;W. in the region of 347-360,000 (411-2). It is a 
complex macrcmolecule containing five subunits termed o, 6, Y, 6» e in 
order Qf decreasing M.W. The stoicheiometry of these subunits in the 
complex is difficult to establish,and methods involving dye staining and 
amino acid frequency have been used (411). These indicate that there are
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around 10 polypeptide Components per molecule. There is no consensus 
on the stoicheiometry of subunit composition of ATPase (see Table 
1. 5 ) and estimates ranging from to a2®2Yl ^ e^? have been
made (409-10) .
Table 1.5 Molecular weight and subunit composition of F^ ATPases 
Subunit ___________________Subunit molecular weight____________________
bovine
heart
yeast rat
liver
chloroplast E. coli B . stearo- 
thermophilii
a 54(3) 58 62(3) 62(2) 56(3) 56(3)
8 50(3) 54 57(3) 57(2) 51(3) 53(3)
Y 33(1) 38.5 36(1) 38(1) 32(1) 32(1)
6 17(1) 31 12(1) 21(1) 20(1) 15.5(1)
e 5.7(1) 12 7.5(1) 14(2) 13.2(1) 11(1)
inhibitor 
protein 'ulo - - - - -
M.W.
range 347-360 . 360-384 3.25 360-390 380
M.W. expressed in thousands
Figures in brackets refer to stoicheiometry of subunit per F^ ATPase
Certain F^ ATPase preparations appear to contain an additional sub­
unit of '»<10,000 M.W. This is the ’ATPase inhibitor protein’ which may 
be responsible for the kinetic control of ATPase activity in^  vivo (414) . 
Kinetics of F^ ATPase.- Estimates of the KmATP of F^ ATPase vary widely 
between 0.2 - 1.25 mM. The KmATP changes if the F^ is bound to the 
membrane. ADP is a competitive inhibitor of F^ ATPase activity. The 
true substrate of the enzyme appears to be a MgATP complex (415) . The 
enzyme will also hydrolyse a number of other nucleotide triphosphates 
including inosine and uridine triphosphate.
Bound nucleotides in F^ ATPase.- Adenine nucleotides bind at a number 
of different sites on the F^ ATPase. There appear to be two ADP binding 
sites per F^ (414). However, Slater has reported that there are 5 moles
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of tightly bound adenine nucleotide in isolated.purified f  ^ (416).
The relationship between the tightly bound adenine nucleotides and the 
two high affinity sites for ADP is not clear. Slater's 5 sites only 
undergo a slow exchange with exogenous adenine nucleotides, whereas the 
two high affinity sites for ADP show a rapid nucleotide exchange.
Results presented by Penefsky and coworkers (411,414) go some way to 
reconciling these two sets of data. They found 3 moles of tightly bound 
adenine nucleotide/F^, ^2 moles ADP, ''-l mole ATP and a little AMP. 
Thqralso found two sites that undergo reversible binding of adenylimido- 
diphosphate AMP-PNP, an ATP analogue.
The presence of five adenine nucleotide binding sites in the 
ATPase raises questions as to their role(s) in ATP synthesis and ATP 
exchange. At least one site appears to be involved in adenine nucleo­
tide induced conformational changes in F^. It is not clear whether all 
5 sites must be occupied for catalytic activity. There is no apparent 
difference in the rate of ATPase catalysed by native F^ and adenine 
nucleotide depleted F^. There is evidence to suggest that some of the 
sites may have a function in the control of the catalytic sites (417). 
F^Fq  ATPases.- These are ATPases that possess the hydrophobic membrane 
bound subunits as well as the hydrophilic F^ ATPase molecule. There 
are a number of preparations of these enzymes from different sources.
The purest are probably those of Tzagoloff from yeast (418), Hatefi et 
al. from bovine heart (350, 244) and Kagawa and coworkers from the 
thermophilic bacterium, PS3 (419). Both the oligomycin sensitive ATPase 
(OSATPase) of Tzagoloff and the complex V ATPase of Hatefi are sensitive 
to the inhibitors aligomycin, venturicidin, trialkyltin halides and 
DCCD. The TFxF0 ATPase of Kagawa is unaffected by oligoraycin, a property 
it shares with most other bacterial ATPases, but it is sensitive to DCCD. 
All of these ATPases are purified from the inner membrane using 
chaotropic detergents such as Triton X-lOO, cholic acid and deoxycholic
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acid and are consequently severely delipidated in their final purified 
form. They all require added phospholipid to express maximum ATPase 
activity.
Purified F,F ATPases contain at least 8 different subunits (419) 1 0
and possibly as many as twelve (244).
Table 1. 6 Composition of ATPases:subunit M.W.
Yeast 'OSATPase* (418) Bovine heart PS3 'TF.F (419)
'Complex V  (244) -----------------
83
68
58 a 53 a 56 a (3)
54 e 50 6 53 6 (3)
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38.5 y 33 Y 32 Y (1)
31 & 31 19 (1)
29 24
22 22.5 15.5 6 (1)
18.5 15 6 13.5 (2)
12 (x 2) e 13 11 e (1)
7.5 8-9 e 5.4 (5)
Total M.W. ^460 M50-480 ^458
M.W. in thousands: Greek letters denote F^ ATPase subunits: 
bracketed figures indicate subunit stoicheiometry
Hatefi and coworkers have recently further purified Complex V to 
give a preparation containing 11 - 12 subunits (420). Most of these
subunits have been tentatively described (see Table 1.7 on next page) . 
ATP-P1 exchange in ATPases.- Perhaps the most important difference
between F^ ATPases and F^FQ ATPases is the ability of the latter to 
catalyze an ATP-Pi exchange reaction. Usually preparations of FjFq 
ATPases require added phospholipid to display the exchange activity.
This has been thought to be because the phospholipid and ATPase combine 
to form protein phospholipid vesicles which allows the ATPase to form a
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potential gradient across the lipid membrane that can be used to drive 
ATP-Pi exchange. This chemiosmotic view has been challenged by Hatefi, 
whose complex V contains very low levels of phospholipid (too low to 
form vesicles) but displays high levels of ATP-Pi exchange (244).
Table 1.7 Identification of subunits of Complex V ATPase
Subunit M.W. 
(in thousands)
Identity
53 a subunit F^ ATPase
50 ß subunit F^ ATPase
33 Y subunit ATPase
30 uncoupler binding protein
23 Fq component; pantotheine binding protein (421)
22 oligomycin sensitivity conferring protein (OSCP)
15 6 subunit F^ ATPase
12 DCCD binding protein
8 coupling factor F^ (422)
11-13 ATPase inhibitor? coupling factor B (387-8)
6 e subunit F^ ATPase
Function of the F_ component of ATP synthase.- The subunits that
compose the membrane sector of the ATPase, FQ, have not been shown to 
catalyse any biochemical reactions so far. They are necessary for the 
expression of oligomycin sensitivity and for ATP-Pi exchange activity.
The Fq  sector is supposed to be the region in which the high energy 
state, ,,v', generated by coupled electron transport is transduced to 
,'vp'. The chemical and conformational hypotheses of oxidative phosphoryl­
ation propose that ,'v»' is a chemical bond or strained membrane state 
that is eventually used to produce •'tp' and ATP. The FQ sector then shoul< 
catalyze a series of reactiois in which ,'v' is transduced to ,'vp'. 
Chemiosmotic theory treats ,'v' as a protonmotive force, Ap, generated
4.1
across the coupling membrane. Here the FQ sector is considered to be 
a proton conducting 'well'» spanning the inner membrane,which feeds 
protons to the active site of the F^ ATPase. Submitochondrial 
particles depleted of F^ ATPase leak protons,apparently through the FQ 
ATPase as oligomycin, which binds in the FQ sector, 'plugs' this 
proton leak (22). Experiments on a purified TF^ fraction from PS3 
bacteria suggest a similar function in which TFq acts as a proton well 
which is 'gated' (controlled) by TF^ ATPase (423). Fuller discussion 
of chemical, chemiosmotic and conformational coupling hypotheses can 
be found in Chapter 2.
Three dimensional structure of F^F^ ATPases. - Although the distribution 
of subunits between the F^ and FQ portions of the ATPase has been 
known for some time (409), little has been known about the 3-dimensional 
arrangement of these subunits. A recent paper by Enns and Criddle has 
gone some way to describing this 3D structure (399). They cross-linked 
the ATPase subunits of a yeast OSATPase preparation with methyl-4- 
mercaptobutyriimidate and then subjected the enzyme to 2-dimensional 
polyacrylamide gel electrophoresis. The results of these are shown in 
Fig. 1.4.
Fig, 1.4 Three dimensional structure of F^Fp ATPase, after (399)
Top view. Side view.
numbers refer to subunit type,see(399)
the position of the other subunits of the ATPase complex 
(notably 3,5,7,8) is as yet undefined
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chemical groupings of the ATPase involved in ATP synthesis or 
hydrolysis. STudies with tetranitromethane indicate that there is at 
least one tyrosine residue essential to ATPase activity per F^ (408). 
Experiments with phenylglycoxal and butanedione indicate that the 
enzyme also contains two essential arginine residues. One of them 
appears to be located in the ATPase and concerned with ATP hydrolysis. 
The other appears to be located at or near the uncoupler binding site 
and involved in ATP-Pi exchange (424). Thiol groups may also be 
essential for ATP-Pi exchange activity as £-chloromercuribenzoate 
inhibits the reaction (244).
F^Fq catalysed ATP synthesis.- Isolated preparations of F^Fq  ATPase 
do not catalyse ATP synthesis. There have been reports though that ATP 
synthesis can be observed when F^Fq  ATPases are reconstituted into lipid 
vesicles with systems capable of forming a proton gradient across the 
vesicles; these include complex I (143) and 'purple membrane' protein 
from Halobacterium halobium (425-6).
Relationship between ATPase, ATP-Pi exchange and ATP synthase activities. 
It has generally been assumed that the ATPase reaction is a mere 
reversal of ATP synthase activity in coupling ATPases and that ATP-Pi 
exchange is a residual reflection of ATP synthase activity. There is a 
growing body of evidence, however, which strongly suggests that this is 
not the case. Inhibition studies with certain inhibitors, e.g. ribose 
ring opened ATP, suggests that the catalytic sites responsible for 
ATPase and ATP-Pi exchange activity are not those directly involved in 
ATP synthesis (427) . Studies with antibodies to chloroplast also 
suggest that different sites are involved in ATP-Pi exchange and ATP 
synthesis (428) .
Coupling factors and F^FQ ATPases.- A number of protein factors from 
the inner membrane have been isolated which 'couple' electron transport
Active ca ta ly tic  groupings in ATPase. -  L ittle  is  known about the
4S
particles (22). These 'coupling factors' include factor F^, factor A,
factor A-X, all of which are the F^ ATPase with or without certain
other ATPase subunits. A number of other coupling factors are known which
have no F. ATPase activity; these include factor B (387) and factor F,1 b
(422). Most of these 'factors' are considered to be subunits of the 
F^Fq ATPase (see (51) for review) .
A full understanding of the molecular mechanisms of ATP synthase 
activity is essential for the understanding of energy coupling in 
general. Hypotheses of energy coupling are dealt with in the next
to energy-linked reactions in a se r ie s  o f depleted submitochondria 1
chapter.
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CHAPTER 2 MECHANISMS OF ENERGY TRANSDUCTION
The mechanism by which redox energy released during the oxidation 
of respiratory chain substrates by the respiratory chain is utilised 
by the ATP synthase to phosphorylate ADP to ATP is unknown. It has 
been the subject of intense controversy for the last thirty years.
Many hypothetical mechanisms have been proposed. These fall mainly into 
three broad categories (a) chemical, (b) conformational and (c) 
chemiosmotic hypothesis. They differ over the nature of the high energy 
state linking the processes of respiration and phosphorylation.
Chemical hypothesis.- This was first proposed by Slater and was based 
on Warburg's mechanism of glycolytic phosphorylation. Slater originally 
proposed that the following series of reactions described oxidative 
phosphorylation (407).
1. AH2 + B + C A ^ C + BH2
2. A ^ C + ADP + Pi ---> A + C + ATP
-> A + C
Reaction 3 describes 'uncoupling'. A and B are adjacent respiratory 
carriers. C is an additional grouping required for their interaction. 
This mechanism was later revised to its present form.
3. A ^ C + H20
(I replaces C in some terminologies)
1. AH2 + B + C --- > A ^ C + BH2
2. A * C + X --- > X 'v- C + A
3. X ^ C + Pi --- > X 'V p + C
4. X 'V P + ADP --- > X + ATP
The nature of X and C is undefined.
The high energy state in this series of reactions 
would be X 'V' C. This would be broken down by uncouplers, thus 
preventing ATP synthesis. This series of reactions would be fully 
reversible (62) . The term 'chemical hypothesis' is also used to
describe a whole series of mechanisms which may or may not follow Slater's
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revised scheme. The common feature of all these mechanisms is that the 
high energy state ("v' or X I) of the mitochondrial inner membrane is 
contained in a single covalent chemical bond (or a series of covalent 
bonds). X and C are usually considered to be small, mobile compounds 
dissolved in the lipid phase of the membrane.
Conformational hypothesis.- A mechanism of oxidative phosphorylation 
analogous to the conversion of chemical into mechanical energy during 
muscle contraction was proposed by Boyer (408). Here Boyer proposed 
that the energised state would be brought about by coupling oxidation 
to a conformational change in a protein. The energised protein would 
probably be a respiratory carrier or an associated structure and the 
conformational change could result from the formation or cleavage of 
a covalent bond. This mechanism is clearly only a modification of the 
chemical hypothesis in which proteins replace both the small discrete 
chemical species X and C. Boyer has now (apparently) abandoned this 
hypothesis in favour of one which involves conformational changes 
occurring through multiple non-covalent bonding at the catalytic site 
of the ATP synthase (31). The experimental basis for this latter
hypothesis rests on Boyer's work on the various exchange reactions
18catalysed by the ATP synthase. O exchange between Pi and water was
32found to be less sensitive to the action of uncouplers than ATP-' Pi 
18or ATP-H_ ‘ O exchange. This led to the suggestion that energy may be 
used to promote release of ATP from the catalytic site (see Fig. 2.1, 
scheme A) (31) . Later evidence amplified this viewpoint but also 
suggested that energy was used to facilitate the binding of Pi and/or 
ADP to the ATP synth.ase prior to the synthesis of ATP ( Scheme B) (37) .
Scheme A (31) Scheme B (37)
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Adenine nucleotides are known to be bound both 'loosely* and 'tightly' 
to F^ ATPase; Boyer has suggested that "v' might only favour the 'tight* 
binding of ADP and Pi, viz.
•ADP
Conformational models have also been proposed for the coupling of 
membrane potential to ATP synthesis or hydrolysis (48).
Fig. 2.1 Scheme for coupling membrane potential to ATP synthesis, after(48
The attractive features of the scheme are that any H+/ATP stoi- 
cheiometry could be accommodated by it, and that ATP synthesis could be 
driven by proton gradient or by a membrane potential. There is as yet, 
however, no firm experimental evidence for such a proposal.
Chemiosmotic hypothesis.- Certain practical considerations led some 
workers to doubt the applicability of the chemical hypothesis, based as 
it was on substrate level phosphorylation, to oxidative phosphorylation.
The hypothetical intermediates X and C or any of their adducts had 
not been isolated, nor was there any clear indication of their nature 
although many hypothesis had been proposed (25). Oxidative phosphoryl­
ation appeared to have an obligatory requirement for an intact membrane 
structure (topologically closed), an observation not theoretically 
implicit in the chemical or conformational hypothesis and not readily 
explainable from their basic formulations. Respiration and phosphoryl­
ations could be uncoupled from each other by a series of compounds, e,g. 
dinitrophenol, dicoumarol, salicylate and azide. These are chemically 
dissimilar and it was difficult to imagine how such a group of compounds 
could all lead to the hydrolysis of X 'v C (their proposed mode of action) . 
These and other considerations led Peter Mitchell to propose his 
•chemiosmotic’ hypothesis in 1961 (49). This stated that phosphorylation 
was linked to electron transport by a protonic electrical potential 
across the inner membrane. This potential would be set up by the action 
of a proton motive respiratory chain which would pump protons out of 
the mitochondrial matrix. This potential could be collapsed through 
an ’anisotropic reversible protonmotive ATPase’ with the concomitant 
synthesis of ATP. The high energy state of the membrane, X t C or " V , 
would not exist as a discrete chemical bond but as a potential difference 
across the membrane. Mitchell proposed that uncouplers had their mode 
of action by collapsing this potential as they all appeared to be weak 
acids or bases dissolvable in the lipid phase of the membrane in both 
their acid or base forms, and oould thus cause a proton ’leak1 through 
the membrane.
The hypothesis was published with no experimental evidence and was 
largely ignored until 1965 when evidence supporting it began to appear (301).
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The formulation of the chemiosmotic hypothesis must be considered as 
one of the great landmarks of biochemistry, not because of its truth or 
otherwise but because it gave a framework within which experimentation 
on oxidative phosphorylation could be carried out. It made certain 
predictions about the nature of energy coupling which could be tested, 
a property sadly lacking from the other hypotheses available at the time, 
which really only suggested an (apparently vain) search for X and C. 
Since 1961 the hypothesis has undergone several modifications (50, 56, 
261, 58, 66). Its latest form,essentially that outlined in
(58, 66),is that which will be discussed here.
The chemiosmotic hypothesis has four fundamental postulates:-
1. The ATP synthase is a membrane located reversible proton-trans­
locating ATPase having characteristic H+/P stoicheiometry.
2. The respiratory chain is a membrane located vectorial metabolic 
proton translocating system, having a characteristic H/2e stoicheio­
metry and having the same polarity of proton translocation across the 
membrane for normal forward redox activity as the ATPase has for ATP 
hydrolysis.
3. There are proton linked (or OH linked) solute porter systems for 
osmotic stabilisation and metabolite transport.
4. Systems 1-3 are plugged through a topologically closed insulating 
membrane called the coupling membrane that has a nonaqueous osmotic 
barrier phase of low permeability to solutes in general and to H+ and
OH ions in particular (see Fig. 2.2).
The redox system going forward (towards oxygen) creates a potential 
difference across the membrane by translocating protons. This potential 
difference would be similar to an electrical potential but not identical 
as the vector of its production is the proton not the electron. This 
has led Mitchell to propose the notion of 'proticity' (cf. electricity)
( 1 2 0 )
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Fig. 2.2 Four fundamental postulates of chemosmosis
ADP + POH 
(-+H+/P)H+ 
ATP + HOH
AH2 + B 
( H+/2e”)H+ 
BH2 + A
H+
A~
+C
H stimulation by 
uncoupler
The aqueous media on the inside (M) and the outside (C) of the
inner mitochondrial membrane are quite different. Mitchell proposed
that there is a significant protonic potential difference arising from
the effective concentration difference of mobile protons as well as
from their electric potential difference. Therefore, the total protonic
^ +or protonmotive potential difference Ap (or ApH ) must be given as the 
sum of the electric potential difference Aip and a concentration potential 
difference that is equal to -RTlnß ApH or -ZApH, where Ai// is measured in 
mV. This gives
Ap A<|i - ZApH
This is the fundamental mathematical formulation of chemiosmotic theory: 
both A^ > and -ZApH are osmotically derived terms, l.e. they depend for 
their magnitude on bulk concentrations of protons and other ions, ¿tp 
is in effect the membrane potential of the system. One of the main 
functions of the solute porters (postulate 3) would be to regulate the 
contributions of Ai|i and -ZApH to Ap.
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When the membrane is not leaky and most of the proton current 
generated by the redox system passes back through the reversible ATPase 
there will be stoicheiometric coupling between oxidoreduction and 
phosphorylation. The P/O (or P/2e ) quotient of the overall process 
is given by the ->H+/2e quotient of the redox system divided by the 
-+H+/P quotient of the ATPase.
P/2e” = -*-H+/2e”/-*H+ /P
Assuming an -*-H+/P of 2 and a H+/2e value of 2 at each site, a standard 
free energy of hydrolysis of ATP corresponding to a hydrolysis constant 
of lO 5 M \  Ap should be ^210 mV at 25° C at a phosphate concentration 
= 10 mM when ADP / ATP = 1. For an ADP / ATP = 20 and Pi = 10 
mM, Ap will be 2l250 mV, Respiratory control in mitochondria would 
be expected to occur at Ap values of ^250 mV.
A short circuiting proton conducting pathway across the membrane 
would collapse Ap and would release its control effect on redox and 
ATPase activity. It would also uncouple phosphorylation while allowing 
redox activity to accelerate. Mitchell proposed that uncouplers 
provide this short circuit by being lipid soluble weak acids (or bases) , 
lipid soluble in both their protonated and anionic forms. Most 
uncouplers appear to be compounds of this type (58).
Chemiosmosis, while proposing a chemically simple respiratory chain, 
requires that it is physically highly organised across the plane of the 
membrane. Mitchell originally proposed that it was organised into 3 
proton translocating loops (Fig. 2.3) . Present evidence suggests that 
the respiratory chain is not folded into such loops (222). This is 
discussed later in .this chapter. The lack of support that transmembrane 
spatial organisation studies on the inner membrane has given to the 
concepts of loops 2 and 3 has led Mitchell to propose an alternative to 
them, his 'protonmotive ubiquinone cycle' (342-3) (see Fig. 7.1 and 
associated discussion ) . It is worth pointing out that this hypothesis
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Fig. 2.3 Proton translocating loops 1-3, after (58) .
2H
2H+ <-
2H
2H
NAD
FeSH
FMN
cyt b
UQ
FAD
cyt b
UQ-
-UQ
-cyt c
cyt c a , a^ Cu
'SH2
NAD linked
"S loop 1
• 2H+
loop 2
■ 2H
FAD linked
loop 2
-2H
*j02 + 2H loop 3
• h 2o
requires a certain distribution of b cytochromes across the membrane and 
that the available evidence suggests that this distribution is unlikely 
( 222) .
The chemiosmotic hypothesis is independent of the molecular 
mechanisms by whidh proton translocation may be stoicheiometrically 
coupled to ATPase of ATP synthase and to respiratory activity in the redox 
systems. It states that there are no intermediates common between the 
proton pumping respiratory chain and ATPase systems. This does not mean 
that there are no intermediates and/or conformational changes involved in 
either of these systems. However, the apparent lack of intermediates 
involved in ATP synthesis has led Mitchell to postulate that they do not
exist (72) .
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Mitchell has proposed a mechanism for H+ translocation by the
ATPase involving the translocatinofHjO one way and the translocation of 
2 -0 between and the terminal P atom of ATP the other. This produces 
a net translocation of 2H+ (Fig. 2.4).
Fig. 2.4 Proton translocation by the F.F ATPase — 2------------------------ i-----1 - 0 -----
Certain authors have been quick to point out that mechanistic 
considerations make this hypothesis highly unlikely (85, 48, 35) although 
Mitchell, with small modifications (HjO enters from the matrix side) 
retains it (66) .
Much experimental evidence has accrued since 1961 supporting the four 
basic postulates of the chemiosmotic hypothesis (see (58, 66) for list of 
references). The respiratory chain and the F^F^ ATPase have been shown 
apparently translocate H+ in the direction predicted. Mitchell and 
Moyle found that 2H+ were translocated out across the membrane for every 
2e transversing each phosphorylation site (58). This electron transport 
between NADH and 02 causes the extrusion of 6H , between succinate and 
Oj 4h+ and between an ascorbate (TMPD) couple and 02 2H+. Similar 
ratios were found in bacterial systems. Studies on the ATPase indicated 
that 2H+ were translocated for every ATP hydrolysed. Experimental
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estimates of Ap gave values in the region of 200-230 mV in good 
agreement with the theoretical expected, 250 mV. Mitchell incorporated 
H+/site and -►1I+/ATP ratios of 2 into his hypothesis. Later analysis 
of all these experimental findings has suggested that the situation 
might not be as simple as was first thought. These considerations are 
discussed later.
Whatever the fate of the 1 chemiosmotic hypothesis' as proposed by 
Mitchell, its impact on and importance to all subsequent experimental 
and theoretical work in bioenergetics is difficult to overestimate. It 
has been more successful as a general framework within which bio- 
energetic phenomena can be described than any other single theory, and 
all subsequent hypotheses of energy coupling have to explain both its 
strengths (which are many) and its weaknesses, which are few but are of 
fundamental importance.
A number of hypotheses of energy coupling, which are broadlv chemi­
osmotic in nature but diasgree with Mitcheil on the mechanism of proton 
translocation,have been proposed. These usually replace Mitchell's 
protonmotive redox loops by a redox linked proton pump (456). The 
mechanism by which protons are translocated through these 'pumps' is not 
defined.
Localised proton hypothesis.- At the same time as Mitchell first 
proposed his chemiosmotic hypothesis, an alternative model also 
involving protons as the active intermediaries between electron transport 
and ATP synthesis was proposed by R.j.p. williams (95-6). He proposed 
that as the formation of ATP from ADP and Pi is a condensation, then ATP 
synthesis could be 'driven' by stabilizing water, ADP-OH + P-OH -* ADP-OP 
+ HjO. He suggested that water was 'stabilized' by H+ generated by 
electron transport through the respiratory chain. This stabilization of 
water would only be possible in a nonaqueous region of space and if done
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by H+ , where H+ was generated far from bulk water. He proposed that 
these events took place in a highly localised intramembrane space within 
which protons could exist at a very high activity.
Fi9- 2-5 The localised proton model for ATP formation
represent a particle of high hydrophobicity within which ADP and Pi are 
condensed to ATP (by the ATPase).
The model above becomes chemiosmotic if,and only if,the membrane is present
+  2- and all H is released to phase (c) and all O 2 to phase (a).
Williams argues that ATP synthesis would be controlled kinetically 
by the diffusion of H+ (H^O+) from the active site (ATPase) which is 
hydrophobic in nature (or close to a hydrophobic site containing H+) into 
the hydrophilic phase nearby (that is, to an aqueous phase or to bound 
charges localised near the hydrophobic (hydrophilic) interface ) . There 
are obvious similarities between the localised proton theory and chemi- 
osmosis. Chemiosmosis would be a specific type of localised proton effect 
in which the diffusion of H+ was controlled by the bulk (osmotic) 
concentrations of H+ in the two aqueous phases ((a) and (c) in Fig. 2.5) 
topologically isolated from each other by the membrane. Williams has 
made several significant criticisms of chemiosmosis on theoretical grounds. 
These are discussed later in this chapter (97-98) . Williams does not 
make specific proposals about the actual catalytic steps which produce 
ATP,as he believes that too little is known about the structure of bound 
ADP, Pi and ATP in ATP utilising and producing enzymes. He does, however,
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Fig■ 2.6 Indirect localised proton coupling model, after (97-8)
The model requires 3 sites, X, Y, Z. The reactions proceed
diagram
1. ADP and Pi bound at X A
2. nH+ generated at site Y %by electron transport
apparatus) A
3. nH+ diffuse to site Z. Site Y relaxes and can accept
propose a generalised model for a coupling mechanism between electron
transport and ATP synthesis (Fig. 2.6) .
new reducing equivalents A
4. Binding of nH at Z causes a conformational change
in Z B
5. At "x, ADP + Pi -*■ ATP + H_0 (H-O moves to Z to react
with nH ) B
6. Release of nH+ or H ,0+ from Z and release of ATP from Y C
7. Relaxation of Y and Z to receive next round of
reactants C-D
CA. B.
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An open channel model is shown so that it could (ATP)
in principle be linked to chemiosmotic gradients 
although this is not required by the theory.
There is perhaps one' other energy coupling hypothesis worth considering 
in some detail here; this is the 'paired moving charge' model proposed 
by D.E. Green (59).
Paired moving charge (PMC) model.- This model has its roots in earlier 
hypotheses by Green (112) and Green and Ji (129) which were broadly
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conformational in type. A brief description of it is not easy as 
Green's assumptions about the nature of the components of the inner 
mitochondrial membrane differ from most other workers in the field. He 
proposes that the electron transport components and the ATPase are 
arranged in ribbon structures in the membrane. These ribbon structures 
are composed on two 'continuums', the tripartite continuum and the 
electron transport continuum. The former contains all the systems 
required for coupled ATP synthesis, ATP hydrolysis, active transport of 
cations and the translocation of metabolites. The latter contains the 
four complexes of the respiratory chain. These four complexes and the 
ATPase are all multisubunit enzymes. Green proposes that among the 
components of these enzymes are a series of ionophoroproteins, iono- 
phoroenzymes, track proteins and cation-binding proteins. It is these 
components that allow the charge pairing and charge movement essential 
to Green's hypothesis to take place.
Green proposes that there are two types of transmembrane charge 
flow involved in energy coupling. These are a symport charge flow 
(e and M+ together) which favours active transport, and an antiport 
charge flow (e and A in opposite directions) which favours oxidative 
phosphorylation. He proposes a number of ground rules on which the PMC 
model is based (see Fig. 2.7 on following page).
The initial event in energy coupling is charge separation followed
by paired charge movement and charge elimination. The charges move
within tracks that traverse the membrane. The track may be the electron
transport chain for e or the inner core of a track protein in the case
of an ionophorous moving charge, K+ . ATP is generated by anionic forms
2+of Pi and ADP, complexed with Mg and ionophores to cationic forms, 
moving in symport with electron flow. Phosphate is used to phosphorylate 
AMP bound in the ATP synthase (144) . The ADP produced by this then 
reacts with ADP to give bound AMP and 'free' ATP (Fig. 2.7).
F ig . 2 .7 Ground rules for the PMC model
A. exergonic centre endergonic centre B.
A. paired charge separation 
, HOH
OH
Ic.
D.
A + D is the electron 
transfer chain
B. paired transmembrane charge 
movement
elimination of a charge at the 
termination of a coupling cycle
&O H
HC1
mechanisms of charge transfer ^ + OH
inner core of 
track protein 
(lipid filled). 
K+ is complexed
with an 
phore
iono-
In the PMC model, control of coupling is not exerted on individual 
proteins but on proteins which are part of a continuum. The co-operative 
nature of the ribbon structure ensures that it is the ribbon as a unit 
which responds to the trigger action of the control mechanism. The mito­
chondrion would then behave as if it were one giant protein molecule 
that undergoes shape changes dictated by the ion fluxes in the membrane.
Green proposes that there are two basic states of the membrane! the N+
2+ 2+ 2+ state induced by Mg. and the Ca state induced by Ca (Table 2.1).
Chemiosmosis and the PMC model both have a charge separation as the 
initial step in coupled processes; they differ, though, in several 
important aspects. In the 'PMC model charge' (a) separation is always 
paired, (b) coupling is designed to avoid rather than create a membrane
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potential, (c) the flow of C is directly coupled to e~ flow, (d) coupling 
does not require an osmotically intact membrane.
Fig. 2.8 PMC molecular mechanism for coupled ATP synthesis,after (59)
ionophorous forms [_______
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+ 2+Table 2.1 Properties of the mitochondrion in the N and Ca state
N state 2+Ca state
oxidative phosphorylation 
coupled transhydrogenation 
active transport of cations 
cyclical transport of cations 
respiratory control . 
permeability to sucrose 
response to uncoupler 
configuration aggregated orthodox
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It is very difficult to assess the validity of the PMC model. Green 
appears to have isolated many of the ionophorous components and 'track 
proteins' that his theory requires. He also presents evidence from 
electron micrographs supporting his ideas on membrane structure (59, 189, 
193, 227). There has been little or no evidence supporting his hypo­
thesis published from outside his group, though it is fair to point out 
that this is largely because his ideas have been ignored. It is also 
worth noting that, if Green is right, then mitochondria and energy 
coupling processes are far more complicated than they have generally 
been thought to be.
The high energy state of the membrane '•v* generated by electron 
transport in coupled systems can be used to drive a number of reactions: 
these include ATP synthesis, nicotinamide nucleotide transhydrogenation, 
ion transport, mitochondrial shrinkage and swelling and reversed electron 
transport. The chemical and conformational hypotheses consider ,,v' to 
be a chemical bond (or bonds), while the chemiosmotic hypothesis considers 
■'V'tobe an electrochemical protonmotive force generated across the 
coupling membrane. It was one of the major theoretical triumphs of 
chemiosmosis that it predicted that mitochondria should display redox 
linked proton movements. These observations would not be expected from 
the chemical or conformational hypotheses in their earlier forms which 
later proposed that the observed proton movements were due to a 
driven proton pump and that "v' was in a close equilibrium with Ap. Ap 
would control ion transport processes across the inner membrane, but ',v' 
would be the primary high energy intermediate produced in the membrane.
The chemiosmotic hypothesis is the most testable of all current 
energy coupling hypotheses. The bulk of evidence appears to give 
support to it (see (58) for list of references) . However, there is a 
(growing) body of experimental data and some theoretical considerations 
which strongly suggest that the hypothesis as presently stated should be 
modified or possibly dismissed. Some aspects of these criticisms of
chemiosmosis will be reviewed.
The mechanism of uncoupling.- Uncoupling is the process by which the 
kinetic restraints acting between electron transport and ATP synthesis 
(or ■'V' consuming processeslare released, dissipating , usually as 
heat. A wide range of compounds possess this ability. A complete 
understanding of the mechanism of uncoupling would of necessity involve 
a similar understanding of the coupling mechanism. Investigation of 
the former should then throw light on the latter. Mitchell proposed 
that uncouplers are weak acids or bases, lipid soluble in both their 
protonated and unprotonated forms,and that they act by allowing a 
short circuiting of the proton gradient across the coupling membrane.
Much evidence has been produced to support this hypothesis (58). 
Comparisons have been made of the effectiveness of uncouplers in mito­
chondria and in different artificial membrane systems. There appears 
to be a poor correlation between uncoupling in mitochondria and the 
uncouplers'ability to stimulate ion fluxes through black lipid 
membranes. There is a good correlation between uncouplers1uncoupling 
activity in mitochondria and their ability to collapse a proton 
gradient across liposome membranes containing artificial redox
systems (433). Although there does appear to be a general correlation
+between uncoupling ability and the ability to transport H across lipo­
some membranes, this does not hold when the full range of uncouplers is 
tested for the ability to uncouple oxidative phosphorylation and collapse 
ApH across liposomes made from mitochondrial phospholipids. If this is 
done there is not an exact correlation between the two,which suggests 
that the ability to transport H+ across lipid membranes is not the only 
factor involved in uncouplers1 mode of action (397).
In chemiosmotic terms, uncouplers act by dissipating -zApH. It is 
difficult then to understand quite how they manage to inhibit coupled 
reactions so completely. The proton motive force, Ap, is composed of 
two terms, At|i and -zApII. The contributions of Aiji and-Z ApH to Ap vary,
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but it has been estimated that -ZApH is usually < 50% of Ap and 
occasionally has a value of 0 (434, 453). Ai); is a term that maybe 
is related to ApH but does not directly relate to bulk concentrations 
of protons. Collapsing of ApH should leave Ai(i intact; systems in 
which Ai)i is Ap should not be rapidly affected by uncouplers unless 
A\j> is somehow collapsed rapidly in response to ApH being collapsed or 
unless uncouplers directly affect Ai¡i. This latter possibility may be
what happens. Recent work by Green and coworkers suggests that 
uncouplers, singly and when paired with ionophores, are highly effective 
at transporting cations across phospholipid membranes (471-2). They 
could thus directly collapse At|i.
The chemical and conformational hypotheses propose that uncouplers 
act by dissipating '%>' in the membrane possibly by hydrolysis of an 
anhydride-like intermediate. Williams suggests that uncouplers act by 
sequestering protons away from their intramembrane 'high activity' sites.
There is some evidence to suggest that uncouplers bind to protein 
components in the membrane.
Trinitrophenol penetrates the mitochondrial inner membrane only 
rather slowly, and is not an effective uncoupler in mitochondria. It 
is, however, a highly efficient uncoupler in SMP's,suggesting that it 
has to interact with a membrane site only accessible from the matrix 
side of the inner membrane (435).
Hanstein and Hatefi have synthesised an azido derivative of DNP, 
2-azido-4-nitrophenol. This is a potent uncoupler which will in the 
presence of u.v. light covalently bind to protein groupings. They have 
demonstrated that .this uncoupler appears to bind to two components in 
the mitochondrial membrane, an F^ subunit and a 30,000 m.w. protein.
This binding is specifically prevented by other uncouplers (DNP, PCP, 
CCCP, S13) but not by ATPase inhibitors. The 30,000 m.w. component is 
probably an F^ suburit (397, 420, 436). They suggest that this subunit
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is responsible for, or involved in, the transduction of and that 
this may be a major locus of action for uncouplers in the mitochondrial 
inner membrane.
The precise mechanism of uncoupling thus remains obscure; see (397) 
for review.
Function of the coupling membrane.- It is fundamentally implicit in 
the chemiosmotic hypothesis that a topologically closed, proton 
impermeable, membrane system is required so that a Ap may be maintained 
across it and collapsed through it to generate ATP. Coupled processes 
do not appear to take place in the absence of such as membrane (58, 261) . 
There have in recent years,however, been a number of reports suggesting 
that such a membrane is not required for energy coupling to take place in 
mitochondria. Azzone and Masari reported that EDTA particles (SMP's 
stripped of F^ by EDTA treatment) which do not have oxidative phosphoryl­
ation did have respiration-driven transhydrogenase activity (a coupled 
process utilising . These particles were osmotically leaky and
were permeable to inulin and 15,000 MW dextrans. They concluded that 
the chemiosmotic terms Ai|/ and ApH, which are osmotically derived, play 
no direct role in energy conservation (430).
More interesting and possibly more important are the results 
reported by Komai et a)^ . (431-2) . Lysolecithin is a detergent 
and collapses membrane structure. Mitochondria treated with lysolecithin 
have no vesicular structure observable under the electron micrsocope. 
They do, however, retain coupled functions. These functions are 
insensitive to ionophores but retain sensitivity to uncouplers and ATPase 
inhibitors. Komai et ad. claim that these results present clear 
evidence that topologically closed, proton impermeable, membrane 
structures are not essential for energy coupling processes to tadce place 
in mitochondria. Support for the idea that closed membrane vesicles are 
not essential prerequisites for energy coupling comes from the reported
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purification of an ATP-Pi exchangease, complex V ATPase, by Hatefi and 
coworkers (350, 244). They claim that purified complex V, which has 
too low a phospholipid content to form protein-lipid vesicles, displays 
high ATP-Pi exchange rates. This reaction has generally been thought 
to be due to a reversal of ATPase activity generating ATP. Chemi- 
osmotic theory proposes that it should therefore require a closed 
vesicular system in which to take place. Hatefi's results suggest that 
this may not be so. If Komai's and Hatefi’s results are confirmed 
then they may invalidate postulate 4 of the chemiosmotic hypothesis.
The transmembrane distribution of respiratory chain redox carriers.- 
Chemiosmotic theory requires a specific transmembrane distribution of 
redox carriers to form the proton translocating loops 1, 2 and 3 (58) 
(Fig. 2.9A). Present evidence indicates that the actual trans­
membrane distribution would not allow transmembrane H+ (or e ) transfer 
via a series of loops (222) (Fig. 2.9B) .
Fig. 2.9 Transmembrane distribution of respiratory chain redox 
centres, after (222)
M M
A: distribution required for
chemiosmotic loops 1, 2 and 3 
(58)
B: Actual distribution (see also 
Fig. 2.10)
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Mitchell has partially recognised this by discarding loops 2 and 3 
and replacing them with a proton motive,loop 2-3, cycle (Fig. 7.1) (342-3). 
This, however, requires a certain distribution of the complex III b cyto­
chrome across the inner membrane. Present evidence suggests that they 
lie at similar depths in the membrane and that transmembrane electron 
flow between them would be unlikely (Fig. 2.10).
Onishi and coworkers have used paramagnetic ions and e.s.r. 
techniques to investigate the transmembrane distribution of redox 
centres (437,-8) . These studies probably give the best picture currently 
available (Fig. 2.10). If this picture is correct then it precludes 
the existence of any proton translocating 'loops’ across the membrane.
It does not, however, exclude a chemiosmotic mechanism which uses 
proton pumps to generate ApH.
The role of the proton motive force and membrane potential in bio- 
energetic systems.- Chemiosmotic theory states that the respiratory 
chain generates a proton motive force, Ap, composed of two osmotic 
terms, a membrane potential, Aij) and a proton gradient term, -RTLn^ApH.
Ap is collapsed through the ATPase generating ATP or through other 
endergonic systems, e.g. the energy linked nicotinamide nucleotide 
transhydrogenase. The rate and extent of coupled processes such as ATP 
synthesis should then be directly related to the magnitude of Ap. Much 
research effort has been devoted to measuring Ap,Ai|i and ApH in bio- 
energetic systems. Assuming an H+/ATP ratio of 2, then a Ap of ' 250 mV 
would be required to drive the synthesis of 1 ATP per coupling site 
(1-3). Measurements made by Mitchell and others indicate that a Ap of 
'v 200-250 may indeèd exist across bioenergetic membranes (see refs.
(58, 261) for extensive reviews and references relating to these 
investigations). There are workers, however, who do not accept that Ap 
and A<|i are of this magnitude and that they are directly related to the 
energy coupling capacity of the membrane systems tested.
The most tenacious and longstanding opponent of the idea that there 
is a significant metabolically dependent membrane potential in mito­
chondria is probably Henry Tedeschi. Tedeschi has measured mito­
chondrial inner membrane potential directly, using microelectrodes,and 
has concluded from these studies that it is snail (9-15 mV) , does not 
alter when the metabolic state of the mitochondria alters and that it 
is +ve inside (chemiosmosis requires that it is -ve inside) (449, 450). 
This work has been much criticised (22) but more recent work by 
Tedeschi,using a series of dyes to estimate the electrical potential of 
the membrane,largely confirms his earlier findings (451). Here he 
reports that Aip is variable and usually very low, even in the presence 
of respiratory substrates. He concludes that the results indicate that 
a large membrane potential is not established on the initiation of 
metabolism and that it does not play a significant role in ADP 
phosphorylation. These results have generally been ignored or dismissed, 
a fate not worthy of the excellence of the reported work. Tedeschi 
considers that all observable membrane potentials are due to simple 
Gibbs-Donnan type effects and can be described by the Nernst equation 
(470).
Other workers have reported that the measurable inner mitochondrial 
membrane potential and proton motive force is too small to account for 
observable ATP synthesis (452).
While many workers would not accept this, there is a growing body 
of evidence suggesting that there is no strict relationship between 
Ap and the phosphorylation rate (453-5).
Proton translocation; H*/*» ratios.- Experimental observation has 
apparently demonstrated that mitochondria and bacteria are able to eject 
protons into the suspending medium during respiration by a process 
closely linked to electron transport down the respiratory chain (58). 
There have been differing views as to how this proton translocation is
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achieved. Mitchell proposed that it is due to the vectorial 
arrangement of alternating H+ and e carriers in the inner membrane 
into chemiosmotic loops (261, 58) and into more complex cyclic loops 
(342-3) . Some authors, while broadly accepting the four basic 
postulates of chemiosomosis, reject the loop hypothesis and consider 
the redox pump in more general terms with H+ translocation driven by 
electron transport dependent pK changes or similar effects (456). 
Indirect proton pumps models have been postulated, driven by a 'high 
energy' intermediate generated by electron transport (457) or by an 
energy linked conformational change driving an electroneutral cation-H+ 
exchange (458).
Mitchell and Moyle measured the H+/,v , (H+/2e , H+/slte) ratios
of the entire respiratory chain and found them to be in the region of 
2H+/'V' at each site, with no H+ extrusion at the level of cytochrome 
oxidase (459). Much support has been forthcoming for the ejection of 
two H+/site by the respiratory chain (58) and it has been incorporated 
into the theoretical framework of chemiosmotic H+ ejection and ATP 
synthesis (72, 66).
This work has, however, been challenged, firstly by Pressman and 
coworkers who reported K+/^ (equivalent to H+/'v) ratios 4-7 K+/^ (460) ,
then by Azzone and coworkers who reported K+/'v ratios of 4K+/'v (461,
458, 448),and more recently by a large body of work emanating from the 
laboratories of Lehninger (462-6) and of Brand (467, 472) which reports 
charge/site ratios of 4 and H+/site ratios of 3-4 H+/site. These 
higher H+/''< and charge/site ratios have been obtained by taking into 
consideration the movement of certain anions, notably phosphate which 
buffers H+ ion movement in the experiments described by Mitchell and 
Moyle. Phosphate can be removed from the system,or phosphate transport 
prevented by blocking it with N-ethyl maleimide; this gives higher 
H+/'v< ratios (448, 466) . This approach has been criticised by Moyle and
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Mitchell (468), although it is fair to point out that these 
criticisms are far from convincing (466).
These charge/'v ratios of 3-7 charges/'v- cannot be incorporated into 
a chemiosmotic theory requiring Mitchellian redox loops (58) or his 
mechanism of ATP synthesis (66). They can, however, be incorporated 
into one in which proton ejection is effected by redox linked proton 
pumps.
The conditions under which respiration-driven H+ transport is 
observed are highly artificial; that is, compounds to collapse 
and compounds to prevent phosphate transport are usually present. The 
respiratory chain is often blocked in various places with various 
inhibitors. This has led some authors to question the physiological 
relevance of the observed H+ movements (97, 98, 409). Archold et al. 
have reported that under phyaological conditions there is no observable 
H+ ejection by the mitochondrion during ATP synthesis (469). They also 
report that ATP synthesis is accompanied by the masking and unmasking 
of fixed charge sites on the inner membrane which may be important in 
regulating Ai|i ’, which may control the rate of ATP synthesis.
The role of cytochrome oxidase.- The chemiosmotic hypothesis, as 
described by Mitchell (58), requires that cytochrome oxidase constitutes 
the electron translocating arm of loop 3 catalysing vectorial transport 
of e between cyt c, on the C side of the membrane and a^ on the M side. 
A large body of evidence has accumulated supporting this idea (58, 222, 
439). Recent work by Wikstrom and others has, however, fundamentally 
challenged this idea by suggesting that cytochrome oxidase acts as a 
proton pump, pumping H+ from the M phase to the C phase (440-1). This, 
if it happened, would short-circuit any redox loop operating at this 
level. The experimental evidence supporting the idea has been 
vigorously contested by Mitchell and others (442-3). The actual role 
of cytochrome oxidase in proton transport remains uncertain, although
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a growing body of evidence now exists suggesting that it does act as 
a proton pump,as proposed by Wikstrom (440-1, 444-8). If this is the 
case, any chemiosmotic mechanism proposed with redox loops as the method 
of H+ translocation would be invalid.
Williams' criticisms of chemiosmosis.- Although Williams 'localised 
proton' model has some features in common with chaniosomosis, he has 
always had several severe theoretical criticisms of chemiosmosis. There 
is not space here to go into these in detail (see (95-8, 474-6) for a 
further discussion) but several of his most prominent criticisms can be 
summarised.
Mitochondria lie in the cell cytoplasm; this has a high buffering 
capacity. Williams says that attempts to form pH gradients against this 
buffering capacity represent an energy leak rather than a form of stored 
energy. This criticism has bever been answered thoroughly although 
claims have been made that it has (66, 97). Mitchell has suggested 
that H+ diffusion away from the outer side of the inner membrane may 
be restricted so that it is not buffered by the cytoplasm. If this is 
so, then the basic mathematical formulation of chemiosmosis, Ap = Ai)i-ZApH, 
must fall as Aiji and ApH are osmotic terms that describe bulk 
concentrations of ions and protons.
As stated above, in chemiosmosis Ap = Ai/i -ZApH, that is, the general 
energy across the whole membrane is given by 
AG = + ApH
For extreme local models, Williams states 
AG = A(AG°) + ip'
where i(»' is the membrane potential due to fixed charges and A (AG°) is 
the chemical potential of the system (not including any contribution 
frcm fixed charges). Williams claims that Ap does not give an adequate 
description of the'free energy change of protons across the coupling site 
which is given by
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AG = A(AG°) + Ai)/' + ZApH
AG = Ap + A(AG°) + A4» ' - Ai|i
Chemiosmosis does not take account of the terms Aiji ' and A(Ag °) which
may make important contributions to the energy available to ATP 
synthesis (469, 473, 97, 98, 475). Williams also suggests that the 
natural elasticity of bioenergetic membranes makes energy conservation 
in bulk osmotic gradients of ions across the membrane unlikely (475-6).
There have been indications that thiol groups may be closely 
involved in the mechanism of energy coupling (318) . Several mechanisms 
of oxidative phosphorylation which involve the formation of thioesters 
have been proposed, e.g. (385, 386, 377). Model reaction systems 
linking ATP synthesis to the oxidation of thiols have been constructed. 
These mimic some of the properties of oxidative phosphorylation 
remarkably (see (472) and following three papers).
Griffiths has reported that derivatives of lipoic acid and oleic 
acid have the ability to drive ATP synthesis in ATPase systems (248). 
The involvement of these and other lipids in the energy coupling 
systems of the mitochondrial inner membrane was investigated.
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CHAPTER 3
THE INTERACTION OF LIPOIC ACID AND RELATED COMPOUNDS WITH
ENERGY COUPLING SYSTEMS
Introduction
Lipoic acid was first described as a growth requirement for micro­
organisms and later as an 'acetate replacing factor', protogen A
(360-2). It was eventually isolated in pure form but very low yield 
from a water insoluble extract of beef liver. The structure was later 
demonstrated to be 1,2-dithiolane-3-valeric acid, i.e.
also known as aDL 6,8-thioctic acid or lipoic acid. The disulphide 
bridge in the compound is easily reducible, giving dihydrolipoic acid.
Its described role as a coenzyme has so far been confined to a 
relatively small number of enzymes, most notably pyruvate dehydrogenase, 
a-ketoglutarate dehydrogenase, lipoic acid reductase, transacetylase 
or succinylase, lipoamide Oxidoreductase, lipoamidase and a lipoic acid 
activating system (363) .
The a-keto acid dehydrogenases catalyse the following overall 
reaction in mammalian systems:-
RCOCOOH + HS - CoA + NAD+ ---> RCO m SCoA + COj + NADH + H+
They are the only known enzymes that contain a protein bound lipoic 
acid (bound as an amide linkage with a e NHj group from lysine) . There 
are two distinct enzymes in mitochondria, pyruvate dehydrogenase and 
a-ketoglutarate dehydrogenase. The a-keto dehydrogenase exists as 
multienzyme complexes with a molecular weight of several millions (364) .
COOH
S- •S
HS SH
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Three types of enzyme have been isolated from these complexes: -
(i) a thiamin pyrophosphate containing decarboxylase;
(ii) a lipoic acid containing lipoic acid reductase transacylase;
(iii) an FAD containing lipoamide oxidoreductase.
The individual enzymes are linked by non-covalent bonds between lipoic 
acid reductase transacylase and the other two enzymes (there appear to be 
no bonds between the decarboxylase and lipoamide oxidoreductase)(365) .
Pyruvate dehydrogenase obtained fran Escherichia coli contains 
12 molecules of pyruvate decarboxylase of M.W. 183,000 each; 6 
molecules of lipoamide oxidoreductase, M.W. 112,000 each and 1 
aggregate of lipoic acid reductase transacetylase, M.W. 1,600,000. 
Lipoamide oxidoreductase contains 2 moles FAD per mole enzyme. Lipoic 
acid reductase transacetylase contains one mole protein bound lipoic 
acid per 35,000 grams protein.
The a-ketoglutarate dehydrogenase complex differs from pyruvate 
dehydrogenase in several respects. Its lipoic acid reductase trans- 
succinylase (equivalent to transacetylase) has a molecular weight of 
1,200,000 and the final amino acid sequence for protein bound lipoic 
acid is slightly different.
gly-asp-lipoyllys-ala lipoic acid reductase transacetylase
thr-asp-lipoyllys-val-(val-leu)-glu-NH2 lipoic acid reductase
transsuccinylasc
Lipoic acid reductase transsuccinylase contains one mole lipoic acid 
per 84,000 grams protein.
The lipoamide oxidoreductases of the complexes appear to be 
identical. These are the most studied of all the lipoic acid 
utilising enzymes, they catalyse the following reaction:-
dihydrolipoate + NAD+ w oxidised lipoic acid + NADH + H+
(dihydrolipoamide) (lipoamide)
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They are also known by the generic term diaphorases and also as lipo- 
amide dehydrogenases. Lipoamide dehydrogenase was first isolated by 
Straub (366) as a ' flavoprotein diaphorase'. The pure enzyme has a 
yellow colour and displays absorption and fluorescence spectra 
characteristic of a flavoprotein. The holoenzyme can be dissociated 
under appropriate conditions into a colourless apolipoprotein and a 
prosthetic group which was shown to be FAD (367-8). The enzyme 
contains t 2 moles FAD/mole.
The bound lipoic acid contained in lipoic acid reductase trans- 
acetylase is stable and does not appear to exchange with free lipoic 
acid. This will only exchange into the apoprotein in the presence of 
a 'lipoic acid activating system' which catalyses the formation of an 
energy rich adenyl lipoate.
lipoic acid + ATP ..- AMP lipoate + PPi
AMP lipoate + apoenzyme ---- > holoenzyme + AMP
Adenyl lipoate will not replace the activating system. There is also an 
enzyme, lipoamidase, which catalyses the hydrolysis of protein bound 
lipoic acid from the holoenzyme.
The major biochemical reactions so far known to involve lipoic 
acid can then be summarised: -
RCOCOOH + TPP-E^ --- > RCH(OH) - TPP-Ej^ + CC>2
RCH(OH) - TPP-E^ + lipS2 - E2 ---RCO - S - lipSH - Ej + TPP-Ej^
PCOS - lipSH - E2 + HSCoA lip(SH)2 - E2 + RCO ^ SCoA
lip (SH) 2 - E2 + FAD - E3 FADH2 - E3 + lipSg - E2
FADH2 - E3 + NAD+ s = *  FAD - E3 + NADH + H+
E^i TPP containing decarboxylase; E2: lipoic acid reductase trans- 
acylase; E3 : lipoamide oxido reductase. (For a more detailed 
discussion of these reactions, see discussion to Chapter 5).
The open structure of the dehydrogenase multienzyme ccmplex and 
the fixed positions of the subunit enzymes make it difficult to envisage
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how lipoic acid firmly bound to one of these enzymes can react with 
the active sites of the other two enzymes. This has led Reed to 
propose the following mechanism (369) (see Fig. 3.1).
Figure 3.1
Conformational changes in the three enzymes and disulphide inter­
changes have also been proposed to explain interactions between the 
protein complexes (370) .
Work in this laboratory on the mode of inhibition of energy linked 
reactions by dibutylchloromethyltin chloride suggested that the 
inhibitor titrated a lipophilic ncn-protein component of the mito­
chondrial inner membrane. This was later identified as either lipoic 
acid or a closely related compound (315,317,235,371). Dihydrolipoic 
acid was also shown to drive the synthesis of ATP in a variety of 
ATPasas derived from mitochondria (248,372). Aspects of this 
'dihydrolipoate'-driven ATP synthesis were investigated.
Materials
All chemicals used were of AnalaR or similar grade. Organic 
solvents of AnalaR grade were redistilled before use. 8-Methyl lipoate
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Table 3.1 Llpoic acid and related compounds: structures
Name
lipoic acid
aDL 6,8-thioctic acid
Structure
dihydrolipoic acid
lipoamide
M • W.
206
208
207
8-methyl lipoic acid 220
7-methyl thiheptic acid 192
3-lipoic acid 
(several forms)
222
oleoyl-S-lipoate 
(presumed structure)
472
ch3 (ch^ ch c h(ch2)75--S SH
V ' ^ / ^ C 0 0 H
adenyl lipoate 502
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was a gift fran Dr. J.R. Guest, Department of Microbiology,
University of Sheffield. The uncoupler 4,5,6,7-tetrachloro-2-trifluoro- 
methylbenzimidazole, TTFB, was a kind gift from Professor B. Beechey, 
Shell Research Ltd., Sittingbourne, Kent. Oligomycin, fatty acyl 
chlorides, lipoic acid, dihydrolipoic acid, lipoamide, valinomycin, 
gramicidin D, fatty acids, carbonyl cyanide-M-chlorophenylhydrazone 
(CCCP) were obtained from the Sigma Chemical Company. Dicyclohexyl 
carbodiimide (DCCD) was obtained from B.D.H. Ltd. 1,1,5,5-trifluoro-
methyl-l,5-hydroxy-pentan-3-one ('1799') was a kind gift from Dr. P. 
Heytler. Nigericinand efrapeptin were obtained from Dr. R. Hamill,
Eli Lilley & Co.
Methods
Freshly excised bovine hearts were brought on ice from a nearby 
slaughter house; all subsequent operations, preparation of submito- 
chondrial particles and enzymes, were carried out at 4° C unless other­
wise stated. Fat, connective tissue and ligaments were carefully 
trimned from the muscle tissue which was then cut up in to 2 cm cubes 
and passed through a meat grinder. The resulting minced tissue was 
resuspended in 2 volumes ice cold 0.25 M sucrose, the pH was adjusted 
to pH 7.0-7.5 by addition of 1 M Tris base, and the suspension was 
homogenised in a Waring tissue blender for 40 seconds at top speed.
The suspension was then pH'd to a stable pH 7.0-7.5 by the addition of 
1 M Tris base with rapid stirring; care has to be taken at this stage 
to ensure that the pH is stabilised and is not above 7.5. The 
suspension was then centrifuged at 2,000 rpm in a Mistral 6L centrifuge 
4 x 1.25 L rotor for 30 minutes at 4° C. The supernatant was passed 
through 4 layers of muslin and the pH adjusted to 7.5 with 1 M Tris base 
before being centrifuged at 10,000 rpm for 20 minutes in a Sorval RC-2B 
centrifuge G.S.A. rotor, pre-cooled to 4° C. The supernatant from 
this spin was carefully removed by aspiration, as was the top light
layer of the pellet. Any fat lining the centrifuge bottle was then 
carefully removed by wiping with a tissue. The dark brown mitochondrial 
pellet was then resuspended and homogenised in a gLass homogeniser fitted 
with a teflon pestle in 0.25 M sucrose; lO mM Tris-Cl, pH 7.5, diluted 
to 0.5 - 1.0 litres in the same buffer and recentrifuged at 10,000 rpm 
for 20 minutes in a SorvallRC-2B centrifuge G.S.A. rotor. The super­
natant was removed as previously and the pellet resuspended in 0.25 M 
sucrose, 10 mM Tris-Cl and recentrifuged as above. The pellet from 
this centrifugation was resuspended in 0.25 M sucrose; 10 mM Tris-Cl, 
pH 7.5; 5 mM M g C ^  as recentrifuged as above. The mitochondrial
pellet was resuspended to 40 mg protein/ml in 0.25 M sucrose; lO mM 
Tris-Cl, pH 7.5; 1 mM EDTA often 5 mM in succinate; 2 mM in ATP; 5 mM 
in MgCl2 and either frozen immediately or kept at 4° C as required.
Submitochondrial particles were prepared by sonication of 
mitochondria. Frozen mitochondria were thawed rapidly and diluted to 
t 10 mg/ml protein concentration and sonicated for 1 minute (4 bursts 
of 15 seconds interspersed by 30 second gaps) in an MSE 60W sonicator 
at maximum amplitude. The suspension was centrifuqed at 15,000 rpm 
for 15 minutes in a Sorvall RC-2B centrifuge SS34 rotor. The super­
natant was then centrifuged at 100,000 g for 30 minutes in a Beckman 
L2-50 centrifuge, 40, 50 Ti or 65 rotor. The pellet frcm this centri­
fugation was resuspended in 0.25 M sucrose; 10 mM Tris-Cl, pH 7.5;
1 mM EDTA and recentrifuged as above. The submitochondrial pellet was 
resuspended in the same buffer to a final protein concentration of 
^ 20 mg/ml.
Electron transport particles (ETP ) were prepared by the sameH
method as submitochondrial particles except .that the sonication buffer 
contained 2 mM sodium succinate; 2 mM ADP; 5 mM MgCl^.
Complex V ATPase was prepared as described by Hatefi and co-workers 
(350, 244), using bovine heart submitochondrial particles as a starting
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material. SMP's were pelleted and resuspended in 0.66 M sucrose;
50 mM Tris-Cl, pH 8.0; 1 mM histidine to a protein concentration of 
23 mg/ml. Potassium deoxycholate was added to a final concentration 
of 0.3 mg/mg protein from a stock solution 10% w/v, pH 9.0. Potassium 
chloride was then added to 72 g/L and allowed to dissolve at 4° C with 
stirring. The suspension was then centrifuged at 30,000 rpm for 30 
minutes in a Beckman 30 rotor. The precipitate was discarded (or used 
for cytochrome oxidase preparations) while the reddish supernatant was 
diluted with 0.25 volumes of water and recentrifuged at 30,000 rpm for 
40 minutes in the No. 30 rotor. The supernatant from this step was 
dialysed against 10-20 volumes 10 mM Tris-Cl, pH 8.0 for 3 hr at 4° C. 
The dialysate was centrifuged for 90 minutes at 30,000 rpm in the No.
30 rotor. The upper 2/3 of the supernatant from this step was ranoved 
from the loosely packed pellet, frozen in liquid nitrogen and stored 
until used. This supernatant was then passed through a Sephadex G25 
column pre-equilibrated and eluted with 10 mM Tris-acetate, pH 7.5 at 
100-130 ml per column of size 10 x 22 cm at 4° C. The pink column 
eluant was taken to 42% saturation with neutral saturated (NH^'^SO^ 
at 4° C and centrifuged for 15 minutes at 70,000 g. The pellet fran 
this step was resuspended in 0.25 M sucrose; 10 mM Tris-acetate, pH 8.0 
to a concentration of 15-20 mg/ml protein. Potassium cholate was then 
added to 0.35 - 0.38 mg cholate/mg protein (from a 20% w/v stock 
solution, pH 7.9) followed by (NH4)2S04 to 25% saturation. The 
suspension was then centrifuged after 10 minutes stirring at 4° C at 
40,000 rpm for 15 minutes in a No. 40 rotor. The precipitate was 
discarded and the supernatant taken to 42% saturation with saturated 
(NH^JjSO^ at 4° C. The supernatant was centrifuged as before and the 
pellet collected, redissolved to 'v 20 mg/ml in 0.60 M sucrose; 50 mM 
Tris-Cl, pH 8.0; 1 mM histidine, frozen in liquid nitrogen and stored 
until used. This is complex V ATPase.
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'Proton translocating' ATPase was prepared essentially as 
described by Serrano at a^. (245) . Bovine heart mitochondria, 40 mg 
protein/ml in 0.25 M sucrose were diluted with water and 0.1 H sodium 
pyrophosphate, pH 7.4 to 20 mg protein/ml and 0.01 M sodium pyro­
phosphate and then sonicated for 2 minutes (20 second bursts inter­
spersed by 30 seconds) in an M.S.E 60W sonicator at maximum amplitude 
before being centrifuged at 26,000 g for 15 minutes. The supernatant 
was then centrifuted at 105,000 g for 45 minutes. The pellet from 
this stage was resuspended in 10 mM Tris-SO^, pH 7.5; 0.5 mM EDTA;
1 mM MjSO^; 10% satd. (NH4>2S04; 1.5% cholic acid neturalised with
NaOH to pH 7.5 (last addition) to a protein concentration of 25 mg/ml, 
Buffer systems described by Serrano et al. (245) all contain 0.5 mM 
DTT. This was omitted in any ATPase preparations with which dihydro- 
lipoic acid or derivatives were to be used. The suspension was 
stirred @ 4° C for 7 minutes and centrifuged at 50,000 rpm for 50 
minutes in a Beckman No. 60 rotor. The supernatant from this step 
was taken to 38% saturation by addition of 0.45 ml saturated (NH^^SO^/ 
ml buffer. This suspension was then centrifuged at 15,000 g for 15 
minutes in a Sorvall SS34 rotor. The clear supernatant was taken to 
42% saturation by addition of 0.127 ml saturated (NH^)^SO^ per ml 
and recentrifuged as above. The pellet from this step contains 
'proton translocating' ATPase and was resuspended in 50 mM sucrose;
10 mM Trls-SO^; 0.5 mM EDTA; 1 mM MgCl2, pH 7.5 to 20 mg protein/ml, 
giving a clear pale yellow solution which was frozen in liquid 
nitrogen and stored at -20° C until use.
Rat liver mitochondria.- Rats were killed by stunning and partial 
exsanguination. The abdomen was washed with 90% ethanol, the liver 
dissected out and washed in three changes of 0.25 M sucrose and 
transferred to a tared beaker. Approximately 15 g of liver tissue was 
homogenised in 40 ml of 0.25 sucrose; 1 mM EDTA with 2 to 3 passes of
a glass-teflon hcmogeniser. The homoqenate was centrifuged twice at 
800 g for 20 minutes and the pellets discarded. The supernatant was 
centrifuged at 9,000 g for 10 minutes and the supernatant and loosely 
packed pellet (upper layer) of microsomes discarded. The brown,hard 
packed pellet of mitochondria (lower layer) was resuspended in 0.25 M 
sucrose; 1 mM EDTA in a homogeniser and centrifuged at 9,000 g, the 
supernatant and upper layer (pink) of microsomes again being discarded. 
The mitochondrial pellet was washed again and finally resuspended to 
20 mg protein/ml in 0.25 M sucrose; 10 mM Tris-Cl, pH 7.5; 1 mM EDTA.
Escherichia coli and Rhodospirillum rubrum were prepared as 
described in Chapter 5. A DCCD sensitive F^F^ type ATPase enzyme was 
prepared from Escherichia coli vesicles by the method of Friedl et al. 
(351).
Oxidative phosphorylation.- Oxidative phosphorylation was assayed in a 
glucose-hexokinase trap system. Assays containing 0.5 mg - 1.0 mg 
enzyme in 1 ml of 0.25 M sucrose; 20 mM glucose; 20 mM Tris-Cl, pH 
7.3; 2 mM MgCl2~ 0.2 mM EDTA; 4 mM K2HP04 either 0.2 mM or 2 mM in 
ADP and several units of hexokinase (usually either Sigma type F-30O 
or C-300),ranging from 1-5 in the case of mitochondria or bacterial 
vesicles to 10-25 units in the case of purified ATpase 
enzymes,were preincubated with any inhibitors, e.g. rotenone, antimycin 
A, oligcmycin, DCCD, uncouplers, ionophores, etc. for 5 minutes prior 
to initiation of assay in a wide-based phosphorylation tube in a shaking, 
heated water bath at 30° C. Assays were usually run for 10-30 minutes 
prior to termination. Assays were terminated by taking 0.2 ml 
aliquots into 0.2 ml 10% trichloroacetic acid (TCA) or 0.2 ml perchloric 
acid (PCA). Coagulated protein was removed by centrifugation in a 
bench centrifuge. Oxidative phosphorylation was measured either as 
the disappearance of phosphate from the medium or as the appearance 
of glucose-6-phosphate.
Estimation of glucose-6-phosphate.- ATP can act as a phosphate donor to
glucose in the presence of the enzyme hexokinase (ATP:D-hexose-6-phospho-
transferase EC 2.7.1.1) producing glucose-6-phosphate:- 
__  . _ , hexokinase _ „ATP + D-glucose — -.........  D-glucose-6-phosphate + ADP
This reaction is used as the basis for the assay of ATP produced by 
oxidative phosphorylation. ATP is used by a glucose-hexokinase trap 
system to produce glucose-6-phosphate; the ADP released by this reaction 
can then be rephosphorylated by the ATP synthase system to produce ATP. 
This allows the ADP concentration of the assay to be kept low as ADP can 
recycle until the free phosphate concentration of the assay becomes limiting 
After oxidative phosphorylation was terminatedby taking an 0.5 ml 
aliquot from the glucose-hexokinase trap system into 0.2 ml 1 M P.C.A. 
coagulated protein was removed by centrifugation. An 0.5 ml aliquot from 
the supernatant of this step was taken into sufficient 6 M KOH to 
neutralise it (75 pi). The tubes were kept at 0° C for 20 minutes to 
ensure complete precipitation of KCIO^ which was then removed by centri­
fugation. An 0.1 ml supernatant aliquot was taken into 1.9 ml 0.5 M 
Tris-Cl, pH 7.5, containing 0.5 pinoles NADP+ and 2-3 units G6P dehydrogen­
ase which converts G6P to glucono-6-lactone-6-phosphate with the con­
comitant reduction of NADP+ to NADPH. NADPH was estimated from its
2absorption at 340 nm: NADPH E .. = 6.22 cm /pmole. The amount of ATP (addedmM
as NADPH was virtually 100%.
Estimation of inorganic phosphate.- Phosphate was determined by the metho 
of Fiske and Subbarow (352). This method is based on the formation of a 
phosphate molybdate complex which can be assayed spectrophotometrically. 
Phosphate will, in acid conditions, form a phosphomolybdous complex with 
ammonium molybdate. This can be reduced by an appropriate reducing agent 
(l-amino-2-naphthol-4-sulphonic acid) to a phosphomolybdic complex which 
has a Characteristic blue colour that can be assayed spectrophotcmetricaUy.
Assay Procedure.- Inorganic phosphate (10-500 nmoles) in 0.5 ml water is 
added to an assay tubfe containing 1.5 ml water and 0.2 ml 2.5% ammonium 
molybdate in 5 N HjSO^. The contents are mixed on a vortex shaker and 0.3 
ml of a 0.2% l-amino-2-naphthol-4-sulphonic acid) 12% NaHSO^. 2.4% 
Na,S03.7H20 solution (ANSA reagent) are added. The tubes are vortex
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mixed and allowed to stand for 30 minutes at room temperature after 
which time their optical density at 691 nm is read against a blank 
containing water, molybdate reagent and ANSA reagent. The A^g^ values 
obtained can be used to construct a standard curve for phosphate. Free 
phosphate concentration in assays, e.g. ATPase assays, can be obtained 
by taking aliquots through the procedure above and comparing the 
A^g^ values to the standard curve
ATPase assay.- ATPase activity was determined by assaying phosphate 
released by the hydrolysis of ATP. Assays containing 100-200 pg 
mitochondrial protein or 1-10 pg purified ATPase protein were incubated 
in 1 ml 50 mM Tris-Cl, pK 8.5; 5 mil MgCl2 (assays were carried out at
pH 0.5 unless specified otherwise) for 5 minutes with effectors and 
inhibitors,if any are present in the assay, at 30° C prior to 
initiation of the assay with 5 pmoles ATP. Assays were terminated 
after 5-15 minutes. By addition of 0.5 ml 10% TCA. Coagulated protein 
was removed by centrifugation in a bench centrifuge and a 0.5 ml aliquot 
of the supernatant was taken into an assay to determine inorganic 
phosphate (Pi).
ATP-Pi exchange.- ATP-Pi exchange activity was determined as described
by Stigall et: al. (244). A solution was prepared: 50 mM Tris-Cl, pH 7.5; 
500 mM sucrose; 30 mM MgSO^; 40 mM potassium phosphate (pH 7.5) and 
6 mg/ml bovine serum albumin. To 0.5 ml of this reaction medium at 30° C 
were added 10^ cpn of carrier-free ^ P i  or 33Pi and water to bring the 
volume to 0.90 - 0.95 ml. Mitochondrial protein, 1 mg (50-100 pi volume) 
was then added and the assay preincubated with any inhibitors or 
effectors for 5 minutes at 30° C. The reaction was started with 12 
pmoles ATP, pH 7.5, and terminated after 5 minutes by addition of 0.5 ml 
1 M PCA or 0.5 ml 10% TCA. Coagulated protein was removed by bench 
centrifugation and a O.5 ml aliquot from the supernatant taken for 
determination of "*2P or ^ P  labelled ATP by a method based on that 
described by Pullman (353). The 0.5 ml assay aliquot was taken into a 
10-20 ml glass test tube containing 1.0 ml 5% ammonium molybdate in 
5NH2B0^; 1 ml acetone was then added and the mixture mixed vigorously
on a vortex shaker.0.1 ml Br water was added followed by 5mls water sat­
urated isobutanol benzene (1:1).The mixture was vortex mixed for 30 secs 
and the upper layer removed by aspiration. The process was
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repeated. 5 ml of water-saturated isobutanol were then added, the 
mixture vortexed and the upper layer removed by aspiration. The 
remaining aqueous layer was extracted twice by water-saturated
diethylether (5 ml) which was also removed by aspiration. An aliqupt
32from the remaining aqueous layer was taken for determination of P 
or ^ P  by liquid scintillation counting.
Radiolabelled glucose-6-phosphate was determined by the same
32method described for P labelled ATP above as it partitions between 
isobutanol/benzene and water in the same way as ATP.
The use of benzene has now been terminated in this laboratory. 
Toluene has replaced benzene in the extraction procedures outlined 
above.
NADH-Ferricyanide reductase activity.- This was assayed by the method
of Hatefi et aj^ . (3 54) in 1 ml of a 50 mM Tris-Cl, pH 7.5 buffer
containing 0.7 mM potassium ferricyanide; 0.25 mM NADH and 3-30 pg
enzyme (depending on degree of activity, i.e. 3 pg complex I or 30 pg
submitochondrial particles) . The reaction was initiated with NADH and
the ferricyanide reductase activity determined by following the
absorbance change at 410 nm in a Pye Unicam SP1800 dual beam recording
spectrophotometer using E .. K,Fe(CN)_ ox-red = 1 at 410 nm.mM 3 6
Cytochrome c reductase.- Cytochrome c reductase was assayed by the
method described by Hatefi £t al^ . (354) in 1 ml of a buffer
containing 20 mM potassium phosphate, pH 8.0; 2 mM sodium azide; 0.7
mg oxidised cytochrome c; 0.15 mg mixed phospholipid,O.25 pmole NADH
or 5 pmole sodium succinate. Assays were initiated by addition of
1-100 pg enzyme (depending on degree of purity) . Activity was
followed at 550 rm in a Pye-Unicam dual beam recording spectrophotometer.
E „ cyt c ox-red - 18.5 at 550 nm. mM
Energy linked transhydrogenase was assayed as described in the 
methods section to Chapter 6.
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Protein determination.- Mitochondrial protein was estimated by the 
biuret method of Gornall £t al^  (355) . Purified enzyme protein was 
estimated by the Folin-Lowry method described by Lowry et al. (356) . 
Preparation of dihydrolipoic acid.- This was either obtained as 
such fretn the Sigma Chemical Company or was prepared from oxidised 
lipoic acid by sodium borohydride reduction.
Before use, all glassware used in the preparation of dihydrolipoic 
acid was washed in chloroform/methanol (2:1) , methanol, then 200 mM 
EDTA followed by 0.5 M potassium phosphate before being rinsed in 
several changes of triple glass-distilled water and left to dry.
One gram oxidised lipoic acid was weighed out into a round
bottomed 250 ml quickfit glass flask containing a small teflon coated
magnetic follower. The oxidised lipoic acid was then dissolved by
addition of 100 ml saturated sodium bicarbonate solution. A four-fold
molar excess of sodium borohydride was then added over a period of
10 minutes to the flask with rapid stirring. The reaction mixture
was then left stirring in the dark at RT for 1 hr. The pH was then
taken to 1-2 by the addition of concentrated HC1 . Thisaq
precipitated dihydrolipoic acid which was renoved from the reaction 
mixture by extraction with 2 x 100 ml of redistilled 'AnalaR' chloro­
form (redistilled to remove ethanol) . The chloroform extracts were 
pooled and evaporated in a rotary evaporator to remove the bulk of 
the chloroform. This gave a preparation of dihydrolipoic acid 
substantially free of oxidised lipoic acid. Further purification of 
dihydrolipoate was obtained by vacuum distillation at 50° C, 0.001 
mm Hg. This gives a preparation of dihydrolipoic acid free frem any 
Impurities (by TLC) . Dihydrolipoic acid obtained in this way is a 
mobile colourless liquid. That obtained from Sigma or by borohydride 
reduction prior to vacuum distillation is a yellow visous liquid due 
to contamination by oxidised liploic acid and by lipoic acid polymers.
Dihydroplioate was stored in de-ionised borosilicate vials under
nitrogen.
Preparation of dihydrolipoate solutions.- Unless otherwise described, 
dihydrolipoic acid solutions were normally prepared as follows. 
DihydroLipoic acid was weighed out into a de-ionised glass or boro­
silicate vial: enough 0.25 M sucrose; 10 mM Tris-Cl, pH 7.5; 1 mM EDTA 
was added to give an 0.4 M (or 0.2 M) solution. Tris base (1 M) was 
then added until dissolution of dihydrolipoate was obtained; the final 
volume of the solution was adjusted to 0.2 M (or 0.1 M) by addition of 
the requisite volume of 0.25 M sucrose; 10 mM Tris-Cl, pH 7.5; 1 mM 
EDTA. The final pH of these solutions was usually 7.5 - 7.8. Dihydro­
lipoate solutions were stored at 4° C or at -20° C unless otherwise 
stated.
Preparation of oleoyl-S-lipoate.- Dihydrolipoic acid (0.5 mmole) was 
dissolved in 10 ml redistilled tetrahydrofuran + 10 ml triple distilled 
water. The pH was adjusted to 7.5 with 1 M MaOH. Oleoyl chloride 
(0.5 mmole) was then added to this reaction mixture with rapid stirring. 
The mixture was then stirred in the dark at room temperature for 3-4 
hours; the pH was monitored and kept between pH 7.5-8 by addition of 
1 M NaOH. The mixture was assayed for thiol content by the DTNB 
method. After 3-4 hours the reaction was adjudged to be complete 
(using the disappearance of thiol as the parameter). The reaction 
mixture was acidified to pH 2-3 by addition of 1 M HC1 and extracted 
with 50 ml diethylether which was then removed from the reaction 
products by rotary evaporation. Oleoyl-S-lipoate was the major 
reaction product as indicated by TLC in a system containing toluene: 
ethyl formate:formic acid, 5:4:1. Further purification was carried 
put using preparative thin layer chromatography eluting with the same 
solvent system. Oleoyl-S-lipoate was dissolved in dimethylformamide 
and assayed by the acyl ester methods of Snyder and Stevens (243) or
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Lipmann and Tuttle (242),as described in Chapter 5.
Other fatty acyl-S-lipoates were prepared in the same manner from 
the respective fatty acyl chlorides.
Fatty acyl lipoates were occasionally synthesised fran the 
N-hydroxy-succinimide esters of the appropriate fatty acids (357-8). 
Preparation of adenyl lipoate.- Adenyl lipoate was synthesised 
essentially as described by Reed et al. (359). Lipoic acid (288 mg) 
was dissolved in 1.5 ml redistilled acetonitrile and kept stirring on 
ice. DCCD (144 mg) was added as a solution in 0.5 ml acetonitrile.
The reaction was stirred for 30 minutes at RT after which time dicyclo­
hexyl urea was removed by filtration. Acetonitrile was removed by 
rotary evaporation leaving lipoic anhydride. This was redissolved in 
2.5 ml acetonitrile and immediately added to a solution of AMP (500 mg) 
in 5.25 ml 32% aqueous pyridine. The mixture was stirred at RT for 50 
minutes prior to addition of 5 ml ice cold water. The mixture was then 
extracted with 2 x 10 ml peroxide free diethyl ether and then with 2 x 
lO ml CHClj. A light yellow precipitate was deposited from the 
aqueous layer after chloroform extraction. This was filtered off and 
washed in ice cold water and dried. The yield was rather low (10-20%). 
The product showed a single spot on paper chromatography in an isopropyl 
alcohol/water system (7:3) and displayed u.v. maxima at 259 nm and 
332 nm.
Estimation of thiol groups.- Thiols were estimated by determination with
5,5'-dithiobis-2-nttrobenzoic acid (DTNB) , using an extinction coefficient
K = 13.6 at 412 nm. mM
Results
'Dihydrolipoate'-driven ATP synthesis was a very rarely observed 
reaction. The results presented here are most of the dihydrolipoate- 
driven ATP syntheses observed over a two year period and represent 
about 1% of the total number of experimental attempts to demonstrate
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this reaction. Possible reasons for the low frequency of observing 
this reaction are examined in the discussion section to this chapter. 
ATP synthesis was assayed in a glucose-hexokinase trap system. Here, 
ATP synthesised during (say) oxidative phosphorylation is used by hexo- 
kinase to act as a phosphate donor to glucose producing glucose-6- 
phosphate. ATP synthesis can then be estimated either by following 
the free phosphate content of the system or assaying the glucose-6- 
phosphate produced. The latter is done using the enzyme glucose-6- 
phosphate dehydrogenase which converts glucose-6-phosphate to glucono-6- 
lactone-6-phosphate with the concomitant reduction of NADP+ to n a d p h . 
This NADPH produced can be assayed spectrophotometrically at 340 nm.
Table 3.2 shows apparent dihydrolipoate and oleoyl-S-lipoate- 
driven ATP synthesis in bovine heart mitochondria. These mitochondria 
have had their respiratory chains blocked with antimycin A and 
rotenone. One jjmole dihydrolipoate appears to produce between 1.0 
and 1.3 pmoles of ATP. The stoicheiometry of ATP synthesis-driven by 
oleoyl-S-lipoate is more difficult to establish as the acyl ester was 
added as a crude oil assumed to be 50% pure, the amount added was 
calculated on a weight basis to be about 2 or 5 ymoles. If it was 
100% pure, this amount was 4-10 pmoles. This was, however, unlikely 
as TLC's show that it contained substantial amounts of lipoic acid 
The same is true for oleoyl-S-lipoate added in Tables 3.5,8,9. ATP 
synthesis, driven by oleoyl-S-lipoate calculated by the glucose-6- 
phosphate method was substantially higher than that calculated by the 
phosphate disappearance method. This may be due to a stimulation of 
mitochondrial myokinase activity. Absorbance changes observed in 
this assay were in the order of 0.09 A,„, units/pmole ATP produced
0 7 1
for the phosphate assay and 0.21 A u n i t s / p m o l e  ATP produced for
the glucose-6-pho8phate assay. These are ¿A,_, values of 25% and691
AAj^0 values of 34% over no enzyme and substrate controls.
Table 3.2 Dihydrolipoate and oleoyl-S-lipoate-driven ATP synthesis
in bovine heart mitochondria
Additions ATP synthesis ymoles/2Q minutes
1 2
none O O
none + dihydrolipoate (1 ymole) 1.3 1.0
none + dihydrolipoate (2 ymole) 1.9 1.6
none 4* dihydrolipoate (1 ymole) 3 1.1 1.2
none + dihydrolipoate (1 ymole) +
oligomycin (5 yg) 0 0.15
none + oleoyl-S-lipoate (^  2 ymole) 0 2.7
none + oleoyl-S-lipoate (^  5 ymole) 1.5 3.1
estimated by phosphate disappearance
2 estimated by glucose-6-phosphate appearance; corrected for any 
myokinase activity
3 containing 25 units Sigma C-300 hexokinase
Assays containing 1.4 mg mitochondrial protein were preincubated, 
with rotenone and antimycin A (1.38 yg/mg protein) and oligcmycin, 
where indicated, for 5 minutes at 30° C in a shaking water bath in a 
1.1 ml glucose hexokinase trap system, 2 mM in ADP, containing 25 
units Sigma F-300 hexokinase, except where indicated. Assays were 
initiated by addition of dihydrolipoate (as a 0.2 M solution in 0.25 
M sucrose; 10 mM Tris-Cl, pH 7.5; 1 mM EDTA) or oleoyl-S-lipoate 
(added as a crude oil in CHCl^ : molarity estimated by weight) 
and terminated and assayed for phosphate and glucose-6-phosphate
as described in Table 3.4.
synthesis in these purified enzymes appeared to require the presence 
of an unsatprated fatty acid and oleoyl CoA in cofactor-like 
quantities. Both the 'proton translocating ATPase' of Serrano and 
Racker and Hatefi's complex V on occasion have catalysed dihydro­
lipoate-driven ATP synthesis. This synthesis appears to be roughly 
stoicheiometric with the amount of dihydrolipoate added. Table 3.3 
shows ATP synthesis catalysed by 'proton translocating ATPase'. This 
was measured by three methods simultaneously, i.e. phosphate 
disappearance, glucose-6-phosphate appearance and 33p glucose-6- 
phosphate appearance. There was generally a good correlation between 
the amounts of ATP produced indicated by these methods. Here 1 limole 
of ATP produced gave AAgg  ^of t 0.1; AAg4Q °f ^ 0.18 and 271 cpm 
33P under the conditions of assay; this corresponds to A absorbances 
of 25%, Aa340 100% respectively, compared to substrate and
enzyme blanks. Radioactive background counts and substrate and 
enzyme gave 'v 38 cpm. Similarly ATP synthesis was observed in 
complex V preparations incubated with dihydrolipoate (Tables 3.4-5) . 
Again this synthesis was assayed simultaneously by phosphate 
disappearance, glucose-6-phosphate appearance and 33p labelled glucose 
6-phosphate appearance. Under the conditions of assay used, 0.72 
limole ATP was equivalent to AAggi of 0.065, AAg40 of 0.155 and 33p cpm 
6 0 counts over a background of 31 (Table 3.4), corresponding to AAggl 
of 15% and AAg4Q of t 95% compared to no enzyme and no substrate 
controls. In Table 3.5, 0.351 pmoles ATP was equivalent to AAgg  ^of 
0.045, AAg4Q of 0.07 and radioactive 33p 116 cpm over background and 
no enzyme and no substrate controls. This corresponds to AAfigl of 
^ 10%, AAg4o of 33% compared to no substrate and no enzyme controls. 
Dihydrolipoate-driven ATP synthesis in these enzymes was sensitive to
Dihydrolipoate-driven ATP synthesis was observed in preparations
of ATPases from bovine heart mitochondria. Tables 3.3-7). ATP
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Table 3.3 Dihydrolipoate-driven ATP synthesis in 'proton 
translocating ATPase
Additions ATP synthesis Mmoles/20 mins
Proton translocating ATPase + oleate
1 2 3
+ oleoyl CoA
Proton translocating ATPase + oleate
o 0 0
+ oleoyl CoA + dihydrolipoate (1 Mmole) 
Proton translocating ATPase + oleate
1.2 1.12 1.15
+ oleoyl CoA + dihydrolipoate (1 Mmole) 
Proton translocating ATPase + oleate
0.96 0. 50 1.36
+ oleoyl CoA + dihydrolipoate (1 umole) 
Proton translocating ATPase + oleate
0.96 1.12 1.22
+ oleoyl CoA + dihydrolipoate (2 umole) 
Proton translocating ATPase + oleate
1.98 1.60 2.34
+ oleoyl CoA + dihydrolipoate (1 Mmole) 
Proton translocating ATPase + oleate
0.96 0.94 0.74
+ oleoyl CoA + dihydrolipoate (1 Mmole) 
+ oligomycin (lO Mg)
1 _ .
0 o 0.01
estimated as phosphate disappearance
estimated as glucose-6-phosphate appearance; values corrected for 
any myokinase activity
estimated as "^P labelled glucose-6-phosphate and ^ P  labelled ATP 
containing 25 units Sigma C-300 (NH^j^SO^ precipitated hexokinase
Assays containing 0.57 mg proton translocating ATPase, 5 nmoles oeloyl 
CoA; 15 nmoles oleate were preincubated with these and inhibitors, 
where indicated, for 5 minutes at 30° C in a 1 ml glucose-hexokinase 
trap system, 2 mM in ADP, containing 25 units of Sigma F-300 hexo­
kinase except where indicated, in a shaking water bath. Assays were 
initiated by addition of dihydrolipoate (0.2 M in 0.25 M sucrose; 10 
mM Tris-Cl, pH 7.5; 1 mM EDTA) and terminated after 20 minutes,as
described in Table 3.4.
93
Table 3.4 Dihydrolipoate-driven ATP synthesis in 'complex V ’ ATPase 
from bovine heart mitochondria
Additions ATP synthesis ymoles/2Q mins
1 2 3
complex V + oleate + oleoyl CoA 0 0 O
complex V + oleate + oleoyl CoA
+ dihydrolipoate (1 nmole) 0.72 0.88 0.75
ccmplex V + oleate + oleoyl CoA
+ dihydrolipoate (2 nmole) 1.68 1.29 1.45
complex V + oleate + oleoyl + CoA
+ dihydrolipoate (1 nmole) 1.02 0.83 0.60
complex V + oleate + oleoyl + CoA 
+ dihydrolipoate (1 nmole) +
oligomycin (lO ng) 0 0.14 0.02
estimated by phosphate disappearance
estimated by glucose-6-phosphate appearance ; values corrected 
for any myokinase activity
estimated as ^ P  labelled glucose-6-phosphate and "^P labelled ATP
Assays containing 1 mg ccmplex V protein, 5 nmoles oleoyl CoA, 15 
nmoles oleic acid were preincubated with inhibitors and effectors, 
where indicated, for 5 minutes at 30° C in a 1.2 ml glucose-hexo- 
kinase trap system, 2 mM in ADP, containing 20 units of Sigma C-300 
hexokinase in a shaking water bath. Assays were initiated by 
addition of dihydrolipoate (as a 0.2 M solution in 0.25 M sucrose:
10 mM Tris:, 1 mM EDTA, pH 7.5) . Assays were terminated by (i) taking 
0.1 ml aliquot into 0.1 ml 10% TCA and assaying for phosphate as 
described in the methods section to Chapter 3. (ii) Taking 0.5 ml 
into 0.25 ml 30% PCA and assaying for glucose-6-phosphate as 
described in the methods section to this chapter, (iii) Taking 0.5 ml 
into 0.25 ml 30% PCA,removing coagulated protein by centrifugation and 
taking 0.5 ml of the supernatant into 0.1 ml aqueous brcmine water 
and 1.0 ml 5% ammonium molybdate in 5 NH^SO^ and assaying for P 
labelled glucose-6-phosphate as described in the methods section to 
Chapter 3.
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Table 3 ■ 5 Dihydrolipoate-driven ATP synthesis in complex V ATPase
Additions ATP synthesis pmoles/25 min
1 2 3
complex V + oleate + oleoyl CoA 0 0 0
complex V + oleate + oleoyl CoA +
dihydrolipoate (0.5 pmole) 0.35 0.337 0.34
complex V + oleate + oleoyl CoA +
dihydrolipoate (1.0 pmole) 0.58 0.48 0.42
complex V + oleate + oleoyl CoA + 
dihydrolipoate (5 pmoles) 0 0 0.25
complex V + oleate + oleoyl CoA +
dihydrolipoate (1 pmole) + oligomycin 0.35 o  • 0
complex V + oleate + oleoyl CoA + 
dihydrolipoate (1 pmole) + DCCD 0 0 0
complex V + oleate + oleoyl CoA + oleoyl-S-
lipoate ("p 2 pmoles) 0 2.12 2.37
complex V + oleate + oleoyl CoA + oleoyl-S-
lipoate ( p  5 pmoles) 0.66 3.80 3.94
complex V + oleate + oleoyl CoA + oleoyl-S- 
lipoate (p  2 pmoles) + oligomycin 0 0.19 0.04
complex V + oleate + oleoyl CoA + oleoyl-S- 
lipoate (p  2 pmoles) + DCCD 0 0.14 0.01
estimated by phosphate disappearance
2 estimated by glucose-6-phosphate appearance 3
3 33estimated as P labelled glucose-6-phosphate and ATP. 1 ml phosphoryl­
ation buffer contains 50,000 cpm 33P
Assays containing 0.5 mg complex V protein, 5 pg oleate and 5 pg oleoyl 
CoA were preincubated with 1 pg inhibitors, where indicated, for 5 
minutes at 30° C in a shaking water bath in a 1 ml glucose-hexokinase 
trap system, 2 mM in ADP, containing 25 units Sigma F-300 hexokinase 
prior to initiation by addition of dihydrolipoate (as a 0.1 M solution in 
0.25 M sucrose; lO mM Tris-Cl, pH 7.5; 1 mM EDTA) or oleoyl-S-lipoate 
(as a crude oil in chloroform, molarity estimated by weight). Assays
were terminated after 25 minutes and aliquots taken for phosphate,
33glucose-6-phosphate and P G6P assay as described in Table 3.4
oligomycin (Table 3.3-4) and showed stoicheoimetries ranging between 
0.351 - 1.2:1 pmoles ATP produced/pmole dihydrolipoate added. There 
was generally good correlation between the methods used to estimate 
ATP synthesis. Oleoyl-S-lipoate-driven ATP synthesis was also observed; 
this was sensitive to inhibition by oligomycin and DCCD (Table 3.5).
It is rather difficult to estimate the stoicheiometry of ATP synthesis 
driven by oleoyl-S-lipoate under these conditions as the acyl lipoate 
was added as a crude oil.
The requirement for an unsaturated fatty acid in dihydrolipoate- 
driven ATP synthesis by purified F^Fq  ATPases appears to be specific 
for oleic acid, a cis A-9 monoenoic acid. ATP synthesis was not 
observed in the presence of other cis A-9 monoenoic acids such as 
palmitoleic, myristoleic and ricinoleic acid or the trans isomer of 
oleic acid, elaidic acid (Table 3.6) which appeared together with 
erucic acid to be fairly potent ihhibitors of dihydrolipoate-driven 
ATP synthesis in 'proton translocating ATPase' (Table 3.7). The AA^ g.^  
observed in Table 3.6 was 0.07 ( 30% cf. to controls) and 0.11 (33% cf. 
to controls) in Table 3.7.
A time course assay on dihydrolipoate-driven ATP synthesis gave 
initial velocities for the reaction of a» 500 nmoles ATP synthesised/min/mg 
at 30° C in the presence of 2 vimoles dihydrolipoate and 200 nmoles ATP 
synthesised/min/mg at 30° C in the presence of 1 pmole dihydrolipoate 
(Fig. 3.2); AA^g^ of 0.08 corresponds to 1 wmole under the conditions 
of assay (AA^g^ of 25% cf. to controls). Oleoyl-S-lipoate-driven ATP 
synthesis was also observed in bovine heart SMP; elaidoyl-S-lipoate 
appeared to be unable to drive ATP synthesis (Tables 3.8-9).
Dihydrolipoate-driven AlP synthesis was also observed in rat liver 
mitochondria (Tables 3.10-13). This synthesis was sensitive to oligo­
mycin and the uncouplers DNP and CCCP. Stoicheiometry ranging between 
0.44 and 1.17:1 Umoles ATP produced/pmole dihydrolipoate added was 
observed in these experiments.
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oligomycin (Table 3.3-4) and showed stoicheoimetries ranging between 
0.351 - 1.2:1 pmoles ATP produced/pmole dihydrolipoate added. There 
was generally good correlation between the methods used to estimate 
ATP synthesis. Oleoyl-S-lipoate-driven ATP synthesis was also observed; 
this was sensitive to inhibition by oligomycin and DCCD (Table 3.5).
It is rather difficult to estimate the stoicheiometry of ATP synthesis 
driven by oleoyl-S-lipoate under these conditions as the acyl lipoate 
was added as a crude oil.
The requirement for an unsaturated fatty acid in dihydrolipoate-
driven ATP synthesis by purified ATPases appears to be specific
for oleic acid, a cis A-9 monoenoic acid. ATP synthesis was not
observed in the presence of other cis A-9 monoenoic acids such as
palmitoleic, myristoleic and ricinoleic acid or the trans isomer of
oleic acid, elaidic acid (Table 3.6) which appeared together with
erucic acid to be fairly potent ihhibitors of dihydrolipoate-driven
ATP synthesis in 'proton translocating ATPase' (Table 3.7). The Aa  n691
observed in Table 3.6 was 0.07 (30% cf. to controls) and 0.11 (33% cf. 
to controls) in Table 3.7.
A time course assay on dihydrolipoate-driven ATP synthesis gave 
initial velocities for the reaction of t 500 nmoles ATP synthesised/min/mg 
at 30° C in the presence of 2 pmoles dihydrolipoate and 200 nmoles ATP 
synthesised/min/mg at 30° C in the presence of 1 pinole dihydrolipoate 
(Fig. 3.2); AA^g^ of 0.08 corresponds to ^ 1 pmole under the conditions 
of assay (AA^g^ of 25% cf. to controls). Oleoyl-S-lipoate-driven ATP 
synthesis was also observed in bovine heart SMP; elaidoyl-S-lipoate 
appeared to be unable to drive ATP synthesis (Tables 3.8-9).
Dihydrolipoate-driven ATP synthesis was also observed in rat liver 
mitochondria (Tables 3.10-13). This synthesis was sensitive to oligo­
mycin and the uncouplers DNP and CCCP. Stoicheiometry ranging between 
0.44 and 1.17:1 Pmoles ATP produced/pmole dihydrolipoate added was 
observed in these experiments.
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Fig 3.2 Dihydrolipoate driven ATP synthesis in 
complex V ATPase: time course.
Assays»containing lmg complex V ATPase protein, were 
preincubated in 2mls of a phosphorylation buffer (see 
methods section chapter 3 for composition) 0.2mM in 
ADP;'»mM in Pi containing 20 units sigma F-300 hexo- 
kinase,10 nmoles oleate,10 nmoles oleoyl CoA for 5 
minutes at 30 C prior to initiation by dihydrolipoate. 
Samples (0.2ml) were taken at various times for Pi 
analysis us described in the methods section to ch.3.
2 •
2 .•-- • assay Initiated with 2 jimoles lip(SH)O---O >• '• » 1 nmole lip(SH)
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Table 3.6 Dihydrolipoate-driven ATP synthesis in 'complex V' ATPase:
fatty acid specificity
Additions ATP synthesis nmoles/20 min
complex V ATPase 0
complex V + dihydrolipoate (1 nmole) 0
complex V + dihydrolipoate (1 nmole) + oleic acid 0
complex V + dihydrolipoate (1 nmole) + oleic acid
+ oleoyl CoA (10 nmole) 0.69
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + stearic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(10 nmole) + elaidic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + erucic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + linoleic acid 0
complex V + dihydrolipoate (lnmole) + oleoyl CoA
(lO nmole) + linolenic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + ylinolenic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + arachidonic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + palmitoleic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(10 nmole) + ricinoleic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(10 nmole) + ricinelaidic acid 0
complex V + dihydrolipoate (1 nmole) + oleoyl CoA
(lO nmole) + myristoleic acid 0
Assays containing 1 mg complex V ATPase were preincubated with 
oleoyl CoA (lO nmoles) and 5 ng fatty acids (except dihydrolipoate) 
for 5 minutes in a 1 ml glucose-hexokinase trap system, 0.2 mM in 
ADP, containing 25 units Sigma F-300 hexokinase at 30° C in a shaking 
water bath. Assays were initiated by addition of dihydrolipoate 
and terminated after 20 minutes and assayed for phosphate,as 
described in Chapter 3.
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Table 3.6 Dihydrolipoate-driven ATP synthesis in 'complex V 1 ATPase:
fatty acid specificity
Additions ATP synthesis pmoles/20 min
complex V ATPase O
complex V + dihydrolipoate (1 pmole) O
complex V + dihydrolipoate (1 pmole) + oleic acid O
complex V + dihydrolipoate (1 pmole) + oleic acid
+ oleoyl CoA (10 nmole) 0.69
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole) + stearic acid O
complex V + dihydrolipoate (1 pinole) + oleoyl CoA
(10 nmole) + elaidic acid O
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 rmole) + erucic acid O
complex V + dihydrolipoate (1 pinole) + oleoyl CoA
(10 nmole) + linoleic acid O
complex V + dihydrolipoate (lpmole) + oleoyl CoA
(10 nmole) + linolenic acid O
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole) + y-linolenic acid O
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole) + arachidonic acid O
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole) + palmitoleic acid O
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole). + ricinoleic acid O
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole) + ricinelaidic acid 0
complex V + dihydrolipoate (1 pmole) + oleoyl CoA
(10 nmole) + myristoleic acid O
Assays containing 1 mg complex V ATPase were preincubated with 
oleoyl CoA (10 nmoles) and 5 pg fatty acids (except dihydrolipoate) 
for 5 minutes in a 1 ml glucose-hexokinase trap system, 0.2 mM in 
ADP, containing 25 units Sigma F-300 hexokinase at 30° C in a shaking 
water bath. Assays were initiated by addition of dihydrolipoate 
and terminated after 20 minutes and assayed for phosphate,as 
described in Chapter 3.
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Addition ATP synthesis ymoles/20 min
proton translocating ATPase O
proton translocating ATPase + oleate + oleoyl CoA O
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + oleate (15 nmole) 1.7
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + erucate (15 nmole) O
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + oleate + elaidate (15 nmole) O
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + oleate + erucate (15 nmole) O
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + oleate + elaidate (1.5 nmole) O
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + oleate + erucate (1.5 nmole) O
proton translocating ATPase + dihydrolipoate + oleoyl
CoA + oleate (30 nmole) 1.7
proton translocating ATPase + dihydrolipoate + cleoyl
CoA + oleate + oligomycin (5 yg) O
Assays containing 0.725 mg of proton translocating ATPase protein 
were preincubated with oleoyl CoA (lO nmoles) and fatty acids (15 
nmoles, except where indicated) for 5 minutes at 30° C in a shaking 
water bath in a 1 ml glucose-hexokinase trap system, 0.2 mM in ADP 
containing 22 units of Sigma C-300 hexokinase. Assays were initiated 
by the addition of 2 ymoles dihydrolipoate as a 0.2 M solution in 
0.25 M sucrose; lO mM Tris-Cl, pH 7.5; 1 mM EDTA. Assays were 
terminated and phosphate determined as described in Table 3.4
Table 3.7 Inhibition of dihydrolipoate-driven ATP synthesis in
■proton translocating' ATPase by fatty acids
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Table 3.8 Oleoyl-S-lipoate-driven ATP synthesis in bovine heart SMP 
and teomplex V'ATPase
Additions ATP synthesis ymoles/20 min
sutmitochondrial particles (1.9 mg) 
submitochondrial particles + oleoyl-S-lipoate
o1 o1
(,v 2 ymoles)
submitochondrial particles + oleoyl-S-lipoate
1.24 0.95
('v 5 ymoles) 1.85 1.50
complex V (0.5 mg) O 0
complex V + oleoyl-S-lipoate ("v 5 ymoles) 
complex V + oleoyl-S-lipoate ('v 2 ymoles) +
1.75 1.09
oligomycin (5 yg) 0.55 0
1 parallel determinations by taking separate aliquots to test for
phosphate disappearance
Assays containing either subnitochondrial particles or complex V were 
preincubated with inhibitors (rotenone and antimycin in case of SMP's,
2 yg/mg) for 5 minutes in a 1 ml glucose hexokinase trap system, 2 mM 
in ADP containing 25 units Sigma F-30O hexokinase in a shaking water 
bath at 30° C. Assays were initiated by addition of solutions of oleoyl- 
S-lipoate in dimethylformamide and were terminated after 20 minutes by 
taking 0.2 ml aliquots into 0.2 ml 10% TCA and assaying for phosphate 
as described in Table 3.4.
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Table 3.9 Oleoyl-S-lipoate-driven ATP synthesis in bovine heart SMP
Additions ATP synthesis Mmoles/2Q min
none O
oleoyl-S-lipoate (t 2 Mmoles) 1.09
oleoyl-S-lipoate ("v 5 Mmoles) 2.08
oleoyl-S-lipoate ('v 2 Mmoles) + 5 yg oligomycin 0.16
elaidoyl-S-lipoate (1 Mmole) O
elaidoyl-S-lipoate (2 Mmole) 0
Assays containing 2 mg bovine heart submitochondrial protein were 
preincubated with rotenone and antimycin (1.5 Mg/mg SMP) and oliganycin, 
where indicated, for 5 minutes in a 1 ml glucose-hexokinase trap 
system, 2 mM in ADP, containing 12.5 units Sigma F-300 hexokinase,prior 
to initiation with solutions of fatty acyl lipoates in dimethylformamide. 
Assays were terminated after 20 minutes by taking O.2 ml aliquots into 
0.2 ml 10% TCA. Protein was removed by centrifugation and ATP synthesis 
was estimated as disappearance of phosphate by the method of Fiske and 
Subbarow, as described in the methods section of Chapter 3.
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Table 3.10 Dihydrolipoate-driven ATP synthesis in rat liver 
mitochondria
Additions ATP synthesis pmoles/20 min
rat liver mitochondria 0
rat liver mitochondria + succinate (20 pmoles) 2.32
rat liver mitochondria + antimycin A +
dihydrolipoate (1 pinole) 0.44
rat liver mitochondria + antimycin A +
dihydrolipoate (2 pmole) 0.907
rat liver mitochondria + antimycin A +
dihydrolipoate (3 pmole) 0.974
rat liver mitochondria + antimycin A +
dihydrolipoate (2 pmole) + oligomycin (1 pg) 0.168
rat liver mitochondria + antimycin A +
dihydrolipoate (2 pmole) + DNP (1 pg) 0.100
Assays containing 1 mg mitochondrial protein, 1 pg rotenone, 1 pg 
antimycin A, oligomycin and DNP, where indicated, were preincubated in 
a 1 ml glucose-hexokinase trap system,Q.2mM in ADP, containing 28 
units of Sigma C-300 hexokinase for 5 minutes at 30° C in a shaking 
water bath. Assays were initiated by addition of sodium succinate or 
dihydrolipoate (added as a 0.2 m solution in 0.25 M sucrose; 10 mM 
Tris-Cl, pH 7.5; 1 mM EDTA) and terminated after 20 minutes and
assayed for phosphate as described in Table 3.11.
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mitochondria
Additions
rat liver mitochondria
rat liver mitochondria + succinate
rat liver mitochondria + antimycin A +
1di hydro1ipoate'
rat liver mitochondria + antimycin A +
'dihydrolipoate'
rat liver mitochondria + antimycin A +
'dihydrolipoate'
rat liver mitochondria + antimycin A +
'dihydrolipoate* 1
rat liver mitochondria + antimycin A +
'dihydrolipoate'
assayed by phosphate disappearance 
Dihydrolipoates 1-4 as in Table 3.12
Assays containing 1 mg mitochondrial protein, 2 Pg rotenone and 
antimycin A, 1 pg oligomycin, where indicated, were preincubated for 
5 minutes in a shaking water bath at 30° C prior to initiation by 
addition of 10 moles sodium succinate, pH 7.5, or 2 pmoles (10 pi of 
0.2 M solutions in 0.25 M sucrose; 10 mM Tris-Cl, pH 7.5; 1 mM EDTA) 
dihydrolipoate. Assays were terminated by taking 0.2 ml aliquots into 
0.2 ml 10% ice cold TCA. Protein was removed by centrifugation and 
0.2 ml of the supernatant was assayed for free phosphate by the method 
of Fiske and Subbarow, as described in the methods section to this 
chapter. Assays were carried out in a 1 ml glucose hexokinase trap 
system, 0.2 mM in ADP.
Table 3.11 Dihydrolipoate-driven ATP synthesis in rat liver
ATP synthesis pmoles/2Q min 
O
3.77
2.13
2.01
2.05
0.86
4 + oligoraycin O
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Table 3.12 Dihydrolipoate-driven ATP synthesis in rat liver
mitochondria
Additions ATP synthesis umoles/15 min
rat liver mitochondria o
rat liver mitochondria + succinate 2.05
rat liver mitochondria + antimycin A O
rat liver mitochondria + antimycin A + dihydrolipoate 1 0.87
rat liver mitochondria + antimycin A + dihydrolipoate 2 0.59
rat liver mitochondria + antimycin A + dihydrolipoate 3 0.73
rat liver mitochondria + antimycin A + dihydrolipoate 4 0.17
rat liver mitochondria + antimycin A + dihydrolipoate 5 0
rat liver mitochondria + antimycin A + dihydrolipoate 1
+ oligomycin (1 ug) 0.03
rat liver mitochondria + antimycin A + dihydrolipoate 1
+ DNP (60 nmoles) 0.03
rat liver mitochondria + antdimycin A + dihydrolipoate 1
+ CCCP (2 Mg) O
rat liver mitochondria - antimycin A + succinate +
8-methyllipoic acid (5 Mg) 1.42
rat liver mitochondria - antimycin A + succinate +
7-methylthiheptic acid (5 Mg) 1.22
Dihydrolipoate 1-3 prepared from Sigma Grade II dihydrolipoic acid; 
dihydrolipoate 4 prepared from double distilled dihydrolipoic acid 
obtained initially by borohydride reduction of oxidised lipoic acid; 
dihydrolipoate 5 obtained by reduction of oxidised lipoic acid by 
sodium borohydride. All dihydrolipoates were added as 0.2 M solutions 
in 0.25 M sucrose- 10 mM Tris-Cl, pH 7.5; 1 mM EDTA.
Assays containing 1 mg rat liver mitochondrial protein and 2 Mg 
rotenone were preincubated for 5 minutes at 30° C in a shaking water 
bath in a 1 ml glucose-hexokinase trap system, 0.2 mM in ADP, 
containing 28 units of Sigma C-300 hexokinase with 1 Mg antimycin A and 
other inhibitors, where indicated. Assays were initiated by addition 
of sodium succinate or 2 Mmoles dihydrolipoate, and terminated after 15 
minutes and assayed for phosphate as described in Table 3.11.
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Table 3.13 Dihydrolipoate-driven ATP synthesis in rat liver 
mitochondria
Additions ATP synthesis pmoles/15 min
Rat liver mitochondria O
rat liver mitochondria + succinate (20 pmoles) 2.09
rat liver mitochondria + antimycin A 0
rat liver mitochondria + antimycin A + dihydrolipoate 1 .1.17
rat liver mitochondria + antimycin A + dihydrolipoate 2 1.06
rat liver mitochondria + antimycin A + dihydrolipoate 3 0.11
rat liver mitochondria + antimycin A + dihydrolipoate 5 0.04
rat liver mitochondria + antimycin A + dihydrolipoate 5A O
rat liver mitochondria + antimycin A + dihydrolipoate 5B 0.40
rat liver mitochondria + antimycin A + dihydrlipoate 5C 0
rat liver mitochondria + antimycin A + dihydrolipoate 5D 0
Dihydrolipoates 1,2,3 and 5 as in Table 3.12; dihydrolipoates 5A, B, C 
and D were aliquots of dihydrolipoate 5, stored at R.T. in the dark and 
light and at 4° C in the dark and light respectively for 18 hr prior to 
experiment.
Assays containing 1 mg rat liver mitochondrial protein, 2 pg rotenone 
and 5 pg antimycin A, where indicated, were preincubated for 5 minutes 
at 30° C in a shaking water bath in a 1 ml glucose-hexokinase trap 
system, 0.2 mM in ADP, containing 28 units Sigma 0-300 hexokinase, prior 
to initiation with sodium succinate or dihydrolipoate (2 pmoles). Assays 
were terminated after 15 minutes and phosphate content was determined 
as described in the legend to Table 3. 11.
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Table 3.14 Dark phosphorylation in Rhodospirillum rubrum
chromatophores
Additions ATP formed pmoles/20 min
chromatophores O
chromatophores + dihydrolipoate (1 pmole) 0.69
chromatophores + dihydrolipoate (2 ymole) 1.61
chromatophores + oleoyl-S-lipoate (1 umole) 0.70
chromatophores + elaidoyl-S-lipoate (1 ymole) O
chromatophores + stearoyl-S-lipoate (1 pmole) O
chromatophores + palmltoleoyl-S-lipoate (1 ymole) 0.45
Assays containing 1 mg chromatophore protein were preincubated with 
5 pg HOQNO in a 1 ml glucose-hexokinase trap system, 0.2 mM in ADP, 
containing 25 units Sigma 03 0 0  hexokinase for 5 minutes at 30° C in 
a shaking water bath. Assays were initiated by addition of dihydro­
lipoate or fatty acyl lipoate and were terminated after 20 minutes 
by taking a 0.2 ml assay aliquot into 0.2 ml 10% TCA. ATP was 
estimated by the disappearance of phosphate as described in the 
methods section of Chapter 3.
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Table 3.IS Dihydrolipoate-driven ATP synthesis in a DCCD sensitive 
ATPase from Escherichia coli^: fatty acid specificity
Additions
none
dihydrolipoate + oleoyl 
dihydrolipoate + oleoyl 
dihydrolipoate + oleoyl 
dihydrolipoate + oleoyl 
dihydrolipoate + oleoyl
CoA + oleate
CoA + elaidate
CoA + erucate
CoA + palm i täte
CoA + oleate + erucate
ATP synthesis 
umole Pi/20 minutes
0
2.52
O
O
O
O
enzyme prepared by the method of Friedl et al. (351)
Assays containing 1 mg enzyme were preincubated with fatty acids (15 
nmole) and oleoyl CoA (5 nmole) for 5 minutes at 30° C in a 1 ml glucose- 
hexokinase trap system, 0.2 mM in ADP, containing 25 units hexokinase. 
Assays were initiated with 3 pmole dihydrolipoate and terminated after 
20 minutes by taking a 0.5 ml assay aliquot into 0.5 ml 10% TCA. ATP 
synthesis was estimated by phosphate disappearance; method as 
described in the methods section to Chapter 3.
107
fatty acid specificity
Table 3.16 Fatty acyl lipoate-driven ATP synthesis in 'complex V
Additions ATP synthesis pmoles/20 min
none O
oleoyl-S-lipoate 0.92
stearoyl-S-lipoate 0
elaidoyl-S-lipoate 0
erucoyl-S-lipoate 0
palmitoyl-S-lipoate o
linoleoyl-S-lipoate 0
linolenoyl-S-lipoate 0
oleoyl-S-lipoate + erucoyl-S-lipoate (1 nmol) 0.50
oleoyl-S-lipoate + erucoyl-S-lipoate (5 nmol) 0.27
oleoyl-S-liqoate + erucoyl-S-lipoate (10 nmol) O
oleoyl-S-lipoate + elaidoyl-S-lipoate (10O nmol) 0.27
oleoyl-S-lipoate + elaidoyl-S-lipoate (1 pmol) 0
Assays containing 0.5 mg protein were initiated by addition of 1 pinole 
fatty acyl lipoate, except where indicated. Incubations were carried 
out in a 1 ml glucose-hexokinase trap system, O. 2 mM in ADP, 
containing 25 units hexokinase, for 20 minutes at 30° C and were 
terminated by taking an 0.5 ml assay aliquot into 0.5 ml 10* TCA.
ATP synthesis was estimated by the disappearance of phosphate as
described in the methods section to Chapter 3.
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Under the conditions of the assay used, 1 pinole ATP was
equivalent to AA of a» 0.14 (AA of 25% cf. to controls), by i  by j. —
Chrcmatophores prepared from Rhodospirilium rubrum also displayed
dihydrolipoate and oleoyl-S-lipoate-driven ATP synthesis (Table 3.14)
although here 0.69 pinole ATP was only equivalent to AA of 0.0326yi
(AA,„, of t 10% cf. to controls).691 --
A chloroform released 'F^' like ATPase from bovine heart submito- 
chondrial particles did not appear to catalyse dihydrolipoate-driven 
ATP synthesis in the presence of a dihydrolipoate preparation that 
would drive ATP synthesis in bovine heart SMP in a parallel 
experiment (Table 3.17).
As stated before, dihydrolipoate-driven ATP synthesis was a rarely 
observed reaction. Possible reasons for this were investigated. It 
had been noticed, in the course of work, that certain solutions of 
dihydrolipoate had the ability to inhibit oxidative phosphorylation at 
fairly low concn. (Table 3.20). A number of solutions of lipoic acid 
were prepared and assayed over a period of time for the ability to 
drive ATP synthesis in bovine heart mitochondria (Table 3.19). The 
dihydrolipoates were also assayed for thiol content; their profiles 
in a chloroform/methanol/formic acid-silica gel TLC were also followed 
(Figs. 3.3-4). Those dihydrolipoates that appeared to drive ATP 
synthesis showed characteristic TLC profiles, lipoics D, E and I 
(Figs. 3.3-4). These profiles were similar to those observed in 
preparations of dihydrolipoic acid that stimulated an 'energy-linked' 
transhydrogenase reaction (see also Chapter 6). Possibly
the most notable result obtained in this experiment was that obtained 
with dihydrolipoate I, whose thiol content fell from 100% of the 
theoretical expected to 0%, but still retained the ability to drive 
ATP synthesis. Dihydrolipoates that drove ATP synthesis had a very 
noticeable smell, best described as that of broken digestive biscuits.
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F i g 3.4. Thin layer chromatograms of dihydrolipoates 
assayed for the ability t.o drive ATP synthesis.
Conditions as in fig 3.3. See also table 3.19
Table 3.17 Dihydrolipoate-driven ATP synthesis in bovine heart
SMP and chloroform released ATPase
Additions ATP synthesis pmoles/20 min
SMP O
SMP + dihydrolipoate (2 pmoles) 0.546
CHC13 released ,pl’ ATPase 0
CHC13 released ,Fl'’ ATPa se + dihydrolipoate (2 pinoles) 0
CHC13 released
1 TT 1
F1 ATPase + oleoyl-S-lipoate (1 pmole) 0
Assays containing either 1 mg SMP protein, 1 pg rotenone and 1 pg 
antimycin A or 100 pg chloroform released 'F^1 ATPase protein were 
preincubated for 5 minutes at 37° C in a 1 ml glucose-hexokinase trap 
system, 0.2 mM in ADP, containing 25 units Sigma F-300 hexokinase, 
prior to initiation by addition of dihydrolipoate (as a 0.2 M solution 
in 0.25 M sucrose- 10 mM Tris-Cl, pH 7.5; 1 mM EDTA) or oleoyl-S-lipoate 
(as a 0.1 M solution in dimethylformamide) . Assays were terminated 
after 20 minutes by taking an 0.2 nl aliquot into 0.2 ml 10% TCA.
Protein was removed by centrifugation and 0.2 ml of the supernatant 
was assayed for phosphate as described in the methods section to
Chapter 3.
112
'dihydrolipoate'-driven ATP synthesis in bovine heart 
mitochondria
Table 3.18 Effect of an 'inhibitory dihydrolipoate ' on
Additions ATP synthesis moles/20 min *1
mitochondria 0
mitochondria + pyruvate/malate (10 ymoles/1 ymole) 4.92
mitochondria + rotenone + antimycin A 0
mitochondria + rotenone + antimycin A +
dihydrolipoate I (2 ymoles) 1.72
mitochondria + rotenone + antimycin A +
dihydrolipoate B (2 ymoles) O
mitochondria + rotenone + antimycin A +
dihydrolipoate I (2 vimoles) + 
dihydrolipoate B (200 moles) 1.16
mitochondria + rotenone + antimycin A +
dihydrolipoate I (200 moles) + 
dihydrolipoate B (2 ymoles) 0.15
Dihydrolipoate I and B are as described in the legend to Table 3.18.
Assays containing 1 mg mitochondrial protein were preincubated with
1 yg rotenone and, where indicated, for 5 minutes at 37° C in a shaking 
water bath in a 1 ml glucose-hexokinase trap system, 0.2 mM in ADP, 
containing 25 units Sigma F-300 hexokinase,prior to addition of dihydro- 
lipoates. Similar quantities of dihydrolipoates (200 nmoles) were 
added 1 minute before larger amounts (2 ymoles). Assays were terminated 
after 20 minutes and phosphate content determined as described in
Table 3.17.
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Table 3.21 Inhibition of NADH -+■ Fe(CN)^3 reductase activity in 
bovine heart mitochondria and SMP's by plip (S-S)
Additions Rate'*'
SMP mitochondria
none 0 0
NADH 7.97 4.42
NADH + 2200 nmole plip(s-s) 0.47 O
NADH + 200 nmole plip(s-s)3 1.17 0.94
NADH + 2170 nmole oleate 7.97 4.42
NADH + 170 m o l e  oleate3 7.97 4.42
NADH + 100 yg •1799'2 7.97 nt
NADH + 2lO ng DBCT 7.97 nt
1 Umoles ferricyanide reduced/min/mg
2 addition during assay
3 preincubated with enzyme prior to NADH addition
Assays containing 32 yg SMP protein or 26 yg mitochondrial protein 
were initiated by addition of 250 nmoles NADH. Fericyanide reductase 
activity was determined as described in the methods section to this 
Chapter. Activities quoted were corrected for any non-enzymic 
reduction of ferricyanide.
plip(s-s): polymerised lipoate, originally an ozidised lipoate solution,
0.2 M in methanol
Fig 3.5. Inhibition of NADH — Fe(CN)^~ reductase 
activity by plip(S-S).
Assays containing 32pg bovine heart SMP protein 
were performed as described in the methods section
to chapter 3.
Q __Specific activity: 5.156 pmoles Fe(CN)^ reduced / 
min / mg.
See also table 3.21.
100
Fig 3.6. Inhibition of ATP driven transhvdroqenase 
by pi ip(SH)^•
Assays containing lmg bovine heart SMP protein were 
preincubated with plipiSHjj for 5 minutes at 30°C 
before being assayed for ATP driven transhydrogenase 
activity as described in the methods section to 
chapter 6.
Specific activity of the uninhibited transhydrogenase 
= 57.4 nmoles NADP+ reduced / min / mg SMP protein.
Fiq 3.7. Thin layer chromatograms of (polymerised)
lipoic acids.
solvent front
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Solvent system. CHCl^/CH^OH/HCOOH. 
See also table 3.22
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C 3 spots visualised with iodine vapour.
spots visualised with I^SO^ and charring.
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Not all lipoates that possessed this smell had the ability to drive ATP 
synthesis, but most of those that did drive synthesis did smell like 
this.
Dihydrolipoic acid and oxidised lipoic acid solutions have a
strong tendency to photooxidise and polymerise. It was polymerised
products of these two that were responsible for the inhibition of
oxidative phosphorylation observed (Table 3.20). These compounds
were further investigated to find their mode and/or locus of action.
Polymersied lipoic acid inhibits electron transport through site 1
(Table 3.21; Fig. 3.5). The levels of polymerised lipoate required
to inhibit electron transport were, however, substantially higher than
those required to inhibit oxidative phosphorylation. A locus of action
close to the coupling mechanism was suggested by their ability to
inhibit ATP-driven energy linked transhydrogenase (Fig. 3.6) and to
stimulate the coupled ATPase activity of bovine heart and rat liver
mitochondria (Tables 3.22-23). Uncoupling agents will also stimulate
coupled ATPase (by releasing respiratory control).Polymerised lipoate,
however, differs from uncouplers in its ability to stimulate uncoupled
mitochondrial ATPase activity (Table 3.23,Fig. 3.9). This stimulation
of ATPase activity was not due to a partial release of F^ ATPase as the
stimulated activity displayed the same sensitivity to ATPase inhibitors
as normal mitochondrial ATPase (Table 3.25; Figs. 3.11-12).
Determinations of the Km ATP of mitochondrial ATPase in the presence of
lipoate showed that the affinity for ATP was lowered but the v ofmax
the system was increased (Fig. 3.10).
The rarity of' observed dihydrolipoate-driven ATP synthesis, 
coupled with the extreme complexity of lipoic acids solution chemistry, 
made identification of the components in di hydro Update solutions 
responsible for ATP synthesis very difficult. Lipoic acid has a rather
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Table 3.22 Effect of various dihydrolipoates on ATPase activity in 
bovine heart mitochondria and SMP
Additions ATPase
mitochondria SMP
specific 1 
activity
% activity specific^ % 
activity
activity
none 0.916 100 2.55 loo
dihydrolipoate 1 0.924 101 2.59 lOl
dihydrolipoate 2 0.822 90 2.55 100
dihydrolipoate 3 1.814 198 2.76 108
dihydrolipoate 4 0.800 87 2.59 101
dihydrolipoate 5 0.962 105 3.10 121
dihydrolipoate 6 2.100 229 2.89 113
Mmoles phosphate released/min/mg
Assays containing either 100 Mg mitochondrial protein or 57 Mg SMP 
protein were preincubated with 20 nmoles dihydrolipoates for 5 minutes 
at 30° C in 1 ml 50 mM Tris-Cl, pH 8.5; 5 mM MgClj prior to initiation 
of assay with 5 Mmoles ATP. Assays were terminated with 0.5 ml 10%
TCA and phosphate was determined as described in the methods section 
to Chapter 3.
See Fig. 3.7 for TLC of dihydrolipoates
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Table 3.23 Stimulation
polymerised
of rat liver mitochondrial 
lipoate
ATPase by
Additions ATPase specific activity'
-plip(s-s) +plip(s-s)
none 0.386 0.749
DNP 0.492 0.759
ÏTFB 0.606 0.914
Gramicidin D 0.633 0.820
Valinomycin 0.351 0.890
pmoles phosphate released/min/mg
Assays containing lOO pg mitochondrial protein were preincubated with 
ionophores, uncouplers (1 pg/assay) and polymerised oxidised lipoate 
(plip(s-s)) for 5 minutes at 30° C prior to initiation by addition 
of 5 pmoles ATP. Assays were terminated after 5 minutes at 30° C by 
addition of 0.5 ml 10% TCA. Phosphate was determined as described 
in the methods section to this Chapter. Assays were incubated in 1 ml 
50 mM Tris-Cl, pH 8.5,- 5 mM MgCl2.
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nmoles plipfSH^ / mg protein.
Fig 3.8. Stimulation of coupled bovine heart 
mitochondrial ATPase by plip(SH) ^
Assays containing 155pg bovine heart mitochondrial 
protein in 0.9 ml 50mM Tr.is-Cl pH 8.5;5mM MgC^ were 
preincubated with plip(SH)^, for 5 minutes at 30°C. 
Assays were initiated by the addition of 5 pmoles ATP 
and terminated after 5 minutes at 30°C by the add­
ition of 0.5 mis ice cold 1C% TCA.Free Pi and hence 
ATPase activity was determined as described in the 
methods section to chapter 3.
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Table 3.24 Polymerised dihydrolipoate stimulated bovine heart
mitochondrial ATPase: effect of uncouplers and ionophores
Additions ATPase specific activity^
2 3coupled ATPase uncoupled ATPase
none 1.78 0.60
plip (SH) 2 3.34 0.97
plip(SH)2 + FCCP 3.34 0.97
plip(SH)2 + CCP 3.61 nt
plip(SH)2 + 1799 3.44 nt
plip(SH)2 + TiT ’B 3.34 0.97
plip (SH) 2 + DNP 3.61 0.97
plip (SH) 2 + PCP 3.70 nt
plip(SH)2 + DBrP 3.70 nt
plip(SH)2 + S13 3.70 0.90
plip(SH)2 + valinomycin 4.01 0.97
plip(SH)2 + nigericin 4.32 0.97
plip(SH)2 + gramicidin 4.41 1.02
moles phosphate released/min/mg
2 coupled ATPase. ATPase activity in coupled mitochondria that display 
respiratory control and uncoupler stimulated ATPase
uncoupled ATPase: ATPase in mitochondria lacking repsiratory control 
or an uncoupler stimulated ATPase
Assays containing either lOO ug coupled or uncoupled mitochondrial
protein were preincubated with either lOO nmoles or 10 nmoles
4polymerised dihydrolipoate and either 0.65 yg or 0.5 yg ionophores 
or uncouplers for 5 minutes at 30° C in 1 ml 50 mM Tris-Cl, pH 8.5(
5 mM MgClj prior to initiation of assay with 5 ymoles ATP. Assays 
were terminated after 5 minutes with 0.5 ml 10% TCA; phosphate was 
determined as described in the methods section to this Chapter.
^ nmoles polymerised dihydrolipoate, plip(SH)2* expressed as nmoles 
dihydrolipoate expected from initial molarity of solution prior to 
polymerisation.
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nmoles plipiSH^ / mg protein.
Fig 3.9 Stimulation of uncoupled bovine heart 
mitochondrial ATPase by plip(SH)„._
Assays containing 155 ug bovine heart mitochondrial 
protein were preincubated with plip(SH ) 2  for 5 
minutes at 30°C .Assays were performed as described 
in fig 3.8.
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Table 3.25 Effect of inhibitors on 'polymerised lipoate' 
stimulated bovine heart mitochondrial ATPase
Additions ATPase specific activity1
none 0.634
polymerised lipoate 1.02
polymerised lipoate + FCCP 1.08
polymerised lipoate + TTFB 1.02
polymerised lipoate + oligomycin 0.04
polymerised lipoate + venturicidin 0.12
polymerised lipoate + DBCT 0.01
polymerised lipoate + TET 0.03
polymerised lipoate + efrapeptin 0
polymerised lipoate + aurovertin 0.04
gmoles Pi released/min/mg
Assays containing lOO gg mitochondrial protein were preincubated 
with 13 nmoles polymerised dihydrolipoate^ for 5 minutes at 30° C 
prior to preincubation with 1 gg inhibitors and uncouplers for a 
further 5 minutes at 30° C in 1 ml 50 mM Tris-Cl, pH 8.5; 5 mM MgCij. 
Assays were initiated by addition of 5 gmoles ATP and incubated at 
30° C for 5 minutes before termination by addition of 0.5 ml 10% TCA. 
Protein was removed by centrifugation and phosphate determined by the 
method of Fiske and Subbarow, as described in the methods section to 
this Chapter.
2 nmoles of polymerised lipoate expressed as nmoles dihydrolipoate
l.e.with reference to original molarity of solution prior to its 
polymerisation (see discussion section to this Chapter).
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Fig 3.10.Bovine heart mitochondrial ATPase;Km: effect 
of plip(SH)2.
ATPase assays containing 130pg bovine heart mito­
chondrial protein preincubated with 30 nmoles 
plip(SH ) 2  for 5 minutes at 30°C were initiated with 
ATP and assayed essentialy as described in fig 3.8.
O-- O -plip (SH)
• -- • +plip (SH) 2 .
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Fig 3.11. Oliqomycin inhibition of bovine heart 
mitochondrial ATPase; effect of plip(SH) ,^.
•--• bovine heart mitochondria
O--O " " preincubated with
plipCSH^» 300 nmoles / mg protein.
Assays containing 130|ug bovine heart mitochondrial 
protein were preincubated with oligomycin and 
plip(SH ) 2  , where indicated,lor 5 minutes at 30°C prior 
to initiation of the assay with 5 pmoles ATP. Assays 
were terminated aftçr 5 minutes at 30°C and ATPase 
activity was determined as described in the methods 
section to chapter3
Specific activity ATPase = 1.32 umoles/min/mg.
Fig 3.12. VE2283 inhibition of bovine heart mito­
chondrial ATPase: effect of plip(SH)„.
•--»bovine heart mitochondria.
O--O " " " preincubated with
plip(SH)2 >182 nmoles / mg protein.
Assays containing 22 0|ug bovine heart mitochondrial 
protein were preincubated with VE2283 and plipiSH^, 
where indicated,for 5 minutes at 30°C.Assays were 
carried out as described in fig 3.11.
Specific activity ATPase = 0.86 umoles ATP hydrolysed 
/ min /mg. ^
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Fig 3.13.Dihydrolipoate-metal ion u.y.spectra: 
Mn_' ,Mq2+,Ca2+,K4,Na + ,MH4,Co2 + .
II: as I + 0.2umole M g C ^ . H :  as 1+ O.ljumole CoCl^ 
III: as I + 0.4 " " III: as I + 0.4 " "
Spectra were recorded in a Pye-Unicam SP1800 dual­
beam recording spectrophotometer in 1ml 50mM Tris-Cl 
pH 7.5. Spectra were recorded against blanks cont­
aining 1 ml 50mM Tris-Cl and metal ions at a concen­
tration equivalent to that in the sample cuvette.
2+ 2 +Similar spectra were also observed with Mn ,Ca ,
K ,Na4 and NH4.
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wavelength nm.
Fig 3.14 Dihydrolipoate-metal Ion u.v. spectra;Fe^+.
Spectra were recorded in a Pye-Unicam SP1800 dual 
beam spectrophotometer as described in fig 3.13.
I : 200 nmole lip(SH)2 .
I I  s " + 0 . 1  umole F e C l j .
I I I  : " + 0.2 urn,ole FeClj.
IV s " +0.4 nmole FeCl^»
U)
c
Q)
fdU•H+jao
Fig 3.15 Dihydrolipoate-metal ion spectra: Fe2 +
U.V. spectra were recorded in a Pye-Unicam SP1800 
dual beam recording spectrophotometer as described
in fig 3.13.
Spectrum I. 0.4 pmoles lip(SH) 2I II. + 0.1 umoles FeS04.
I III. + 0.2 I • 1
I IV. + 0.3 I I
I V. + 0.4 I I
• 1 VI. " 1.0 I I
F i g  3 . 1 6  ' A c t i v e '  d i h y d r o l i p o a t e - F e ^ + u . v .  s p e c t r a .  
S p e c t r a  w e r e  r e c o r d e d  a s  d e s c r i b e d  i n  f i g  3 . 1 3 .
T h i s  s a m p le  o f  1 d i h y d r o l i p o a t e '  d r o v e  A T P  s y n t h e s i s ;  
s t i m u l a t e d  A T P - P i  e x c h a n g e  a n d  s t i m u l a t e d  a n  e n e r g y  
l i n k e d  t r a n s h y d r o g e n a s e  i n  b o v i n e  h e a r t  S M P .
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w a v e le n g t h  nm .
F l u  3 . 1 7 ' A c t i v e '  d i h y d r o l l p o a t e - F e J u . v .  s p e c t r a . 
T h i s  d i h y J r u l i p o a t e  s t i m u l a t e d  A T P  s y n t h e s i s .
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nondescript u.v. spectrum and virtually no fluorescence characteristics. 
Nuclear magnetic resonance spectroscopic analysis of solutions was not 
possible as the complex nature of the buffer system (sucrose; Tris-Cl; 
EDTA) made interpretation of spectra obtained impossible. Mass spectro­
metry only revealed the basic skeleton (M.W. 206) expected of lipoic 
acid.
Titration of dihydrolipoic acid with certain metal ions yields 
complexes which have characteristic u.v. spectra in the region 210-400 
nm. Dihydrolipoic acid solutions were investigated, using various 
metal ions as 'probes' for structure or specific states. Metal ions 
such as Mn^+ , Mg^+ , Ca^+, K+, Na+, NH^+ induced no observable 
structural changes in dihydrolipoates u.v. spectrum in the 210-400 
nm region (Fig. 3.13).:metals such as Fe^+, Fe^ + , Cr^+ , Co^+, Cu^+, Ni^+ 
did, however (Figs. 3.14-15). Of these, Fe^+ proved the most useful 
probe of dihydrolipoates 'active structure'. Solutions of dihydro- 
lipoate that drove ATP synthesis and energy linked transhydrogenase 
reactions displayed characteristic Fe^+-u.v. spectra (Figs. 3.16-17). 
These spectra may give some indication of the chemical nature of active 
dihydrolipoate.
Discussion
There are perhaps two central questions relating to the 'ATP 
synthesis' described in this chapter that must be asked. The first is 
is the observed synthesis real synthesis or an artefact of the assay?
The second is if this synthesis is real, what relevance does it have 
to that observed in oxidative phosphorylation?
ATP synthesiseld during oxidative phosphrylation was routinely 
assayed ina glucose-hexokinase trap system which uses ATP to phosphorylate 
glucose producing glucose-6-phosphate. ATP synthesis can thus be 
assayed either by the disappearance of phosphate or the appearance of
glucose-6-phosphate
135
Phosphate was assayed by a method based on that described by 
Fiske and Subbarow (352) . Here inorganic phosphate is complexed with 
molybdate in the presence of sulphuric acid,producing a phosphomolybdic 
canplex (NH^)^(PMo 1204q)aq . This, when reduced to a molybdous form 
has a deep blue colour which can be assayed spectrophotometrically.
The 'molybdenum blue' complex can be used to estimate inorganic 
phosphate quantitatively. The phosphomolybdic complex was reduced 
with 1-amino, 2-naphthol, 4-sulphonic acid.
When ATP is synthesised, Pi is removed from the assay. This is 
observed as a reduction in the amount of 'molybdenum blue' complex 
produced. Phosphorylation assays were customarily performed in buffers 
containing 4 pmoles-6 pmoles Pi/ml. The production of 1 pmole ATP in 
these conditions would produce a drop in the absorbance due to 
molybdenum blue of between ■v 17-25%, depending on the original Pi 
concentration. Artefactual ’ATP syntheis’ would be observed in this 
system if Pi was removed by a method other than esterification into ATP, 
or if the phosphomolybdic complex was formed with reduced efficiency, 
or if it were not reduced to the molybdous form with the same 
efficiency (relative to standard conditions, i .e. determination of Pi 
in the absence of enzymes or substrates). The source of these errors 
could be due to either non-enzymic or enzymic effects. No enzyme, 
control assays run in the presence of substrate show no diminution in 
the amount of detectable phosphate compared to standard assays, 
suggesting that non-enzymic effects (such as precipitation of a Pi- 
lipoate adduct) are not responsible for the diminution in the 
phosphate content observed. Indeed dihydrolipoate has the opposite 
effect, if any, increasing the amount of 'molybdenum blue' complex.
This is because dihydrolipoate can reduce the canplex to its Inolybdous 
blue'form. The amount of dihydrolipoate usually 'carried over' from 
the phosphorylation assay into the phosphate determination step is too
small to appreciably effect the amount of 'molybdenum blue* produced.
There are a number of possible (though not probable) enzymic 
effects that could result in an apparent ATP synthesis. Phosphate 
could be adduced directly to glucose by some lipoate mediated or 
stimulated enzyme system present in mitochondria, SMP' s or mitochondrial 
F1Fq  ATPases. This enzyme system is unknown and if it exists would have 
the rather interesting properties of being inhibited by energy transfer 
inhibitors such as oligomycin (thought to be a specific inhibitor of 
the F^Fq ATPase complex) and uncoupling agents such as S13, 1799, FCCP 
and DNP, and copurifying with the ATPase complex. As ATP was not 
determined directly (by chromatographic purification for example), 
there remains a possibility that this or a similar reaction was taking 
place. Phosphate could have been esterified into some other component of 
the assay system,e.g. sucrose, 'Tris'base or glucose, by an unknown 
enzymic contaminant stimulated or mediated by lipoate. Again this 
contaminant would have to be present in mitochondria and purified 
F^Fg ATPase systems and be sensitive to energy transfer inhibitors and 
uncoupling agents. Such an enzymic system would not, however, explain 
the apparent production of glucose-6-phosphate (Tables 3.2-5) and can 
probably be discounted as a source of spurious 'ATP synthesis'.
Mitochondria and hexokinase are contaminated by myokinase activities. 
These are enzymes which can convert ADP to ATP and AMP.
2 adp ATP - amp
The glucose hexokinase trap systems used to estimate ATP synthesis were 
2 mM or 0.2 mM in ADP; myokinase or dihydrolipoate stimulated myokinase 
activity could have produced <v, 2 or 'v o. 2 pmoles ATP by this mechanism. 
This could have been used to phosphorylate glucose, producing glucose-e- 
phosphate. Myokinase activity could thus give a spurious ATP synthesis 
as assayed by the appearance of glucose-6-phosphate. This could, however,
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not explain the observed parallel disappearance of phosphate from the 
assay system (Tables 3.2-5) and can then be discointed as a source of 
major error in the assays. (For a further discussion of myokinase 
activity arj£ possible artefactual systems associated with it in these 
assays, see the discussion section to Chapter 5). Control experiments 
have failed to demonstrate a dihydrolipoate stimulated myokinase 
activity in either mitochondria or hexokinase.
The observed ATP synthesis then cannot be ascribed to any simple 
artefact or contaminating enzyme system. This being so, we must 
assume that it is real ATP synthesis and attempt to relate it to the 
known ATP synthesising pathway in mitochondria, oxidative phosphorylation 
mediated via the ATP synthase enzyme. The observation of dihydrolipoate- 
driven ATP synthesis in mitochondria and submitochondrial particles, and 
the requirement for an unsaturated fatty acid and fatty acyl CoA as 
cofactors for synthesis in purified F^Fq ATPase preparations (248) led 
to the suggestion that there might be a series of reactions analogous 
to those of substrate level phosphorylation associated with the energy 
transduction apparatus of bioenergetic membranes (235) . Substrate 
level phosphorylation involves the generation of succinyl lipoate, its 
transacylation to CoA and the generation of GTP via a succinyl 
phosphate intermediate (these reactions are discussed in greater detail 
in the discussion to Chapter 5). Griffiths postulated the oleoyl cycle
as a framework for further experimentation (235) .
lipoate
respiratory chain ol eoy 1-S -1 ipoa te
oleate
ATP * oleoyl phosphate
-------^CoA (ACP)
oleoyl CoA (ACP
PiADP
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'Dihydrolipoate' -driven ATP synthesis was observed on a number of
occasions in mitochondria, submitochondrial particles and photosynthetic
bacteria chromatophores. Synthesis was not observed in purified F F1 0
ATPases (such as complex V, 'proton translocating' ATPase) with dihydro­
lipoate alone; here two further components had to be present in cofactor­
like quantities. These were an unsaturated fatty acid and an unsaturated 
fatty acyl CoA. There appeared to be a specificity for oleic acid in 
these reactions (Tables 3.3-7; Fig. 3.2). Although other cis A-9 mono- 
enoic acids (palmitoleic, ricinoleic acids) have been reported to 
substitute for oleic acid (320, 375), this effect was not observed. 
Oleoyl-CoA was the only CoA effective in these reactions, palmitoyl CoA, 
acetyl CoA and free HSCoA had no effect (see (240)). Various fatty acyl 
lipoates were synthesised;again there appeared to be a requirement for 
oleic acid in the fatty acyl moiety of these compounds (Tables 3.8-9,14,15) 
as stearoyl lipoate, elaidoyl lipoate, erucoyl lipoate and other fatty 
acyl lipoates did not drive ATP synthesis under any conditions in either 
vesicular ATPase or purified ATPase preparations. Certain fatty acids, 
notably elaidic acid, the transisomer of oleic acid, and erucic acid 
appeared to be potent inhibitors of dihydrolipoate-driven ATP synthesis 
(Tables 3.7,14,15). Similar results were obtained with elAidoyl and 
erucoyl derivatives on oleoyl phosphate-driven ATP synthesis (see Chapter 
5) .
Dihydrolipoate-driven ATP synthesis was observed with ATPase systens 
derived from a number of sources, bovine heart and rat liver mitochondria, 
Escherichia coli and Rhodospirillum rubrum. Assays performed with mito­
chondria, submitochondrial particles or bacterial vesicles were run in 
the presence of respiratory chain inhibitors such as rotenone and 
antimycin or hydroxy quinoline-N-oxide (in the case of bacterial vesicles). 
Particles that have their respiratory chain blocked with cyanide do not 
display dihydrolipoate-driven ATP synthesis. This could be for two
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reasons; cyanide reacts with thiol groups, giving isothiocyanates
a lipoic acid, isothiocyanate derivative might inhibit dihydrolipoate 
requiring reactions; a similar inhibition has been observed with the 
8-methyl derivative of lipoic acid. The effect of cyanide may be due to a 
reaction with cytochrome oxidase, however. Dihydrolipoate has the ability 
to reduce cytochrome c in solution (not shown) and might under certain 
conditions be able to supply redox energy to this portion of the 
respiratory chain in a manner like that observed for ascorbate/TMPD 
couples. If this was so, then there could be a redox chain mediated 
transfer of redox energy between dihydrolipoate and oxygen via cyt c and 
cytochrcme oxidase. Redox energy passing through this area of the 
respiratory chain can be used by coupling site 3 to synthesise ATP from 
ADP and phosphate.
ADP ATP ADP ATP ADP ATP
antimycin A
tsuccinate td i hyd ro1ipoa te
Cyanide would inhibit this reaction. This reaction should not take 
place in purified f ^Fq  ATPase preparations as they should contain no 
cytochrcmes and other respiratory chain enzymes which 
strongly suggests that ATP synthesis does not occur via this pathway. 
Respiratory chain mediated dihydrolipoate-driven ATP synthesis cannot be 
completely ruled out, however, as both complex V and proton translocating 
ATPase contain low levels of respiratory chain components (particularly
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'proton translocating ATPase'), most notably complex I as assayed by 
NADH-ferricyanide reductase activity (a partial reaction of complex 1 
(see (244),(245)). Complex I contains several types of thiol groups 
(see Chapter 1); it is not clear whether they are involved in the 
coupling site contained in this complex. The iron sulphur centres, 
however, probably are involved in the coupling mechanism, particularly 
centre la. The redox potentials of pyruvate/malate and NAD+/NADH couples 
are -0.32 and -0.33 volts at pH 7 in aqueous solution, while that of 
lipoate ox/red is -0.29 under the same conditions: reduced lipoate would 
be quite able to tap into canplex I at or around the level of the (Fe-S) 
centres. Redox active groupings in hydrophobic environments (lipid- 
protein membranes) can occupy a wide range of redox potentials, depending 
on their microenvironment. It might be possible for dihydrolipoate to 
reduce NAD+ under these conditions. It is interesting to note that 
diaphorase-like activities have been detected in complex V and proton 
translocating ATPase prepared in this laboratory (376). Reversal of 
this reaction would generate NADH from lipiSH).,. This might then 
produce "v' via complex I which would, in turn, drive ATP synthesis via 
the ATP synthase ccmplex (see Fig. 3.18 for details of these mechanisms).
The requirement for an unsaturated fatty acid and fatty acyl CoA 
for these reactions in purified ATPases makes these contamination 
explanations rather unlikely or very simplified, although these lipids 
may have a function in providing the correct hydrophobic environment for 
the enzymes. This is unlikely as the free fatty acid content of mito­
chondrial membranes is very low. Mechanisms of energy conservation at 
site I involving fatty acid groupings have been proposed, notably that 
by Weiss'(377), which involves the reduction of a fatty acyl thioester to 
an aldehyde by NADH. Oxidation of this aldehyde by a non-haem iron centre 
gives a fatty acyl group which initially binds to a membrane base. As
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Fig 3.18.Dlhydrollpoate driven ATP synthesis mediated bv 
contaminating complex I in F^F^ATPase preparations.
1/. Chemiosmotic mechanism requires closed vesicles 
a/, direct loop
2/.Chemical,conformational or proton in membrane model . 
no requirement for closed vesicles
3 / . V a r i a n t  m e c h a n is m . R e v e r s a l  o f  d ia p h o r a s e  l i k e  a c t i v i t y  
c o n t a m i n a t i n g  F ^ F ^ A T P a s e  p r e p a r a t i o n s .
l i p ( S H )  ^ - N A d V
z d ia p h o r a s e  ) -------> a s  1  o r  2 .
l i p ( S - S ) - * ^  ^  NADH
4/.Variant mechanism.Reduction of complex I flavin.
l i p  (SH ) 2 
l i p ( S - S )
flavin ox. 
flavin red
A T P
------ F e - S  c e n t r e s
I
y A D P + P i
F^ F QA T P a s e
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non-haem iron reduces, entropy is lost through the stretching of a lipid 
bilayer attached to non-haem iron and the membrane to which the fatty acid 
chain binds. Simultaneously, energy is expended in separating a carboxyl 
from the protonated base. This charge separation induces a movement of 
protons and reactants,resulting in ATP formation. An essential step in 
this mechanism is the reduction of flavin by NADH; the reduced flavin 
then reduces the fatty acyl thioester to a fatty aldehyde form and the 
reaction proceeds as outlined above. Dihydrollocate is fully capable 
of reducing flavins and could tap into this reaction pathway at this level.
The requirement for a fatty acid can be explained in terms of the 
oleovl cycle. Here lipoate (whether it is bound, 'free' or in seme 
conjugate form is not defined) is acylated to oleoyl-S-lipoate by oleate 
or an oleoyl X (where X is an oleoyl carrier, possibly an oleoyl ubiquinone 
conjugate) . Purified ATPases such as complex V and 'proton trans­
locating' ATPases are prepared by cholate and deoxycholate fractionation 
of mitochondria followed by ammonium sulphate precipitation. All these 
procedures delipidate the enzymes being purified; indeed, the ATPases 
eventually obtained require added phospholipid for maximal activity.
Oleoyl, lipooyl and similar lipid groupings would also be stripped from 
the ATPase complex by these detergent fractionation steps (assuming that 
they are not bound to the bulk protein of the complex). This could 
explain the requirement for fatty acids and fatty acyl CoA's in dihydro- 
lipoate-driven ATP synthesis in these purified ATPases. The added lipids 
would replace (or reactivate) the natural cofactors of the reaction 
removed (or damaged) during the isolation of the ATPases. It is worth 
noting that dihydrolipoic acid and oleoyl CoA will under appropriate 
conditions nonenzymically form oleoyl-S-lipoate in solution.
Support for the concept of the 'oleoyl cycle' might be derived from 
the observed oleoyl-S-lipoate-driven ATP synthesis in F^Fg ATPase enzymes.
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This synthesis had an apparent specificity for oleoyl-S-lipoate. However, 
other interpretations may be made of these results. Dihydrolipoate- 
driven ATP synthesis has a requirement for oleic acid (or a similar fatty 
acid ) (Table 3.6 )i other fatty acids inhibit this reaction. Oleoyl-S- 
lipoate prepared by the methods outlined earlier in this chapter contains 
some free dihydrolipoate; it may be that this was responsible for the 
observed ATP synthesis. Dihydrolipoate itself may not be the actual 
species responsible for driving ATP synthesis (this is discussed in 
greater detail later in this chapter)j oleoyl-S-lipoate may contain or 
mimic this 'active' form of lipoic acid which drives ATP synthesis under 
these conditions. If this were so, other fatty acyl-S-lipoates might be 
expected to contain this active form of lipoate which might drive ATP 
synthesis. This did not appear to be the case (Tables 3.9,14,16) . This 
does not mean, however, that oleoyl-S-lipoate has the specific ability 
among fatty acyl lipoates to drive ATP synthesis. Certain fatty acids 
and fatty acyl lipoates have the ability to inhibit dihydrolipoate- 
driven ATP synthesis (Tables 3.7,15,16). This may be happening in assays 
containing fatty acyl lipoates other than oleoyl-S-lipoate.
Until this point, for simplicity's sake, the lipoic acid species 
resonsible for driving ATP synthesis has been referred to as dihydro­
lipoate. This was because those solutions which drove ATP synthesis all 
originally contained dihydrolipoate. There is evidence to suggest that 
this is not the case. As stated in the first sentence of the results 
section of this chapter, 'dihydrolipoate-driven ATP synthesis'was a 
reaction only very rarely observed. It has never,in my experience.been 
observed in freshly.prepared solutions of dihydrolipoic acid, only in 
solutions that have been 'aged' in sane way, usually by 2-3 cycles of 
freeze-thawing over a period of days. The solution chemistry of lipoic 
acid is complex; dihydrolipoate oxidises to the disulphide form fairly 
rapidly in solution on standing, especially in the light. Solutions of
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'dihydrolipoate' that drive ATP synthesis display a unique TLC profile; 
that is, they appear to contain a compound, that of Rf value 0.74in chloro­
form: methanol ¡formic acid (8:1:1) TLC systems. This compares with a Rf 
value of 0.92 for authentic oxidised lipoic acid and 0.95 for dihydro­
lipoate. Polymeric and sulphoxide forms of lipoic acid display varying 
Rf values, generally decreasing with increasing molecular weight (see 
Figs. 3.3,4,7). Experiments have also shown that there is no strict 
correlation between the stoicheiometry of 'dihydrolipoate'-driven ATP 
synthesis and dihydrolipoate's thiol content (see Table 3.19) .Indeed, 
samples of dihydrolipoate that have been shown to contain no free thiol 
groups stillpossesses the ability to drive ATP synthesis (see dihydrolipoate I, 
Table 3.19: Fig. 3.3). Solutions of lipoic acid capable of driving ATP 
synthesis have a rather peculiar smell that can only be described as that 
of broken biscuits. The smell is intense and appears to be associated 
with most of these active forms. The nature of this active form of 
lipoic acid has been investigated, but as yet no firm conclusions have been 
reached. This is largely because of the complex nature of lipoic acids 
solution chemistry. This chemistry is complex mainly because of the 
reactivity of the dithiolane ring structure and the number of valence 
states that sulphur can occupy. The strain energy of lipoic acid's dithio­
lane ring is small, being only 4-6 k cal/mole (373-4); its reactivity 
comes from the ease with which the S-S bond is broken, giving a reactive 
dithiylyl radical
The energy required to break the S-S bond is small and can be supplied 
by light energy in the visible-ultraviolet range. Polymerisation is 
common in dithiolane compounds. These usually take the form of long
linear polymers.
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These polymers can be as much as 10-200 lipoate units in length (378). 
Similar polymerisations have been observed in dihydrolipoate solutions.
Sulphur can exhibit a number of valency states, most notably 2,4 6,8. 
Lipoic acid compounds often display the higher valency state in one or 
more of their sulphur atoms. The most widely known of these compounds 
are the monosulphoxides or thiosulphinates, also known as B-lipoic acid or 
'protogen B'. They have the general structures: -
There are 8 isomeric forms of the lipoate monosulphoxides, 4 for the d 
and 4 for the 1 form of lipoic acid (380). B-lipoic acid was first 
isolated as an oxidation product of a-llpoic acid frcm bovine liver 
extracts (381) and has the structure:-
These compounds are formed by oxidation of lipoic acid by molecular oxygen 
in the presence of light.
or
II
0
I0
s s s-- s
0
*
o
s-- sr >3 ---R
H
(CH2)4C00H
i
lipoic acid + 02
+ lipoic 
acid _>  2 lipoate
monosulphoxides
V 8-
zwitterion intermediates
146
These intermediates can also give rise to a series of thiosulphonates of 
general structure.
Further oxidation products, thiosulphonic acids, are also known. 
Another important, but little studied,group of oxidation compounds are 
the sulphenic acids, which have a general formula.
Photolysis of lipoic acid solutions produces the unstable rrHS SOH
which later oxidises to the monosulphoxide. Sulphenic acids are known to 
play a role in enzyme catalysis. The sulphenic acid of cysteine 
R-CH2SOH may participate in acyl phosphatase activity via an intermediate 
acyl sulphenylate.
e c h2-soh R-C
\O-PO, H
//E-CH.-S-O-C' //(HO) 2P'
O'
•y // +ECH2S-c ' + 2H 0 --- > ECH2SOH + RC' + H30
R O
Glyceraldehyde-3-phosphate dehydrogenase catalyses the dehydrogenation 
of glyceraldehyde-3-phosphate. A thiol group derived from cysteine 149 
is essential to this reaction. If it is oxidised to a sulphenate 
(-S-OH) the enzyme becomes an acyl phosphatase (382) .
All the above mentioned compounds are likely breakdown products of 
dihydrolipoic acid in solution. Thiolactone compounds may also be 
formed in these solutions. These may have the structures
RS
^ 0 " " ^  0
internal thiolactone 
R = H or lipoic acid
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external thiolactone 
(acyl sulphenylate)
The internal ring thiolactones would be highly strained and thus rather 
unstable.
These lipoic acid compounds are all rather difficult to study in
the complex solutions in which dihydrolipoate was originally made up.
These solutions contain sucrose, Tris base and EDTA and make NMR studies
of lipoic acid very difficult. It is unlikely that sucrose, Tris and
EDTA play any direct part in the ATP synthesis observed as solutions of
dihydrolipoate in dimethylformamide have also driven ATP synthesis,
although with a much lower frequency than those in sucrose, Tris and
EDTA buffers. Mass spectrometry of lipoic acid solutions yield only the
basic skeleton of a-lipoic acid. Any unstable forms would break down
under the ionisation conditions used. The u.v.-visible absorption
spectrum of lipo.ic acid is rather nondescript, with a broad maximum at 333
n m . Dihydrolipoic acid solutions were titrated with metal ions to
2+ 2+ 2+investigate possible structures. Metal ions such as Mn , Mg , Ca ,
K+ , Na+, NH4+ induced no observable change in lipoic acid's u.v. spectra
(Fig. 3.13). Metals such as Fe^+, Fe^+ , Cr^+ , Co^+ , Co^+, Ni^+ , Sn^+ 
did, however (Figs. 3.14,15) . Of these, Fe^+ proved the most useful
probe of dihydrolipoates 'active structure'. Solutions of dihydrolipoate
that drove ATP synthesis and energy linked transhydrogenase displayed
characteristic u.v.-Ffe3+Epectra(Fig. 3.16,17). The chemical nature of
lipoic acid in these complexes is unclear, but the spectra do display
some similarity to that of 0-lipoic acid (363) . Preparations of complex V
and the purple membrane of tfr.To bacterium haloblum (383) that supported
dihydrolipoate-driven ATP synthesis displayed rather similar Fe3+-u.v.-
visible absorption spectra. It is worth noting that solutions of active
lipoate eventually precipitate as a white crystalline polymer which 
appears rather similar to polymers derived frcm oxidation products of 
a-DL lipoic acid.
During these investigations into the structure of 'active' lipoic 
acid, it was noticed that certain dihydrolipoate and lipoate solutions 
appeared to be fairly potent inhibitors of oxidative phosphorylation 
(Table 3.20). Investigation suggested that these inhibitory lipoates 
were linear chain polymers of lipoic acid (hereafter referred to as 
plip (SH) ^  or plip(S-S), depending on the nature of the original solution). 
These polymerised lipoates have a number of modes of action in mito­
chondria. They inhibit electron transport in complex I between NADH and 
ferricyanide (Table 3.21; Fig. 3.5) and also between succinate and 
oxygen (data not shown). They are more effective, however, at inhibiting 
energy linked reactions such as ATP-driven transhydrogenase (Fig. 3.6) 
and ATP-Pi exchange (data not shown) . It should be pointed out that 
inhibition values expressed for plip(SH>2 or plip(S-S) are quoted in 
terms of nmoles lip(SH>2 or lip(S-S). This is done because the molecular 
weight of the polymers is not constant and each polymer may contain up to 
several hundred lipoate units, although lO to 20 is more normal. The 
inhibition of oxidative phosphorylation, ATP-Pi exchange and ATP-driven 
transhydrogenase suggested that plip(SH>2 or plip(S-S) might act at the 
locus of the FjF ATPase. The polymerised lipoates do not inhibit the 
mitochondrial F^Fg ATPase, however; they stimulate it (Table 3.22). 
Mitochondrial ATPase activity can be stimulated by uncoupling agents.
This is thought to be due to release of the kinetic restraints imposed 
by respiration on the ATPase in coupled mitochondria. Polymerised lipoate 
can mimic this reaction, suggesting that it might act as an uncoupling 
agent (Tables 3.22-24; Fig. 3.8). However, plip(SH>2 and plip(S-S) 
retained this ability to stimulate ATPase in uncoupled mitochondria
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that is, mitochondria that display no uncoupler stimulated ATPase (Fig.
3.9; Table 3.24). Polymerised lipoate did not stimulate SMP ATPase
(Table 3.22) or F ATPase activity (data not shown). Double reciprocal
plots of ATPase and stimulated ATPase activity reveal an increase in
v of the ATPase and an increase in the K _ value (Fig. 3.10). The max mATP
stimulated ATPase activity is not due to a release or partial release of 
F^ ATPase as it exhibits the same sensitivity to F F ATPase inhibitors 
as unstimulated ATPase (Table 3.25; Figs. 3.11-12). Polymerized lipoate 
may act by activating (or deactivating) a thiol group involved in ATPase 
(or ATP synthase) activity by disulphide exchange.
The scant evidence suggests that the active form of lipoic acid may 
be a thiolactone or oxidation product (sulphenate, sulphenylate) of 
dihydrolipoate. Other lipoic acid derivatives, lipoamide, dihydrolipo- 
amides, 8-methyl lipoic acid, adenyl-lipoate and 6-lipoic acid have not 
been observed to drive ATP synthesis under any conditions. Weiss has 
proposed a mechanism of oxidative phosphorylation in which a lipoate 
monosulphoxide and oleate play vital roles (384) .
lipoic acid S-monoxide associated with 
| |>(CH2 ) 4COOH ATPase enzyme (may be bound to protein
S ---- S. _ via -COOH group)
0
+ protonation within active site
(c h2)4co oh
protonated enzyme bound lipoic acid S-oxide
RCOO could be oleate bound to the same 
enzyme and involved in the same active site
R - c - o - o  o  wx i
(c h2)4cooh
150
OIIR-C-O- r > < .(CH,).COOH SOH ¿
acyl sulphenylate which reacts with 
phosphate to give acyl phosphate.
If the intermediate enzyme bound 
complex is required to have a
reasonable lifetime prior to the appearance of a phosphate anion (and 
then ADP) , the sulphenic acid group (SOH) might be stabilised by adding
across the double bond in oleic acid, viz.
R-S"" °""'H R-S— I1
/" s í<
these are known reactions 
and are readily reversible
0II (CH ) COOH
R-C-O-S SOH 2 4
H 3°
R-C-O-S
(CH,).COOH 
SOH
second protonation step
protonated sulphenylate
(h o)2p ^ o”
nucleophilic attack of 
phosphate
o 
o
8 - p
¿H HO S
CH,).COOH 
S OH ¿
acylphosphate + bis
(sulphenic acid)
-h2°
P * <S-- s, CH2)4COOH spontaneous reformation of lipoic 
monoxide + water
Weiss also suggested an alternative scheme in which acyl phosphate was 
not an obligatory intermediate, viz.
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The former of these two mechanisms has obvious similarities to the 
'oleoyl cycle'. Active lipoate and oleoyl lipoate might drive ATP 
synthesis by tapping into these cycles at some stage.
There have been several suggestions that vicinal dithiol compounds
may be involved at the coupling sites of oxidative phosphorylation,
notably those of Fluharty and Sanadi (385,386) who demonstrated that the
2+dithiol reagents, y-(p-arsenophenyl) -n-butyrate and Cd acted like 
uncoupling agents. Further direct evidence was not forthcoming. Several 
proteinaceous oxidation phosphorylation factors have been isolated from 
the mitochondrial inner membrane (see (51) for review). One of these, 
Factor B, isolated by Sanadi and co-workers (387) contained two essential 
thiol groups. Hatefi et aJU (388, 389) have purified a similar factor 
to a higher degree of homogeneity. This factor stimulates various energy 
linked reactions and also contains an essential dithiol (or 4 a dithiol) 
grouping. Similarly, McKinney et al. (390) have demonstrated that the 
ATPase coupling factor, CF^ ,^ from chloroplast contains a thioredoxin-like 
activity buried deep in its structure. The active grouping in true thio-
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The former of these two mechanisms has obvious similarities to the 
'oleoyl cycle'. Active lipoate and oleoyl lipoate might drive ATP 
synthesis by tapping into these cycles at some stage.
There have been several suggestions that vicinal dithiol compounds
may be involved at the coupling sites of oxidative phosphorylation,
notably those of Fluharty and Sanadi (385,386) who demonstrated that the
2+dithiol reagents, y-(p-arsenophenyl) -n-butyrate and Cd- acted like 
uncoupling agents. Further direct evidence was not forthcoming. Several 
proteinaceous oxidation phosphorylation factors have been isolated frcm 
the mitochondrial inner membrane (see (51) for review) . One of these, 
Factor B, isolated by Sanadi and co-workers (387) contained two essential 
thiol groups. Hatefi et al. (388, 389) have purified a similar factor 
to a higher degree of homogeneity. This factor stimulates various energy 
linked reactions and also contains an essential dithiol (or *j a dithiol) 
grouping. Similarly, McKinney et al_. (390) have demonstrated that the 
ATPase coupling factor, C F ^  from chloroplast contains a thioredoxin-like 
activity buried deep in its structure. The active grouping in true thio-
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CHAPTER 4
THE EFFECT OF FATTY ACIDS ON THE DICYCLOHEXYL- 
CARBODIIMIDE INDUCED INHIBITION OF MITOCHONDRIAL 
ATPases
Introduction
Studies on the nature of the inhibition of energy linked reactions 
by dibutylchloromethyl tin dichloride (DBCT) suggested that it titrated 
a mobile cofactor of these reactions in the inner mitochondrial membrane 
(315,396). Bovine heart submitochondrial particles incubated with 
sufficient DBCT to induce 95% inhibition of ATPase activity, when mixed 
with an equal amount of non-inhibited particles, recover up to 10O% of 
their normal ATPase activity (50% would be the theoretical maximum 
expected) (235). This suggested that the DBCT binding component could 
diffuse off the ATPase complex or be replaced by an uninhibited component 
from a pool of such moieties in the membrane. Binding studies had shown 
that DBCT was bound to a non-proteinaceous lipophilic component of the 
innter mitochondrial membrane which might be lipoic acid, or a lipoic 
acid derivative(315).
Dihydrolipoic acid apparently exhibited a specific ability to 
reverse the effect of the presumed covalent inhibitor of energy linked 
reactions, DBCT (315,235). These observations lead to the suggestion 
that dihydrolipoic acid or a derivative of it might be directly involved 
in the mechanism of ATP synthesis in mitochondria.
Dicyclohexylcarbodiimide (DCCD), a well-known covalently binding 
inhibitor of energy linked reactions (394) also appeared to titrate some 
mobile component in the inner membrane, as DCCD inhibited bovine heart 
SMP recovered activity in similar experiments to those described above. 
Attention was thus focussed on a search for a compound, or groups of 
compounds, that might reverse the inhibition of energy linked reactions 
induced by DCCD which, by analogy to the apparent relationship between
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DBCT inhibition and dihydrolipoate, might also be involved in the 
mechanism of ATP synthesis in mitochondria.
Materials
All chemicals used were of the highest purity available, usually 
'AnalaR' or a similar grade. All organic solvents were of 'AnalaR1 
grade, redistilled. Fatty acids, fatty acid methyl esters, coenzyme A 
and derivatives, carnosine, anserine, thiamin monophosphate, glutathione, 
lipoic acid, carnitine and oligomycin were all obtained from the Sigma 
Chemical Company. Efrapeptin was obtained from Dr. R.L. Hamill of Eli 
Lilley & Co. Ltd.
Methods
Bovine heart mitochondria, submitochondrial particles and electron 
transport particles were prepared as described in Chapter 3.
DCCD inhibited 'proton translocating' ATPase was prepared from bovine 
heart SMP, incubated overnight at 4° C with sufficient DCCD to induce 
100% inhibition of oxidative phosphorylation and F^F ATPase activity 
(2-5 nmoles DCCD/mg SMP protein), essentially as described for the non- 
inhibited enzyme in Chapter 3.
Oxidative phosphorylation was assayed in a glucose-hexokinase trap 
system as described in Chapter 3.
ATPase activity was assayed essentially by the method of Griffiths 
and Houghton, as described in Chapter 3.
ATP-driven energy linked transhydrogenase activity was assayed as 
described in Chapter 6.
Protein was routinely assayed by a 'quick' biuret method (355) and 
by the Folin-reagent.method of Lowry et al. (356).
Results
A wide spectrum of compounds was tested for the ability to reverse 
the DCCD induced inhibition of both submitochondrial particle ATPase and 
a purified ATPase preparation, the 'proton translocating' ATPase of
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Fig 4.1. Structures of fatty acids.
Stearic acid : octadecanoic acid
'COOH
-COOH
Palmitic acid s hexadecanoic acid
Oleic acid:
acid (all cis)
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Table 4.1 Effect of various compounds on DCCD inhibited proton 
translocating ATPase
Effector ATPase activity yimoles/min/mq
None (DCCD inhibited ) o
Coenzyme A (100 pg) 0.18
Acetyl coenzyme A (lOO pg) o
Glutathione (lOO pg) o
Dihydrolipoate (400 nmoles) o
DL carnitine (50 pg) o
Car nosine (50 pg) o
Anserine (100 pg) o
Thiamin monophosphate (lOO pg) o
Methyl linolenate (lOO pg) 1.70
Cardiolipin (lOO pg) 0.30
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
Dihydrolipoate
(400 nmoles) 
(400 nmoles) 
(400 nmoles) 
(400 nmoles) 
(400 nmoles) 
(400 nmoles) 
(400 nmoles) 
(400 nmoles) 
(400 nmoles)
+ coenzyme A (lOO pg)
+ acetyl coenzyme A (50 pg! 
+ glutathione (lOO pg)
+ DL carnitine (50 pg)
+ carnosine (50 pg)
+ anserine (lOO pg)
+ thiamin monophosphate
+ methyl (1°° •*>
linolenate (lOO Pg) 
cardiolipin (100 pg)
0
0.96
O
O
0
O
O
3.30
0.45
Non-inhibited proton translocating ATPase (parallel preparations) sp Act 
usually 2-6 pmoles/min/mg.
Assays containing 90 pg enzyme protein suspended in 0.9 ml 0.25 M sucrose; 
50 mM Tris-Cl, pH 9.0; 5 mM MgC^; 1 mMEDTA were preincubated with 
indicated amounts of effectors (added as ethanolic or aqueous solutions) 
for 5 minutes at 30° C. The reaction was initiated by the addition of 
5 pmoles ATP and incubated for 5 minutes at 30° C. Assays were terminated 
after 5 minutes by the addition of 0.5 ml ice cold 10% T.C.A. Coagulated 
protein was removed by bench centrifugation and a 0.5 ml aliquot from the 
supernatant was taken for phosphate assay by the method of Fiske-Subbarcw, 
as described in Chapter 3.
DCCD inhibited proton translocating ATPase was prepared by the method of 
Serrano and Racker (245) from DCCD inhibited SMP (5 nmoles DCCD/mg SMP 
protein).
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Table 4.2 Effect of coenzyme A and derivatives on DCCD inhibited 
'proton translocating 1 ATPase
Coenzyme A derivative ATPase activity ymoles/min/mg
None (DCCD inhibited) O
Coenzyme A (lOO tig) 0.3
Acetyl coenzyme A (lOO yg) o
Oleoyl coenzyme A (20 yg) 2.87
Non-inhibited proton-translocating ATPase (parallel preparations) 
sp Act usually 2-6 ymoles/min/mg
Assays containing lOO yg enzyme protein in 0.9 ml 0.25 M sucrose; 50 mM 
Tris-Cl, pH 9.0; 5 mM MgClj; 1 mM EDTA were preincubated with effectors 
(added as aqueous solutions) for 5 minutes at 30° C and were initiated 
by the addition of 5 ymoles ATP. Assays were terminated after incubation 
for 5 minutes at 30° C by addition of 0.5 ml ice cold 10% T.C.A. 
Phosphate was assayed as described in Table 4.1.
DCCD inhibited proton translocating ATPase was prepared by the method 
of Serrano and Racker (245) from DCCD inhibited SMP (5 nmoles DCCD/mg
SMP protein) .
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Table 4.3 Effect of various lipids on a partially DCCD inhibited 
preparation of 'proton translocating' ATPase
Effector ATPase activity ymoles/min/mq
None (DCCD inhibited) 0.65
Methyl linolenate (lOO yg) 2.30
Linolenic acid (lOO yg) 1.80
Dihydrolipoic acid (400 nmoles) 0.65
Coenzyme A (lOO yg) 0.90
Oleoyl -coenzyme A (lOO yg) 2.10
Non-inhibited proton translocating ATPase (parallel preparations). 
sp Act usually 2-6 moles/min/mg.
Assays containing lOO yg enzyme protein suspended in 0.9 ml. 0.25 M 
sucrose; 50 mM Tris-Cl, pH 9.0; 5 mM M g C l 1 mM EDTA were preincubated 
with effectors (added as ethanolic or aqueous solutions) for 5 minutes 
at 30° C. Assays were initiated with 5 ymoles ATP, terminated after 
5 minutes at 30° C incubation with 0.5 ml 10% T.C.A. and assayed for
phosphate as described in Table 4.1.
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Serrano and Racker (245). A typical set of results from these
experiments is listed in Table 4.1. It can be seen that two classes of
compound appear to reverse the DCCD inhibition of ATPase activity; these
are compounds of a generally lipid-like nature, and compounds related
to coenzyme A. The former are the more effective. The lipids most
effective as reversing agents are fatty acid methyl esters and free
fatty acids. Coenzyme A and derivatives also partially reverse the
inhibition, the most effective derivative tested being oleoyl-S-
coenzyme A. This is, however, no more effective as a reversing agent
\
than methyl oleate (Tables 4.2-3). All the fatty acyl methyl esters 
tested could reverse the DCCD inhibited ATPase activity at roughly the 
same levels (Table 4.4). This broad specificity was narrowed, though 
when free fatty acids were tested (as the sodium or 'Tris' salt) (Table 
4.5). Here the most effective reversing agents were the unsaturated 
fatty acids, especially oleic acid. Saturated fatty acids such as 
palmitic, stearic and arachidic acid would also reverse the inhibition, 
but rather less effectively (Table 4.5 and Figures 4.4-5). Shorter 
chain length fatty acids such as caprylic acid and lipoic acid (both 
in the oxidised and reduced form) had no effect on the inhibited 
ATPase at the concentrations tested (Table 4.5).
Bovine heart sutmitochondrial particles (ETP ), incubated withH
levels of DCCD which induced complete inhibition of oligomycin sensitive 
ATPase and ATP synthase activities were also treated with various fatty 
acids. Reversal of inhibited ATPase activity was observed with oleic and 
linolenic acids, oleic acid being slightly the more effective (Figure 
4.3). Although ATPase activity was reversed, ATP synthase (Table 4.6), 
ATP-Pi exchange and ATP-driven energy linked transhydrogenase (Figure 4.2) 
activities were not restored by incubating DCCD inhibited ETP^ with 
levels of oleate which gave substantial reversal of ATPase activity.
The fatty acid induced ATPase activity of DCCD treated ETPH and 
detergent purified ATPase preparations had altered sensitivities to some 
of the well-known inhibitors of ATPase and energy linked reactions, e.g.
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Table 4.4 Effect of fatty acid methyl esters on a DCCD inhibited
'proton translocating' ATPase
Ester ATPase activity pmoles/min/mg
None (DCCD inhibited) o
Methyl linolenate (lOO pg) 3.02
Methyl oleate (lOO pg) 4.20
Methyl palmitoleate (100 pg) 3.52
Methyl heptadecanoate (lOO pg ) 4.13
Non-inhibited proton translocating ATPase ( parallel preparations) 
sp Act usually 2-6 moles/min/mg.
Assays containing lOO pg enzyme protein in 0.9 ml 0.25 M sucrose; 50 mM 
Tris-Cl, pH 9.0; 5 mM MgClj! 1 mM EDTA were preincubated with methyl 
esters for 5 minutes at 30° C prior to initiation of assay with 5 pmoles 
ATP. Assays were terminated after 5 minutes incubation at 30° C by
addition of 0.5 ml ice cold 10% T.C.A. 
described in Table 4.1.
Phosphate was determined as
DCCD inhibited enzyme was prepared by the method of Serrano and Racker 
(245) from DCCD inhibited submitochondrial particles (5 nmoles DCCD/mg
SMP protein)
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Table 4.5 
Additions
Effect of fatty acids on a DCCD 
'proton translocating' ATPase
inhibited preparation of 
ATPase activity ymoles/min/mq
None (DCCD inhibited) O
Caprylate (lOO yg) 0
Lipoate (20 yg) o
Palmitate (40 yg) 1.80
Stearate (40 yg) 1.74
Oleate (40 yg) 5.15
Linoleate (40 yg) 3.50
Linolenate (40 yg) 4.37
y-linolenate (lOO yg) 2.49
Arachidonate (40 yg) 5.05
Arachidic (lOO yg) 1.61
Non-inhibited 'proton translocating' ATPase (parallel preparations) 
sp Act usually 2-6 ymoles/min/mg.
Assays containing lOO yg enzyme protein suspended in 0.9 ml 0.25 M 
sucrose; 50 mM Tris-Cl, pH 9.0; 5 mM MgC 12 ; 1 mM EDTA were preincubated 
with fatty acids (added as the free acid in ethanolic solution: fatty 
acids added in dimethylformamide or as sodium salts in aqueous buffer 
systems have similar effect) for 5 minutes at 30° C prior to initiation 
of assay with 5 ymoles ATP. Assays are terminated after 5 minutes 
incubation at 30° C by addition of 0.5 ml 10% T.C.A. Phosphate was 
determined as described in Table 4.1.
DCCD inhibited enzyme was prepared by the method of Serrano and Racker 
(245) from DCCD inhibited SMP (5 nmoles DCCD/mg SMP protein).
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Fig 4.3. Effect of fatty acids on DCCD inhibited 
bovine heart SMP ATPase activity.
Assays containing 0.55mg SMP protein were preincubated 
with fatty acids (added as methanolic solutions) for 
10 minutes at 30°C in 0.9ml 0.25M sucrose;50mM Tris—Cl 
pH 9.0;5mM MgClj.'lmM EDTA prior to initiation by the 
addition of 5 pmoles ATP.Assays were terminated and 
ATPase activity determined as described in table 4.1.
O--Oassays preincubated with oleate.
linolenate.
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Table 4■6 Effect of oleic acid on DCCD inhibited bovine heart submito- 
chondrial particles: oxidative phosphorylation
Additions Rate nmoles Pi esterif ied/min/mg
ETP 0H
ETP + sodium succinate 170H
DCCDi ETP 0H
DCCDi ETP + oleate (150 nmoles) 0H
DCCDi ETP + oleate (300 nmoles) 0H
DCCDi ETP„ + oleate (1 ymole) OH *1
Oxidative phosphorylation was assayed in a glucose-hexokinase trap
system, 0.2 mM in ADP as described in Chapter 3. All assays contained
1 mg of ETP . ETP„ were inhibited with DCCD by incubation with 15 H n
nmoles DCCD/mg ETP,, for 30 minutes at 4° C prior to commencement of H
assay. ETP„ were incubated in 1 ml phosphorylation buffer with oleate,H
where indicated, for 15 minutes prior to initiation of assay by addition 
of lo ill 1 M sodium succinate, pH 7.3. Assay terminated after 15 minutes by 
removii^ a 200 yl aliquot into 200 yl 10% T.C.A. and assaying for phosphate 
disappearance from the assay by the method of Fiske and Subbarow, as 
described in the methods section to Chapter 3.
Fig 4.4 Reversal of DCCD inhibition of 'proton- 
translocating 'ATPose activity by fatty acids;lino- 
lenate;arachidonate;oleate.
Assays containing 90pg DCCD inhibited 'proton trans­
locating' ATPase in 0.9ml,0.25M sucrose;50mM Tris-Cl, 
pH 9.0;5mM MgC^/'lmM EDTA;were preincubated with 
fatty acids for 5 minutes 30°C.Assays were init­
iated with 5pmoles ATP and incubated for 10 mins at 
30°C prior to termination with 0.5ml ice-cold TCA. 
ATPase activity was determined as described in table 
4.1.ATPase prepared as described in Fig 4.5.
O— o assays preincubated with linolenate.
•— • " " " arachidonate.
A  a  " 1 " oleate.
Fig 4.5 Reversal of DCCD inhibition of 'proton 
translocating1 ATPase by fatty acids:linoleate; 
palmitate.
Preincubation conditions and ATPase activity deter­
minations were as those described in fig 4.4.
O-- O assays preincubated with linoleate.
•-- • " " " palmitate.
DCCD inhibited 'proton translocating' ATPase was
prepared as described in the methods section to ch.4.
3.5
mg fatty acid / mg ATPase protein.
Fig 4.5 Reversal of DCCD inhibition of 'proton 
translocating1 ATPase by fatty acids:linoleate? 
palmitate.
Preincubation conditions and ATPase activity deter­
minations were as those described in fig 4.4.
O-- O assays preincubated with linoleate.
•-- • " " " palmitate.
DCCD inhibited 'proton translocating' ATPase was
prepared as described in the methods section to ch.4.
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oligomycin, efrapeptin, DBCT and DCCD itself (Tables 4.7-8). Oleate 
induced ATPase activity in DCCD treated 'proton translocating* ATPase 
is almost entirely insensitive to further additions of DCCD and DBCT 
even at levels 10-20 times greater than those required to give DCCD and 
DBCT inhibition of 'normal' ETP and proton translocating ATPaseII
activities (Figure 4.6). The situation is somewhat different with oligo­
mycin (Figure 4.7) and efrapeptin (Figure 4.8). Here the oleate restored 
activity is partially sensitive to high levels of oligomycin and rather 
more sensitive to efrapeptin. The oleate restored ATPase activity is, 
however, rather insensitive to all the inhibitors tested.
Discussion
Reversal of DCCD induced inhibition of SMP ATPase and 'proton 
translocating' ATPase activity was obtained by incubating the inhibited 
enzymes with fatty acids and fatty acid methyl esters. Fatty acids were 
the most effective compounds in relieving DCCD inhibition (Tables 4.1-5). 
Although all fatty acids of chain length > C ^  tested could relieve the 
inhibition induced by DCCD, some were far more effective than others.
The most effective were the C^g unsaturated fatty acids, oleic, linoleic 
and linolenic acid and the polyunsaturated arachidonic acid (for 
structures, see Figure 4.1). Of these,oleic acid appeared to be marginally 
the most effective (Figures 4.3-5).
Although oleic acid could reverse the DCCD induced inhibition of 
mitochondrial ATPase, it was unable to reverse the inhibition of energy
linked reactions such as oxidative phosphorylation (Table 4.6), ATP-driven
32energy linked transhydrogenase (Figure 4.2) and ATP- Pi exchange 
reactions (data not shown). This discrepancy of action can be explained 
by a number of possible mechanisms (Figure 4.9). These ares-
(a) Oleate causes F^ ATPase to dissociate completely from FQ, thus 
apparently reversing DCCD inhibition.
(b) Oleate causes a dislocation of F^  ^and FQ subunits, releasing an
Fj^-like activity.
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Table 4.7 Reversal of DCCD inhibition of bovine heart SMP ATPase:
effect of further inhibitors
Additions ATPase activity pmoles/min/mq
SMP 2.31
DCCD inhibited SMP (5 nmoles DCCD/mg
SMP protein) 0.03
DCCD inhibited SMP + oleate (70 pg) 2.06
DCCD inhibited SMP + oleate
+ tributyltin chloride (1 pg) 1.99
DCCD inhibited SMP + oleate + VE2283 (1 pg) 2.06
DCCD inhibited SMP + oleate
+ oligomycin (1 pg) 1.01
DCCD inhibited SMP + oleate
+ efrapeptin (1 pg) 0.61
DCCD inhibited SMP +oleate '■ DCCD (10 nmoles) 2.01
Assays containing lOO pg SMP in 1 ml 50 mM Tris-Cl, pH 8.5;
5 mM MgCl2 were incubated with inhibitors for 5 minutes at 30° C: 
oleate was then added and preincubation was continued for 5 minutes 
at 30° C. Assays were initiated with 5 pinoles ATP and terminated 
after 5 minutes incubation at 30° C by addition of 0,5 ml 10% T.C.A. 
Phosphate was determined as described in Table 4.1.
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oleate umoles/ mg ATPase protein 
Fig 4.6 Reversal of DCCD inhibition of 'proton trans­
locating 'ATPase by oleate seffect of further DCCD____
and DBCT.
Assays containing lOOpg DCCD inhibited1 proton trans­
locating ATPase protein in 0.9ml 0.25M sucrose;50mM 
Tris-Cl,pH 9.0;lmM EDTA;were preincubated with 
i/oleate for 5 minutes I 30 C then, ij/ DCCD or DBCT 
(lOjug/ mg protein) for 5 minutes @) 30 C.Assays were 
initiated by the addition of 5pmoles ATP and incubated 
for 10 minutes (§> 30°C prior to termination by the 
addition of O.Smls ice cold 10% TCA.ATPase activity 
was determined as described in table 4.1.
O--Oassays preincubated with oleate•--• » '• " " +DBCT.
A--a » • 1 •' » +DCCD.
Oleate was added as either a methanolic solution of 
the free acid or as the sodium salt (both produce the 
same effect.ATPase prepared as described in fig 4.5.
oleate jumoles / mg ATPase protein.
Fig 4.7. Reversal of DCCD inhibition of 'proton 
translocating1 ATPase by oleate;effeet of oligomycin.
Preincubation conditions and ATPase activity determ­
inations were as those described in fig 4.6.
•---• assays preincubated with oleate.
O-- O " " " " + oligomycin
(10 ng / mg ATPase protein).
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Fig 4.8. Reversal of DCCD Inhibition of 'proton 
translocatinq'ATPase by oleate: effect of efrapeptin.
Preincubation conditions and ATPase activity 
determinations were carried out as described in fig 
4.6.
O---O assays preincubated with oleate.
• ---• " " " " + efrapeptin
( 10pg / mg ATPase protein).
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Table 4.8 Sensitivity of fatty acid reversed DCCD inhibited ATPase
activity of 'proton translocating' ATPase to further inhibition
Additions
+ oligo- 
mycin
+ efra- 
peptin + DCCD + DBCT
Oleate (10 Mg) 1.82 1.30 1.15 1.80 1.87
Linoleate (10 Mg) 1.43 nt 0.85 nt nt
Linolenate ( 1 0  pg) 0.59 0.49 0.41 0.59 0.58
y-linolenate (loo Mg) 2.3 1.48 nt nt nt
Arachidonate (loo Mg) 1.48 1.20 0.736 nt nt
Palmitate (loo Mg) 0.52 0. 21 nt nt nt
DCCD inhibited proton translocating ATPase specific activity O
Hon-inhibited proton translocating ATPase (parallel preparations) sp. Act 
usually 2-6 pmoles/min/mg.
Assays containing 100 Mg DCCD inhibited ATPase protein suspended in O.9 
ml 0.25 M sucrose; 50 mM Tris-Cl, pH 9.0; 5 mM MgCl2; 1 mM EDTA were 
incubated with inhibitors (1 p9 of indicated inhibitor per assay) 
where indicated for 5 minutes at 30° C. Fatty acid was then added 
and the preincubation continued for 5 minutes at 30° C. Assays 
were initiated by addition of 5 Mmoles ATP and were terminated after 
incubation for 5 minutes at 30° C by the addition of 0.5 ml 10%
T.C.A. Phosphate was determined as described in Table 4.2.
DCCD inhibited proton translocating ATPase was prepared by the method 
of Serrano and Racker (245) from DCCD inhibited SMP (5 nmoles DCCD/mg 
SMP protein) .
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(c) Oleate induces a true reversal of DCCD inhibition but also 
simultaneously uncouples energy linked reactions.
Mechanism (a) is unlikely as oleate treated DCCD inhibition does 
not release from the membrane (ATPase activity partitions with oleate 
treated DCCD inhibited SMP membranes in differential centrifugation 
experiments; results not shown). Mechanisms (b) and (c) are rather 
more difficult to distinguish between. Mechanism (b) supposes oleate 
induces a dislocation between the and F^ portions of the ATPase, 
resulting in a functional uncoupling of ATP consuming or producing 
reactions. Mechanism (c) postulates that oleate truly relieves DCCD 
inhibition, allowing the ATPase to generate a high energy membrane state 
' a» ' but that free oleate acts in its well known role as an uncoupler 
of energy linked reactions (397), thus dissipating ' 'v '. This would 
result in a reversal of ATPase activity, but apparently not of 
oxidative phosphorylation or ATP-driven transhydrogenase.
In order to throw light on the mode of relief of DCCD inhibition, 
the fatty acid induced ATPase activity was examined to ascertain whether 
it was sensitive to various inhibitors of 'normal' mitochondrial ATPase 
activity, viz, further DCCD, DBCT, oligomycin and efrapeptin. Oligomycin, 
DCCD and DBCT all inhibit the complete ATPase, that is, the F^FQ ATPase 
complex. They do not inhibit free F^ ATPase activity and can thus be 
used as markers for the structural integrity of the F^Fq complex. Efra­
peptin, a polypeptide fungal product, is a potent inhibitor of the 
isolated F^. If the oleate induced ATPase activity is sensitive to 
efrapeptin but not to the other inhibitors, then it would be probable 
that F^ ATPase is released or dislocated from the FQ portion of the 
enzyme.
The results in Figures 4.6-8 show that the actual situation is 
somewhat more confused than this. DCCD and DBCT are unable to inhibit 
the oleate induced ATPase, whereas efrapeptin can, suggesting that F^-like
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activity has indeed been released. However, this activity is partially 
sensitive to oligomycin (Tables 4.7-8 and Figure 4.7). The activity is 
only partially sensitive to efrapeptin also: this is probably due to 
the high levels of fatty acid used, sequestering the inhibitors away 
from their sites of action. Essentially the same results are obtained 
if the inhibitors are incubated with the DCCD inhibited enzyme before or 
after oleate addition. A variant on mechanism (b) is that oleate does 
cause a dislocation of F^ from FQ, but this dislocation is only local in 
that it disturbs the binding sites of DCCD and DBCT enough to release 
ATPase activity, but not enough to render it oligomycin insensitive. This 
would require a functional separation of the binding sites for DCCD, DBCT 
and oligomycin.
The DCCD induced inhibition of bovine heart mitochondrial ATPase
14can be correlated with the covalent binding of C DCCD to a hydro- 
phobic component of the inner membrane (393) which has been identified 
as a subunit of the ATPase complex, subunit 9 (393). Oligomycin also 
binds somewhere in the hydrophobic FQ sector of the ATPase. Studies by 
Criddle et al. (398) suggest that oligomycin might also bind to subunit 9. 
Alkyltin compounds such as DBCT also appear to act in a very similar 
manner to oligomycin but studies with radiolabelled triethyl tin (396) 
have shown that the tin binding site is distinct from the oligomycin 
binding site, and that this is also located on or around subunit 9. Thus 
all three binding sites are close together but are structurally different. 
This structural dissimilarity might then explain the apparent partial 
inhibitor sensitivity of oleate induced ATPase activity observed.
Although, in subunit 9, purified from bovine heart mitochondria 
14incubated with C DCCD, radioactivity co-purifies with the protein, it is 
far from clear to which grouping DCCD is bound in the proteolipid 
or indeed whether it exerts its function by primarily binding to a 
protein derived grouping at all. A number of possible binding scenarios
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Fig 4.9. Possible mechanisms of oleate induced 
reversal of DCCD Inhibition of ATP utilising and 
producing systems in bovine heart mitochondria.
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are displayed in Figure 4.10. The most likely is that DCCD binds to 
a -C00H residue derived from glutamic or aspartic acid. This makes 
mechanism (c), true reversal of DCCD inhibition by oleate, unlikely as 
oleate has at best a rather unreactive carboxyl group which is unlikely
to strip reacted DCCD away from its binding site.
Figure 4.10 Some possible stable covalent adducts of DCCD and protein 
functional groups, adapted after (395)
Functional group Car
ÿj-COOH
So it is likely that oleate causes a disruption or dislocation 
of the DCCD inhibited FjFq  ATPase complex which releases a partial F^Fg 
ATPase activity sensitive to efrapeptin and oligomycin, but insensitive 
to DCCD and DBCT rather than inducing a true reversal of DCCD inhibition 
and then uncoupling the energy transducing apparatus of the inner
mitochondrial membrane.
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CHAPTER 5
STUDIES ON THE ROLE OF ACYL PHOSPHATES IN ENERGY COUPLING 
Introduction
Studies on dihydrolipoate-driven ATP synthesis in 'complex V  
ATPase and 'proton-translocating1 ATPase preparations from bovine heart 
mitochondria together with the ability of certain fatty acids to reverse 
DCCD inhibition of the ATPase activity of these enzymes indicated that 
fatty acids might play a role in mitochondrial ATP synthesis. Indeed, 
dihydrolipoate-driven ATP synthesis in these enzymes appeared to require 
the presence of both a cis- -9 monoenoic acid, such as oleic acid, 
and oleoji-CoA in small cofactor like quantities. This led Griffiths 
to postulate that the terminal stages of ATP synthesis might involve a 
series of reactions analogous to those of substrate level phosphorylation. 
These latter reactions, the generation by oxidative decarboxylation of 
a keto acid, the generation of succinyl lipoate and its transacylation 
to coenzyme A and the generation of GTP (and hence ATP) via succinyl 
phosphate led to the hypothesis that the terminal steps of oxidative 
phosphorylation consisted of a series of similar reactions, termed the 
'oleoyl cycle' (235) (see Fig. 6.21). In this the ATPase would 
catalyse a transphosphorylation from oleoyl phosphate to ADP in a 
manner similar to the transphosphorylation from succinyl phosphate to 
ATP (GTP) catalysed by succinyl thiokinase.
Oleoyl phosphate was synthesised and tested for its ability to 
stimulate ATP synthesis in a series of ATPase enzymes derived fran 
mitochondria, Escherichia coli and photosynthetic bacteria vesicles. 
Materials
All chemicals used were of 'AnalaR' or equivalent grades of 
purity. All organic solvents used were of AnalaR grade and redistilled. 
Oleoyl chloride and other fatty acyl chlorides were obtained from the 
Sigma Chemical Company, as were acetyl phosphate, methyl oleate and
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oligomycin. Efrapeptin was obtained from Dr. R. HamiU of Eli Lilley 
Co. '1799' was a kind gift from Dr. P. Heytler. DBCT was synthesised 
here by Dr. K. Cain.
Methods
Bovine heart mitochondria, submitochondrial particles, electron 
transport particles, 'complex V  ATPase and 'proton translocating' ATPase 
were prepared as described in Chapter 3. Oxidative phosphorylation and 
ATPase was assayed as described in Chapter 3.
Chloroform released F ATPase was prepared essentially after the 
method of Beechey et el. (236). Submitochondrial particles were 
suspended in a buffer containing 0.25 M sucrose; 10 mM Tris-Cl, pH 7.5;
1 mM EDTA to a final protein concentration of 20 mg/ml. Redistilled 
AnalaR chloroform (0.5 volumes) was added, and the two phases were 
vigorously mixed for 30 seconds using a vortex shaker. The emulsion 
was broken by centrifuging in a Sorval RC-2B centrifuge SS34 rotor at 
2,000 rpm for 10 minutes. The upper 2/3 of the aqueous layer was then 
centrifuged at 40,000 rpm for 30-60 minutes in a Beckman L5-65 centrifuge 
65 rotor. The supernatant contained the ATPase activity which usually 
had a specific activity in the region of 20-30 ymoles/min/mg and 
occasionally 50-70 Umoles/min/mg.
Chloroform released ATPases were prepared from E. coli vesicles; 
Rhodopseudomas capsulata and Rhodospirillum rubrum chromatophores by 
a similar procedure to that above.
Escherichai coli strain K12-W1485 was grown essentially as 
described by Herbert and Guest (237) .
Cells were grown aerobically in baffle flasks in a shaking incubator 
for 18 hr @ 37° C and isolated by centrifugation at 5,000 g for 15 minutes 
in a Sorval RC2B centrifuge, GSA head. Membrane vesicles were then 
prepared from the cells, either by a disruption in a French press or 
or by a lysozyme and oonotic shock treatment. The French press method
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was modified after that of Bragg et al. (238) . After centrifugation, 
cells were resuspended in 50 mM potassium phosphate, pH 7.0 (1 g cells 
wet weight/5 ml buffer). They were then disrupted in a French pressure 
vessel at 16,000 psi. The suspension was then centrifuged at 17,000 g 
for lO minutes to remove unbroken cells and larger fragments of cell 
debris. The supernatant was then centrifuged at 120,000 g for 2 hrs.
The pellet was washed and resuspended in 50 mM Tris-Cl, pH 7.5; 10 mM 
MgClj. In the lysozyme method, cells were resuspended in 250 mM 
sucrose, 50 mM Tris-Cl, pH 8.0 and spheroplasts were prepared by lyso­
zyme treatment of washed cells as described by Witholt et al. (239) and 
stabilised by the addition of 20 mM MgCl2" The spheroplasts were 
washed by centrifugation at 10,000 g for 15 minutes and broken by 
osmotic shock by resuspension in 20 mM potassium phosphate, pH 8.0, 
containing DNAase (20 pg/ml). Unbroken cells and large fragments 
of cell debris were removed by centrifugation at 10,000 g for 15 minutes. 
Membrane vesicles were isolated by centrifugation of the 10,000 g super­
natant at 100,000 g for 30 minutes. The vesicle pellet was then 
resuspended in the desired buffer. Both methods result in a population 
of vesicles which consists of a large proportion with 'inside out' 
morphology (238,240) ,that is,their ATPases protrude into the 
suspension medium.
The photosynthetic bacteria, Rhodospirillum rubrum and Rhodopseudo- 
monas capsulata, were grown in a media containing (quantities in g/L) , 
yeast extract, 0.5; L-glutamic acid, 4.0; dl-malic acid, 3.5; CaC^. 
0.04; MgS04, 0.2; trisodium citrate, 0.8; KHgPO^f 0.12; K2HP04, 0.18; 
pH was adjusted to 6.8 with 60% KOH. Bacteria grown in a lOO ml starter 
culture from stock slabs were inoculated into flasks containing 10 
litres of the above medium and were grown anaerobically under strong 
white light illumination, with stirring for 4-5 days. Cells were 
isolated from the growth media by centrifugation at 2,000 rpm for 30
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minutes in an MSE 'Mistral' centrifuge, 4 x 1.25L head. Cells were 
resuspended in 10 mM Tris-Cl, pH 7.8, and washed by centrifugation at 
10,000 rpm for 15 minutes in a Sorval RC-2B centrifuge, SS34 rotor.
To prepare chrcmatophores, cells were resuspended in 10 mM Tris-Cl, 
pH 7.8, and sonicated in an MSE 60W sonicator at maximum amplitude for 
2 minutes @ 4° C. The suspension was then centrifuged at 15,000 rpm 
for 10 minutes in a Sorval RC-2B centrifuge SS34 rotor. The supernatant 
was then centrifuged at 100,000 g for 1 hr. Chromatophores were 
resuspended in 10 mM Tris-Cl, pH 7.8, and used immediately or, if wanted 
for more than 24 hrs, were made 50% in glycerol and stored under 
nitrogen at -20° C.
Bacteriochlorophyll was determined by taking a 0.1 sample of
chromatophores into 30 ml of distilled water and reading the absorbance
at 880 nm (E bacteriochlorophyll = 140 @ 880 nm) . mM
Preparation of oleoyl phosphate.- Dry orthophosphoric acid (0.325 g) 
was weighed into a round bottaned, quickfit, 250 ml flask, to which was 
added 30 ml dry, redistilled acetonitrile. The flask contents were 
then stirred, using a magnetic stirrer and follower. Triethylamine 
(500 yl) was added to facilitate the dissolution of orthophosphoric 
acid. Oleoyl chloride (1 ml) was then added, and the reaction was left 
to stir for l*j hours in the dark at room temperature. After this time 
lOO ml 1 M aqueous sodium chloride was added, followed by 70 ml 
redistilled AnalaR chloroform. The reaction mixture was shaken and 
transferred to a separating funnel where the chloroform and aqueous 
phases were allowed to separate. The aqueous phase was then re-extracted 
with 30 ml chloroform and the two chloroform phases were pooled. This 
was then shaken with water to remove any free phosphoric acid and, after 
separation, the chloroform layer was dried over anhydrous sodium sulphate 
for 10-20 minutes. The chloroform was then decanted from the sodium 
sulphate and filtered through chloroform washed Whatman No. 1 filter
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paper to ranove any suspended sodium sulphate. The filtrate was then 
evaporated to dryness in a Buchi evaporator. The remaining material is 
crude oleoyl phosphate. Thin layer chromatography in a chloroform 
methanol (2:1) system shows it to consist of one spot. Purification 
using silica gel thin layer chromatography is difficult as oleoyl 
phosphate undergoes decomposition on silica gel rather easily. 
Characteristaion of oleoyl phosphate.- Infra-red spectra of crude 
oleoyl phosphate show v maxima at 1780 cm ^ for 0=0 of acyl 
phosphate, 1250-1300 cm ^ for P=0 and 2660 cm  ^ for hydrogen bonded 
OH strongly indicating that the crude product does contain substantial 
amounts of oleoyl phosphate.
The crude product was also assayed for its acyl ester content by 
the hydroxamate assay of Lipman and Tuttle (see methods) and its 
hydrolysable phosphate content (see methods). Both these methods, 
together and singly, showed that (a) crude oleoyl phosphate contained 
equimolar amounts of fatty acyl ester and hydrolysable phosphate, and 
(b) both the ester and phosphate contents were consistent with the 
'crude' oleoyl phosphate being 90-100% pure (usually 95-100% pure).
The ^ P NMR spectrum of crude oleoyl phosphate shows a chemical 
shift at 6.38 ppm against a reference H^PO^ as zero consistent with 
the product being an acyl phosphate.
The mass spectrum of 'crude' oleoyl phosphate displays a very 
weak molecular ion peak, m/e 362. A base ion peak, due to loss of 
H2P04 occurs at m/e 265 (100%) . Further loss of CO results in an R+ 
ion at m/e 237. These results are consistent with a breakdown
pattern as follows.: -
0 0 0
Il II
R - C - O - P - O H ■97 ■» R - C
II
OH
oleoyl phosphate 
m/e 362
base ion peak (100%) 
m/e 265
r - c h 3(c h 2)7c h = c h (c h 2)
m/e 237
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The mass spectrum shows no signs of the higher molecular weight dioleoyl 
or trioleoyl phosphate esters whichmight possibly be produced by the 
synthetic method used (this is unlikely). This,together with the ester 
and phosphate content assays,indicate that the 'crude' oleoyl phosphate 
is largely pure. Silica gel thin layer chromatography in a chloroform: 
methanol:acetic acid: water (85:15:10:1) system shows that the only 
major contaminant is oleic acid. This however was usually only present 
at 1-5% (by weight) in freshly prepared oleoyl phosphate.
Oleoyl phosphate was also prepared by the method described by 
Johnson and Criddle (241). This entailed the mixing of 92% ortho- 
phosphoric acid with oleoyl chloride at 0° C and extracting the mixture 
after 15-30 minutes with diethyl ether. The diethyl ether was then 
evaporated to an oil and stored at -20° C. Although Johnson and 
Criddle report a yield of 80-90% oleoyl phosphate using this method, we 
found the product to be more usually 50-60% oleoyl phosphate, the rest 
being oleic acid. This is probably because 92% phosphoric acid contains 
substantial amounts of higroscopio water which causes hydrolysis of 
oleoyl chloride to oleic acid and HC1.
The purest preparations of oleoyl phosphate are not oils at room 
temperature but waxy solids; preparations that are oils may contain 
either large amounts of residual solvent (it is rather difficult to remove 
all the chloroform from oleoyl phosphate by rotary evaporation) or may 
be a solution of oleoyl phosphate in oleic acid. This variation in 
substrate preparation is discussed more fully later (see discussion) . 
Hydroxamate assay for acyl esters.- Oleoyl phosphate and other fatty 
acyl esters (e.g.oleoyl-S-llpoate, erucoyl phosphate) were assayed, using 
a modified hydroxamate assay procedure based on the original method of 
Lipman and Tuttle (242). Tubes containing the acyl ester under test 
and 200 Ml 10% sodium dodecyl sulphate (electrophoretic grade) were 
made up to a final volume of 500 yl with distilled water. Hydroxylamine 
reagent (0.5 ml) and acetate buffer (0.5 ml) were then added, the tubes
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were then vortexed and allowed to stand for lO minutes at room 
temperature. Then 0.5 ml HC1 solution, 0.5 ml 12% trichloroacetic acid 
and 0.5 ml ferric chloride reagent were added with mixing. The assays 
were allowed to stand at room temperature for 15 minutes and their 
optical density at 500 nm was measured in a Unicam SP60O spectrophoto­
meter or an MSE Servoplns %>ectrophotometer. The amount of acyl ester was 
then estimated from a standard curve constructed using either methyl 
oleate, acetyl phosphate or stearoyl oleate as a standard.
Hydroxylamine reagent was prepared for each assay from equal 
volumes of stock solutions of 28% hydroxylamine hydrochloride (w/v) and 
14% sodium hydroxide (w/v). Acetate buffer consists of 0.1 M acetic 
acid and 0.1 M sodium acetate., 2:8. Ferric chloride reagent is 6% 
FeCl^.B^O in 0.1 M HC1 (w/v). Hydrochloric acid solution is a 
dilution of the concentrated acid (36% HC1) , 1:3 with water (v/v) .
Fatty acyl phosphates were assayed for hydrolysable phosphate content. 
Samples of 0.2 M solutions of fatty acyl phosphate dissolved in dimethyl- 
formamide were added to 0.5 ml water: 0.5 ml 60% perchloric acid was then 
added and the assay was incubated at 30° C for 30 minutes with frequent 
mixing. 10% SDS was added to aid dissolution of acyl phosphate if 
required. At the end of this period 0.5 ml samples were taken to 
assay for phosphate in a standard Fiske Subbarow phosphate assay.
Samples were also taken for phosphate assay prior to addition of 
perchloric acid and immediately after it. Oleoyl phosphate preparations 
were generally found to contain little or no free inorganic phosphate.
Acyl ester content of oleoyl phosphate was occasionally estimated, 
using the method of.Snyder and Stevens (243). Stock solutions of the 
following assay reagents were made:- reagent A - stock ferric 
perchlorate:i 5 grams ferric perchlorate dissolved in lO ml 20% 
perchloric acid + 10 ml water diluted to lOO ml with cold absolute
ethanol
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reagent B; alkaline hydroxamate, 4%: 2.0 g hydroxylamine dissolved in
2.5 ml water diluted to 50 ml with cold absolute ethanol; 
reagent C: ethanolic sodium hydroxide, 8%; 4 g sodium hydroxide
dissolved in 2.5 ml water diluted to 50 ml with cold absolute ethanol. 
Assay reagents were prepared immediately prior to use:- reagent D - 
acid ferric perchlorate: 4 ml reagent A + 3 ml 70% perchloric acid 
diluted to lOO ml with cold absolute ethanol; reagent E - alkaline 
hydroxylamine: equal volumes of reagent B + C were mixed and the 
precipitated sodium chloride removed by centrifugation. The supernatant 
was used immediately.
Reagent E (1 ml) was added to a dry acyl ester sample (i.e. no 
solvent present) in a pyrex test tube. This was then heated at 65° C 
for two minutes in a water bath and then left to cool at roan 
temperature for five minutes. Reagent D (2.5 ml) was then added with 
mixing and the assay was allowed to stand for 30 minutes at roan 
temperature, prior to reading its optical density at 530 nm. Acyl 
ester was estimated by comparision to standard curves prepared with 
acetyl phosphate or methyl oleate, usually the latter.
Table 5■ 1 Structures of acyl phosphates
trivial name systematic name structure MW
oleoyl phosphate. cisA9 octadecanoyl
phosphate
elaidoyl phosphate. trans A9 octadecenoyl
phosphate
erucoyl phosphate.cisûl3 docosaenoyl
phosphate
palmitoyl phosphate, hexadecanoyl phosphate
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Results
Oleoyl phosphate was synthesised and characterised as described in 
the methods section of this chapter (see Table 5.1 for structures and 
molecular weights of oleoyl and other fatty acyl phosphates) and was 
normally found to be in the region of 90-100% pure acyl phosphate.
Oleoyl phosphate was tested for its ability to reverse the DCCD induced 
inhibition of Serrano and Raker's 'proton translocating ATPase' (Table 
5.2) and was found to be at least as effective as other oleoyl derivatives 
at reversing this inhibition. The restored ATPase activity was 
insensitive to further additions of DCCD, DBCT, TET and the uncoupler 
•1799’, but was completely sensitive to efrapeptin, thus reinforcing the 
hypothesis proposed in Chapter 4 that oleoyl derivatives 'reverse' the 
DCCD induced inhibition of ATPase activity by a dislocation of the enzyme 
rather than by a true reversal.
Oleoyl phosphate was then tested for its ability to drive ATP 
synthesis in bovine heart submitochondrial particles in a glucose-hexo- 
kinase trap system. ATP synthesis was observed with an apparent 
stoicheiometry of 0.5 moles ATP produced per mole oleoyl phosphate added 
(Table 5.3 and Fig. 5.1). Stoicheiometry of ATP production was 
generally found to be in the region of 0.6 - 0.9 mole ATP produced per 
mole pleoyl phosphate added in experiments where any ATP synthesis was 
observed. This ATP synthesis in bovine heart submitochondrial particles 
was insensitive to the inhibitors of ATP synthesis, DBCT, TET, oligo- 
mycin and the uncoupler '1799' but sensitive to DCCD and efrapeptin 
(Table 5.4).
Oleoyl phospha.te was then shown to drive ATP synthesis in two 
purified ATPase preparations; 'complex V' of Hatefi and coworkers (244) 
and the 'proton translocating' ATPase of Serrano and Racker (245). This 
synthesis was also sensitive to efrapeptin and DCCD but insensitive to 
oligcmycin (Tables 5.5-6). The insensitivity of oleoyl phosphate-driven
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Table 5.2 Effect of oleoyl phosphate on DCCD inhibited 'proton 
translocating' ATPase
Additions ATP hydrolysis Total phosphate
moles/min/mg released (nmoles
DCCD inhibited proton translocating ATPase 0 0
DCCD inhibited proton translocating ATPase
+ oleoyl phosphate (50 nmoles) 0.34 18
DCCD inhibited proton translocating ATPase
+ oleoyl phosphate (125 nmoles) 2.29 124
DCCD inhibited proton translocating ATPase
+ oleoyl phosphate (250 nmoles) 2.92 157
DCCD inhibited proton translocating ATPase 
+ oleoyl phosphate (125 nmoles) + DBCT 2.00 108
DCCD inihibited proton translocating ATPase 
+ oleoyl phosphate (125 nmoles) + TET 2.11 114
DCCD inhibited proton translocating ATPase 
+ oleoyl phosphate (125 nmoles) + DCCD 2.16 117
DCCD inhibited proton translocating ATPase 
+ oleoyl phosphate (125 nmoles) + 1799 2.29 124
DCCD inhibited proton translocating ATPase
+ oleoyl phosphate (125 nmoles) + efrapeptin 0 O
Assays containing 90 pg enzyne were preincubated with oleoyl phosphate 
(as a 50 mM solution in dimethylformamide) and 2 pg effectors, were 
indicated,for 5 minutes at 30° C in 1 ml 50 mM Tris-Cl, pH 8.5; 5 mM 
M g C ^  prior to addition of 5 pmoles ATP. Assays were terminated by 
addition of 0.5 ml 10% T.C.A. Phosphate was determined by the method 
of Fiske/Subbarow as described in Chapter 3. Parallel experiments 
indicate no oleoyl phosphatase activity in the absence of ATP.
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Table 5.3 Oleoyl phosphate-driven ATP synthesis in bovine heart
submitochondrial particles: stoicheiometry of ATP production
Additions ÛA, . 340 ATP, formed nmoles/ZO i
none 2O O
SMP + azolectin o2 o
SMP + oleoyl phosphate (0.4 unoles) 0.06 0.29
SMP + oleoyl phosphate (1.0 nmoles) 0.105 0.51
SMP + oleoyl phosphate (1.4 nmoles) 0.105 0.51
SMP + oleoyl phosphate (2.0 nmoles) 0.160 0.77
SMP + oleoyl phosphate (3.0 nmoles) 0.305 1.47
SMP + oleoyl phosphate (1 nmole) + 2 n g 
aurover tin 0 O
SMP + oleoyl phosphate (1 nmole) + 5 ng DCCD 0 o
SMP + oleoyl phosphate (1 nmole) + 5 ng 1799 0.08 O. 30
SMP + oleoyl phosphate (1 nmole) - ADP 0 O
measured as NADPH
assays read against blanks containing all assay components except 
enzyme or substrate (separate controls)
Assays containing 2 mg SMP's were preincubated with inhibitors, where 
indicated, for 5 minutes in a 1 ml glucose-hexokinase trap system, 2 mM 
in ADP at 30° C in the presence of 2 ng rotenone and 2 ng antimycin. 
Assays were initiated with oleoyl phosphate (as a 0.2 M suspension in 
10 mg/ml azolectin/water), Assays were terminated after 20 minutes and 
assayed for ATP synthesis as described in Table 5.5.
Fig,5.I Oleoyl phosphate driven ATP synthesis in 
bovine heart submitochondrial particles : 
stoicheiometry of ATP production.
Assays were performed as described in table,5.3.
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Table 5.4 Oleoyl phosphate-driven ATP synthesis in bovine heart sub- 
mitochondrial particles: sensitivity to inhibitors of 
oxidative phosphorylation
Additions ATP synthesis
ymoles/15 minutes
7 A340none 0.02 0
oleoyl phosphate (3 ymoles) 0.80 2.75
oleoyl phosphate (3 ymoles) + DBCT 2 yg 0.70 2.41
oleoyl phosphate (3 ymoles) + TET 4 yg 0.62 2.12
oleoyl phosphate (3 ymoles) + oligomycin 4 V<3 0.75 2.58
oleoyl phosphate (3 ymoles) + DCCD 20 nmoles 0.02 O
oleoyl phosphate (3 ymoles) + •1799' 10 yg 0.50 1.69
oleoyl phosphate (3 ymoles) + efrapeptin 4 vg 0.07 0.17
estimated as glucose-6-phpsphate (NADPH)
assays were measured against no substrate and no enzyme blanks (both 
separately
Assays containing 2 mg submitochondrial particles, 2 yg antimycin, 2 yg 
rotenone, were incubated with inhibitors where indicated for 5 minutes 
at 30° C in a 1 ml glucose-hexokinase trap system, 2 mM in ADP, for 5 
minutes prior to addition of oleoyl phosphate. Assays were incubated for 
15 minutes at 30° C and terminated by addition of loo yl 3N HCLProtein was 
removed by centrifuqation and 0.1 ml supernatant was taken into 1.9 ml 
0.5 M Tris-Cl, pH 7.5 and assayed for glucose-6-phosphate as described
in Chapter 3.
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Table 5.5 Oleoyl phosphate-driven ATP synthesis in 'complex V  ATPase
Addition ^A34o nadph produced ATP synthesis
-----  pmoles/20 minutespmoles/20 minutes
none O
azolectin O
complex V 0.09 0.434 -
ccmplex V + oleoyl phosphate 
(1 pmole) 0.235 1.133 0.699
complex V + oleoyl phosphate 
(2 pmoles) 0.420 2.025 1.591
complex V + oleoyl phosphate 
(1 pmole) + 5 pg DCCD 0.12 0.578 0.144
canplex V + oleoyl phosphate 
(1 pmole) + 5 pg '1799' 0.27 1.3022 0.868
oAssays containing 0.5 mg complex V were incubated for 5 minutes at 30 C 
in 1 ml 250 mM sucrose; 20 mM Tris-Cl, pH 7.3; 20 mM glucose; 5 mM 
MgCl2; 0.2 mM EDTA; 2 mM ADP plus 20 units of hexokinase, with inhibitors, 
where indicated. Assays were initiated by addition of an oleoyl phosphate 
azolectin suspension ('v 0.2 M) and were incubated for 20 minutes at 
30° C. Assays were terminated by the addition of 0.425 ml 1 M perchloric 
acid. Coagulated protein was removed by centrifugation in a Jobling bench 
centrifuge; 75 |il 6 H KOH was added to the supernatant which was then 
stood in ice for 20 minutes to allow complete precipitation of potassium 
perchlorate. This was then removed by centrifugation and 0.1 ml of the 
supernatant was added to 1.9 ml 0.5 M Tris-Cl, pH 7.5. To this, 0.5 
Unole NADP and 1-2 units of glucose-6-phosphate dehydrogenase was added.
The tubes were whirlimixed and allowed to stand for 15 minutes prior to 
reading their absorbance at 340 nm in a Pye-Unicam SP1800 dual beam 
spectrophotometer. .Assays were measured against no enzyme and no substrate 
controls.
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Table 5.6 Oleoyl phosphate-driven ATP synthesis in bovine heart 
mitochondrial F^Fq  ATPase complex preparations
Addition ATP synthesis1 
Umoles/20 minutes
•complex V 0
•complex V  + oleoyl phosphate (3 Mmoles) 2.47
'complex V  + oleoyl phosphate (3 Mmoles) +
2 Mg efrapeptin 0
•proton translocating' ATPase 0
•proton translocating' ATPase + oleoyl
phosphate (3 Mmoles) 2.19
•proton translocating' ATPase + oleoyl
phosphate (3 Mmoles) + 2 Mg oligomycin 2.19
•proton translocating' ATPase + oleoyl
phosphate (3 Mmoles) + 2 Mg efrapeptin
1 measured as NADPH
0
Assays, 2 mM in ADP, containing 1 mg ATPase protein were carried out 
as described in Table 5.4
\
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Table 5.7 Oleoyl phosphate-driven ATP synthesis in a chloroform 
released ATPase from bovine heart SMP
Additions ATP synthesis  ^
Mmoles/20 minutes
p a l m i t o y l  p h o s p h a t e  (1  M mole) O
e l a i d o y l  p h o s p h a t e  (1  M mole) O
e r u c c y l  p h o s p h a t e  (1  M mole) O
o l e o y l  p h o s p h a t e  (1  M mole) 0 .8 4
o l e o y l  p h o s p h a t e  (1  Mmole + e r u c o y l  p h o s p h a t e  ( l o o  n m o le s )  O
oleoyl phosphate (1 Mmole) + elaidoyl phosphate
(lOO nmoles) O
oleoyl phosphate (1 Mmole) + palmitoyl phosphate
(lOO nmoles) 0.83
oleoyl phosphate (1 Mmole) + palmitoyl phosphate
0.000 n m o le s ) O
Assays containing lOO Mg CHCl^ released ATPase were preincubated with 
indicated fatty acyl phosphates (second column) for 5 minutes at 30°
C in a 1 ml glucose-hexokinase trap system, 0.2 mM in ADP. Assays 
were initiated by addition of acyl phosphates (as 0.2 M solutions in 
dimethylformamide and terminated after 20 minutes at 30° C by 
addition of perchloric acid. ATP was determined as described in 
Chapter 3 .
1 ATP synthesis quoted has been corrected for myokinase activity
('t 0.1 Mmoles ATP)
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ATP synthesis to inhibitors of the ATPase such as oligomycin, DBCT and 
TET, all of which act on the membrane bound FQ fraction of the ATPase 
and its sensitivity to efrapeptin (an F^ inhibitor)suggested that all 
the steps of the oleoyl phosphate -+■ ATP reaction occur on the F^portion of the 
ATPase. A chloroform released F^ ATPase from bovine heart submito- 
chondrial particles was prepared according to the method of Beechey et 
al. (236) . ATP synthesis was observed with oleoyl phosphate in this 
enzyme (Table 5.7). Other fatty acyl phosphates, elaidoyl, erucoyl and 
palmitoyl phosphates did not drive ATP synthesis (Table 5.7).
As dihydrolipoate-driven ATP synthesis in purified ATPase 
preparations was found to be very sensitive to certain fatty acids 
(especially erucicacid and elaidic acid) (see Chapter 3) oleoyl 
phosphate-driven ATP synthesis was examined to see if it displayed a 
similar sensitivity to other fatty acyl phosphates. Elaidoyl phosphate 
and erucoylphosphate appeared to be extremely effective as inhibitors 
of the reaction, whereas palmitoyl phosphate was rather ineffective 
(Table 5.7). The free fatty acids, elaidic and erucic acid and elaidoyl 
lipoate and erucoyl lipoate (analagous to the postulated oleoyl lipoate 
intermediate) also strongly inhibit this reaction (Figs. 5.2-4). All 
the elaidoyl and erucoylderivatives tested appeared to be extremely 
potent inhibitors of oleoyl phosphate driven ATP synthesis (Table 5.8), 
the phosphates being more effective than the lipoates,which in turn 
were more effective than the free fatty acids.
Chloroform released F^ ATPase in common with other F^ ATPase
32preparations displays no ATP- Pi exchange activity. As this exchange 
activity is thought to be indicative of residual ATP synthase activity,
it might be thought that an F^ ATPase displaying apparent ATP synthesis
32could also catalyse ATP- Pi exchange. Oleoyl phosphate was thus tested
32for its ability to stimulate ATP- Pi exchange in chloroform released
32F^ ATPase from bovine heart submitochondrial particles. ATP- Pi
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• ------ • e r u c i c  a c i d .
A s s a y s  c o n t a i n i n g  lO O ju g  c h l o r o f o r m  r e l e a s e d  A T P a s e  
p r o t e i n  from , b o v in e  h e a r t  SMP w e re  p r e i n c u b a t e d  w i t h  
f a t t y  a c i d s , a d d e d  a s  s o l u t i o n s  i n  d im e t h y l f o r m a m id e ,  
f o r  5 m in u t e s  a t  3 0 ° C  p r i o r  t o  a d d i t i o n  o f  1 0  n m o le s  
A T P .  A T P P i  e x c h a n g e  w as a s s a y e d  a s  d e s c r i b e d  i n  t h e  
m e th o d s  s e c t i o n  t o  c h a p t e r  3 .
See also table 5. 9 .
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F i g , 5 . 6 . I n h i b i t i o n  o f  o l e o y l  p h o s p h a t e  s t i m u l a t e d  
32A T P -  P i  e x c h a n g e  b y  f a t t y  a c y l  l i p o a t e s .
O — o e l a i d o y l  l i p o a t e  
• — # e r u c o y l  l i p o a t e
A s s a y s  c o n t a i n i n g  lO O jag  c h l o r o f o r m  r e l e a s e d  A T P a s e  
f r o m  b o v in e  h e a r t  s u b m i t o c h o n d r i a l  p a r t i c l e s  w e re  
p r e i n c u b a t e d  w it h  f a t t y  a c y l  l i p o a t e s  a d d e d  a s  d i ­
m e t h y l  f o r m a m id e  s o l u t i o n s  f o r  5 m in u t e s  a t  3 0 ° C
3 2
p r i o r  t o  a d d i t i o n  o f  lO p m o le s  A T P . A T P -  P i  e x c h a n g e  
w as a s s a y e d  a s  d e s c r i b e d  i n  m e t h o d s  s e c t i o n  c h a p t e r  
3 .
F i g  5 . 7 .  I n h i b i t i o n  o f  o l e o y l  p h o s p h a t e  s t i m u l a t e d
3 2A T P -  P i  e x c h a n g e  b y  f a t t y  a c y l  p h o s p h a t e s .
O ------ O e l a i d o y l  p h o s p h a t e .
• ------ • e r u c o y l  p h o s p h a t e .
A s s a y s  c o n t a i n i n g  1 0 0  p g  c h l o r o f o r m  r e l e a s e d  A T P a s e  
p r o t e i n  f r o m  b o v in e  h e a r t  SMP w e re  p r e i n c u b a t e d  
w i t h  f a t t y  a c y l  p h o s p h a t e s , a d d e d  a s  d im e t h y lf o r m a m id e  
s o l u t i o n s , f o r  5 m in u t e s  a t  3 0 ° C  p r i o r  t o  a d d i t i o n o f
O O
1 0  p m o le s  A T P . A T P -  P i  e x c h a n g e  a c t i v i t y  w as a s s a y e d  
a s  d e s c r i b e d  i n  t h e  m e th o d s  s e c t i o n  t o  c h a p t e r  3 .
See also table 5.9 .
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Table 5.8 Oleoyl phosphate 
* 1 ATPase frcra 
acyl dérivatives,
stimulated reactions in CHCl^ released 
bovine heart SMP: inhibition by fatty 
, I5o values
Compound ATP synthesis 32ATP- Pi exchange
Ir„ value 50 I50 Value
(pmoles/mg) (pmoles/mg)
erucate 105 117
erucoyl lipoate 47 11
erucoyl phosphate 12 8
elaidate 155 160
eladioyl lipoate 72 30
elaidoyl phosphate 19 18
palmitoyl phosphate > looo > lOOO
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Table 5.9 Oleoyl phosphate stimulated ATP- Pi exchange in F^ 
ATPases from bovine heart mitochondria
32
Additions
CHC13 extracted ,F11 ATPase
CHC13 extracted 'F1’ ATPase + oleoyl phosphate (1 Mmole)
CHC13 extrae ted 'F11 ATPase + oleoyl phosphate (2 Mmole)
CHC13 extracted 'F1' ATPase + (1 Mmole)
oleoyl phosphate 
+ erucate (24 pmol)
CHC13 extracted 'F1 ' ATPase + oleoyl phosphate (1 Mmole) + elaidate (24 pmol)
CHC13 extrae ted 'F1' ATPase + oleoyl phosphate(1 Mmole) + erucoyl phosphate 
(20 pmol)
32ATP- Pi exchange 
nm o le s/m in/mq____
O
2653
4766
30
796
O
CHCl^ extracted 'F^' ATPase + oleoyl phosphate
(1 Mmole) + elaidoyl phosphate
(20 pmol) 0
CHClj extracted 1F^' ATPase + oleoyl phosphate 
(1 Mmole) terucoyl lipoate
(20 pmol) 0
CHCL3 extracted 1F^' ATPase + oleoyl phosphate 
(1 Mmole) + elaidoyl lipoate
(20 pmol) O
F^ ATPase (Knowles and Penefsky (262)) O
F^ ATPase + oleoyl phosphate (1 wmole) O
Assays containing lOO vg protein were incubated with fatty acid 
derivatives (not oleoyl phosphate) for 5 minutes at 30° C prior 
to initiation of reaction with oleoyl phosphate and ATP (10 umoles) . 
ATP-Pi exchange was determined as described in Chapter 3.
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Table 5.IQ Oleoyl phosphate-driven ATP synthesis in CHCl^ released 
•F^' ATPases from bacterial vesicles
Additions ATP synthesis ymoles/20
minutes
1 2 3
none o o O
oleoyl phosphate (1 ymole) 0.71 0.66 0.61
oleoyl phosphate (2 ymole) 0.95 O.B4 nt
oloeyl phosphate (1 ymole) + erucoyl 
phosphate (10 pmole) o O 0
oleoyl phosphate (1 ymole) + elaidoyl 
phosphate (10 pmole) O O 0
oleoyl phosphate ( 1 ymole) + erucate 
(25 pmole) o O 0
oleoyl phosphate (1 ymole) + elaidate 
(2 5 pmole) o O o
oleoyl phosphate (1 ymole) + erucoyl 
lipoate (lO pmole) o O 0
oleoyl phosphate (1 ymole) + elaidoyl 
lipoate (lO pmole) o O 0
oleoyl phosphate (1 ymole) + FCCP (20 yg) o nt nt
oleoyl phosphate (1 ymole) + DCCD
(20 nmole) o nt 0.24
Rhodospirillum rubrum (50 yg/assay)
2 Rhodopseudomonas capsulata (50 yg/assay)
3 Escherichia coli F^ (40 yg/assay)
Assays containing CHCl^ released F^ ATPase were preincubated with 
elaidoyl and erucoyl derivatives for 5 minutes at 30° C in a shaking 
water bath in a 1 ml glucose-hexokinase trap system, 0,2 mM in ADP. 
Assays were initiated by the addition of oleoyl phosphate (as a 0,2 M 
solution in dimethylformamide) . Assays were terminated after 20 
minutes with perchloric acid. ATP was estimated by the G-6-P method, 
as described in Chapter 3.
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Table 5.11 Inhibition of bovine heart mitochondrial oxidative 
phosphorylation by fatty acyl phosphates
Additions
none
1 mg mitochondria
1 mg mitochondria + 10 nmole pyruvate/1 nmole
malate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + 1 nmole oleoyl phosphate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + IO nmole oleoyl phosphate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + 1 nmole oleoyl phosphate
1 mg mitochondria
1 mg mitochondria + 10 nmole pyruvate/1 nmole
ma late
1 mg mitochondria + IO nmole pyruvate/1 nmole 
malate + IO nmole erucoyl phosphate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + 100 nmole erucoyl phosphate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + lo rmole elaidoyl phosphate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + lOO nmole elaidoyl phosphate
1 mg mitochondria + 10 nmole pyruvate/1 nmole 
malate + 1 nmole elaidoyl phosphate
ATP synthesis 
nmoles/min/mq
O
O
218
91
69
0
0
150
57
O
H O
80
O
Assays containing 1 mg mitochondrial protein were preincubated, where 
indicated, with fatty acyl phosphates for 5 minutes at 30° C in a 1 ml 
glucose-hexokinase trap system, 0.2 mM in ADP in the presence of 5 units 
Sigma , F-300 hexokinase. Assays were initiated by the addition of 10 
nmoles sodium pyruvate + 1 nmole sodium malate, pH 7.3, and run for 20 
minutes at 30° C in a shaking water bath. The assays were terminated by 
removal of an 0.2 ml aliquot into 0.2 ml 10% ice cold T.C.A. Coagulated 
protein was removed by bench centrifugation and an 0.2 ml aliquot from
the supernatant was assayed for phosphate by the method of Fiske and 
Subbarow (see Chap. 3). Fatty acyl phosphates were added as solutions in 
dlmethylformamlde.
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exchange activity was observed under these conditions {Table 5.9). This 
activity was inhibited by elaidoyl and erucoyl derivatives much as was 
the oleoyl phosphate stimulated ATP synthesis except that it was, if 
anything, slightly more sensitive (see Tables5.8-9 and Figs. 5.5-7). 
Although oleoyl phosphate stimulated an ATP-Pi exchange activity in 
chloroform released ATPase, it failed to do so (or to drive ATP 
synthesis) in an F^ ATPase of high specific activity (70-80 ymoles/min/mg) 
prepared by the method of Knowles and Penefsky (262) (Table 5.9).
Chloroform released F^-like ATPases were also prepared from ' lyso- 
zyne' and 'French press' vesicles obtained from the bacterium 
Escherichia coli and from chromatophore preparations of the photo­
synthetic bacteria Rhodospirillum rubrum and Rhodopseudomonas capsulata. 
Oleoyl phosphate stimulated ATP synthesis in these enzymes. This 
synthesis was also sensitive to erucoyl and elaidoyl derivatives and 
DCCD (Table 5.10).
Pyruvate/malate driven oxidative phosphorylation in bovine heart 
mitochondria was inhibited by oleoyl, erucoyl and elaidoyl phosphates 
(Table 5.11) .
Residual oleoyl phosphatase activity was observed in various 
ATPase preparations under conditions in which no oleoyl phosphate-driven 
ATP synthesis could be detected. Bovine heart mitochondria (Tables 
5.12-13), ETPH (Tables 5.14-15), chloroform released F1 ATPase (Table 
5.16) and an OS ATPase preparation from yeast mitochondria (Table 5.17) 
all appeared to catalyse this reaction at fairly low rates (0-75 nmoles/ 
min/mg) . This activity was inhibited by efrapeptin and aurovertin, 
(Tables 5.12-13, 15-.18) . Uncouplers occasionally inhibited the 
reaction (Table 5.13) but more usually had little effect (Table 5.14). 
Because of the difficulty with which some oleoyl phosphates disperse 
in aqueous buffer systems, various detergents were tested for their 
abilty to stimulate mitochondrial oleoyl phosphatase activity (Table
205
Table 5.12 Oleoyl phosphatase activity in bovine heart mitochondria
Additions Oleoyl phosphatase
nmoles Pi released/min/mg
none 0
0.2 ymole oleoyl phosphate 56
0.5 nmole oleoyl phosphate 21
1.0 nmole oleoyl phosphate 10
0.5 nmole oleoyl phosphate + 200 mg efrapeptin 0
0.5 nmole oleoyl phosphate + lO ng aurovertin 5
Assays containing 115 ng enzyme were incubated with inhibitors, where 
indicated, for 5 minutes at 30° C in 1 ml 50 mM Tris-Cl, 5 mM MgCl2 , 
pH 7.4, 0.5 mM ADP prior to addition of oleoyl phosphate (as a 0.1 M 
methanolic solution) . Assays were then incubated for 10 minutes @ 
30° C before being terminated by the addition of 0. 5 ml 104 T.C.A. 
Phosphate was determined by the method of Fiske/Subbarow, as described
in Chapter 3.
Table 5.13 Oleoyl phosphatase activity in bovine heart mitochondria
2 06
Additions Oleoyl phosphatase 
moles Pi released/min/mg
none O
2.16 pinoles oleoyl phosphate 9.1
4.3 2 limóles oleoyl phosphate 13.7
2.16 limóles oleoyl phosphate + 5 lig efrapeptin 4.5
2.16 ymoles oleoyl phosphate + 5 lig DNP 1.4
2.16 limóles oleoyl phosphate + 5 pg 1799 1.8
2.16 ymoles oleoyl phosphate + 5 lig S13 1.9
Assays containing 1.28 mg mitochondria were incubated at 30° C in 1 ml 
50 mM Tris-Cl, pH 7.5; 5 mM MgCl2 with uncouplers, where indicated,
prior to addition of oleoyl phosphate as an 0.108 M solution in 
methanol. Assays were terminated by the addition of 0.5 ml 10% T.C.A. 
Phosphate was determined by the method of Fiskfe/Subbarow,as described
in Chapter 3.
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Table 5.14 Oleoyl phosphatase activity in bovine heart
submitochondrial particles (e t ph)
Additions Oleoyl phosphatase
nmoles Pi hydrolysed/min/mg
none 0
1.0 ymole oleoyl phosphate $ 1 ÎO
2.0 ymole oleoyl phosphate # 1 47
1.0 nmole oleoyl phosphate | 1 + '1799' 18
1.0 ymole oleoyl phosphate ff 1 + DNP 18
1.0 ymole oleoyl phosphate $ 2 14
Protocols. Assays containing lOO yg ETP in 1 ml 50 mM Tris-Cl, pH 
7.4; 5 mM MgCl2 and 2 yg uncouplers, added as methanolic solutions,
where indicated, were incubated at 30° C for 5 minutes prior to the 
addition of oleoyl phosphate. After 15 minutes at 30° C, assays 
were terminated by addition of 0.5 ml 10* T.C.A. Phosphate was 
assayed by the method of Fiske/Subbarow,as described in Chapter 3. 
Values given above were corrected for any non-enzymic hydrolysis of 
oleoyl phosphate. Oleoyl phosphate was added as a O.2 M solution
in methanol.
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Table 5.15 Oleoyl phosphatase activity in bovine heart submito-
chondrial particles (ETP ): effect of H pH
Additions Oleoyl phosphatase rmoles Pi hydrolysed/min/mg
pH 7.4 pH 8.5
none 0 o
0.195 limóles oleoyl phosphate 25.1 28.9
0.390 limóles oleoyl phosphate 51.0 38.0
0.585 limóles oleoyl phosphate 73.2 68.4
0.390 limóles oleoyl phosphate 
+ 1 lig efrapeptin 30.0 nt
Assays containing 224 iig ETP were assayed for oleoyl phosphataseH
activity as described in Table 5.14. Oleoyl phosphate was added 
as a 39 mM solution in dimethyl formamide.
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Table 5.16 Oleoyl phosphatase activity in a chloroform released
F^ ATPase from bovine heart submitochondrial particles *1
Additions Oleoyl phosphatase 
nmoles Pi released/min/mg
none O 
1 ymole oleoyl phosphate 47 
1 ymole oleoyl phosphate + lO yg efrapeptin 0
1 ymole oleoyl phosphate (- ADP) O
Assays containing lOO yg CHCl^ released ATPase were incubated with 
efrapeptin, where indicated in a buffer 50 mM in Tris-Cl, pH 8.5;
5 mM MgC^; 0.5 mM in ADP; 0.5% in potassium cholate prior to the 
addition of oleoyl phosphate (as a 0.1 M solution in methanol). 
Incubations were carried out at 30° C and were terminated by the 
addition of 0.5 ml 10% T.C.A. Phosphate was determined by the 
method of Fiske/Subbarow,as described in Chapter 3.
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Table 5.17 Oleoyl phosphatase activity in an OS ATPase 
preparation from yeast mitochondria
Additions Oleoyl phosphatase
nmoles Pi released/min/mg
none O 
0.25 pmoles oleoyl phosphate 35 
0. 5 ymoles oleoyl phosphate 60 
1.0 ymoles oleoyl phosphate 60 
0.5 ymoles oleoyl phosphate + 1 yg efrapeptin O
Assays containing 100 yg OS ATPase prepared by the method of 
Ryrie (429) were incubated in 1 ml 50 mM Tris-Cl, pH 8.5; 5 mM
MjCl^ at 30° C and were initiated by the addition of oleoyl phosphate 
(as an 0.05 M solution in the above buffer, 10% in potassium cholate) . 
Assays were terminated by the addition of 0.5 ml 10% T.C.A. Phosphate 
was determined by the method of Fiske/Subbarow, as described in
Chapter 3
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Table 5.18 Oleoyl phosphatase in bovine heart mitochondria: effect
of detergents
nmoles Pi/min/mg
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 0
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 21.4
0.5% in potassium cholate
50 mM Tris-Cl, pH 7.4; 5 mM MgCl ; 0.5 mM ADP 8.9
0.5% in Triton X-1I4
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 0
0.5 % in Triton X-114 + 1 yg efrapeptin
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 18.0
0.5% in Tween 20
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 7.1
0.5% in Tween 2 0 + 1  iig efrapeptin
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 18.0,
0.5% in Tween 80
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP 1.8
0.5% in Tween 80 + 1 yg efrapeptin
50 mM Tris-Cl, Ph 7,4; 5 mM MgCl2; 0.5 mM ADP 0
0.5% in potassium deoxycholate
50 mM Tris-Cl, pH 7.4; 5 mM MgCl2; 0.5 mM ADP
0.5% in sodium dodecylsulphate 0
Assays containing 204 yg protein were assayed as described in
Table 5.14
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5.18), potassium cholate and the non-ionic detergents Tween 20 and 80 
appeared to be the best. The various ATPase preparations usually 
required ADP to display oleoyl phosphatase activity (Table 5.16) ; this 
was not always the case, however, and oleoyl phosphatase rates of up 
to 80 nmoles/min/mg have been observed in the absence of ADP.
Discussion
Any discussion about the results presented in this chapter must 
be prefaced by an attempt to functionally classify the oleoyl phosphate
preparations used. At best, oleoyl phosphate-driven ATP synthesis and
32oleoyl phosphate stimulated ATP- Pi exchange can be described as 
reactions which occur rarely and which are extremely difficult to 
reproduce. The reasons for this unreproducibility are not at all clear 
although some suggestions will be made in the course of this discussion.
Oleoyl phosphate can be usefully classified into three functional 
groups: (a) those which drive ATP synthesis and ATP-Pi exchange, (b)
those which can be partially phosphorylysed by various ATPases, i.e. 
ones which support a residual oleoyl phosphatase activity, (c) those
which have no ability to drive any of the reactions reported driven by
32oleoyl phosphate (oleoyl phosphokinase, ATP- Pi exchange, oleoyl 
phosphatase) .
Of the thirty or so preparations of oleoyl phosphate synthesised, 
only four could be classified in group (a), the rest being in (b) and 
(c), mainly in the latter. All four of the oleoyl phosphates in group 
(a) were synthesised by the method described previously and were in the 
region of 90-100% pure by acyl ester and hydrolysable phosphate content.
Some differences could be noticed in different oleoyl phosphate 
preparations. These were their physical state and their solubility in 
organic solvents. Some oleoyl phosphates appeared to become hard 
waxy solids at room temperature whereas some were dense, oily fluids 
only solidifying when cooled below 0° C. Preparations of oleoyl
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phosphate differed in their solubility: some would dissolve easily in
methanol up to at least 0.2 M; some, however, would hardly dissolve in
methanol. Those that were soluble in methanol could be further
classified by their ability to disperse when methanolic solutions were
added to aqueous buffer systems. Some would, producing optically clear
solutions, others would form emulsions on shaking, while others remained
as large globules, waxy in texture and very difficult to disperse.
Those methanolic solutions of oleoyl phosphate which would not disperse
ointo aqueous buffer systems also precipitated on standing at 4 C or 
below. This precipitate was identical in acyl ester and hydroysable 
phosphate content to the original sample of oleoyl phosphate but would 
not redissolve in methanol when warmed above 4° C. All oleoyl 
phosphates tested were soluble in dimethylformamide,although here again 
not all dimethylformamide solutions would disperse into aqueous buffer 
systems.
The reasons for these differences are not clear. All the oleoyl 
phosphates were made by an identical procedure from similar starting 
materials (i.e. Sigma oleoyl chloride, grade 1, and Fisons '100% ortho- 
phosphoric acid'). There was some variation, however, in the nature of 
the orthophosphoric acid used; 100% orthophosphoric acid is extremely 
hydroscopic and some samples of the acid, even though stored when 
obtained under vacuum dessication, contained rather more hygroscopic 
water than others. The differences in solubility amd ability to 
disperse in aqueous buffers of the oleoyl phosphate preparations may be 
related to water retained by the phosphate grouping or differences in the 
nature of the phosphate group. Orthophosphates have the general
structure:-
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O
OR. if R,R„R., = H
| 1 1 2  3
P - OR 
I £ R1R2 = H ;R3
OR R, = H; R_R„3 1 2 3
orthophosphoric acid
Na sodium hjdrogen phosphate
Na disodium, hydrogen phosphate etc.
Oleoyl phosphate then could exist in a number of forms.
O 
II
c h 3 (c h 2)7c h=c h (c h 2)7c - O - P = 0
OR,
I
I
0R„
R1R2 = H oleoyl phosphoric acid
Rx = Na; R2 = H sodium hydrogen 
oleoyl phosphate
R1R2 Na disodium oleoylphosphate etc.
Any one, or a mixture,of these compounds could have been produced by 
the synthetic procedure used. Another complex salt of oleoyl phosphate, 
triethylanmonium oleoyl phosphate, might have been produced as phosphate 
was solubilised by triethylamine in the synthetic procedure. Thus
the following salt may have been produced:
0 - +OR
CH., (CH0) CH+CH(CH„) C - 0 - P = 0 3 2 7 2 7
OR+
+ ^where one or both R 's is (C2Hg)3NH.
Wet orthophosphoric acid will dissolve in the acetonitrile used in 
the assay without the addition of triethylamine. This gives oleoyl 
phosphate that is indistinguishable chromatographically and functionally 
(with respect to groups (b) and (c)) from that prepared by the normal 
method. Triethylamine phosphate had no ability to act as substrate 
for any of the reactions attributed to oleoyl phosphate.
The existence of these different salts of oleoyl phosphate could 
account for both the solubility and physical differences observed in 
the samples. It might also account for the difference in ability to act 
as substrates for ATP synthesis with various ATPase enzymes which might 
require oleoyl phosphate (as substrate) as a specific salt, or in a 
specific hydration state. It is worth noting that all four 
preparations of oleoyl phosphate that routinely drove ATP synthesis
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ÎR1 if R ^ R  = H orthophosphoric acid
P - OR. 
1 R1R2 “ H 7 R3
= Na sodium hydrogen phosphate
0R3 r i = H; r 2r 3 = Na disodium, hydrogen phosphate
Oleoyl phosphate then could exist in a number of forms.
0
li
c h 3 (c h2)7c h=c h (c h2)7c - O
?R1 
P = o 
I
0R„
V 2 = H oleoyl phosphoric acid
R3 = Na; R2 = H sodium hydrogen 
oleoyl phosphate
R1R2 = Na disodium oleoyl
phosphate etc.
Any one, or a mixture,of these compounds could have been produced by 
the synthetic procedure used. Another complex salt of oleoyl phosphate, 
trie thy larm onium oleoyl phosphate, might have been produced as phosphate 
was solubilised by triethylamine in the synthetic procedure. Thus
the following salt may have been produced:-
O - +OR
ICH3 (CH2) 7CH+CH(CH2) ?c  - o - p = o
OR
where one or both R 's is (C2Hg>3NH.
Wet orthophosphoric acid will dissolve in the acetonitrile used in 
the assay without the addition of triethylamine. This gives oleoyl 
phosphate that is indistinguishable chromatographically and functionally 
(with respect to groups (b) and (c) ) from that prepared by the normal 
method. Triethylamine phosphate had no ability to act as substrate 
for any of the reactions attributed to oleoyl phosphate.
The existence of these different salts of oleoyl phosphate could 
account for both the solubility and physical differences observed in 
the samples. It might also account for the difference in ability to act 
as substrates for ATP synthesis with various ATPase enzymes which might 
require oleoyl phosphate (as substrate) as a specific salt, or in a 
specific hydration state. It is worth noting that all four 
preparations of oleoyl phosphate that routinely drove ATP synthesis
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Fig 5.8.Thin layer chromatograms of oleoyl phosphate 
preparations.
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were oils at room temperature solidifying below 4° c, dissolved in 
methanol and dimethylformamide, and these solutions when added to aqueous 
buffer systems gave optically clear solutions up to 2 ymoles oleoyl 
phosphate/ml buffer.
Further evidence for the view that functional oleoyl phosphate 
preparations are rather different in properties to non-functional ones 
may be obtained from their activity in ATPase assay systems. Both 
Johnson and Criddle (241) and Hyams et al. (246) report that oleoyl 
phosphates capable of driving ATP synthesis are fairly potent inhibitors 
of ATPase activity. Groups (b) and (c) oleoyl phosphates either have a 
slight stimulatory effect on ATPase activities or none (247) .
Heavily loaded thin layer chromatograms of oleoyl phosphate (Fig. 
5.8) show that a number of different species of oleoyl phosphate may be 
present although this must be a tentative conclusion as oleoyl phosphate 
decomposes on silic a gel plates and the spots may be due to decomposition 
products. Only the spot, A, contains hydrolysable phosphate.
Because of the difficutly in observing oleoyl phosphate-driven ATP 
synthesis, the results presented in this chapter must be discussed in a 
manner which tries to define their 'true nature'. That is, is the 
observed ATP synthesis real or an artefact of the assay techniques used 
and, if real, is ATP synthesis catalysed by ATP synthase (ATPase) 
enzymes?
ATP synthesis was measured routinely in a glucose-hexokinase trap 
system (248) . The buffer system used was 250 mM sucrose; 20 mM Tris-Cl, 
pH 7.3; 20 mM glucose; 5 mM MgCljJ 0.5 mM EDTA; 0.2 mM ADP containing 
5-30 units of hexokinase (Sigma types F-300 or 0-300). This high level 
of hexokinase was used to minimise any possible ATP hydrolysis by the 
ATPase enzymes. The assay,usually containing O.5-1.0 mg ATPase enzyme, 
was incubated in a shaking water bath at 30° C during the experiment, 
and was terminated by the addition of perchloric acid. After centri­
fugation to remove coagulated protein, addition of potassium hydroxide
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to neutralise the perchloric acid and centrifugation to remove potassium 
perchlorate; aliquots were taken into a buffer containing 1-2 units of 
glucose-6-phosphate dehydrogenase and 0.5 Mmoles NADP. Any ATP formed 
in the assay will be used to convert glucose to glucose-6-phosphate by 
hexokinase. This glucose-6-phosphate is then converted by glucose-6- 
phosphate dehydrogenase to D glucono-<5-lactone-6-phosphate with the 
concomitant reduction of NADP to NADPH. This NADPH can be assayed 
spectrophotometrically at 340 nm.
One obvious source of 'apparent* (i.e. non-real) ATP synthesis in 
this system would be a reaction in which oleoyl phosphate donates its 
phosphate directly to glucose, giving glucose-6-phosphate. This, 
however, is unlikely. Oleoyl phosphate has no non-enzymic effect when 
incubated in a glucose hexokinase trap system lacking an ATPase enzyme. 
The possibility remains, however, that there is an enzyme or a non- 
enzymic catalyst (e.g. protein surface or metal ion) present in the 
enzyme preparations used in the assays which catalyses this reaction.
It is rather more difficult to definitely exclude this possibility, 
but there is evidence to suggest that it does not occur. This is that 
the observed ATP synthesis is sensitive to two specific inhibitors of 
the ATPase enzyme, efrapeptin and aurovertin. Also ATP synthesis has 
been observed with a number of ATPase preparations of varying degrees 
of purity from different tissue sources. The artefactual catalyst would 
have to copurify with the ATPases and be sensitive to the same 
(apparently specific) inhibitors of the ATPase. This is unlikely. The 
oleoyl phosphate-driven synthesis of 'ATP' (real or apparent) also 
requires ADP, which is strongly suggestive that ATP is being made. The 
sensitivity of the reaction to efrapeptin and aurovertin coupled with 
the substrate specificity of the reaction (other acyl phosphates do not 
appear to drive ATP synthesis) militates gainst the reaction being 
catalysed by a non-enzymic catalyst.
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Other possible sources of 'non-real ATP synthesis' would be the 
production of substances which also absorb at 340 nm, thus appearing 
to be NADPH, or the production of substances which g lue ose-6-phosphate 
dehydrogenase (G6PDH) either converts to compounds absorbing at 340 nm 
or uses to produce NADPH. The first possibility is easily dismissed 
as control experiments show no production of substances absorbing at 
340 nm prior to the addition of G6PDH and NADPH to the assay. The 
second possibility is also unlikely as G6PDH has a fairly strict 
specificity for glucose-6-phosphate. Also, control experiments show 
the 'ATP synthesis' requires an ATPase and ADP.
Another source of spurious 'ATP synthesis' could have been the
production of turbidity which would cause light scattering, giving an
absorption at 340 nm. Again this turbidity would require the presence
of an ATPase, ADP, glucose-6-phosphate, hexokinase NADP and wculd be
abolished or prevented by efrapeptin, aurovertin and DCCD. It should
be pointed out at this point that the conditions of the assay
routinely lead to measuring A OD34o's of °'2 ” 0-4 0D units ah°ve the
value of no substrate and no enzyme blanks (usually 0 - 0.15 OD units)
and occasionally A OD,. . of •v 1.0 OD units above the blank values,340 s
so small OD changes scaled up by large dilution factors can be 
excluded as a major error (+ 10% maximally) in estimating ATP made.
Is the observed ATP synthesis due to the action of the ATP 
synthase enzyme or is it due to other side reactions? Mitochondria and 
many commercially obtainable enzymes (e.g. hexokinase and gluocse-6- 
phosphate dehydrogenase) contain a (contaminating) ’myokinase' activity. 
This enzyme, or enzymic activity, as it is far from clear whether all 
'myokinase' activity is due to a single enzyme, catalyses the 
dismutation of ADP to ATP and AMP, viz.
ADP + ADP ^myokinase> ATp + ftMp 
Mg
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Thus, if mitochondria are incubated in a qlucose hexokinase trap 
systan containing ADP, but no other substrates, ATP synthesis due to 
myokinase activity can be observed. The first experiments carried 
cut in which oleoyl phosphate-driven ATP synthesis was observed were 
done in a glucose-hexokinase trap system, 2 mM in ADP (Tables 5.3-6,
Fig. 5.1). That is, submitochondrial particles were incubated with 
2 pmoles of ADP. Myokinase activity could theoretically produce 2 
ymoles ATP (measured as G-6-P equivalents) in this system. Apparent 
oleoyl phosphate-driven ATP synthesis could thus be due to myokinase 
or an oleoyl phosphate stimulated myokinase activity in this system. 
Certain considerations make this unlikely. All assays were measured 
against, or compared with, blanks containing substrate or enzyme, and 
hexokinase. The optical densities observed were substantially above 
these blank values (occasionally as much as 0.5 - 1.0 abs. 340 units). 
Synthesis was apparently sensitive to efrapeptin and DCCD and required 
the presence of oleoyl phosphate. Oleoyl phosphate may, however, 
specifically stimulate a mitochondrial myokinase activity. It is 
worth pointing out here that occasionally, in our hands, mitochondrial 
myokinase activity appeared to be partially inhibited by inhibitors of 
the ATPase enzyme such as oligomycin and efrapeptin. Thus it is very 
difficult to exclude the possibility that an oleoyl phosphate stimulated 
myokinase activity was responsible for the observed ATP synthesis. To 
remove or reduce this possible problem with contaminating myokinase 
activity, all subsequent glucose-hexokinase trap assay systems were 
made 0.2 mM in ADP. In this system, myokinase could maximally produce 
0.2 ymoles in ATP .(in fact levels of myokinase activity under the assay 
conditions used usually gave 'v 0.1 moles ATP as a maximum) . Oleoyl 
phosphate-driven ATP synthesis was observed under these conditions at 
levels substantially above this theroetical maximum (Tables 5.7-10,
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where is a-ketoglutarate decarboxylase
is dihydrolipoate transsuccinylase
E^ is dihydrolipoate (lipoamide) dehydrogenase.
In manmalian systems, succinyl thiokinaso then catalyses.
Succinyl'tSCoA + Mg GDP + Pi c~ succinate + MgGTP + CoASH
The phosphate «sterified in GTP can then be incorporated into ATP by
the action of a nucleoside diphosphate kinase enzyme, viz.
2+
GTP(NTP) + ADP --^ GDP(NDP) + ATP
The situation is somewhat different in E. coli and higher plants; 
here succinyl thiokinase catalyses the following reactions:-
(i) Enz + succinyl'VSCoA + Pi ^— - Enz. succinyl'vp + CoASH
(ii) Enz.succinyl'vp + Pi ■ ■*■ Enz'vp + succinate
(iii) Enz-vp + ADP Enz + ATP
An unstable Enz'vCoA intermediate may also be formed in step 1.
The enzyme catalysing these reactions has been isolated and purified. 
It has a molecular weight of 141,000 and two N-3 histidine residues 
are involved in its phosphorylation (249-253). A similar enzyme may 
be operational in mammalian systems, probably involving phospho- 
histidine residues as well (254) .
The 1oleoyl’ cycle postulated as a hypothetical framework for 
experimentation by Griffiths (235) requires the production of 
oleoyl lipoate, free or enzyme-bound, by the respiratory chain, 
analogous to the production of enzyme-bound succinyl lipoate. This 
is then acted on by CoASH or a similar acyl carrier protein-like 
grouping to produce an oleoyl'vs-CoA (or oleoyl'vs-ACP) moiety. This 
is then acted on by Pi to produce oleoyl phosphate which in turn 
donates its phosphate to ADP, giving ATP. All these reactions would 
be catalysed by the oligcmycin sensitive ATP synthase (ATPase) complex 
of the inner membrane. The multisubunit enzyme would then catalyse a 
number of partial reactions. The terminal ’partial1 reaction would be
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an oleoylphosphokinase reaction in which oleoyl phosphate would act 
as the phosphate donor to ADP, converting it to ATP.
Oleoyl phosphate-driven ATP synthesis was observed in various 
ATPase preparations, ETP , 'complex V','proton translocating' ATPase 
and chloroform released F^ ATPase, all from bovine heart mitochondria. 
This ATP synthesis was insensitive to various inhibitors of the 
ATPase enzyme, notably DBCT, TET and oligomycin. These inhibitors 
all act at the level of the F^, membrane bound portions of the ATPase 
and are thought in chemiosmotic terms either to prevent (or block)
p r o t o n  pum pin g  t h r o u g h  t h e  F q  p o r t i o n  o f  t h e  A T P a se , th u s  p r e v e n t i n g
a,the collapse of AyH and the concomitant synthesis of ATP (62) or, in 
terms of the chemical or conformational hypotheses, to prevent the 
conversion of a non-phosphorylated high energy state (X'vi or •'v.') to 
a high energy phosphorylated state, X'vp or ’^ P’ (62). They would,
therefore, not be expected to inhibit a reaction in which a putative 
X^P or X'vp analogue drives the synthesis of ATP.
The inhibitors of ATP synthesis,efrapeptin and aurovertin, are 
thought to act at the level of the phosphorylated high energy state 
or intermediate, that is, they prevent the transphosphorylation 
between '''-P1 and ADP giving ATP. Oleoyl phosphate-driven ATP 
synthesis is sensitive to these inhibitors and is also sensitive to 
DCCD in the chloroform released F^ ATPase. Here DCCD also prevents 
ATPase activity (236) in a mechanism dissimilar to its inhibitory 
action in mitochondria, submitochondrial particles or purified F^Fq 
ATPase preparations. Uncouplers, which discharge the high energy non- 
phosphorylated state of the membrane, have been reported to have varying 
effects on oleoyl phosphate-driven ATP synthesis (241, 246) . Most 
(for example) FCCP, TTFB, 1799 have no effect on ATP synthesis in 
these systems, whereas 2,4-dinitrophenol strongly inhibits it. Compound 
•1799' was also reported to inhibit the synthesis in chloroform
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released enzymes but not in vesicular preparations (241,246) . These 
findings are generally confirmed here, though it must be pointed out 
that rather high levels of *1799' (1 mg/mg enzyme) were used to 
inhibit oleoyl phosphate-driven ATP synthesis in chloroform released 
enzymes.
Certain fatty acids have been shown to strongly inhibit dihydro- 
lipoate-driven ATP synthesis in isolated ATPase preparations (see
Chapter 3) . Among the most interesting of these fatty acids were 
elaidic acid and erucic acid. Elaidic acid is the trans isomer of 
oleic acid, i.e. trans A 9 .octadecenoic acid, and appeared to inhibit 
strongly reactions which involved oleic acid as a cofactor. Trans 
unsaturated C^g fatty acids, elaidate among them, have been reported 
to be ineffective in supporting the growth of unsaturated fatty acid 
auxotroph of Saccharomyces cerevisiae KD.115 (255) and to inhibit 
the growth of this strain supplied with oleate (256). Trans C^g fatty 
acids will also not support the growth of Escherichia coli mutants 
that could not synthesise fatty acids (256) .
Rape seed oil, which can be as much as 45% erucic acid, has been 
observed to have severe cardiopathogenic effects when fed to 
laboratory animals (259) . Fatty infiltration of rat cardiac muscle 
observed after short periods of higherucic acid rape seed oil feeding 
has been related to a decreased efficiency of mitochondrial ATP 
synthesis (257,258). Erucic acid is also almost completely unable to 
support the growth of the Saccharcmyces cerevisiae fatty acid auxotroph 
KD.115 (255).
Work by Haslam et^  al. (260) has suggested that the inhibition of 
energy linked reactions produced by depletion of fatty acids fran the 
mitochondrial membrane is not due to an effect on electron transport 
but is probably due to an effect on the respiratory control functions 
of these membranes, that is, an effect on the terminal steps involved
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in oxidative phosphorylation. The results presented here on the 
inhibition of oleoyl phosphate-driven ATP synthesis and ATP- Pi 
exchange in chloroform released enzymes by elaidate, enicate and 
various derivatives of these fatty acids suggests a possible mechanism 
for the toxic effects of these (and other) fatty acids on oxidative 
phosphorylation; that is, they might prevent the terminal phosphate 
transfer of oxidative phosphorylation. The fact that the free fatty 
acids are less effective inhibitors than the fatty acyl lipoates,which 
in turn are less effective than the fatty acyl phosphates in
32inhibiting oleoyl phosphokinase and oleoyl phosphate stimulated ATP- Pi 
exchange , suggests that these compounds might act by competing for the 
same site as oleoyl phosphate, thus preventing or reducing the transfer 
of phosphate frcm oleoyl phosphate to ADP. Oleoyl phosphate was the 
only acyl phosphate tested that could support ATP synthesis; elaidoyl, 
erucoyl.palmitoyl would not.
Oxidative phosphorylation in bovine heart mitochondria,driven by 
respiratory chain substrates such as pyruvate/malate and succinate, is 
inhibited by oleoyl, elaidoyl and ercoyl phosphates. The mechanism is 
unclear, but a number of possibilities exist. The first is that if 
oleoyl phosphate is a true intermediate in ATP synthesis or a close 
analogue of an enzyme-bound acyl phosphate, it would only be present 
in the membrane in very low levels (repeated searches have failed to 
find a phosphorylated intermediate (261) ) . High levels of the 
intermediate might then cause a feedback inhibition of oxidative 
phosphorylation. Fatty acyl phosphates have a detergent-like structure, 
that is, they contain discrete hydrophobic and hydrophilic regions and 
may cause a disruption of the mitochondrial membrane, muchasdo other 
detergents such as Triton X-100, potassium cholate and potassium 
deoxycholate, thus preventing ATP synthesis. Fatty acids are known to 
uncouple oxidative phosphorylation in a manner that is assumed to be
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related to their ability to collapse ApH across membranes (261).
Fatty acyl phosphate could possibly act in a similar way.
As pointed out previously in this discussion, oleoyl phosphate-
driven ATP synthesis is a reaction that is poorly reproducible. The
reasons for this are not clear, but sane of the data presented here
may suggest why. Oleoyl phosphate preparations that drive ATP
synthesis do not do so in all ATPase preparations, be they ETP or
CHCl^ released F^ ATPases, even when these enzymes appear to exhibit
their normal properties (oxidative phosphorylation and ATPase). This
suggests that something is either periodically present or missing in
the assay system or that the enzymes need to be in a particular state
to catalyse oleoyl phosphate-driven reactions. The 'residual' oleoyl
phosphatase activity displayed by certain enzymes with group (b)
oleoyl phosphates may give us an indication about this 'state'. This
reaction is often non-existent unless ADP is present which appears to
induce the activity up to levels of 70-80 nmoles/min/mg. ADP might
act by allowing the enzyme to adopt a configuration in which it can
catalyse oleoyl phosphatase reactions. Various attempts have been
made to stimulate oleoyl phosphate-driven ATP synthesis in those enzymes
that normally display none. These include preincubation of the enzyme
with oleoyl-S-CoA, coenzyme A, dihydrolipoate, oxidised lipoic acid,
2+ 2+ 3+ 2+ 2+oleic acid and various metal ions such as Sn , Ni , Cr , Cu , Ca , 
2+ 2+ 2+ 2+ 3+ 2+Mg , Mn , Zn , Fe , Fe , Co . None of these compounds induced 
oleoyl phospatase or ATP synthesis. The nature of a putative 'missing 
cofactor' then remains obscure. There is a possibility that there is 
normally in the assay system a component which inhibits oleoyl 
phosphate-driven reactions. All the chemicals used in the assay system 
were of the highest purity available, 'AristaR' grade where possible.
The other main source for an inhibitory component in the assay is the 
substrate. As shown earlier, certain fatty acids and fatty acyl
V
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derivatives are extremely potent inhibitors of oleoyl phosphate-driven 
ATP synthesis. Oleoyl phosphate preparations could contain low levels 
of other fatty acids or fatty acyl phosphates which would inhibit 
these reactions. The level of contamination needed to inhibit these 
reactions would only need to be 1-10%. Thus 1 ymole oleoyl phosphate 
would only need to contain 10-100 nmoles fatty acyl-X to completely 
inhibit oleoyl phosphate-driven ATP synthesis (see Table 5.8). It 
may be that the group (a) oleoyl phosphates were fortuitously free 
from (or low in) these contaminants.
The evidence obtained with oleoyl phosphate suggests that an acyl 
phosphate (or similar enzyme-bound phosphate) may be involved in the 
terminal stages of ATP synthesis in oxidative phosphorylation. Oleoyl 
phosphate has appeared to give a stoicheiometric production of ATP in 
a reaction sensitive to several well known inhibitors of oxidative 
phosphorylation. Phosphate transfer from oleoyl phosphate to ATP could 
proceed by two pathways, one of which involved the formation of an 
enzyme phosphate intermediate, viz.
oleoyl phosphate + enzyme < ■ ■'*• enzyme phosphate + oleoyl (carrier: 
enzyme phosphate + ADP r- ATP + enzyme
The other possibility is that oleoyl phosphate may transfer its 
phosphate to ADP via a transition state; here an enzyme phosphate 
would have a transitory lifetime.
The involvement of an acyl phosphate intermediate in the terminal 
stages of oxidative phosphorylation could be incorporated into all the 
main hypothesis of oxidative phosphorylation without the sacrifice of 
their major principles. Because of the poor reproducibility of the 
reactions, however, much work needs to be done to confirm and define 
the role (if any) of acyl phosphates in oxidative phosphorylation.
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CHAPTER 6
THE EFFECT OF DIHYDROLIPOIC ACID ON NICOTINAMIDE 
NUCLEOTIDE TRANSHYDROGENATION
Introduction
The nicotinamide nucleotide transhydrogenases (EC 1.6.1.1) are 
a group of enzymes that catalyse a direct and reversible transfer of 
hydrogen between NADH and NADP+ ,
i.e. NADH + NADP+ t - s NAD+ + NADPH
The first example of this group was discovered by Colowick et al. in 
extracts frcm Pseudomonas fluorescens (263) . The enzyme was later 
isolated from mammalian tissue extracts; the activity appeared to be 
associated with the mitochondrial inner membrane (264-4) .
The first indication that this mitochondrial transhydrogenase 
activity was energy linked was found by Krebs (267) who found that NADPH 
dependent dehydrogenase reactions were sensitive to the uncoupler DNP.
He suggested NADP+ reduction was controlled by an ATP dependent flavo- 
protein. Analysis of the steady state reduction levels of NAD+ and 
NADP in mitochondria revealed that the NADP+ pool was usually more 
reduced than the NAD+ pool. This led Klingenberg and Slenczka to 
propose that mitochondria contain an asymmetric energy linked trans­
hydrogenase controlled by oxidative energy (268) . Much support was 
later forthcoming for this proposal (269). Danielson and Ernster 
demonstrated that in submitochondrial particles prepared by sonic 
disruption of mitochondria, ATP or respiration will provide energy 
which stimulates the reduction of NADP+ by NADH (270). This energy 
input causes a shift in the equilibrium of the reaction NADH + NADP+
NADPH + NAD+ from 1 to 500 in favour of NAD+ and NADPH production 
(271). Later Lee et^  al^  demonstrated that the hydrogen transfer between 
NADH and NADPH is stereospecific for the 4A hydrogen of NADH and the 
4B hydrogen of NADPH (272) .
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Respiring bacteria, such as Escherichia coli,and some photo­
synthetic bacteria, e .g. Rhodospirillum rubrum also possess trans- 
hydrogenases similar to the mitochondrial enzyme (269) .
Mammalian submitochondrial particles prepared by sonic disruption 
of mitochondria carry out a rapid reduction of NADP+ by NADH driven by 
ATP or respiration (270). Attempts to release this transhydrogenase 
activity from the inner membrane by detergent extraction cause an 
uncoupling of energy linked reactions probably due to disruption of 
the membrane, thus the released transhydrogenase only displays its non­
energy linked activities, some of which can be restored if the enzyme 
is re incorporated into phospholipid vesicles. Kaplan et al. (264) used 
digitonin extraction of mitochondria followed by calcium phosphate gel 
adsorption chromatography to produce a transhydrogenase preparation 
lO x purified with respect to digitionin particles. Further purification 
failed as the enzyme was very sensitive to delipidating agents such as 
acetone and bile salts. Other workers (273-4) produced preparations 
of transhydrogenase 14 x and 25 x purified with respect to digitonin 
particles, the latter by repeated sucrose density gradient centrifugation 
of digitonin particles. Again, furtharpurification was prevented by the 
sensitivity of the preparation to inhibition by organic solvents, bile 
salts and phospholipases.
Rydstrom and co-workers (275) solubilised transhydrogenase 
selectivity from bovine heart submitochondrial particles by lysophospho- 
tidyl choline. The preparation was 7 x purified and, unlike previous 
preparations of transhydrogenase, was largely free from cytochromes 
(except cytochrome c ). Differential centrifugation of this enzyme 
produces a further, purification to 12 x. The method was only useful 
for the preparation of small quantities of the enzyme. Cholate and 
ammonium sulphate fractionation of bovine heart SMP's followed by 
sucrose density gradient centrifugation in the presence of cholate and
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phosphatidyl choline gives a 7 x purified transhydrogenase 
uncontaminated by cytochromes and ATPase activity (276) . Both these 
last two preparations were reconstitutively active, that is, they are 
capable of catalysing some energy linked reactions when incorporated 
into liposomes (269) .
Recently two methods producing enzymes purified to a high degree 
of homogeneity have been reported, those of Kojeberg and Rydstrom (277) 
and Anderson and Fisher (286).
Hojeberg and Rydstrom extended the method of Rydstrom et: al. (276) 
by subjecting an ammonium sulphate fraction from this preparation to 
chromatography on a DEAE sepharose CL-6B column eluting with buffers 
containing triton X 10O. Eluate fractions from this column were pooled 
and concentrated, and then subjected to hydroxylapatite column 
chromatography. Transhydrogenase activity was eluted from the column 
with a 10O mM potassium phosphate buffer. This final purification step 
gives an enzyme with a specific activity 40 x that of the original SMP 
preparation.
Table 6.1 Purification of bovine heart mitochondrial transhydrogenase 
(after 277)
specific activity1 purification x fold
SMP
38-43p fraction 
DEAE-sepharose pool 
hydroxylapatite pool
1 nmoles NADH formed/min/mg
0.11 1.0
0.25 2.3
0.90 8.2
4.40 40.0
The final preparation is devoid of respiratory chain activities 
such as NADH dehydrogenase and succinate dehydrogenase, ATPase and cyto­
chromes. The absorption spectrum of the enzyme indicates that it is not 
a flavoprotein. Direct assay of flavin content indicates that the
preparation contains less than 0.1 mole flavin per mole enzyme. SDS 
PAGE indicates that the preparation is almost completely homogeneous 
with respect to a single 97,000 dalton component.
This purified transhydrogenase protein, when incorporated into lipid 
vesicles, catalyses the NAD , NADPH dependent uncoupler sensitive uptake 
of tetraphenylboron and also displays a rate of NAD+ reduction by NADPH 
that can be stimulated 13 x by uncouplers or valinomycin and nigericin.
Anderson and Fisher have also purified bovine heart mitochondrial 
transhydrogenase to a high degree of homogeneity (286). Their method 
involves the treatment of SMP's with a chaotropic agent, sodium 
chlorate. This removes 20% of the NADH dehydrogenase from the inner 
membrane and leaves the remainder insoluble. The submitochondrial pellet 
is then treated with lysolecithin (final concentration 0.1%) which 
releases transhydrogenase activity. This is then removed from the 
insoluble SMP fraction by centrifugation. The transhydrogenase is then 
titrated with alumina gel (1 mg gel/mg protein) and eluted with a series 
of sodium phosphate buffers of varying concentrations, all 10 mM in 
mercaptoethanol and 0.05% in lubrol WX. The fractions containing trans­
hydrogenase activity are then eluted and titrated with calcium phosphate 
gel (2 mg gel/mg protein). Activity is eluted from the gel with buffers 
similar to those used in the alumina gel system. The eluate from this 
is then passed down an NAD+-sepharose affinity chromatography column 
twice. On its first passage, transhydrogenase activity is eluted without 
any binding to the affinity matrix, but is purified from several other 
proteins. On its second passage, transhydrogenase activity is immobilised 
on the column; this is eluted with a buffer system containing NADH.
The eluate is then passed through a sephadex G-50 column. The eluate 
from this is the final purified 'transhydrogenase' fraction.
The purified product is fairly insoluble, losing 30-50% of its 
3-acetylpyridine adenine dinucleotide reductase activity in 48 hours
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when kept at 4° C. Freezing destroys its activity, even if done in 
the presence of substrates. The fluorescence spectum of the enzyme 
reveals that it contains tryptophan and no flavin. The enzyme is free 
of containinating cytochromes, NADPH dehydrogenase, NADH dehydrogenase,
NADPH-ferricyanide reductase and NADPH-DCPIP reductase activities.
2+Palmitoyl coenzyme A, Mg and pH all have similar effects on the 
purified transhydrogenase as they do on SMP transhydrogenase activity. 
SDS PAGE reveals that the transhydrogenase preparation consists of 
essentially one protein of t 120,000 molecular weight. Recent work 
from Fisher's laboratory has, however, suggested that this 120,000 
M.W. protein may be composed of two subunits, one of which is v 54,000 
M.W. (304).
The relationship between transhydrogenase and the mitochondrial 
NAD (H) and NADP(H) dehydrogenases has been investigated, as both these 
types of activities are located in the same membrane and both sets of 
nucleotide binding sites are located on the same (M) side of the inner 
mitochondrial membrane. Little is known about the structure and 
topology of the transhydrogenase molecule and the only known link 
between the two systems is the functional one, that is the requirement 
for NAD(P)(H). Ubiquinone 9 has been reported to be a component of 
the transhydrogenase system on the basis of solvent extraction and 
reconstitution experiments. The effect of UQg on this system is not 
defined, but is unlikely to be a 'general lipid activation' effect as 
the system requires UQ alone. Whether UQg functions as a cofactor or 
has a more specific lipid activation effect is not clear (305-6).
A structure-function relationship between transhydrogenase and 
NADH dehydrogenase is possible (for the reasons outlined above) but is 
unlikely as the NAD(H) binding sites of the enzymes differ in their 
stereospecificity with respect to the 4H of NADH;the enzymes also differ 
in their sensitivity to various inhibitors. Hatefi and Hanstein (307)
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and Ragan et al. (285, 157) have evidence showing that part of mtio- 
chondrial transhydrogenase activity is recovered with complex I 
(NADH-UQ reductase) upon the detergent fractionation of the mitochondrial 
inner membrane. Activity is not recovered with the other complexes 
(307). Ragan has also shown that this activity can be removed from 
complex I by lysophosphatidyl choline treatment, suggesting that it is 
not an integral part of complex I activity. Rossi et al^  have reported 
that purified NADH dehydrogenase oxidises NADPH at a low rate (308), 
while Hatefi has shown that NADPH is oxidised under aerobic conditions 
in the absence of NAD+ by the mitochondrial respiratory chain (307, 309) 
and proposed that this occurs via a separate pathway from that of NADH 
oxidation, NADPH entering on the oxygen side of FMN and the Fe-S 
centre 1 of NADH dehydrogenase, since NADPH only reduces Fe-S centres 
2, 3, 4. NADPH oxidation exhibits a pH dependence similar to that of 
non-energy linked transhydrogenase activity. Hatefi proposed that these 
reactions were a reflections of transhydrogenase activity. This, however, 
is unlikely as none of these reactions are inhibited by palmitoyl CoA 
or trypsin. It was later shown that NADPH does reduce centre 1, but at 
a much lower rate than NADH (310). Thus there is little direct 
evidence to suggest structural or functional links between trans­
hydrogenase and the nicotinamide nucleotide dehydrogenase.
Mitochondrial transhydrogenase is inhibited by a number of compounds. 
These can be divided into three main groups: -
(i) non-specific inhibitors. These include various SH reagents (154,
273, 278)»
(ii) site directed inhibitors. These are compounds that appear to 
exhibit their inhibitory properties by competing for the NAD+ (H) 
or NADP+ (H) sites on the enzyme.
Table 6.2 Site specific inhibitors of mitochondrial transhydrogenase
(after 269)
Inhibitor Specificity Ki PM
non-energy linked energy-linked
Adenosine NAD(H) 500 500
5 '-AMP NAD(H) 300 700
ADP NAD (H) 300 400
Dephospho CoA NAD(H) 9 40
Acetyl dephospho CoA NAD (H) 11 40
2'-AMP NADP (H) 700 1200
3 '-AMP NADP(H) 700 1200
CoA NADP (H) 200 700
Acetyl CoA NADP (H) 200 700
Palmitoyl CoA NADP(H) 0.15 0.15
3 ': 5 ' -AMP NADP(H) 400 500
(iii) Energy transfer inhibitors: energy transfer inhibitors inhibit
the energy linked transhydrogenase reactions by their ability to inhibit 
the generation of "\»' by the respiratory chain or the ATPase. These 
include ollgmycin, trialkyltin halides, venturicidin, aurovertin, 
efrapeptin, DCCD and DBCT which inhibit the ATP-driven energy linked 
transhydrogenase. The uncouplers (e.g. FCCP, CCCP, '1799', TTFB, S13, 
DNP etc.) and the ionophores valinomycin + nigericin and gramicidin D, 
which dissipate the high energy state of the menbrane,thus inhibiting 
all energy linked transhydrogenase reactions. Cyanide, antimycin A 
and other inhibitors of electron transport inhibit respiration-driven 
transhydrogenase but have no effect on the ATP-driven transhydrogenase 
activity.
There are several other compounds which inhibit transhydrogenase 
reactions. These include the anthraquinone derivative rhein, which was
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thought to be a specific transhydrogenase inhibitor but was later shown 
to inhibit several other NAD+ dependent reactions (281). Transhydrogenase 
activity is also inhibited by the sulphydryl reagent, 5,5'-dithiobis- 
(2-nitrobenzoic acid) (286).
Trypsin inhibits the enzyme irreversibly, suggesting that the 
transhydrogenase may contain an essential arginine residue (282) . 
Confirmation of this suggestion came when Djavadi-Ohaniance and Hatefi 
found the arginine binding reagent, butanedione, selectivity inhibited 
the transhydrogenase of bovine heart mitochondria. NAD+ and/or NADP+ 
prevented this inhibition, suggesting an arginine residue might be 
involved at one of the binding sites (283) .
Transhydrogenase activity is highly sensitive to delipidating 
agents such as detergents, organic solvents and phospholipases. The 
phospholipases have different effects, phospholipase A being more 
effective than phospholipase C, which is more effective than phospho­
lipase D at inducing inhibition of the transhydrogenase (284).
Rydstrom et^  al. (284) demonstrated that non-energy linked activity 
can be restored to an inactive delipidated lysophosphatidylcholine 
preparation of transhydrogenase by addition of phospholipids. Neutral 
lipids will not restore the activity. Cardiolipin was the most effective 
in restoring activity but inhibited it at high concentrations. Less 
effective, but still active, were phosphatidylcholine, phosphatidyl- 
ethanolamine and lysolecithin. It is unlikely that this stimulation is 
due to a simple dispersion of the enzyme by phospholipids as detergents 
do not have a similar effect. It is possible that phospholipids act 
in stabilising an active configuration of the enzyme by occupying 
hydrophobic surfaces on the molecule. Ragan and Widger (285) have 
reported that a 4s1 phosphatidyl ethanolamine / phosphatidylcholine 
mixture was the most effective in reconstituting an energy linked trans­
hydrogenase, but other workers have found that an energy generating
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transhydrogenase (i.e. a reversal of the energy linked reaction 
generating ATP) functioned optimally with pure phosphotidylcholine 
as added phosphlipid (276), suggesting the 4:1 phosphatidyl ethanol- 
amine, phosphatidyl choline system of Ragan and Widger probably
reflects the phosphlipid dependence of the ATPase rather than the
32transhydrogenase (ATP- Pi exchange is optimally stimulated by the 
same mixture) .
Kinetic properties of the transhydrogenase reaction
Steady state kinetic data indicate that the transhydrogenase 
reaction proceeds by way of a very short lifetime ternary complex, 
possibly by a 'Theorell-Chance1 type mechanism (287-8).
Figure 6.1 'Theorell-Chance' type reaction mechanism
QE + P
where E = enzyme 
A & B = substrates 
P & Q = products
The Theorell-Chance mechanism is a special case of this general
substrate mechanism where kc >> k_, k. >> k„, (ke + k_) >> kr and
5 7 4  2 5  7 6
k2 + k4 >> k3’ Under these conditions, the steady state concentrations 
of the ternary complexes are very low (transitory) and the first 
product appears to be formed from B by interaction with the A-E complex.
Kinetic analysis reveals competitive relationships between the oxidised 
and reduced forms of the nucleotides and non-competitive relationships 
between NAD+ and NADP+, and NADH and NADPH. Product inhibition 
patterns indicate that the transhydrogenasc has separate sites for
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This mechanism is consistent with the observation of Fisher and 
Kaplan (290) that cleavage of the C-H bonds of the reduced nucleotides 
is not rate limiting.
At neutral pH the maximum initial velocities of NADPH and NADH 
formation differ by a factor of 'v 5, the former being the slower. The 
reduction of NADP+ by NADH is maximal at about pH 5.5, whereas NAD+ 
reduction by NADPH is optimal at pH 7.0.When the reduction of NADP+ 
by NADH reaches equilibrium, the rate constant of the reaction is 
increased, indicating that the activity of the transhydrogenase is 
related to the accumulation of NAD+ and NADPH. Addition of energy to 
the system, from respiration or ATP hydrolysis, leads to a 5-10 x 
increase in the maximal initial velocities of NADP+ reduction by NADH 
(272, 279, 288).
NAD (H) and NADP (H). Studies with site specific inhibitors (see
Table 6.2) indicate that NAD (H) binds before NADP(H) (289).
Table 6.3 Kinetic constants for the mitochondrial transhydrogenase 
reactions (adapted from 269)
Constant Non-energy linked Energy-linked
“n a d h (pM) 9.0 12.6
kn a d p+ (pm) 40.0 6.5
W  (PM) 28.0 43.5
‘Sjadh (wM) 20.0 20.0
k^  (pM ^min *) 1.4 5.3
k2 (min 1 ) 10.8 % o
k^  (pM m^in S 0.3 10.2
k4 (pM m^in S 3.0 2.1
kg (min S 20.6 166.0
kg (pM ^min 1) 2.1 1.0
where K* s are the respective Michaelis constants and
kg are rate constants for binding of NADH, release of NADH, binding of 
NADP+, binding of NADPH, release of NAD+ and binding of NAD+ respectively.
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The energy linked transhydrogenases are linked to the energy 
transfer systems in the membrane in which they are located. Mammalian and 
respiring bacterial transhydroqenases may be driven from any of their 
energy coupling sites, for example, in rat liver or beef heart mito­
chondria, energy linked activity can be stimulated by NADH, succinate, 
reduced cytochrome c or hydrolysis of ATP (272, 291) . Similarly, 
energy linked transhydrogenase can be driven by ATP or respiration in 
the respiratory bacteria (292-3). In the photosynthetic bacteria , 
e.g. Rhodospirilium rubrum, energy linked transhydrogenation can be 
driven by light-induced electron transport, hydrolysis of ATP and GTP 
and the hydrolysis of inorganic pyrophosphate. In both bacterial and 
mammalian systems, half maximal stimulation of transhydrogenase by energy 
is attained at considerably lower energy levels than those required to 
give a half maximal rate of oxidative or light-driven phosphorylation.
The energy expenditure of the energy linked transhydrogenase 
reaction in mitochondria and SMP's has been estimated to be one high 
energy bond, or equivalent (•'v') per NADPH formed. This stoicheiometry 
was estimated in the initial phase of the reaction, that is, under non­
equilibrium conditions (291, 294-5). The idea that energy expenditure 
is stoicheiometric with the net formation of NADP implies that the 
reduction of NAD+ by NADPH should generate energy. This was shown to 
be the case by the work of Skulachev and co-workers (296-7) and van de 
Stadt et al_. (298) . The overall energy linked reaction can thus be 
written:-
NADH + NADP+ + ATP * - * NAD+ + NADPH + ADP + Pi
or NADH + NADP+ + NAD+ + NADPH
It was assumed for a long time that the energy linked trans­
hydrogenase was essentilly irreversible, that is, could not be used to 
generate ’'t'. However, Skulachev and co-workers found that the reduction 
of NAD+ by NADPH in SMP's was linked to an uptake of lipophilic anions
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similar to that observed during the oxidation of respiratory chain 
substrates or the hydrolysis of ATP. This uptake was abolished by 
uncouplers and was assumed to reflect a high energy state of the SMP 
membrane. The amount of lipophilic anion uptake may be used as a 
measure of the energy generated by the transhydrogenase reaction. Van 
de Stadt et al. went on to show that if the NAD+ and NADPH concentrations 
were kept high and constant with regenerating systems, and if SMP's 
were incubated with ADP + Pi in a glucose-hexokinase trap system, then 
ATP was formed. This ATP synthesis was abolished by uncouplers. These 
reactions convincingly demonstrated that transhydrogenase is capable of 
generating energy provided that the nicotinamide nucleotide potential 
is sufficiently high. This has led to the suggestion that the 
transhydrogenase functions as a fourth coupling site, site O (299). 
Mechanism of energy coupling
The mechanism by which energy is transferred from ATP hydrolysis 
or respiration to the transhydrogenase is unknown,as is the precise 
mechanism of energy coupling in general (see Chapter 2). Hypotheses 
have been proposed then, which come under the more general categories 
of the chemical, chemiosmotic and conformational hypothesis of energy 
coupling.
Early mechanisms of energy linked transhydrogenase involved either 
an alteration to or transport of one of the nicotinamide nucleotides 
involved. Danielson and Ernster (291) and Lee and Ernster (295) 
suggested that NADH (or NADP+; may react as an NADH'v (or NADP+,v) form 
which is de-energised after the H transfer steps: here the reverse 
energy linked reaction was regarded as uncoupled. Klingenberg proposed 
a directional transhydrogenase where NAD+ was constantly removed by an 
active ion transport mechanism (269). Papa et al. proposed a rather 
similar mechanism in which NADPH was removed from the transhydrogenase 
site in an energy linked manner (300) .
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Mitchell and Moyle proposed that the transhydrogenase acted in an 
electrogenic manner across the SMP membrane. Addition of NADH plus 
NADP , causing an acidification of the medium,and addition of NAD+ plus 
NADPH, an alkalinization of the medium (301). They therefore 
propos ?d that the transhydrogenase acts as a proton pump carrying 
protonated species across the inner mitochondrial membrane (299).
Later evidence suggested that the tranhydrogenase proton pumping driven 
by NAD and NADPH exhibited an H+/2e ratio of close to 2, in agreement 
with the postulated chemiosmotic mechanism.
Fig. 6.2 Hypothetical chemiosmotic transhydrogenase mechanism 
(after 299)
inner membrane
A rather similar but subtly different mechanism has been proposed 
by Skulachev et al. (296-7), based on the distribution of lipophilic 
anions transported across submitochondrial particle membranes in response 
to transhydrogenase reactions. Here the transhjdrogenase is in close 
relationship with the ATPase molecule and acts as a fourth chemi­
osmotic loop, loop 6.
Both Mitchell's and Skulachev's hypotheses are unlikely as even in 
their protonated forms NAD+ and NADP+ are insoluble in the mitochondrial
inner membrane.
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Fig. 6.3 Transhydrogenase as coupling loop '0 ' (after 297)
THC - transhydrogenase 
proton carrier
TEC - transhydrogenase 
carrier
(both hypothetical)
Several mechanisms based on conformational hypotheses have been 
proposed. As with most conformational proposals, these suffer from 
being rather vague about the 'excited' state of the transhydrogenase 
molecule. Rydstrom et al. (288, 302-3) proposed that energy,possibly 
derived from ¿pH , drove conformational changes in the trans­
hydrogenase molecule, converting it from an inactive to an active form,
viz. energy + TH ----- > TH* TH = transhydrogenase
NADH + NADP+ + TH* ^--- * TH + NAD+ + NADPH
This model was later expanded to a more complex form.
Fig. 6.4 Conformational model of transhydroqenase action
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Conformational changes in the transhydrogenase molecule on addition 
of various nicotinamide nucleotides are well documented, but it is far 
from clear if these can be used to produce or convert redox energy in a 
form which can be used to drive energy linked transhydrogenation or 
whether they are merely a result of these energy linked processes.
The precise mechanism of the mitchondrial energy lined trans- 
hydrogenase is unclear and its elucidation will probably depend on a 
further understanding of the general mechanism of energy coupling.
The transhydrogenase reactions in some photosynthetic bacteria 
are rather interesting. Orlando (311) has reported a stimulation of 
the light-driven transhydrogenase of Rhodopseudomonas chromatophores 
by a soluble thiol containing protein factor and certain thiol and 
dithiol compounds. These also stimulate the ATP driven (dark) energy 
linked transhydrogenase. Of these compounds, only dihydrolipoic acid 
stimulated a dark energy linked transhydrogenase reaction in the 
absence of ATP. This reaction was as fast as the 'soluble protein 
factor1 stimulated ATP-driven energy linked transhydrogenase. Similarly, 
Knoblock has reported that in crude cell free extracts from Rhodopseudo­
monas palustris, ATP can drive an energy linked NADP+ transhydrogenation 
and reversed electron transport (from cytochrome c to NAD+). ATP can 
be replaced by ADP or pyrophosphate as energy donor. Likewise, acetyl 
phosphate or acetyl CoA (+ Pi) can function as an energy source. 
Similarly, lipoic acid with thiamin pyrophosphate and pyruvate and/or 
acetate will function even more effectively in replacing ATP as the 
energy donating system (312) . oligomycin inhibited the ATP and acetyl- 
phosphate dependent reactions and arsenate inhibited the acetyl CoA 
and acetylphosphate driven reactions.
As dihydrolipoate apparently exhibited the ability to drive ATP
synthesis in mitochondrial preparations, it was decided to see if it had
any effect on energy linked reactions such as transhydrogenation of 
nicotinamide nucleotides. The results of these investigations are 
presented in this chapter.
Methods
Mitochondria, submitochondrial particles, Escherichia coli vesicles 
and Rhodospirillum rubrum vesicles were all prepared as described in 
Chapter 3 or Chapter 5.
The ATP and respiration driven transhydrogenases were assayed as 
described by Sweetman and Griffiths (305) with slight modifications. 
Submitochondrial particles (0.5 - 2.0 mg) were suspended in 3 ml of a 
buffer, 0.25 M in sucrose; 50 mM in Tris-Cl, pH 8.0; 5 mM in MgClj. An 
NADH regenerating system, consisting of 40 nmoles NAD+, lo yl ethanol 
and 5-10 units alcohol dehydrogenase, was then added. The non-energy 
linked reaction was initiated by the addition of 0.5 ymoles NADP+. The 
ATP-driven transhydrogenase activity was assayed in the presence of 
rotenone (1 yg) and antimycin A (1 yg) per mg submitochondrial particle 
protein or in the presence of rotenone (1 yg) and KCN, 1 mM. Assays 
were initiated by the addition of ATP and monitored at 340 nm in a Pye- 
Unicam SP1800 dual beam spectrophotometer connected to a Pye-Unicam 
chart recorder. Assays were monitored againt control cuvettes, 
containing all the above additions,with the exception of NADP+ and ATP, 
at room temperature (18 - 20° C).
Respiration-driven transhydrogenase was monitored similarly except 
for the omission of antimycin A and cyanide. The non-energy linked 
reaction was initiated by the addition of 0.5 ymoles NADP+. Energy 
linked activity was. initiated by the addition of sodium succinate and 
monitored as described for ATP driven transhydrogenase.
Reverse electron transport activity, that is ATP-driven reduction 
of NAD+ by succinate, was assayed essentially as described by Griffiths 
and Roberton (314). Submitochondrial particles ( 0 . 5 - 1  mg) were
2 4 2
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incubated in a 3 ml buffer system containing 0.25 M sucrose; 5 mM MgCl2 ; 
50 mM Tris-Cl, pH 8.0; 1 mM NAD ; 1 mM KCN or 1 yg/mg protein antimycin 
A; 5 mM succinate at 30° C. Assays were initiated by the addition of
2 ymoles ATP and monitored as described for transhyrdogenase activity.
Inhibitors were usually added as methanolic solutions (1 mg/ml). 
Dihydrolipoic acid solutions were prepared as described in Chapter 3. 
Oleoyl lipoate, elaidoyl lipoate and oleoyl phosphate were prepared as 
described in Chapters 3 and 5.
Materials
All chemicals used were of 'AnalaR' or equivalent grade. Organic 
solvents were redistilled prior to use. NAD+ , NADH, ATP and alcohol 
dehydrogenase were all obtained from the Boehringer Mannheim chemical 
corporation. Oligomycin, gramicidin D, valinomycin, quercetin.and DCCD 
were obtained from Sigma Chemical Company. Efrapeptin and leucinostatin 
were kind gifts from Dr. R. Hammill, Eli Lilley and Co.
Results
Submitochondrial particles display non-energy linked and energy 
linked transhydrogenase activities. The energy linked activity can be 
stimulated by energy derived from respiration or from ATP hydrolysis 
(see Fig. 6.5) . Previous work in this laboratory has suggested that 
lipoic acid or a derivative of it may be either involved in the 
mechanism of ATP synthesis or be able to supply energy to the mito­
chondrial coupling system in such a way that it can be used to drive 
energy linked reactions (see Chapter 3) (248, 235). It was therefore 
decided to investigate whether lipoic acid and derivatives had any 
effect on the transhydrogenase reactions. Dihydrolipoic acid has been 
reported to have the ability to reverse the DBCT induced inhibition of 
various energy linked reactions including ATP-driven transhydrogenase 
(315). Dihydrolipoic acid also appeared to have the ability under 
certain circumstances to reverse the inhibition of ATP-driven trans-
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Fig 6.8. 1 Dihydrolipoate 1 driven transhyd, ,...ienase in 
bovine heart submitochondrial particles: effect of 
antimycin A.
Assays containing lmg SMP protein,lug rotenone,were 
performed as described in the methods section to
chapter 6.
N s 0.5umoles. L s 1 pmole 'dihydrolipoate'.
A : 2 ug antimycin A.
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hydrogenase by oligomycin (Fig. 6.6). This restored activity was not
sensitive to further additions of oligomycin. Oligomycin inhibition
could not be reversed by the addition of further ATP. This reversal
was not a true reversal of the inhibited ATP-driven activity as the
dihydrolipoate preparation that caused this apparent reversal had the
ability to stimulate an energy linked transhydrogenase activity at
rates similar to those driven by ATP (Fig. 6.7). This dihydrolipoate-
driven transhydrogenase reaction could only be obsered with certain
preparations of dihydrolipoic acid. Of the 10 - 15 preparations of
dihydrolipoate tested, only 4 had the ability to stimulate this
energy linked reaction. Dihydrolipoate stimulated transhydrogenase
activity was observed in the presence of rotenone and antimycin A, the
latter appearing to somewhat stimulate the reaction (Fig. 6.8). The
activity was not observed in SMP preparations inhibited with cyanide
rather than antimycin A. Dihydrolipoate stimulated transhydrogenase
was not inhibited by the F, ATPase inhibitor aurovertin, or the F F1 i O
ATPase inhibitors oligomycin, DCCD, DBCT, TET and DBT (Fig. 6.9).
Higher levels of TET do induce some inhibition of activity, possible 
because of an uncoupling effect due to its ability to mediate chloride- 
hydroxyl exchange. Uncoupling agents, such as '1799' TTFB and S13 
have the ability to completely inhibit dihydrolipoate stimulated 
activity (Fig. 6.10). The ionophores gramicidin D and valinomycin (in 
the presence of K+) also have the ability to inhibit the reaction (Fig. 
6.11). The reaction is not inhibited by the iron chelating agent, 
bathophenanthroline, or the plant flavinoid, quercetin, which inhibits 
some ATP utilising .reactions, (Fig. 6.12). It is inhibited, however, 
by leucinostatin, a compound known to affect ATP utilising reactions 
(Fig. 6.12). Its mode of action here,though,is probably due to its 
ability to uncouple energy linked reactions in higher concentrations. 
The stoicheiometry of NADPH production from dihydrolipoate was
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Fig 0.11. 1pjhydrolipoate1 driven transhydroqenase
in bovine heart GMP: effect of ionophores■
A s s a y s  c o n t a i n i n g  lm g  SM P p r o t e i n , l p g  r o t e n o n e ,  l j j g  
a n t i m y c i n  A w e r e  p e r f o r m e d  a s  d e s c r i b e d  i n  t h e  m e t h ­
o d s  s e c t i o n  t o  c h a p t e r  6 .
N : 0 . 5  pmole N A D P  . b : 1 pinole ' dihydrolipoate*
G : 4 p g  g r a m i c i d i n  I). K i 0.75 pinole KCl.
V a l i n o m y c i n  a l s o  i n h i b i t s  t h i s  r e a c t i o n  ( 3 1 7 ) .
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investigated, the results of which are recorded in Table 6.4 and in 
Fig. 6.13.
Table 6.4 Dihydrolipoate driven transhydrogenase in bovine heart SMP:
stoicheiometry of NADPH production
Dihydrolipoate added NADPH produced lipoate:NADPH ratio
nmoles nmoles
lo o 90.7 3 1:0.93
200 162.36 1:0.82
300 237.00 1:0.79
500 307.90 1:0.62
lOOO 4 29.70 1:0.43
lo o o 570.00 1:0.57
Assays were performed as described in the methods section to Chapter 6.
Assays were allowed to run to completion, that is until the 'dihydro-
lipoate' stimulated rate returns to the non-energy linked rate. See
also Fig. 6.13.
A value for dihydrolipoate was estimated (Fig. 6.14) and calculated 
to be 175 uM.
Various other compounds were tested for an ability to stimulate 
transhydrogenase activity; these included oxidised lipoic acid, dihydro- 
lipoamide and the postulated 'oleoyl cycle' intermediates oleoyl-S-lipoate 
and oleoyl phosphate (235). None of these had any ability to stimulate 
transhydrogenase activity (Fig. 6.15). The oleolyl-S-lipoate analogue, 
eladioyl-S-lipoate, had the ability to inhibit the dihydrolipoate 
stimulated reaction (Fig. 6.16). Dihydrolipoate preparations that have 
no ability to stimulate transhydrogenase activity fall into three 
categories; those which have an inhibitory effect on dihydrolipoate 
stimulated transhydrogenase, those which have no effect on this reaction 
and those which have a stimulatory effect (Fig. 6.17). An analogous 
series of effects is observed with ATP-driven transhydrogenase (Figs.
6.18; 3.6).
b o v in e  h e a r t  SM P: Km U l p o a t e )  d e t e r m i n a t i o n .
A s s a y s  w e r e  p e r f o r m e d  a s  d e s c r i b e d  i n  t h e  m e t h o d s  
s e c t i o n  t o  c h a p t e r  6 .
Km = 1 7 5  pM ' d i h y d r o l i p o a t e ' .

A s s a y s  c o n t a i n ;
1. ATP, 5 umole
2. ‘dihydrolipoate1,1 pmole
3. as 2, preincubated with 0.5 nmole 
elaidoyl-1ipoate.
4. as 2, preincubated with 1 nmole 
elaidoy1-1ipoate.
F i g  6 . 1 6  I n h i b i t i o n  o f  d i h y d r o l i p o a t e  d r i v e n  t r a n s -  
h y d r o q e n a s e  b y  e l a i d o y l - l i p o a t e .
A s s a y s  c o n t a i n i n g  lm g  b o v in e  h e a r t  SMP w e r e  p r e i n c ­
u b a t e d  w it h  e l a i d o y l - l i p o a t e , w h e r e  i n d i c a t e d , f o r  1 0  
m in u t e s  a t  R . T . T r a n s h y d r o g e n a s e  a c t i v i t y  w as m o n i t o r ­
e d  a s  d e s c r i b e d  i n  t h e  m e t h o d s  s e c t i o n  t o  c h a p t e r  6 .  
N ; 0 . 5  p m o le s  N A D P+ . L  : 1  n m o le  ' d i h y d r o l i p o a t e ' .
A : 5 p m o le s  A TP  , a s s a y  1  o n l y .
0 . 1
j i g  6 . 1 7  ' D i h y d r o l I p o a t e 1 d r i v e n  t r a n s h y d r o q e n a s e  I n
b o v in e  h e a r t  S M P s e f f e c t  o f  d i f f e r e n t  l i p o a t e s .
A s s a y s  c o n t a i n i n g  lm g  SMP p r o t e i n , l u g  r o t e n o n e , l x ig
a n t i m y c i n  A w e r e  p e r f o r m e d  a s  d e s c r i b e d  i n  c h a p t e r  6 .
N : 0 . 5  u m o le  N ADP . L . : 1  u m o le  a c t i v e  d i h y d r o l i p o a t e
L T  : 0 . 4  u m o le  "
l e i
L 2 s i  u m o le  s t i m u l a t o r y  d i h y d r o l i p o a t e .
L 3 : 1  u m o le  i n h i b i t o r y  l i p o a t e  ;  p l i p ( S H ) 2 s e e  c h .  3 .
A s s a y s  1& 2  s 3&4 a r e  p a i r e d  a s s a y s .
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F i g  6 . 1 9 . E n e r g y  l i n k e d  r e d u c t i o n  o f  N AD + b y  s u c c in a t - . p  
i n  b o v in e  h e a r t  SMP. e f f e c t  o f  1 d i h v d r o l i p o a t e .
A s s a y s  c o n t a i n i n g  lm g  SMP p r o t e i n  w e r e  p e r f o r m e d  as 
d e s c r i b e d  i n  t h e  m e th o d s  s e c t i o n  t o  c h a p t e r  6 .
N s 1  (nm ole N A D + . A : 1  ju m o le  A T P .
L  s 1  (um ole ' d i h y d r o l i p o a t e 1 .
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Dihydrolipoate was also tested for the ability to stimulate the 
reduction of NAD by succinate. This it consistently failed to do, 
even under conditions in which an energy linked transhydrogenase activity 
was stimulated except on one occasion (Fig. 6.19).
Discussion
Mitochondrial energy linked transhydrogenase reactions have been 
known for a number of years. These have been classified into two types; 
those driven by the oxidation of respiratory chain substrates, such as 
succinate, NADI! and ascorbate/TMPD, and those driven by energy derived 
from the hydrolysis of ATP. Both these reactions are thought to 
generate a high energy state, ■'*»', in the membrane which can be used 
by the transhydrogenase molecule to facilitate the transfer of hydrogen 
from NADH to NADPH.
Dihydrolipoic acid appeared to have the ability to reverse the 
oligomycin inhibition of the ATP-driven reaction, but this was not the 
case as later experiments showed that certain preparations of dihydro­
lipoate had the ability to stimulate a transhydrogenase reaction in the 
absence of either respiratory chain suhstrates or ATP. This dihydro­
lipoate stimulated activity can be classified as an energy linked 
activity as it is inhibited by uncoupling agents, gramicidin D and 
valinomycin in the presence of potassium ions. All these compounds 
have the ability to discharge the high energy state of the mitochondrial 
inner membrane. The dihydrolipoate stimulated reaction is unaffected by 
F^ ATPase inhibitors,such as aurovertin,and inhibitors which have their 
locus of action in the Fq  membrane sector of the ATPase, e.g. oligomycin, 
DBCT,DCCD, TET. It also is unaffected by the electron transfer inhibitor 
rotenone and antimycin A. This distinguishes the reaction from 
respiratory chain substrate-driven transhydrogenase which is affected by 
antimycin A. The dihydrolipoate-driven transhydrogenase appears to 
be unlike both the ATP-driven and the respiration-driven reactions.
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ATP-driven transhydrogenase is inhibited by an analogue of lipoic acid, 
8-methyl-lipoic acid (316), while the respiration-driven reaction is 
unaffected. The dihydrolipoate-driven reaction was also inhibited by 
the 8-methyl derivative (317). Thus,in its sensitivity to inhibition, the 
dihydrolipoate driven reaction can be considered as lying between or 
sharing characteristics of both the ATP and respiration stimulated 
transhydrogenase (see Table 6.5). The transhydrogenase has been 
estimated to consume one high energy bond, 'a,', per NADPH formed. The 
stoicheiometry of the dihydrolipoate stimulated reaction was 
investigated. The results from this are recorded in Table 6.4. At 
low levels (O - 200 nmoles) of dihydrolipoate, the stoicheiometry of 
moles NADPH formed per mole dihydrolipoic acid is almost 1:1, while at 
higher levels ( 1 - 2  moles) this stoicheiometry fell to about 0.5:1. 
Table 6.5 Effect of inhibitors on the energy linked transhydrogenase 
Inhibitor Respiration-driven ATP-driven DHL-driven
(succinate)
Rotenone 
Antimycin A 
Cyanide
+
+
- - (s) 
+
Oligomycin - + -
TET - + -
DBT - + -
Aurovertin - + -
1799 + + +
TTFB + + +
S13 + + +
Gramicidin • + + +
Valinomycin + K+ + + +
8-methyl
lipoic acid
+
+ denotes inhibition; - denotes non-inhibition; s denotes stimulation
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obtained with respiration-driven systems (the latter are usually much
/
lower than the theoretical 1:1 ratios). This high stoicheoimetry
suggests a rather efficient conversion of energy,somehow bound up in
dihydrolipoate to ■'v', and hence to the transhydrogenase. A K valuem
for lipoic acid was deteremined and found to be <v> 175 uM, which is of
the same order of magnitude as K values for the nicotinamide nucleo-m
tides. The rate of the dihydrolipoate-driven reaction was comparable 
to that of the ATP-driven reaction in particles in which it was observed* 
the highest rate being % 90 nmoles NADPH produced/min/mg submitochondrial 
particle protein.
Most dihydrolipoates tested exhibited no ability to stimulate a 
transhydrogenase reaction in bovine heart SMP's. Those that did not 
either had no effect on ATP and dihydrolipoate-driven activities or 
stimulated them or inhibited them. This latter class of reactions has 
been observed with many derivatives of both oxidised and reduced lipoic 
acid. This seems to be due to a general effect of these derivatives 
on energy-linked reactions as oxidative phosphorylation was also inhibited. 
The mechanism of this inhibition is discussed in Chapter 3. More 
interesting and possibly more informative was the ability of certain 
dihydrolipoate preparations to stimulate the ATP and dihydrolipoate- 
driven reactions. Incubation of aged submitochondrial particles with 
dihydrolipoate stimulates the ATP-driven reaction to a rate comparable 
to that of the rate in freshly prepared particles (Fig. 6.10), suggesting 
that dihydrolipoate- can reduce a group (possibly a thiol) functionally 
involved in energy linked transhydrogenation.
The commonly shared view of the energy coupling system is outlined
T h e s e  v a l u e s  c o m p a r e d  v e r y  w e l l  w i t h  e x p e r i m e n t a l l y  determined
s t o i c h e i o m e t r i e s  for A T P  and e x t r e m e l y  w e l l  w i t h  s t o i c h e i o m e t r i e s
in Fig. 6.20.
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Fig. 6■20 Mitochondrial energy conservation system
rotenone antimycin A CN
Here the nature of is not defined
It can be seen that reactions driven by the • state should be 
unaffected by ATPase inhibitors such as oligomycin, DCCD, trialkyltins 
and aurovertin, and by respiratory chain inhibitors such as rotenone, 
antimycin A and cyanide. They should, however, be inhibited by 
compounds which abolish the ••v* state, that is, uncoupling agents and 
certain ionophoric compounds.
A comparison of the inhibitor sensitivity of the dihydrolipoate- 
driven reaction to the sensitivity of ,'v-’ -driven reactions reveals a 
close similarity between the two. The only major difference in inhibitor 
sensitivity between the two reactions is that CN- inhibits the dihydro- 
lipoate-driven reaction. This, however, may be due to the formation of 
a thiocyanate adduct of lipoic acid which, like other lipoate 
derivatives, e.g. 8-methyl-lipoic acid, inhibits the dihydrolipoate- 
driven reaction. Cyanide has been reported to inhibit lip(SH)? driven 
ATP synthesis (248)'. It is tempting,then, to suggest that dihydro- 
lipoate drives the reaction from around the level of •'v-'.
If this is the case, what is the nature of the interaction between 
lipoic acid and the energy coupling apparatus? Griffiths has suggested
that the terminal steps of oxidative phosphorylation may be analogous 
to those of substrate level phosphorylation and has proposed the 
hypothetical 'oleoyl cycle' as an experimental framework (Fig. 6.21). 
Here dihydrolipoate-driven ATP synthesis would be sensitive to oligo- 
mycin and aurovertin, but dihydrolipoate-driven transhydrogenase would 
not be sensitive to these inhibitors as it taps into the system between 
‘'v' and the oleoyl cycle of reactions. Dihydrolipoate, then, would 
drive transhydrogenase because it was directly involved in the formation 
or subsequent utilisation of the energy stored as "v'. It is worth 
noting here that other postulated intermediates of the oleoyl cycle, 
oleoyl S lipoate and oleoyl phosphate consistently failed to stimulate 
transhydrogenase activity, even under conditions in which the dihydro­
lipoate stimulated reaction was observed.
Fig. 6.21 The oleoyl cycle hypothesis of oxidative phosphorylation
(after 248)
(ACP)
(ACP)
inhibition
uc: uncouplers
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Two alternative explanations that do not need to invoke the 
existence of such a sequence of reactions can be proposed to explain 
dihydrolipoate transhydrogenase activity. These are that dihydrolipoate 
causes a respiration-driven reaction to occur or that dihydrolipoate 
somehow interacts with ■'v' or the transhydrogenase molecule, donating 
the redox energy in such a way that it can be used to drive trans­
hydrogenase .
Dihydrolipoate-driven transhydrogenase is inhibited or prohibited 
by the presence of CN in the assay system. Cyanide has its major locus 
of action in mitochondria at the level of cytochromes a.a^. Dihydro­
lipoate-driven transhydrogenase activity was usually measured in a 
system containing rotenone and antimycin A. The possibility then 
remains that the reaction could be mediated via coupling site 3, viz.
Several artificial redox systems have been shown to generate •*>#• at 
site 3; dihydrolipoate might possibly fulfil a similar function. It would 
be possible to eliminate this pathway if the reaction was performed under 
anaerobic conditions as oxygen would be consumed during this reaction.
This experiment was not performed, so the possibility of a site 3-driven 
transhydrogenation remains open. There are two considerations, however, 
that make this rather unlikely. The first, and most important,is that 
NADPH production has been observed at levels in these experiments which 
are in excess of the molar concentration of oxygen present in the assay
buffers. Oxygen would diffuse back into these buffers if it was being
succinate lip(SH) _
NADH
rotenone antimycin A
transhydrogenation
depleted, but this would happen at a low rate as the surface to volume 
ratio of the buffers in the cuvettes used to perform the assay was rather
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low. It is possible (but unlikely) that Oj was not being consumed in 
these reactions because the low 02 tension under which the assays were 
performed may have inhibited oxidative electron flow»- i ■ .. The second
consideration making site 3-driven transhydrogenation unlikely is the 
stoicheiometry of the reaction. Site 3-driven transhydrogenation 
rarely exhibits a stoicheiometry of 1:1 (substrate added:NADPH produced), 
and is usually of the order 'v 1:0.1. Dihydrolipoate-driven trans- 
hydrogenase usually exhibited stoicheiometries in the order of iso 5 . o 
(moles dihydrolipoate added:NADPH produced).
Thiol groups have been reported to be involved in the mechanism of 
both energy coupling and transhydrogenation (318, 269); the precise 
natures of these involvements are unclear. Dihydrolipoate may exert its 
effect by supplying energy at the right redox level to a series of 
membrane thiol groups directly involved in these reactions. This idea 
is , though, very vague and rather difficult to test. The ability of 
certain dihydrolipoate preparations to stimulate ATP-(and dihydro­
lipoate) -driven transhydrogenase does suggest that they may be acting 
on some membrane bound group in such a way, although much work remains 
to be done to clarify the issue.
Dihydrolipoate can act as a substrate for the diaphorase enzyme 
(NADH:1ipoamide oxidoreductase EC 1.6.4.3) which is present in mito­
chondrial preparations. This catalyses the reactions.
lipoamide + NADH + H+ <dj-aPhora3e> dihydrol ipoamide + NAD+ 
(lipoate) (dihydrolipoate)
Under the transhydrogenase assay conditions used, submitochondrial
particles are incubated with 40 - 50 nmoles NAD+ and up to 2 pmoles
dihydrolipate. Diaphorase activity might then produce 40 - 50 nmoles
NADH. This might act to push the equilibirum of the non-energy linked
transhydrogenase reaction over to the right, i.e.
/
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NADH + NADP+ ----- ► NADPH + NAD+
The NAD produced could then be rereduced by the diaphorase enzyme and 
the process would continue. Thus dihydrolipoate would exert its action 
by effectively stimulating the non-energy linked reaction. This is, 
however, not an adequate explanation for dihydrolipoates' mode of 
action. This stimulation would be of the non-energy linked reaction, 
which is unaffected by uncoupling agents,and ionophoric compounds. The 
dihydrolipoate-driven process is, indicating that an energy linked 
reaction is being observed.
As with other dihydrolipoate stimulated reactions, the trans- 
hydrogenase was only observed rarely; the reasons for this are unknown 
(see Chapter 3). The reaction has been observed in other laboratories 
(319), although here it was interpreted to proceed via coupling site 3. 
The reaction has also been observed in preparations of E. coli vesicles 
in this laboratory (320). Orlando has reported a similar dihydro­
lipoate stimulated transhydrogenase in vesicles prepared from the 
photosynthetic bacteria, Rhodopseudomonas spheroides (311). This 
activity was also difficult to observe and intermittent in nature (321) . 
The chemistry of dihydrolipoate in solution is extremely complex. It 
may be that one of its (photo-induced) breakdown products or lactone 
forms is of the correct redox potential for it to tap into the sequence 
of reactions between the coupling site and the transhydrogenase 
molecule (see Chapter 3 for further discussion) . The intermittent 
nature of the observed reaction makes this a difficult problem to
investigate.
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CHAPTER 7
SOLVENT EXTRACTION STUDIES ON MITOCHONDRIAL ENERGY 
COUPLING: THE ROLE OF UBIQUINONE
Introduction
The ubiquinones are a series of 2,3-dimethoxy,5,methyl 6 polyiso- 
pentenyl (prenyl) benzoquinones, differing in the length of their 
prenyl side chains.
The natural members of this group are those where n = 6-9 
(although lower chain length homologues are known as breakdown or 
biosynthetic products of these ubiquinones). The commonest type in 
higher plants and animals is ubiquinone 10; ubiquinone 6 is common 
in yeast species, while ubiquinone 9 is the major quinone in rat liver 
mitochondria.
Ubiquinones were first discovered as nonsaponifiable lipids with 
absorption maxima around 272-275 nm in manmalian tissue extracts (331) . 
It was only after their discovery in heart submitochondrial particles 
by Crane et^  al. (332) and the elucidation of their structure by Morton 
and co-workers (333-4) that a possible role in electron transport was 
postulated. Ubiquinone was later found in mitochondria and respiratory 
particles from many sources (76). There have been several reports 
that ubiquinone is also localised in other tissue fragments such as 
nuclei and microsomes, and that it may be involved in aldehyde oxidase 
activity; the evidence presented for this, however, does not absolutely 
exclude contamination by mitochondria or mitochondrial fragments (76).
Cytochrome aa^ can be used as a standard against which the 
stoicheiometry of the other components of the respiratory chain can be
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measured. Using this standard then, it can be shown that ibiquinone 
occurs in mitochondria in a several fold molar excess to cyt aa^. In 
mammalian tissues, the UQ/cyt aa^ ratio varies but is usually between 
6 - 8.5, whereas in yeast and some bacterial preparations ratios as 
high as 36 have been observed.
Table 7,1 Content of quinones in the respiratory chain
Source Preparation UQ
pmoles/g
protein
cyt aa^ 
Vimoles/g
protein
UQ/aa
ratio
rat heart m i toe hondr ia 4.0 0.5 8.0
rat liver mitochondria 1.8 0.25 7.2
rat skeletal muscle mitochondria 3.0 0.35 8.6
rat kidney mitochondria 1.6 O. 27 5.9
bovine heart mitochondria 3.5 1.3 2.7
pig heart mitochondria 4.0 - -
pig kidney mitochondria 1.1 - -
guinea pig kidney mitochondria 1.6 - -
pigeon breast muscle mitochondria 3.9 0.47 8.3
flight muscle 
(locusta migratoria)
mitochondria
•
3.5 0.53 6.6
Saccharomyces
cerevisiae
mitochondria 5.4 0.15 36
Mycobacterium phlei particles 7.2 0.16 45
Azotobacter
vinelandii
particles 8.9 0.67 13
Arum spadix mitochondria 1.4 - -
spinach leaves o.i1 O.OQ252 40
^ plastoquinone moles/mole chlorophyll 
2 cytochrome f mole/mole chlorophyll
Ubiquinone is present in the inner mitochondrial membrane at a 
much higher molar concentration than the other components of the 
respiratory chain.
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Component Ratio1
Table 7 ■ 2 Estimated stoicheloinetry of respiratory enzymes in heart
mitochondria
malate dehydrogenase 0.50
glutamate dehydrogenase 0.01
succinate dehydrogenase 0. 20
NADH dehydrogenase 0.15
ubiquinone 7
cytochrome b 1.10
cytochrome c 0.40
cytochrome c^ 1
cytochrome aa^ 1
estimated per mole cyt aa^ 
Table adapted after (76)
Various spectroscopic techniques have shown that ubiquinone under­
goes redox changes during respiratory chain electron transport. These 
changes involve both the quinone and quinol forms of ubiquinone
quinone quinol
The quinone absorption spectrum has a maximum at 275 nm with a molar 
extinction coefficient of 14,000 whereas the quinol has a maximum at 
290 rm with a millimolar extinction coefficient of 12.2. The maximum 
rate of these redox changes (in vivo) as well as their kinetic 
characteristics are consistent with its role as an electron carrier. 
Spectrophotometrical techniques and 'crossover point1 studies
2 72
show that ubiquinone acts at an early stage in electron transfer between 
the dehydrogenases and oxygen. The site(s) of ubiquinone's function as 
an electron (proton) carrier has been generally thought to lie between 
the flavin linked dehydrogenases, NADH and succinate dehydrogenase 
and the b cytochromes (bggg, b,^) ' or possible directly between the 
dehydrogenases and cytochrome c^, the former being the most favoured 
position (76, 92, 24). The actual position(s) of ubiquinone in the 
respiratory chain is still far from clear. A pool function for 
ubiquinone as a mobile redox component between complexes I, XI and 
complex III has been suggested by Ernster et al. (119) on the basis of 
solvent extraction studies of mitochondria. Various organic solvent 
systems have been used to selectively remove ubiquinone from the inner 
mitochondrial membrane. Ubiquinone can be reconstituted into these 
extracted systems with the concomitant return of certain enzymic 
activities. These techniques are treated more fully in the discussion 
section to this chapter. Solvent extraction studies have established 
beyond doubt that ubiquinone is an essential component of respiratory 
chain activity between NADH and oxygen and succinate and oxygen.
Early studies of the relationships between the kinetics of the 
redox reactions of ubiquinone and its function in electron transport 
gave rise to contradictory conclusions. Change and Redfearn (335) and 
Storey and Chance (336-7) concluded from spectrophotometric studies 
that ubiquinone was not involved in the main pathway of respiratory 
chain electron transfer but in a bypass or side reaction, possibly in 
equilibrium with the main pathway. Redfearn later pointed out that 
while his earlier Kinetic data on ubiquinone could not be reconciled 
with a position in a single pathway, this did not necessarily imply that 
it is on a side pathway of electron transport (338) . He suggested that 
it might act as a link between individual electron transport chains,
e.g.
NADH FD - Fe - b - Fe - c - c - aa
\ /
succinate -» Fg - Fe
NADH
\/A
Fe - c^ - c - aa^ -*■ 02
Fd - Fe - b - Fe - c^ - C - aa3 -> 02
Storey and Chance suggested that electron transfer followed the 
following pathway in electron transport particles (336):-
Studies by Green and coworkers on complexes I - IV lead them to propose 
the following pathway for respiratory chain electron transport.
\  ,
b(2) a
a3
2Cusuccinate ----- > F nhFe
C1
nhFe
Perhaps the most important studies which finally defined the role 
and position of ubiquinone in respiratory chain electron transport 
were those of Kroger and Klingenberg (76, 121,339).In a series of 
elegant kinetic investigations, they showed that the redox responses 
of ubiquinone were consistent with its function as a component of the 
respiratory chain, having a single position between the flavin linked 
dehydrogenases and the b or c^ cytochrcmes. They went on to show 
that the mitochondrial ubiquinone pool consists of two parts, an active 
part (that is, involved in electron transport) , UQa ,and an inactive 
part, UQ^ (defined as that part of the ubiquinone pool non-reducible in 
the presence of substrates and KCN). UQ. can be as much as 10-20% of
total ubiquinone G IO ft
then °ct = U Q a + UQif
also U®a m U®oxidised + U®r educed '
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They showed that the oxidation of UQ^ ^  on aeration of anaerobic SMP
followed first order kinetics and had a reaction constant = V /UQ ,o a
where Vq = oxidation rate of the SMP's. Further analysis showed that 
the rate of UQ reduction (steady state) was equal to the overall 
oxidation rate of the particles, i.e.
Thus ubiquinone fulfils the kinetic requirements of an obligatory 
respiratory component.
Although electron transfer in the respiratory chain is a bimolecular
process, transitions of respiratory carriers from the reduced to the
oxidised state follow first order reaction kinetics. This is feasible
for a chain of fixed carriers along which electrons are drained towards
oxygen. It is, though, difficult to rationalise that a pool of mobile
proton (electron) carriers such as ubiquinone also follows first order
reaction kinetics. Instead, a mixed zero and first order reaction would
be expected, since ubiquinone can be assumed to saturate both its
donating and accepting components. Kroger and Klingenberg attempted to
explain this by proposing that the oxidation reaction of UQ  ^reflectedred
the oxidation of a subsequent fixed carrier (B).
i.e. SH2 -+-*■-*--* D ---> UQ B ---> C ---- ► C>2
This would hold if B and UQ are in a close equilibrium which is 
adjusted faster than B is oxidised. The larger pool size of UQ in 
equilibrium with B as compared to that of C would cause C to reach its
result, the oxidation of Bre(j» and consequently UQre(Jf would follow a 
pseudo first order reaction. The properties postulated for B and C 
are consistent with the observed properties of cyt b and cyt c 
respectively. The redox potentials of UQ and cyt b are almost equal 
under uncoupled conditions (340) i this would enable close equilibrium
V
steady state level almost before the oxidation of Bred starts. As a
to exist between them. The half time of oxidation of the b cytochromes
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is of the same order of magnitude as that of ubiquinone, i.e. n, o . l  s, 
which may indicate that the equilibrium is adjusted faster than b is 
oxidised (123). The half time of oxidation of the c cytochromes ('v 5 ms), 
is considerably faster than those of UQ and the b cytochromes, consistent 
with the proposed scheme.
The redox reactions of plastoquinones involve plastoquinone semi-
quinone radicals (339). The first order reaction kinetics followed by
the redox reactions of UQ^ exclude the possibility that radicals of UQ
react with the donor or the acceptor of UQ. Radicals may be formed,
though, as intermediary products of the reduction of UQ and of theox
oxidation of UQred'
UQ + Bred ox -> UQH + B + H red
The transfer of single electrons is probable since iron-sulphur 
proteins and a cytochrome are likely candidates for the donor and 
acceptor to UQ (D and B in Kroger and Klingenberg1 s scheme) .
Electron spin resonance spectroscopy indicates that the amount of 
semiquinone radicals within the mitochondrial membrane under equilibrium 
conditions in the presence of substrate + KCN did not exceed 1-5% of 
UQtotal  ^341) . The steady state concentration would not be expected to 
be high, however, since the disproportionation of the radical
2UQH ---- > UQ + UQox red
is much faster than its formation by electron transport. Redox active 
ubiquinone, UQ&, appears to be kinetically homogeneous. The
relationship
UQ /UQ = V /(V . + V )ox *a ox red ox
derived by Kroger and Klingenberg is valid for UQfl if either NADH or 
succinate is used as substrate,demonstrating that each ubiquinone 
molecule is accessible to reducing equivalents from both NADH and 
succinate dehydrogenases. This led Kroger and Klingenberg to propose a 
mobile pool function for ubiquinone, i.e.
2 76
rotenone antimycin A
NADH > Dortor I accbnt-or
succinate -> Dorior II 
maldnàte
acceptor
I
:or
>
-> o.
2
This view contrasts to that proposed by Lenaz et al^ (122) who 
suggested that there was a functional compartmentation of ubiquinone 
between NADH and succinate dehydrogenases based on observations of the 
reconstitution of these activities in pentane extracted mitochondria. 
They found NADH respiration has a far higher specificity for various 
ubiquinone homologues than succinate respiration, and requires far 
greater amounts of ubiquinone for reconstitution of pentane extracted 
mitochondiral activity than does succinate respiration. Lenaz' 
interpretation is based on the assumption that ubiquinone is relatively 
fixed in the membrane. His observations may be easily explained, however, 
if ubiquinone is mobile and the dehydrogenases display different enzyme 
specificities and different Km^  ^ values for ubiquinone.
Mitchell has proposed a rather different role for ubiquinone in the 
respiratory chain in his 'proton motive Q cycle' hypothesis, which was 
devised in order to allow the theoretical transport of 2H+ from the 
inside to the outside of the inner membrane by the transfer of only one 
electron from the dehydrogenase site of ubiquinone to cyt c ^  This 
cycle replaces loops2 and 3 of the chemioanotic hypothesis (see 
Chapter 2) (342-3) .
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(a) 2UQ~ -4-+ 2H «Ç-*  UQ + UQH
(b) UQ + 2H = e -- -» UQH
(c) u q h 2 ---> UQ + 2H + 2e
(d) UQ + e u q "
This scheme of reactions has been criticised on theoretical 
grounds by Kroger (344), mainly on the basis of the stability of the 
radical anion of ubiquinone UQ~ which dismutates to UQ and UQH2 far 
faster than it can be produced by the electron transport chain.
The view of ubiquinone as a free mobile proton (electron) carrier 
in the membrane may need to be revised as King and co-workers have 
reported the presence of a number of specific ubiquinone binding 
proteins in the inner membrane. These are found in association with 
complex III (124), as the 'natural electron acceptor' of succinate 
dehydrogenase (123,345) and in association with complex I (124) .Theyclaim 
that it is these protein bound ubiquinones that are the redox active forms 
in the membrane. If this is so, then it raises many as yet unanswered 
questions. How is ubiquinone 'bound' to protein? What reactions does 
it undergo? What is its relationship to free ubiquinone? What then 
is the role of the large free ubiquinone pool?
There have been several suggestions in the past that ubiquinone 
might play a direct role in energy coupling in mitochondria. Clark 
postulated that a hydroquinone phosphate night act as a phosphate donor 
to ADP in oxidative phosphorylation (346). Other schemes involving 
quinone derivatives as possible 'high energy' intermediates have been 
proposed (see (25))-. There is, however, little experimental evidence 
for any of these schemes. ATP synthesis driven byaquinol phosphate 
derivative has been reported (392) but at a very much slower rate than 
normal oxidative phosphorylation. Yamamoto et al_. have reported that 
pentane extraction of ubiquinone from Rhodosplrlllum rubrum chromato-
277
Fig, 7.1 Proton motive ubiquinone cycle after Mitchell (343)
Two electrons and protons are transferred by the diffusion of UQH2 
from the inside to the outside of the membrane. Here UQH2 is oxidised
to UQ which diffuses back inside, only le is passed on to oxygen via 
c^; the other is conducted back inside via the b cytochromes where it 
is transferred to UQ together with an electron donated frcm the 
dehydrogenase. In the oxidation reaction, the specific transfer of 2e 
may be achieved by the b-c^ complex without the involvement of inter­
mediates such as ubiquinone radicals. In contrast to this in the 
reduction of UQ to UQH2 radicals have to be liberated in order to 
equilibrate with UQ and UQH., by the dismutation reaction:-
(a) 2UQ~ + 2H+ *=•=* UQ + UQH2
This is necessary to explain the reduction of ubiquinone in the presence 
of antimycin A. This situation requires that cyt b reacts specifically 
with UQ and the dehydrogenase specifically with the radical. The 
ubiquinone cycle can then be described by the reactions a-d, i.e.
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(a)
(b)
(c) UQH2 ---> UQ + 2H+ + 2e
( d ) UQ + e >  UQ
This scheme of reactions has been criticised on theoretical 
grounds by Kroger (344), mainly on the basis of the stability of the
faster than it can be produced by the electron transport chain.
The view of ubiquinone as a free mobile proton (electron) carrier 
in the membrane may need to be revised as King and co-workers have 
reported the presence of a number of specific ubiquinone binding 
proteins in the inner membrane. These are found in association with 
complex III (124), as the 'natural electron acceptor' of succinate 
dehydrogenase (123,345) and in association with complex I (124) .Theyclaim 
that it is these protein bound ubiquinones that are the redox active forms 
in the membrane. If this is so, then it raises many as yet unanswered 
questions. How is ubiquinone 'bound' to protein? What reactions does 
it undergo? What is its relationship to free ubiquinone? What then 
is the role of the large free ubiquinone pool?
There have been several suggestions in the past that ubiquinone 
might play a direct role in energy coupling in mitochondria. Clark 
postulated that a hydroquinone phosphate might act as a phosphate donor 
to ADP in oxidative phosphorylation (346). Other schemes involving 
quinone derivatives as possible 'high energy' intermediates have been 
proposed (see (25) )•. There is, however, little experimental evidence 
for any of these schemes. ATP synthesis driven bya quinol phosphate 
derivative has been reported (392) but at a very much slower rate than 
normal oxidative phosphorylation. Yamamoto et al.have reported that 
pentane extraction of ubiquinone from Rhodospirillum rubrum chromato­
radical anion of ubiquinone UQ which dismutates to UQ and UQHj far
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phores results in a loss of ATP-Pi exchange activity, oligomycin 
sensitivity, coupled ATP hydrolysis and ATP synthesis. Readdition of 
ubiquinone 10 to this system results in a stimulation of these activities. 
They suggest that ubiquinone lO may function as the link between the 
electron transport and energy conservation systems leading to ATP 
synthesis (347).
This hypothesis together with a report by Dr. E. Bertoli that 
pentane extraction of bovine heart mitochondria reduced sensitivity 
to oligomycin (326) lead to an investigation of possible functions of 
ubiquinone, other than those expected of a strict redox carrier in 
mitochondrial membranes.
Materials
All chemicals used were of 'AnalaR' or similar grade where 
available. Oligomycin was obtained from the Sigma Chemical Company.
Yeast strains D273-10B, E3-24, E3-149 were kind gifts from Dr. Alex 
Tzagoloff. Ubiquinones were obtained from Hoffman La Roche Co. Ltd., 
Basel, Switzerland.
Methods
Bovine heart mitochondrial and submitochondrial particles were 
prepared as described in Chapter 3.
ATPase, ATP- "^Pi exchange and oxidative phosphorylation were 
assayed as described in Chapter 3.
Oxidase activities were assayed using a 'Clarke' type oxygen 
electrode connected to a Servoscribe chart recording device in 2 or 3 ml 
of a buffer, 0.25 M sucrose; lO mM Tris-Cl, pH 7.5; lO mM KC1; 5 mM 
MgClj» 5 mM potassium phosphate at 30° C. Values used for the oxygen 
content of buffer solutions were those of Eastabrook ( 399) , j.e. 210 
nmoles Oj/ml buffer at 30° C.
Yeast (strain D22, ad2a+,a) growth was carried out on a large scale 
in lO L New Brunswick fermenter vessels under vigorous stirring (400 rpm)
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and aeration (lOL/min). The growth media contained 0.5% (w/v) yeast 
extract; 0.1% (w/v) bacterial peptone; 0.01% (w/v) adenine sulphate, 
mineral salts (328); 1.0% v/v ethanol and tributyl citrate (0.01% v/v 
as an antifoaming agent. The culture was inoculated with a 1% (v/v 
suspension) of cells in late logarithmic stage and was harvested in late 
logarithnic phase (36-40 hr) by centrifugation in an MSE Mistral 6L 
centrifuge, 4 x 1.25 (rotor at 2000 rpm). Harvested cells were washed 
twice with cold distilled water and recentrifuged as before. Cells were 
then resuspended in an equal volume of 0.5 M sorbitol; 20 mM Tris-Cl, 
r!; 7.5; 1 mM EDTA; 0.1% in bovine serum albumin and kept at 4° C; all 
following operations were also carried out at 4° C.
Yeast cells were disrupted by shaking cell suspensions with glass 
beads (0.4 5 - 0.5 mm diam.) for 30 seconds in a cooled Braun shaker 
(B. Braun Co., Melsungen) at 4000 rpm. The glass beads were washed 
with 10 ml media between shakes. The cell debris was pelleted by 
spinning the homogenate at 3000 rpm for lO minutes in a Sorval RC-2B 
centrifuge G.S.A. rotor. The pellet was discarded and the supernatant 
recentrifuged until no more pellet was observed (usually 2-3 centri­
fugations) . The mitochondria were sedimented by centrifugation at 
14,000 rpm for 20 minutes in a Sorval RC-2B centrifuge SS34 rotor. The 
mitochondrial pellet was resuspended to 20 mg/ml protein concentration 
in isolation media. This suspension was layered on to a discontinuous 
sucrose gradient (14 ml each of 15%, 30%, 50% and 70% (w/v) sucrose 
solutions containing 20 mM Tris-Cl, pH 7.5; 1 mM EDTA) and centrifuged 
at 23,000 rpm for 3 hr in a Beckman L-2.50 centrifuge S.W. 25.2 rotor. 
The mitochondrial band at a density of 1.20 g/cm3 was collected and 
diluted in mitochondrial isolation media (minus bovine serum albumin) 
and centrifuged as described above to pellet the mitochondria. This 
pellet was resuspended to 20 mg protein/ml and represents the purified 
mitochondrial preparation.
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Submitochondrial particles were prepared by sonication of this 
suspension for 1 min (4 x 15 seconds with 1 minute intervals between 
each) at 4 C in an M.S.E. 60 W sonicator at maximum amplitude. The 
sonicated suspension was diluted with 2 volumes of buffer and 
centrifuged in a Sorval RC-2B centrifuge, SS34 rotor, 14,000 rpm for 
20 minutes. The supernatant was then centrifuged at 100,000 g for 30 
minutes in a Beckman L2-50 or L50 centrifuge. The submitochondrial 
pellet was then resuspended in 0.25M sucrose; lO mM Tris-Cl, pH 7.5;
1 mM EDTA and washed by recentrifugation at 100,000 g for 30 minutes. 
The final pellet was resuspended in the same buffer to a concentration 
of 20 mg protein/ml.
Lyophilisation and pentane extraction procedures were based on 
methods originally described by Szarkowska (329) with substantial 
modifications which are described in the discussion section to this 
chapter.
Yeast strain E3-24 was grown under identical conditions to D22
except that growth media contained 2% glucose (w/v) and no ethanol.
Cells were harvested after growth for 15 hr at 28-30° C.
Table 7■3 Effect of lyophilisation conditions on bovine heart 
mitochondrial activities
Succinate Ascorbate/ Respiratory
Mitochondrial preparation oxidase TMPD oxidase control
Freshly prepared 197 98 Yes
Lyophilised
Lyophilisod in 5 mM MgClj, pH 7.5 193 95 No
Lyophilised in 5 mM MgCl2; 2 mM ATP 170 67 No
Lyophilised in 5 mM MgCl,; 2 mM ATP 182 63 No
+ 1 mM EDTA
Lyophilised in 5 mM MgCl_; 2 mM ATP 194 95 No
* + 1 mM EDTA
+ 1 mM DTT
Lyophilised in 5 mM MgClj) 2 mM ATP 186 64 No
+ 1 mM EDTA
+ 1 mM DTT
+ 1 mg/ml BSA
nmoles 0 consumed/min/mg (for legend to Table, see
overleaf)
2 82
Legend to Table 7.3 (previous page)
Bovine heart mitochondria were suspended to 40 mg/ml protein in 5-10 ml 
buffer placed in a round bottomed quickfit flask and rapidly frozen as 
a thin film in liquid nitrogen. The contents were then lyophilised at 
R.T for 2-3 hr. Oxidase activities were assayed as described in the 
methods section to Chapter 7.
Table 7.4 Reconstitution of succinate oxidase activity in pentane 
extracted bovine heart mitochondria
Additions Succinate oxidase activity
nmoles 00 consumed min/mg
None o 
Ubiquinone 9 (lOO nmole) 189 
Dihydrolipoate (1 pinole) 0 
Cholesterol (lOO nmole) 0 
Oleic acid (lOO nmole) O 
Phospholipids (asolectin) (1 mg) 0 
Vitamin (lOO nmole) O 
Ubiquinone 9 (20 nmole) 22
Assays containing 1 mg bovine heart mitochondria were preincubated with 
lipids for 15 minutes at 30° C in a shaking water bath in 1 ml 0.25 M 
sucrose; 10 mM Tris-Cl, pH 7.5; 5 mM MgC^; 5 mM potassium phosphate;
10 mM potassium chloride, and then transferred to an oxygen electrode 
assay chamber (final volume, 2 ml of above buffer). Succinate oxidase 
activity was assayed as described in methods section to this chapter.
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Results
Several lyophilisation and pentane extraction procedures were used 
to facilitate ubiquinone extraction from mitochondrial membranes. 
Lyophilisation media which proved most useful in these investigations 
were ones designed to protect the ATPase from disruption particularly 
those containing magnesium chloride, ATP, DTT and EDTA (Table 7.3). It 
was important to ensure that mitochondria were thoroughly washed in 
these media prior to lyophilisation as the presence of sucrose and 
buffers such as 'Tris' produced preparations that required long periods 
of lyophilisation and which could only be poorly extracted by pentane. 
Lyophilisation was usually only necessary for 1-3 hours when small 
volumes of mitochondrial suspensions were used, and was carried out by 
freezing 5-10 ml of mitochondria (20 mg protein/ml) as a thin film in 
liquid nitrogen in a round bottomed 250 ml quickfit flask. This flask 
was then connected to a freeze dryer (Virtis freeze drier, Virtis Co. 
Gardiner, N.Y. 12525, U.S.A.) and removed after lyophilisation was 
complete. The lyophilised mitochondria were then resuspended in 
redistilled n-pentane (30 ml/lOO mg protein). The suspension was then 
shaken for 3 hr at 4° C, after which time it was separated by centri­
fugation (5000 rpm for 10 minutes, RC-2 Bcentrifuge SS34 rotor). The 
supernatant was kept; the mitochondria were resuspended in pentane (30 ml/ 
100 mg protein) and shaken for 1 hr at 4° C. This latter step was 
repeated two more times. The supernatants were pooled, evaporated to 
dryness and the residue dissolved in a minimum' volume of ethanol.
This complex solution was hereafter termed 'pentane extract'. Any 
remaining n-pentane was removed from the mitochondria by rotary 
evaporation. The dried mitochondria were either used imnediately or 
stored at -20° C. Before use, lyophilised mitochondria were 
resuspended in lyophilisation medium to 1-5 mg protein/ml and washed 
in this buffer twice before being washed in 250 mM sucrose; 10 mM
Fig 7.2 Oxidase activities in pentane extracted 
bovine heart mitochondria.
Assays containing lmg of protein (except assay 4,-J 
mg protein) were measured in a Clarke type C>2  elec­
trode as described in the methods section ch.7. 
Assays 1&2 were preincubated with UQg (lOOnmole/mg 
protein) for 15 min @30°C in a shaking water bath 
prior to assay.
S j 10 umoles sodium succinate pH 7.5 .
A : 10 yn.oles sodium D iso ascorbate/ 1 pmole TMPD. 
C s 0.5 mg cytochrome C.
M s mitochondria.
Fig 7.3 Succinate oxidase activity in pentane extra­
cted bovine heart mitochondria;effeet of ubiquinone 
by direct addition and preincubation.
Oxidase activities were monitored in a Clarke type 
Oj electrode as described in the methods section to 
chapter 7.
S s 25 umoles sodium succinate pH 7.5.
Q ; 200 nmoles ubiquinone-9.
1 . lmg normal mitochondria
2 . lmg pentane extracted mitochondria,princubated 
with 200 nmoles ubiquinone-9, see fig 7.2.
3 . lmg pentane extracted mitochondria.
M s mitochondria.
Fig7.4.Succinate oxidase activity in pentane______
extracted bovine heart mitochondria:effeet of UQg .
Succinate oxidase activity was monitored as described in fig 7.3.
UQp (added as a 20mM solution in ethanol) was preinc­
ubated with 2.5 mg mitochondrial protein in 4mls 
0.2 5M sucrose; lOrnM Tris-Cl pH 7.5:lmM EDTA for 10 
minutes at 30°C in a shaking water bath. 2ml samples 
were then taken into the reaction chamber of a 
Clarke type oxygen electrode and assayed for succinate 
oxidase activity.
Assays were initiated by the addition of 10 pmoles 
sodium succinate pH 7.5
2 8 7
Fig 7.5. Stimulation of succinate oxidase in pentane
extracted, bovine heart mitochondria¡effect of DBCT.
A s s a y s  containing lmg mitochondrial protein were mon­
itored in a Clarke type electrode as described in 
the methods section to chapter 7.
S : 10 pmoles sodium succinate pH 7.5.
1 . Pentane extracted mitochondria,preincubated with
pentane extract (= to 2nmoles UQ.).
2 . As 1. but preincubated with 2 nmoles UQ.
3. As 1. but pentane extract preincubated with 3 
nmoles DBCT prior to addition to assay.
4. Pentane extracted mitochondria preincubated with
3 nmoles DBCT prior to addition of pentane extract 
. s in 1 .
5. As 1 then 3 nmoles DBCT added prior to sodium 
succinate.
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Tris-HCl; 1 mM EDTA; 5 mM MgCl^ twice, and resuspended in the same to 
a final concentration of 20 mg protein/ml. Pentane extract or ubi­
quinone was reincorporated into mitochondria by one of three methods. 
These were (i) direct addition back to the mitochondria in a simple 
preincubation step prior to initiation of assay, (ii) addition back 
in a preincubation carried out in a shaking water bath on a batch of 
mitochondria prior to start of an experiment, (iii) addition of 
'pentane extract' to a suspension of mitochondria in n-pentane, shaking 
for 30 minutes at 4° C and then removing pentane by rotary evaporation.
Pentane extraction under these conditions produces a mitochondrial 
preparation that is minimally disrupted by the physical techniques used. 
Removal of ubiquinone in this way completely inhibits the succin- 
oxidase activity of the mitochondria, whereas ascorbate/TMPD oxidase 
activity is left largely unaffected (Fig. 7.2). Cytochrome c has no 
stimulatory effect on succinoxidase activity in ubiquinone 
reconstituted, pentane extracted mitochondria, indicating that the 
inner membrane system has been minimally disrupted by the lyophilisation 
and extraction techniques used (Fig. 7.2). Succinoxidase activity 
can be reconstituted by addition back of pentane extract or ubiquinone 
to extracted particles, (Figs. 7.3-4); other lipid compounds do not 
restore this activity (Table 7.4). Ubiquinone 9 added back, either 
as a direct addition to the assay or by incorporation into a 
suspension of mitochondria in pentane, reconstitutes activity, the 
latter being slightly the more efficient method (Fig. 7.3).
Investigations showed that 'pentane extract' appeared to be more 
effective in reconstituting succinoxidase activity than would be 
expected from its ubiquinone content. Its efficacy in reconstituting 
succinoxidase could be reduced to that expected from its ubiquinone 
content it it was incubated with dibutylchloromethyltin chloride, an 
inhibitor of energy linked fuctions in bovine heart mitochondria, prior 
to addition to assay (Fig. 7.5).
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Table 7.5 Pentane extraction of bovine heart mitochondria: effect of
inhibitors
Additions ATPase specific'*'
activity
% Activity
Lyophilised mitochondria 1.08 lOO
Lyophilised mitochondria + oligomycin 0.03 2.7
Lyophilised mitochondria + venturicidin 0.03 2.7
Lyophilised mitochondria + DCCD 0.03 2.7
Pentane extracted mitochondria 1.48 100
Pentane extracted mitochondria 
+ oligomycin
1.27 85
Pentane extracted mitochondria 
+ venturicidin
0.45 30
Pentane extracted mitochondria + DOCD 1.16 78
Pentane extracted, ubiquinone
reconstituted mitochondria
1.46 100
Pentane extracted, ubiquinone
reconstituted mitochondria 
+ oligcmycin
0.04 2.7
Pentane extracted, ubiquinone
reconstituted mitochondria 
+ venturicidin
0.10 6.8
Pentane extracted, ubiquinone
reconstituted mitochondria + DCCD
0.23 15.7
nmoles ATP hydrolysed/min/mg
Assays containing 80 yg lyophilised mitochondria or 125 yg pentane
extracted and pentane extracted/ubiquinone reconstituted mitochondria
in 1 ml 50 mM Tris-Cl, pH 8.5) 5 mM MgClj were preincubated with
inhibitors (1 yg/assay) for 5 minutes at 35° C prior to initiation of
assay with 5 nmoles ATP. Assays were terminated after 5 minutes by
addition of 0.5 ml 10% T.C.A. Phosphate released was assayed as
(continued on next page)
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described in Chapter 3. Ubiquinone was reincorporated into mito­
chondria by addition of an ethanolic solution of ubiquinone to mito­
chondria suspended in a minimum volume of n-pentane which was shaken 
for lO minutes at 4° C. Pentane and ethanol were removed by rotary 
evaporation. The mitochondria were washed and resuspended in 0.25 M 
sucrose; lO mM Tris-Cl, pH 7.5; 1 mM EDTA; 5 mM MgClj to 20 mg protein/ml. 
Ubiquinone was added back to a level of lOO nmoles/mg mitochondrial 
protein. *1
Table 7.6 Effect of pentane extraction on ATP-3~*Pi exchange activity 
in bovine heart mitochondria
Preparation Specific activity
nmoles/min/mg____
Lyophilised mitochondria 52.0
Pentane extracted mitochondria 8.6
Pentane extracted mitochondria + ubiquinone 9 23.9
(lO nmole)
Pentane extracted mitochondria + ubiquinone 9 36.0
(20 nmole)
Pentane extracted mitochondria + pentane extract 28.7
(2 nmole^)
1 Pentane extract added contains 2 nmoles ubiquinone
Assays containing 1 mg mitochondrial protein were preincubated with
ubiquinone where indicated for lO minutes in a shaking water bath at
35° C, prior to initiation of assay with 12 pmoles ATP. Assays were
terminated after 5 minutes incubation at 30° C with 200 yl 30% P.C.A.
33ATP- Pi exchange activity was determined as described in Chapter 3.
Preparation Specific activity
nmoles/min/mg
Pentane extracted mitochondria 31.39
Pentane extracted mitochondria + ubiquinone 9 53.29
(lO nmole)
Pentane extracted mitochondria + ubiquinone 9 67.89
(20 nmole)
Pentane extracted mitochondria + pentane extract 21.9
(lO rmolel)
Pentane extracted mitochondria + ubiquinone 9 O
(lO rmole) + oligomycin
Pentane extracted mitochondria + ubiquinone 9 O
(lO nmole) + TTFB
Pentane extracted mitochondria + ubiquinone 9 O
(lO nmole) + DBCT
33T a b l e  7.7 E f f e c t  o f  i n h i b i t o r s  o n  A T P -  PI e x c h a n g e  a c t i v i t y  In
p e n t a n e  e x t r a c t e d  b o v i n e  h e a r t  m i t o c h o n d r i a
Pentane extract added contains lO moles ubiquinone 
Lyophilised mitochondria sp. act. 61 nmoles/min/mg
Assays containing 1 mg mitochondrial protein were preincubated with 
ubiquinone where indicated for 10 minutes in a shaking water bath at 
35° C. Inhibitors (5 Wg/mg protein) were added and preincubation was 
continued for 5 minutes at 30° C. Assays were initiated with 12 ymoles 
ATP and were terminated by addition of 200 pi 30% P.C.A. after incubation 
for 5 minutes at 30° C. ATP- "^ Pi exchange activity was determined as
described in Chapter 3.
100
90
80
Fig 7.7.Effect of pentane extraction on oliqomycin 
inhibition of bovine heart mitochondrial ATPase. 
Assays were preincubated with oligomycin for 5 min 
at 30°C in 1ml 50mM Tris-Cl pH 8.5;5mM MgC^prior to 
addition of 5 jumóles ATP.Assays were terminated after 
incubation at 30°C for 5 minutes, by addition of 0.5 
ml 10% TCA.Phosphate was determined as described in 
the methods section to chapter 3.
O— Olyophilised mitochondria.
•— • pentane extracted mitochondria.
Specific activity lyophilised mitochondrial ATPase 
= 1.2 4 prnoles / min / mg mitochondrial protein 
(uninhibited).
ATPase activity was determined as described in fig 
7.7.
0_0  lyophilised mitochondria.
O— o pentane extracted mitochondria.
Ki = 0.325 pg oligomycin/mg lyophilised mitochondrial 
protein.
Ki = 3.22 pg oligomycin/mg pentane extracted mitoch­
ondrial protein.
100
90 • 
80
Fig 7.g Effect of pentane extraction on the DCCD 
sensitivity of bovine heart mitochondrial ATPase. 
Assays were preincubated with DCCD for 5 minutes at 
30°C in 1ml 50 mM Tris-Cl pH 8.5; 5mM MgCl2prior to 
addition of 5 ¡umoles ATP. Assays were terminated 
after 5min @ 30°C by addition of 0.5 ml 10% TCA.
Phosphate was determined as described in chapter 3. 
Specific Activity lyophilised mito ATPase= 0.89.
O— O lyophilised mitochondria.
•— • pentane extracted mitochondria.
□ — □ ".reconstituted with ubiquinone-9
incorporated by preincubation (1 0 0 nmole/mg 
protein) in a shaking water bath at 30°C for 
15 min prior to addition of DCCD.
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Fig 7.11.Reconstitution of oliqomycin sensitivity of 
pentane extracted bovine heart mitochondrial ATPase. 
ATPase activity was determined as described in fig 7.7. 
•--• lyophilised mitochondria.
O— O pentane extracted " assayed immediately after
preparation.
â--â as above assayed after standing for 6 hr at 4°C.
g — H pentane extracted mitochondria reconstituted
ubiquinone-9 , assayed immediately.(100nmole/mg).
□ — □ as above , but reconstituted with pentane extract
( 1 0 0  nmoles ubiquinone / mg protein.).
Specific activity lyophilised mitochondrial ATPase 
= 1.43 umoles / min / mg protein (uninhibited).
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Table 7.8 Effect of acetone extraction on bovine heart
mitochondrial ATPase activity
Mitochondrial preparation
Normal mitochondria
'Acetone extracted' mitochondria
'Acetone extracted, ubiquinone reconstituted
mitochondria
'Acetone extracted, acetone extract
reconstituted' mitochondria
^ Mmoles ATP hydrolysed/min/mg
Reconstitution conditions:- 
Ubiquinone 9 reconstitution:- 1 ml acetone extracted mitochondria 
(11 mg) were incubated with 1 ymole ubiquinone 9 (20 pi of a 50 mM 
solution in ethanol) in a shaking water bath for 10 minutes at 30° C.
Acetone extract reconstitution:- Acetone extract was vacuumed down 
to remove acetone. The remaining water was taken to 66% ethanol with 
absolute ethanol. 1 ml acetone extracted mitochondria + 1 ml 0.25 M 
sucrose: 10 mM Tris-Cl, pH 7.5; 5 mM MgCljj 5 mM MnCl2 + 50 ill 
acetone extract were incubated for 10 minutes at 30° C in a shaking 
water bath.
ATPase activity was determined as described in Table 7.5
Specific activity^ 
0.666 
0.894
0.866
1.075
Fig 7.12. Effect of acetone extraction on the oliqo-
mycin sensitivity of bovine heart mitochondrial_____
ATPase.
Assays were performed as described in fig 7.7.Acetone 
extraction procedures were those described in tab 
O— O normal mitochondria.
•— • acetone extracted mitochondria.
q  q  as above, UQ- * reconstituted see table 7.8.
B m  as above but pentane extract reconstituted see
table 7.8.
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Table 7.9 Lack of reconstitution of oxidative phosphorylation in
acetone extracted bovine heart submitochondrial
particles (ETP )H
Additions Oxidative
phosphorylation
ETP + succinate 68.7rl
Acetone extracted ETP oH
Acetone extracted ETP„ + ubiquinone 9 (lOO nmol) 0H
Acetone extracted ETP + ubiquinone 9 (lOO nmol)H
+ dihydrolipoate (lOO rmol) + oleate (30 nmol) 0
Acetone extracted, acetone extract reconstituted ETP 0H
nmoles/min/mg ATP synthesis measured as phosphate disappearance
Assays containing 0.5 mg submitochondrial protein and 1 \ig rotenone 
were preincubated with lipids, where indicated, for 5 minutes at 30° C 
in a shaking water bath prior to initiation of assay with 10 nmoles 
sodium succinate, pH 7.5. Oxidative phosphorylation was assayed in 
a 1 ml glucose hexokinase trap system, 0.2 mM in ADP, as described in 
Chapter 3.
ETP were acetone extracted by addition of 0.5 ml ETP„ (10 mg/ml) to 
1 ml loot acetone, whlrlimixing suspension and removing protein by 
centrifugation. Acetone extract reconstitution performed essentially 
as described in legend to Table 7.8.
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The effect of pentane extraction on the activities of the ATPase
enzyme was investigated. Pentane extraction produces a slight
stimulation of ATPase activity in bovine heart mitochondria. This
stimulated ATPase also loses its sensitivity to the inhibitors oligo-
mycin anA DCCD after extraction. If ubiquinone is reconstituted into
the particles, sensitivity to ubiquinone and DCCD is regained (Table
7.5). Pentane extraction reduces the K value for ATP of them
enzyme, indicating a higher affinity for ATP (Fig. 7.6). Extracted 
particles when reconstituted with ubiquinone 9 or ’pentane extract' 
regain their sensitivity to oligomycin and DCCD (Figs. 7.7-9). Dixon 
plots indicate that extraction reduces the affinity of the enzyme for 
these inhibitors (Figs. 7.8, 7.10). If pentane extraction was not 
complete, then the ATPase did nottose its sensitivity to oligomycin and 
DCCD. Extracted particles left to stand at 4° C for 6 hrs regained 
full sensitivity to inhibition by oligomycin (Fig. 7.11).
ATP-^Pi exchange activity in bovine heart mitochondria was 
reduced or abolished by pentane extraction. The activity could be 
reconstituted by either ubiquinone 9 or pentane extract (Table 7.6) and 
was fully sensitive to uncouplers and ATPase inhibitors (Table 7.7) .
Acetone can also be used as a solvent systan to extract ubi­
quinone from the mitochondrial membrane. Extraction stimulates ATPase 
activity and also reduces its sensitivity to oligomycin. This 
sensitivity is not restored by readdition of pentane extract' or 
ubiquinone 9 to the extracted particles (Table 7.8 and Fig. 7.12). 
Oxidative phosphorylation is abolished by acetone extraction and is not 
reconstituted by addition of ubiquinone 9 or 'pentane extract' (Table 
7.9) .
Pentane extraction of yeast mitochondria or submitochondrial 
particles has similar effects on them as on bovine heart mitochondria. 
ATPase activity is slightly stimulated; this stimulation is reduced by
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Table 7.IQ Effect of pentane extraction on yeast submitochondrial 
particle ATPase activity
Preparation ATP hydrolysis1
Yeast submitochondrial particle lyophilised 2.85
Pentane extracted submitochondrial particles 3.68
Pentane extracted, ubiquinone reconstituted
submitochondrial particles 2.99
Pentane extracted, pentane extract reconstituted
submitochondrial particles 2.94
1 umoles ATP hydrolysed/min/mg
ATPase activity was in a buffer 50 mM in Tris-Cl, pH 9.5; 5 mM MgCl2 
essentially as described in Chapter 3.
Yeast SMP were washed in a buffer lO mM in MgCl_, 1 mM EDTA, 1 mM ATP 
twice before being resuspended to a concentration of 10 mg protein/ml 
in the same buffer. This suspension was then frozen as a thin film in 
liquid nitrogen and lyophilised for 3 hr at R.T. The SMP preparation 
was then homogenised in n-pentane (30 ml/100 mg protein) and shaken 
in the same for 1 hr at 4° C. This procedure was repeated two more 
times. Pentane extracts were pooled and vacuumed to dryness, the 
residue being dissolved in a minimum volume of absolute ethanol. 
Extracted SMP's were lyophilised to remove pentane and were washed twice 
in a buffer system 0.25 mM in sucrose; 10 mM Tris-Cl, pH 7.5; 1 mM EDTA; 
5 mM MgCl2 before being resuspended in the same buffer system to a 
protein concentration of 10 mg/ml. Ubiquinone and pentane extract were 
reconstituted with SMP's by incubating together in a shaking water bath 
for 15 minutes at 35° C.
ft , 1 . 0I V. jumoles ATP hydrolysed 
/min/mg. 0.9
YSMP Kir,ATp = 3.03 mM.
PF.YSMP KmATp = l i 3 4
CRSMP KmATP =3.03 mM.
0 . 6PERPEYSMP Km p = 1.34 mM.
0 0.1 0.2 0.3 0.4 6.5
FI«( 7.13. KmATp dei erminations for yeast SMP ATPase. 
ATPase activity was determined as described in the 
methods section to ch.3.
•— 0 yeast submitochondrial particles, YSMP.
O— o pentane extracted yeast SMP , PEYSMP.
B__I as above , UQ-9 reconstituted 100 nmoles UQ/mg
QRSMP.
q — q  as above but reconstituted with pentane extract 
(100 nmoles UQ / mg protein). PERPEYSMP.
100'
90 '
e f f e c t  o f  p e n t a n e  e x t r a c t i o n , u b i q u i n o n e  a n d  p e n t a n e  
e x t r a c t  r e c o n s t i t u t i o n .
Assays were performed as described i n  fig 7.7 in a 
50 mM Tris-Cl pH 9.0;5 mM MgClj buffer system. 
R e c o n s t i t u t i o n  was performed as described in fig 7.13
0 __^ YSMP.
O --O PEYSMP .
□--□ QRYSMP .
A'--A PERPEYSMP.
Fig 7.15 Oligomycin inhibition of yeast SMP ATPase: 
effect of pentane extraction , ubiquinone and pentane 
extract reconstitution.
Assays were performed essentialy as described in fig 
7.9 in a 50 mM Tris-Cl pH 9.0;5 mM MgCl 2  buffer syst­
em.
•--• YSMP .
O--O PEYSMP .
■ --■ QRYSMP.
□--□ PERPEYSMP.
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Table 7.11 Comparison of specific activities of yeast submitochondrial 
ATPase from two yeast strains
Yeast strain Specific activity1
D273-10B preparation 1 2.03
E2-34 (ubiquinone-less mutant) preparation 1 1.16
D273-10B preparation 2 2.04
E2-34 preparation 2 0.675
Mmoles ATP hydrolysed/min/mg
ATPase activity was assayed in a buffer 50 mM Tris-Cl, pH 8.5; 5 mM 
MgCl2 essentially as described in Chapter 3.
32Table 7.12 ATP- Pi exchange activities in yeast mitochondria from 
two yeast strains
Strain Rate1
preparation 1 preparation 2
D273-10B
E2-34
53.37 49.87
0.69 0.70
Assays containing 1 mg mitochondria were performed essentially as 
described in Chapter 3.
A.
Ubiquinone - mutant E-324. 
3.12 mg protein.
552 563
Fig 7.16. Yeast mitochondria cytochrome spectra. 
Spectra were recorded in a 1 ml volume on a Pye- 
Uuicam SP1800 uv-visible spectrophotometer. 
FetCN)63- oxidised reference cuvette vs. Na 2 S 2 C>4  
reduced.
Fig 7.17 Oligomycin inhibition of yeast mitochondrial 
ATPase.
Assays were performed as described in fig 7.14.
O--Owild type yeast mitochondria I5 0  =1.27 pg / mg
strain D273-10B.
•-- »ubiquinone - mutant mitochondria&strain E-324.
I_„ = 1 . 2 0  pg oligomycin / mg protein.bO
For specific activities of uninhibited ATPases see 
table 7.11.
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reincorporation of ubiquinone 9 or 'pentane extract' (Table 7.10).
The value for ATP in yeast SMP is reduced by pentane extraction 
and increased back to the 'normal' value by subsequent reincorporation 
of ubiquinone 9 or 'pentane extract' (Fig. 7.13) . Sensitivity to 
oligomycin and DCCD in yeast SMP is reduced by pentane extraction and 
restored by addition of ubiquinone 9 or 'pentane extract' to extracted 
particles (Figs. 7.14-15).
The effects of pentane extraction suggested that ubiquinone 
might be involved in some way with the membrane bound portions of 
the ATPase enzyme (F^). To further investigate this,various 
activities were assayed in a ubiquinone-less mutant of the yeast 
Saccharomyces cerevisiae wild type strain D273-10B, termed mutant
'E2-34'. This mutant has a full complement of cytochromes (Fig. 7.16).
32It also has a lowered ATPase activity and a very low rate of ATP- Pi 
exchange (Tables 7.11-12). It does not, however, display a lowered 
sensitivity to inhibition by oligomycin (Fig. 7.17).
Discussion
Several solvent systems have been used to extract ubiquinone from 
the mitochondrial membrane in a manner which will allow its subsequent 
readdition and (hopefully) reconstitution of enzymic activities. These 
include iso-octane (137), acetone (330) and n-pentane (329, 122). Iso­
octane extraction is not a particularly useful technique as it not only 
does not remove all the ubiquinone but it is also retained by the 
particles and inhibits succinoxidase activity (92). Acetone extraction 
is more effective in removing ubiquinone but also removes many other 
lipids from the membrane, most notably phospholipids. Thus it is not 
possible to ascribe the effects of acetone extraction solely to the 
removal of ubiquinone. Reconstitution of oxidase activities requires 
not only ubiquinone but also cytochrome c (and occasionally phospho­
lipids) (330). Extraction using n-pentane was introduced by
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Szarkowska and taken up by other workers. It proved to be a far more 
efficient and specific method of removing ubiquinone from mitochondria 
than either iso-octane or acetone extraction (329, 122). Mitochondria 
have to be lyophilised before extraction with n-pentane. Szarkowska 
(329) and Lenaz et al. (122) both used a lyophilisation medium, 150 mM 
in KC1. This unfortunately results in a preparation that lacks 
respiratory control and oxidative phosphorylation. Several media were 
investigaged in order to discover if these activities could be 
protected in some way and thus be retained after lyophilisation of 
bovine heart mitochondria. These included systems containing 
respiratory chain substrates (succinate, pyruvate/malate and ascorbate) 
and ADP and ATP. None of these were cible to prevent loss of respiratory 
control and oxidative phosphorylation on lyophilisation. The most 
effective lyophilisation media tested were those containing 5-10 mM 
MgCl2. Mitochondria lyophilised under these conditions retained high 
succinoxidase and ascorbate/TMPD oxidase activity prior to pentane 
extraction (Table 7.3) and good ascorbate/TMPD oxidase activity 
after extraction. Mitochondria lyophilised in this system and then 
pentane extracted appeared to be less severely disrupted by solvent 
extraction as they did not require addition of cytochrome c or phospho­
lipids as well as ubiquinone to reconstitute full succinate oxidase 
activity (Fig. 7.2).
Succinoxidase activity can be restored in pentane extracted mito­
chondria by reincorporation of ubiquinone or 'pentane extract' . The 
lyophilisation methods used allow reincorporation either to be done 
directly, that is by addition of ubiquinone imnediately prior to assay, 
or by preincubation steps,both of roughly equal efficacy. A range of 
other compounds was tested for the ability to reconstitute succinate 
oxidase activity in pentane extracted mitochondria; only ubiquinone was 
able to do so, showing that reconstitution was not due to a 'general
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lipid activation1 effect on the extracted menbrane. During the course 
of experiments on the reconstitution of succinoxidase activity in 
extracted mitochondria, it was noticed that some 'pentane extracts' 
(notably those prepared from mitochondria lyophilised in the presence 
of ATP and dithiothreitol) were more effective in restoring activity 
than would be expected from their ubiquinone content. If these pentane 
extracts were preincubated with an equimolar or slight molar excess 
(compared to ubiquinone content) of DBCT prior to addition to the assay, 
then they lost this ability and would only stimulate succinate oxidase 
activity to a level expected from their ubiquinone content. Pre­
incubation of lyophilised and lyophilised, extracted mitochondria with 
DBCT prior to initiation of the assay with sodium succinate had no 
effect on succinoxidase activity (Fig. 7.5). These results suggest 
that 'pentane extract' contains either a form of ubiquinone or another 
component that is sensitive to a known energy transfer inhibitor 
which effects succinate oxidase activity. If DBCT is titrating a 
component that it reacts with in the membrane, then these results 
provide evidence, although of a very tentative nature, of a link between 
electron transfer and energy transfer systems.
Attention was then focussed on the effect that pentane extraction 
of mitochondria had on ATPase and ATPase linked activities. Pentane 
extraction slightly stimulated the specific activity of bovine heart 
mitochondrial ATPase, in ubiquinone reconstituted particles. ATPase 
activity was approximately the same as in extracted particles. The 
main difference in ATPase activity lay in its sensitivity to oligomycin, 
venturicidin and DCCD. Pentane extraction substantially reduces ATPase 
sensitivity to inhibition by oligomycin and DCCD and slightly reduces 
sensitivity to venturicidin. Reincorporation of ubiquinone 
reconstitutes sensitivity to oligcmycin, venturicidin and DCCD (other 
lipids do not do this) (Table 7.5). Pentane extraction also reduces
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the value for ATP of bovine heart mitochondrial ATPase (Fig. 7.6).
Similar results were observed in yeast submitochondrial particles
(Table 7.10, Figs. 7.13-15) . Here the K ATP was also reduced.in
Reincorporation of ubiquinone or 'pentane extract' increased the
Km value to that of the unextracted preparation. All these results
suggest that ubiquinone has a kinetic effect on the ATPase enzyme.
If ubiquinone was involved in the coupling process, then its removal
might be expected to stimulate the reverse ATPase reaction and also
decrease the for ATP of the enzyme. The effect that ubiquinone
extraction and reincorporation has on oligomycin and DCCD inhibition
suggests that ubqiuinone acts in the Fq portion of the ATPase, that is,
at the level at which 't' is thought to be transduced. This view is
reinforced by the effect that ubiquinone extraction has on ATP-Pi
exchange activity, which is thought to be a reflection of ATP synthase
activity in the enzyme. Ubiquinone extraction reduces ATP-Pi exchange
to low levels in bovine heart mitochondria. This activity can be
restimulated by the reincorporation of ubiquinone. This restimulated
activity is fully sensitive to energy transfer inhibitors and uncouplers.
As lyophilised mitochondria exhibit no respiratory control or
oxidative phosphorylation, lyophilised, pentane extracted mitochondria
have limited use as a system to study the possible roles of ubiquinoe
in ATP synthesis. Acetone can be used as a solvent system for
extracting ubiquinone from aqueous suspensions of mitochondria. Acetone
extracted mitochondria and SMP's lose sensitivity to oligomycin and ATP
synthase activity. They do not, however, regain these activities on
reconstitution with 'acetone extract' or ubiquinone. It is probable
that acetone treatment causes a dislocation between the F. and F„1 0
portions of mitochondrial ATPase activity, producing an F^like ATPase 
activity.
The effect of pentane extraction on ATPase oligomycin and DCCD 
sensitivity is only apparent if complete (or as complete as possible)
313
extraction of the ubiquinone pool is achieved. Incomplete extraction 
results in no change in oligomycin sensitivity. If extracted particles 
are left to stand at 4° C for long periods (6-24 hrs) this reduction in 
oligomycin sensitivity is reversed (see Fig. 7.11). This may be due 
to residual ubiquinone redistributing itself in the membrane as it is 
not possible to remove all the ubiquinone by solvent extraction. Even 
if 95% of ubiquinone is removed, this would still leave -v 0.5-1 nmole 
UQ/mg mitochondrial protein in the membrane which is sufficient to 
saturate any possible site that may exist in association with the 
ATPase (0.05-0.10 nmoles/mg mitochondrial protein) . The major 
difficulty in interpreting these results lies in differentiating 
between specific and non-specific (general lipid) effects of 
ubiquinone on the one hand and effects due to disruption by pentane 
extraction on the other. It is probable that ubiquinone is having 
a more direct effect than just that of an integrative lipid in the 
inner mitochondrial membrane as other lipids (phospholipids, 
cholesterol, vitamin K^) do not mimic its effects in these solvent 
extracted systems. The recovery of oligomycin sensitivity on standing 
may be due to a reintegration of the membrane after disruption by 
pentane rather than be due to a dispersal of residual ubiquinone 
through the system.
To further investigate ubiquinone's role in energy coupling and to 
remove any possible spurious effects induced by solvent extraction, a 
mutant strain of Saccharomyces cerevisiae lacking ubiquinone was 
investigated. This mutant,designated E3-24, was derived from a wild 
type yeast stain constructed by Tzagaloff and co-workers, D273-10B 
(for a further description of these yeast strains, see (391)). Strain 
E3-24 lacked NADH and succinate oxidase activities and oxidative 
phosphorylation but did possess a full complement of the other 
respiratory chain components as addition of ubiquinone alone fully
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reconstituted NADH and succinate oxidases. Cytochrome difference 
spectra of D273-10B and E3-24 are almost identical (Fig. 7.16).
Strain E3-24 had a lowered mitochondrial ATPase activity compared 
with D273-10B, but this activity was fully sensitive to inhibition 
by oligomycin, suggesting that ubiquinone plays no direct role in the 
mechanisn of oligomycin inhibition in yeast mitochondria (Fig. 7.17). 
Strain E3-24 did, however, display a very low ATP-Pi exchange activity 
(Table 7.12). Attempts were made to reconstitute or stimulate this 
activity with ubiquinone, but these have so far proved unsuccessful.
Site 3 mediated oxidative phosphorylation has been reported in 
a similar ubiquinone-less mutant of yeast, strain E3-149, albeit at a 
very low rate. The reconstitution of site 2 mediated oxidative 
phosphorylation after addition of ubiquinone to carefully prepared 
E3-149 derived mitochondria has also been observed (326). Currently, 
further attempts to reconstitute ATP-Pi exchange and to investigate 
the kinetics of ATP requiring reactions in these yeast mutants are 
under way.
Recently a model for oxidative phosphorylation has been proposed 
by Santiago and Lopez-Moratolla (348) , based on the presence of redox 
active iron in ATPase preparations. They propose that ubiquinone and/ 
or a flavin act as ligands to this iron. They have adduced the 
stimulation of F^ ATPase preparations by FAD and ubiquinone as evidence 
to support this hypothesis (349).
It would seem, then that ubiquinone plays no direct role in the 
mechanism of ATP synthesis. It is possible though that it exhibits a 
'kinetic control' on the energy coupling apparatus, possibly 
contributing in some way to the mechanism by which respiratory control
is expressed .
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CHAPTER 8
THE EFFECT OF UBIQUINONE ON ENERGY LINKED REACTIONS 
Introduction
Solvent extraction studies on bovine heart mitochondria have 
indicated that ubiquinone may have a more complex function in the inner 
membrane than would be supposed if it merely fulfilled its well-known 
role as a mobile proton (electron) carrier in the electron transport 
chain. To further investigate these possible roles, attention was 
focussed on a lower homologue of the natural ubiquinones 9-10, 
ubiquinone 3.
Ubiquinone 3
This has been reported to possess the ability to uncouple oxidative 
phosphorylation at site II (322). The uncoupling was not a straight­
forward reaction as higher homologues, e .g .ubiquinone 7, had the ability 
to reverse it (see Table 8.1). Data presented in the previous chapter 
has suggested that ubiquinone may play some role in or close to energy 
coupling reactions in mitochondria. Ubiquinone 3 was tested for its 
effect on various mitochondrial reactions, both energy linked and non­
energy linked.
Table 8.1 Effect of UQ3 on oxidative phosphorylation of rat heart 
mitochondria,after (322)
Addition Oxidative phosphorylation P;0 ratios
~~ ymoles/min/mg protein
None 0.125 1.37
UQ3 (67 viM) 0.140 0.04
UQ7 (67 UM) 0.100 1.46
UQ3 + UQ7 (67 yM each) 0.120 0.51
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Materials
All chemical used were of 'AnalaR' or equivalent grade. All organic 
solvents were redistilled before use. Ubiquinones were obtained from 
Hoffman-LaRoche, Basel, Switzerland. Ubiquinone 3 was the kind gift of 
Dr. E. Bertoli. Oligomycin was obtained from the Sigma Chemical Company. 
Methods
Bovine heart mitochondria and submitochondrial particles were 
prepared as described in Chapter 3. Oxidative phosphorylation was 
measured in a glucose-hexokinase trap system, 0.25 M in sucrose; 20 mM 
glucose; 20 mM Tris-Cl, pH 7.3; 5 mM potassium phosphate; 5 mM MgC^;
0.5 mM EDTA; 0.2 mM ADP, containing 5 units hexokinase (Sigma type C-300 
or F-300). ATPase activity was assayed as described in Chapter 3. 
Transhydrogenase activity was assayed as described in Chapter 6.
All preincubations with ubiquinones were carried out in a shaking 
water bath, usually at 30° C. The conditions (time, temperature) of 
preincubation were important as increased preincubation times often 
improved inhibition by UQ^, e.g. see Figs. 8.4-5. Ubiquinones were 
used as solutions in absolute ethanol.
Mitochondrial oxidase activities were monitored in a Clarke type 
electrode system attached to a Servoscribe chart recorder, as described 
in Chapter 7.
Purified F^Fo ATPase was prepared by the method of Berden and 
Voorn-Brouwer (323). A suspension of bovine heart submitochondrial 
particles, 6 mg/ml in 200 mM sucrose; 10 mM Tris-Cl, pH 7.5; 0.2 mM 
EDTA; 1 mM dithiothreitol; 1 mM ATP; 2% methanol; 1% Triton X-lOO 
was made 0.5 M in Na^SO^ by the addition of the solid. After stirring 
for 5 minutes, the homogenate was centrifuged at 150,000 g for 30 
minutes. The pellet was discarded while the supernatant was dialysed 
overnight against 50 volumes of the same medium but without Na2S0..
The dialysate was then centrifuged at 50,000 g for 30 minute«. Virtually
all the oligomycin sensitive ATPase activity was concentrated in the 
precipitate. This was suspended in 250 mM sucrose; 50 mM Tris-Cl, pH 
7.5; 1 mM dithiothreitol; 0.2 mM EDTA and 2% methanol to a final 
concentration of 3 mg/ml and taken to 0.4% in potassium cholate prior 
to the addition of saturated (NH^) 2 S ° 4  to a final concentration of 30%. 
After centrifugation at 50,000 g for 15 minutes, the pellet was 
discarded and the supernatant brought to 50% saturation with saturated 
ammonium sulphate and recentrifuged. The pellet which contained the 
ATPase activity was resuspended in 250 mM sucrose; 50 mM Tris-Cl, pH 7.5;
1 mM dithiothreitol; 0.2 mM EDTA. ATPase of specific activity around 
lO ymoles ATP hydrolysed/min/mg was prepared by this method.
Results and Discussion
Ubiquinone 3 was found to inhibit NADH oxidation in agreement with 
the results reported by Lenaz et al (324). It did not have such an 
effect on succinate or ascorbate/TMPD oxidation, however, as it appeared 
to stimulate succinate oxidation by as much as 95%, while it had very 
little effect on ascorbate/TMPD oxidation (Table 8.2). These stimulated 
(and inhibited) activities were true electron transfer chain activities, 
that is they were not due to bypass mechanisms from UQ 3 to oxygen, as 
they were fully sensitive to rotenone, antimycin and cyanide respectively 
(results not shown). Ubiquinone 9 had very little effect on any of 
these oxidase activities at similar concentrations (0-300 nmoles/mg 
mitochondrial protein).
Ubiquinone 3 had little effect on SMP ATPase activity (Table 8.3), 
producing only 16% Inhibition at concentrations of 4 ymoles UQ^/mg protein. 
Ubiquinone 9 produced 11% inhibition at similar concentrations. Ubi­
quinone 3 did, however, affect the oligomycin inhibition of bovine heart 
SMP ATPase activity (Fig. 8.1) reducing the efficacy of oligomycin as an 
inhibitor. Ubiquinone 9 has no effect at similar concentrations. A 
rather similar effect was observed in the purified FjFq ATPase
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Table 8■2 Effect of UQ^ on bovine heart mitochondrial activities
Additions Rate nmoles consumed/ % Activity % Inhibition
____________________min/mq___________________________________________________
NADH 258 100 0
NADH + 100 nmoles UQ^ 176 68.4 31.6
NADH + 150 nmoles UQ^ 164 63.5 36.5
NADH + 200 nmoles UQ^ 151 58.5 41.5
NADH + 300 nmoles UQ^ 126 48.8 51.2
% Stimulation
Succinate 76 lOO o
Succinate + 100 nmoles UC3 145 190.7 90.7
Succinate + 150 nmoles u Q3 148 194.7 94.7
Succinate + 200 nmoles U03 132 173.6 73.6
Succinate + 300 nmoles u q 3 151 198.6 98.6
% Inhibition
As corbate/TMPD 173 lOO 0
Ascorbate/TMPD + 170 98.2 1.8
lOO nmoles UQ,
Ascorbate/TMPD + 104 94.8 5.2
150 nmoles UQ,
Ascorbate/TMPD + 170 98.2 1.8
200 nmoles UQ,
Ascorbate/TMPD + 177 102 -2
300 nmoles UQ^
Oxidase activities were determined as described in Chapter 7. Assays 
containing 1 mg bovine heart mitochondrial protein were initiated with 
either 4 pmoles NADH, 10 ymoles sodium succinate or lo ymoles sodium-D- 
isoascorbate/1 ymole TMPD. Mitochondria were preincubated with 
ethanolic solutions of UQ^ (20 mM) for 15 mins at 30° C prior to assay. 
Figures quoted above are corrected for any effect of the ethanol on
oxidase activity
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Table 8.3 Effect of UQ^ and UQg on bovine heart submitochondrial
particle ATPase
Additions ATPase
% Activity % Inhibition
None loo 1
lOO nmoles UQ^ lOO O
200 nmoles UQ^ 88 12
300 nmoles UQ^ 82 18
400 nmoles UQ^ 84 16
200 nmoles UQg lOO O
400 nmoles UQg 89 11
ATPase assays were performed as described in Chapter 3. 98 yg protein
was suspended in 1 ml 50 mM Tris-Cl, pH 8.5, and preincubated with 
ubiquinone for 15 minutes at 30° C prior to initiation of the assay with 
5 vimoles ATP. Assays were terminated by the addition of 0.5 ml 10% T.C.A. 
Phosphate was determined as described in the methods section to Chapter 3. 
Ubiquinones were added as 20 mM solutions in ethanol. Assays were 
compared with ones in which ATPase activity was determined in the 
presence of ethanol (i.e. 5, lo, 15, 20 yl).
Specific activity 1.53 ymoles Pi released min 1 mg 11
1 0 0
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pmoles UQ3 / mg protein.
Fig 8.1, Reversal of oliqomycin inhibition of 
bovine heart mitochondrial ATPaseiinhibition by UQ^.
Assay conditions as in table 8.3.
In
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ti
on
nmoles UQ3 / mg protein.
Fig 8,„:. Effect of UQ  ^ on site I mediated activities 
in bovine heart mitochondria.
O— o pyruvate/malate driven oxidative phosphory­
lation3 .. b• — • NADH oxidase .
Assays containing lmg protein were preincubated with 
UQ- for IS minutes at 30 C prior to initiation with 
either pyruvate / malate (lOpmoles/lpmole),or 4 
umoles NADH.Oxidative phosphorylation and NADH 
oxidase activities were assayed as described in the 
methods section to chapter 3.
3specific activity. 137 nmoles ATP formed/mir/mg.
bspecific activity. 250 nmoles 02 consumed/min/mg.
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preparation of Berden and Voorn-Brouwer (Table 8.4). Here ubiquinone 3 
also reduces the inhibition induced by oligomycin. This effect is 
reduced or prevented by coincubating the enzyme with UQg in the presence 
of UQ^. Neither of these ubiquinones had any effect on F^F^ ATPase 
activity itself.
Ubiquinone 3 inhibited oxidative phosphorylation driven by a 
pyruvate/malate (10:1) couple in bovine heart mitochondria (Fig. 8.2), 
but at much lower levels than those required to inhibit NADH oxidase 
activity. Succinate-driven and ascorbate/TMPD-driven-oxidative 
phosphorylation in bovine heart mitochondria and submitochondrial 
particles was also inhibited by ubiquinone 3 at similar levels to those 
that inhibit pyruvate/malate driven activity (Figs. 8.3-5). Ubiquinone 9 
had little effect at similar concentrations; it could, however, reverse 
the inhibition induced by UQg (Table 8.5). Similar effects, inhibition
by ubiquinone 3 and its reversal by ubiquinone 9, were observed on the
32ATP- Pi exchange activity of bovine heart mitochondria (Fig. 8.6;
Table 8.5).
ATP-driven transhydrogenase activity was also inhibited by 
ubiquinone 3; this inhibition was reversed by ubiquinone 9, which was 
without effect on the system (Figs. 8.7-8).
Ubiquinone 3 has been shown to affect a number of mitochondrial 
activities. The inhibition of oxidative phosphorylation driven by 
pyruvate/malate could bethought to be due to an inhibition of NADH 
oxidase activity by UQg. Analysis of the inhibition characteristics of 
these reactions makes this unlikely, however, as oxidative 
phosphorylation is far more sensitive than NADH oxidase to inhibition 
by UQg (Table 8.6) .
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Fig 8.3. Inhibition of succinate driven ATP_______
-:svnt h e s is______ in bovine heart mitochondria by UQ  ^.
Assays containing lmg mitochondrial protein were 
preincubated with UQ- for 15 minutes at 30 C.Assays 
were initiated by addition of 10 pmoles sodjum succ­
inate and terminated after 20 minutes at 30 C with 
10% TCA. Oxidative phosphorylation was measured by 
the dissapearence of phosphate as described in the 
methods section to chapter 3.
O--O assay 1.
• --• assay 2 .
Specific activity: 121 nmoles ATP formed / min / mg.
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Fig,8.4. Inhibition of succinate driven ATP
synthesis_______ in bovine heart SMP by UQ3.
Assays containing Img SMP were preincubated,as 
indicated,with UQ3.Assays were initiated by add­
ition of IOpmoles sodium succinate and terminated 
after indicated times with 10% TCA. Oxidative 
phosphorylation was measured by the disappearence 
of phosphate as described in the methods section, 
chapter 3.
• — #expt.I. preincubated with UQ..I5 '@R.T. inc 10'. 
O — Oexpt.2. " " inc 15'.
□ — Oexpt.3. " I2hr.(§)4°C;I5'@30 C inc 30'.
Assay incubations were carried out @ 30°C. 
specific activity expt.l&2 =113nmoles ATP foimed/min 
/mg. expt 3. 89 nmoles ATP formed /min/mg.
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Fig 8.5. Inhibition of ascorbate / TMPD driven 
ATP synthesis ____________ in bovine heart mitochon­
dria by UQj.
O— O expt.1.preincubated with UQ^ 10 minutes at 30°C. 
•— • expt. 2. " " 15
□ — □ expt. 3. " " 10
Assays containing lmg mitochondria were preincubated 
with UQ, as indicated,then initiated by the addition 
of 10 uiT.oles ascorbate/0.5 nmoles TMPD and incubated 
at 30°C.Assays were terminated with 1M PCA,a£ter 30'. 
Oxidative phosphorylation was measured by the appear­
ance of glucose-6-phosphate as described in the 
methods section to chapter 3.
Specific activity = 79 nmoles ATP formed /min/mg.
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Table 8.4 Effect of UQ^ and UQ^ on the oligomycin inhibition of a 
purified F^FQ ATPase preparation
ATP as e
Addition % Activity % Inhibition A %
None 100 1
Oligomycin (5 u g) 32 68
Oligomycin + ^ 3 lO nmoles 64 36 32
Oligomycin + UC3 30 nmoles 141 -41 (109)
Oligomycin + UG3 50 nmoles 136 -36 (104)
Oligomycin + UG3 70 nmoles 138 -38 (106)
Oligomycin + UG3 100 nmoles 138 -38 (106)
Oligomycin + U29 100 nmoles 64 36 32
Oligomycin + UQ3
UQ9
50 nmoles 
50 nmoles
41 59 9
Assays were performed essentially as described in Table 8.3. Assays
containing 5 yg F^FQ ATPase, prepared by the method of Berden and Voorn-
Brouwer (323) , and asolectin were preincubated with ubiquinones for 5 
ominutes at 30 C
Specific activity = 10.09 ymoles Pi released min 1 mg 11
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Table 8.5 Effect of UQ, and UQ„ on bovine heart mitochondrialJ a 3 2
oxidative phosphorylation and ATP- Pi exchange activity
Additions Oxidative phosphorylation____
% Activity % Inhibition 1234
Pyruvate/malate 1 lOO O
Pyruvate/malate + 20 nmole UQg 53 47
Pyruvate/malate + 50 nmole UQg 1 9
Pyruvate/malate + lOO nmole UQ lOO O
2Succinate lOO O
Succinate + 60 nmole UQg 31 69
Succinate + 300 nmole UQ^ o lOO
Succinate + 60 nmole UQg loo O
Succinate + 300 nmole UQg 60 40
Ascorbate/TMPD 3 lOO O
Ascorbate/TMPD + 40 nmole UQg 41 59
Ascorbate/TMPD + lOO nmole UQg 7 93
Ascorbate/TMPD + lOO nmole UQg 
Ascorbate/TMPD + lOO nmole UQg
lOO O
+ lOO nmoles UQg 88
32ATP- Pi exchange
12
ATP + 32Pi 4 lOO O
32ATP + Pi 80 nmoles UQ- 39 61
32ATP + Pi 80 nmoles UQg 
32ATP + Pi 80 nmoles UQ^
lOO O
80 nmoles UQg loo O
1 Specific activity: 114 nmoles ATP/min/mg
2 Specific activity: 120 nmoles ATP formed/min/mg
3 Specific activity: 68 nmoles ATP/min/mg
4 Specific activity: 49.5 nmoles 32P min 1 mg 1
oxidative phosphorylation was assayed in a glucose-hexokinase trap system, 
0.2 ntt in ADP as described in the methods section to this chapter. 
ATP-32Pi exchange was assayed as described in Chapter 3.
100
90
80
70
heart SMP by U Q j .
O — oexpt.I. specific activity 49.5nmoles/min/mg. 
• — #expt.2. specific activity 48.3nmoles/min/mg.
Assays containing Img protein were preincubated 
with UQ for 15 minutes at 30°C in a shaking water 
bath prior to initiation by addition of IOpmoles 
ATP.Assays were terminated after 5 minutes by add­
ition of 10% TCA.ATP - ^Pi exchange was estimated 
as described in chapter three.
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100
90
80
Fig,8■7.Inhibition of ATP driven transhydroqenase 
in bovine heart SMP by UQ .^
Assays containing Img protein were preincubated 
with UQ.. for 15 minutes at 30°C prior to assay. 
Transhyarogenase activity was estimated as des­
cribed in chapter 6.
Specific activity uninhibited transhydrogenase 
= 72 nmoles NADP + reduced /min / mg SMP protein.
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F i g  8 . 8 .  E f f e c t  o f  UQg a n d  UQg on A T P  d r i v e n  
t r a n s h y d r o g e n a s e  a c t i v i t y  i n  b o v in e  h e a r t  S MP.
N : 0.5 pmoles NADP . 5 pmoles ATP.
1. no additions. 2. + 8 0  nmoles UQg.
3. + 8 0  nmoles UQg. 4. + 8 0  nmoles UQg + 80 nmoles 
UQg •
Assays containing lmg protein were preincubated with 
ethanolic solutions of ubiquinones,where indicated, 
for 15 minutes at 30°C prior to initiation. 
Transhydrogenase activity was assayed as described 
in the methods section to chapter 6.Activities were 
corrected for any effect of ethanol.
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Table 8.6
Activity
Inhibition of bovine heart mitochondrial activities by UQ^:
1_ values 50
I^0 nmoles mg 1 protein
NADH oxidase t 300
Pyruvate/malate oxidative phosphorylation 18
Succinate oxidative phosphorylation <v 30
Succinate oxidative phosphorylation (SMP) 40-70
Ascorbate/TMPD oxidative phosphorylation 27-40
32ATP- Pi exchange 55-60
ATP-driven transhydrogenase (SMP) >v 80
Oxidative phosphorylation driven from sites 2 and 3 is also inhibited
by UQ3 while the respective oxidase activities are either stimulated or
unaffected. This strongly suggests that UQ3 is not acting by dislocating
or inhibiting electron transport, but is having a more direct; action on
the coupling mechanism. This view is reinforced by the inhibition of
32other energy linked reactions, ATP- Pi exchange and ATP-driven trans­
hydrogenase, which have no (known) requirement for electron transport in 
order to exhibit their activity. The locus of inhibition may be at the 
level of the ATPase molecule itself,as all these energy linked reactions 
involve its action in some way. Ubiquinone 3 has very little effect on 
ATPase activity; this is probably because of the exact location of 
ATPase activity in the membrane The active site of ATPase is located on 
the portion of the molecule which is commonly thought to protrude 
out of the membrane into the aqueous matrix space, i.e. away from the 
disruptive effects of UQ3> While ATPase activity is unaffected, UQ3 
will reverse the oligomycin induced inhibition of ATPase activity. 
Oligcmycin has its site of action in the FQ membrane bound portion of 
the ATPase. This suggests that UQ3 is having a disruptive effect on 
the ATPase molecule, dislocating the site of oligomycin inhibition away
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F i g , 8 ■ 9 . F l u o r e s c e n c e  p o l a r i s a t i o n  o f  p e r y l e n e  i n  
rabbit heart mitochondria:effect of ubiquinones.
Presented by kind permission of Dr. E.Bertoli.
Fluorescence polarisation of perylene probe was 
measured in an Hitachi-Perkin Elmer MPF-32 record­
ing spectrofluorimeter (at 440nm with excitation 
at 4l0nm) as described in [32'fl .
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What is the mode of UQ^'s disruptive action? Spisni et al^ . have 
reported that short chain quinones are not freely diffusible across 
bilayers and that they become stacked within the phospholipids (325) , 
thus immobilising the membrane and disrupting many activities which 
take place within it. Support for this hypothesis has come from 
studies on the fluorescence polarisation of perylene incorporated into 
rabbit heart mitochondria (326). The fluorescence polarisation of these 
mitochondria labelled with perylene was found to increase markedly with 
increase of (added) UQ^ concentration. This indicates that the 
rotational mobility of perylene decreases with the increase of UO^ into 
the membrane. Longer chain quinones such as UQ? and UQg have little 
effect on the system (see Fig. 8.9 reproduced here by kind permission of 
Dr. E. Bertoli). While this may be an adequate description of the 
mode of UQ^'s inhibition of NADH oxidase activity, it is not at all 
clear whether it adequately explains the inhibition of oxidative 
phosphorylation which occurs at much lower quinone levels. It does not 
explain either the ability of the longer chain quinones to reverse this 
inhibition. The coupling process is notoriously labile, so low levels 
of UQ3 may produce a sufficiently large disruptive effect to uncouple it. 
The longer chain quinones may reverse this effect by increasing the 
fluidity of the membrane, allowing these processes to take place again.
from the A T P a s e  act i v e  site, thus p r o d u c i n g  a f u n c t i o n a l  d i s r u p t i o n
of the A T P a s e  m o l e c u l e  and a n  'uncoupling' o f  ener g y  l i n k e d  reactions.
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APPENXIX A
Compounds that inhibit energy linked reactions
1. (a) F^ ATPase inhibitors
(b) F,F„ ATPase inhibitors 1 O
2. Uncouplers
3. Ionophores
4. Electron transport inhibitors
1. ATPase inhibitors 
(a) F^ATPase inhibitors
Aurovertins.- The aurovertins are a class of compounds having the 
general formula:-
R1 R2 R 3 R4 molecular weight
Aurovertin A H Me COMe COMe 501
B H Me COMe H 445
C H H COMe H 451
D OH Me COMe H 475
E H Me H H 417
They are obtained frcm cultures of the fungus Calcorisporium arbuscula
and are potent inhibitors of mitochondrial ATP synthesis; ATPase;
18 3 2H2 0-Pi exchange; ATP- Pi exchange; ATP-driven transhydrogenase; ATP- 
driven reversed electron transport; uncoupler induced swelling. D and B 
are the most potent forms.
The locus of action appears to be at the ATPase.
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Efrapeptins.- Efrapeptins are a group of lipophilic polypeptides 
obtained from the hyphomycete Tolypocladium inflatum. The structures are
unclear, but hydrolysis yields glycine, leucine and alanine in a ratio of 
6:7:1 and an unknown amino acid. The polypeptides do not appear to 
possess N-terminal amino acids but do contain a free carboxyl group.
They have a molecular weight somewhere in excess of 1500. They have a 
mode of action similar to- that of the aurovertins but,although they act 
on the F^ ATPase, they appear to have a binding site distinct from that 
of the aurovertins.
(b) f iFq  ATPase inhibitors
B O OH CH3CH2 784
C H2 H CH3CH2 744
D O OH CH3 760
The oligomycins are a group of complex antibiotics obtained from 
cultures of Strcptomyces diasto chromogcnes (oliyomycins A-C) and 
Streptomyces rutgersensls (NRRL. B-1256 (oligomycin D, also known as 
rutamycin)) .
The oligomycins are the 'classical inhibitors' of the F jFq ATPase 
in mitochondria, and are among the most potent known: 1 molecule is 
thought to be sufficient to completely inhibit 1 molecule of ATPase.
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It inhibits oxidative phosphorylation, ATP-Pi exchange, ATP-ADP 
exchange, FjFq ATPase and all energy linked activities consuming or 
producing ATP. It has no effect on the isolated F^ ATPase. Its precise 
mode of action is unclear; it is thought either to block the formation 
of the ,'\,p' state or to prevent proton pumping through the portion 
of the ATPase. It probably interacts with 'subunit 9' of the ATPase. 
Sulphydryl groups have been implicated in its binding site.
Venturicidin The venturicidins are a group of compounds obtained from
B R = H molecular weight 707
Venturicidin has a mode of action similar to that of the oligomycins 
although it is slightly less potent. It acts on the FQ portion of the 
ATPase, inhibiting all ATP utilising and producing reactions. It appears 
to bind to subunit 6 of the ATPase.
Leucinostatin This is a lipophilic polypeptide isolated from the fungus 
Penicillium lilaclnum A-267 . Hydrolysis yields leucine and 4 unknown 
amino acids. It has a complex mode of action, being an uncoupler in 
high concentration but appearing to act like oligomycin or venturicidin 
at lower concentrations. It has no effect on isolated Fj^  ATPase. 
Dlcyclohexylcarbodllmide (DCCD) DCCD is a potent inhibitor of energy 
linked reactions. It appears to exert its inhibitory characteristics 
by covalently binding to subunit 9 of the FQ ATPase in mitochondria and
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to similar low molecular weight proteolipids in chloroplasts and 
bacterial vesicles. It inhibits all ATP utilising and producing 
activities in an oligomycin-like manner. Its binding site appears to 
be separate from that of oligomycin, however.
Trialkyltins These are compounds having the general formula
Rj^R^SnX where R ^ R 2 R 3  are hydrocarbon groupings
X = halogens or -OH (usually) .
They are potent inhibitors of ATP utilising or producing energy linked 
reactions (the compounds where R1R2 R 3  ares n-ethyl or n-butyl,n-propyl 
or phenyl appear to be the most effective). They do not inhibit F^ 
ATPase activity and appear to bind to the subunit 9 component of the 
membrane bound (Fq) portion of the ATPase. They generally act like 
oligomycin but may also facilitate a Cl <— > OH exchange reaction 
across the mitochondrial inner membrane.
Dibutyl chloromethyl tin chloride This is a trialkyl tin, having the 
structure:-
It appears to bind to a nonprotein lipophilic component of the inner 
mitochondrial membrane. It has a similar efficacy, and general 
properties like, the other trialkyl tin compounds.
Compound VE2283 This is a pentacovalent organotin compound having the structure
It appears to act like oligomycin and is at least as potent an inhibitor 
(on a molar basis). Its precise mode of action is at present under
DCCD
molecular weight 318
/
molecular weight 390
investigation.
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What is the mode of UQg' s disruptive action? Spisni £t a^. have 
reported that short chain quinones are not freely diffusible across 
bilayers and that they become stacked within the phospholipids (325), 
thus immobilising the membrane and disrupting many activities which 
take place within it. Support for this hypothesis has come from 
studies on the fluorescence polarisation of perylene incorporated into 
rabbit heart mitochondria (326). The fluorescence polarisation of these 
mitochondria labelled with perylene was found to increase markedly with 
increase of (added) UQg concentration. This indicates that the 
rotational mobility of perylene decreases with the increase of UQg into 
the membrane. Longer chain quinones such as UQ_, and UQg have little 
effect on the system (see Fig. 8.9 reproduced here by kind permission of 
Dr. E. Bertoli). While this may be an adequate description of the 
mode of UQg's inhibition of NADH oxidase activity, it is not at all 
clear whether it adequately explains the inhibition of oxidative 
phosphorylation which occurs at much lower quinone levels. It does not 
explain either the ability of the longer chain quinones to reverse this 
inhibition. The coupling process is notoriously labile, so low levels 
of UQg may produce a sufficiently large disruptive effect to uncouple it. 
The longer chain quinones may reverse this effect by increasing the 
fluidity of the membrane, allowing these processes to take place again.
f r o m  the A T P a s e  active site, thus p r o d u c i n g  a f u n c t i o n a l  d i s r u p t i o n
of  the A T P a s e  m o l e c u l e  and a n  'uncoupling' o f  e n e r g y  l i n k e d  reactions.
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APPENXIX A
Compounds that inhibit energy linked reactions
1. (a) F^ ATPase inhibitors 
(b) FiF0 ATPase inhibitors
2. Uncouplers
3. Xonophores
4. Electron transport inhibitors
1. ATPase inhibitors 
(a) F^ATPase inhibitors
Aurovertins.- The aurovertins are a class of compounds having the 
general formula
R1 R2 R3 R4 molecular weight
Aurovertin A H Me COMe COMe 501
B H Me COMe H 445
C H H COMe H 451
D OH Me COMe H 475
E H Me H H 417
They are obtained from cultures of the fungus Calcorisporium arbuscula
and are potent inhibitors of mitochondrial ATP synthesis; ATPase;
18 3 2H2 0-Pi exchange; ATP- Pi exchange; ATP-driven transhydrogenase; ATP- 
driven reversed electron transport; uncoupler induced swelling. D and B 
are the most potent forms.
The locus of action appears to be at the ATPase.
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unclear, but hydrolysis yields glycine, leucine and alanine in a ratio of 
6:7:1 and an unknown amino acid. The polypeptides do not appear to 
possess N-terminal amino acids but do contain a free carboxyl group.
They have a molecular weight somewhere in excess of 1500. They have a 
mode of action similar to'that of the aurovertins but,although they act 
on the ATPase, they appear to have a binding site distinct from that 
of the aurovertins.
(b) f iFq  ATPase inhibitors
E f r a p e p t i n s .- E f r a p e p t i n s  are a g r o u p  of l ipophilic p o l y p e p t i d e s
o b t a i n e d  from the h y p h o m y c e t e  T o l y p o c l a d i u m  i n f l a t u m . The s t r u c t u r e s  are
C H2 H CH3CH2 744
D O OH CH3 760
The oligomycins are a group of complex antibiotics obtained from 
cultures of Streptomyces dlasto chromogcnes (olicjomycins A-C) and 
Streptomyces rutgersensis (NRRL. B-1256 (oligomycin D, also known as 
rutamycin)) .
The oligomycins are the 'classical inhibitors' of the FjFq  ATPase 
in mitochondria, and are among the most potent known: 1 molecule is 
thought to be sufficient to completely inhibit 1 molecule of ATPase.
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It inhibits oxidative phosphorylation, ATP-Pi exchange, ATP-ADP 
exchange, ATPase and all energy linked activities consuming or
producing ATP. It has no effect on the isolated F^ ATPase. Its precise 
mode of action is unclear; it is thought either to block the formation 
of the ,,vp1 state or to prevent proton pumping through the FQ portion 
of the ATPase. It probably interacts with ’subunit 9 ’ of the ATPase. 
Sulphydryl groups have been implicated in its binding site.
Venturicidin The venturicidins are a group of compounds obtained from
B R = H molecular weight 707
Venturicidin has a mode of action similar to that of the oligomycins 
although it is slightly less potent. It acts on the FQ portion of the 
ATPase, inhibiting all ATP utilising and producing reactions. It appears 
to bind to subunit 6 of the ATPase.
Leucinostatin This is a lipophilic polypeptide isolated from the fungus 
Penlcillium lilacinum A-267. Hydrolysis yields leucine and 4 unknown 
amino acids. It has a complex mode of action, being an uncoupler in 
high concentration but appearing to act like oligomycin or venturicidin 
at lower concentrations. It has no effect on isolated ATPase. 
Dicyclohexylcarbodllmlde (DCCD) DCCD is a potent inhibitor of energy 
linked reactions. It appears to exert its inhibitory characteristics 
by covalently binding to subunit 9 of the FQ ATPase in mitochondria and
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to similar low molecular weight proteolipids in chloroplasts and 
bacterial vesicles. It inhibits all ATP utilising and producing 
activities in an oligomycin-like manner. Its binding site appears to 
be separate from that of oligomycin, however.
Trialkyltins These are compounds having the general formula
R1R2R3SnX where are hydrocarbon groupings
X = halogens or -OH (usually) .
They are potent inhibitors of ATP utilising or producing energy linked 
reactions (the compounds where R^R2 R 3  are: n-ethyl or n-butyl,n-propyl
or phenyl appear to be the most effective). They do not inhibit 
ATPase activity and appear to bind to the subunit 9 component of the 
membrane bound (Fq ) portion of the ATPase. They generally act like 
oligomycin but may also facilitate a Cl •*— > OH exchange reaction 
across the mitochondrial inner membrane.
Dibutyl chloromethyl tin chloride This is a trialkyl tin, having the 
structure: -
It appears to bind to a nonprotein lipophilic component of the inner 
mitochondrial membrane. It has a similar efficacy, and general 
properties like, the other trialkyl tin compounds.
Compound VE2283 This is a pentacovalent organotin compound having the structure
It appears to act like oligomycin and is at least as potent an inhibitor 
(on a molar basis). Its precise mode of action is at present under
DCCD
molecular weight 318,Sn
c h 3c h 2c h 2c h 2 Cl
/
molecular weight 390
investigation.
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2. Uncouplers
These are compounds that dissipate the high energy state,1'''1, of 
the inner membrane; whether they act by dissipating a proton gradient 
or in a more specific manner (e.g. binding to a component of the energy 
coupling apparatus) is not completely clear, although most are lipophilic 
weak acids or bases, capable of conducting protons across artificial 
lipid bilayers. For a more detailed discussion of the mechanism of 
uncoupling, see Chapter 2.
Name r,1 Structure Acronym
JCNm-chloro carbonyl cyanide 
phenyl hydrazone < ^ ^ - n h -n —c v CCCP
CN
trifluoromethoxy carbonyl / ---'
cyanide phenylhydrazone F^CO—
.CN
-NH-N-C
CN
CF,CF, 0 «  
I 3 II I 3
bis hexafluoro acetonyl acetone HO - CCH_-C-CH„-C-OH| z z |
CF„ CF,
4,5,6,7-tetrachloro-2-
trifluoromethylbenzimidazole
5-chloro-3-tert butyl-2•- 
chloro-41 nitrosalicylanilide
2,4-dinitrophenol
Cl
Pentachlorophenol
Cl
Cl
FCCP
’1799'
TTFB
S-13
DNP
PCP
Cl
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3. Ionophore s
These are a group of compounds that have the ability to transport 
cations across lipid membranes. They uncouple oxidative phosphorylation 
either by collapsing the A<<> component of the proton motive force or by 
facilitating energy linked, futile cycles of ions across bioenergetic 
membranes, thus dissipating ,'V'.
Gramicidin D Isolated from cultures of Bacillus brevis. It is a lipo­
philic polypeptide consisting of 15 amino acids of alternating L and D 
forms, i.e.
HCO-val-gly-ala-leu-ala-val-val-val (tryp-leu) -tryp-NHCI^C^OH 
L L D L D L D
It is thought to adopt a helical form in the membrane, effectively poking 
a hydrophilic hole through it, through which ions can pass. It transports 
K+ and H+ with similar efficiencies (K+ slightly > H+).
Valinomycin This is isolated from Streptomyces fulvissimua. It is one 
of the 'cage' form ionophores which enclose cations with a hydrophobic 
shell. It contains 3 moles of L-valine, D-a-hydroxy isovaleric acid, 
D-valine, L-lactic acid, linked alternately to form a 36 membered ring.
It principally transports potassium across membranes, but will also 
transport other monovalent cations with lowered effectivity.
4. Electron transport inhibitors
These are compounds that act by blocking electron flow between 
respiratory substrates and oxygen.
Rotenone Obtained from derris root. It appears to block electron 
transport between NADH dehydrogenase and ubiquinone.
340
Antimycin A Blocks electron transport between cyt b and cyt c;
binds to a protein subunit of complex III.
0 Me
it
Antimycin A^ R = n-hexyl
Antimycin A^ R = n-butyl
molecular weight 558 
molecular weight 530
Cyanide, azide, sulphide , carbon monoxide All block electron transport
at the level of cytochrome oxidase. They act by irreversibly binding to 
the 1 free ligand' of the iron in cytochrome a^'s haem grouping.
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